Emerging food safety issues: An EU perspective.

PubMed

McEvoy, John D G

2016-05-01

Safe food is the right of every citizen of the European Union (EU). A comprehensive and dynamic framework of food and feed safety legislation has been put in place and the EU's executive arm - the European Commission - is responsible for ensuring that the EU member states apply food law consistently. Similarly, the Commission plays an important role in ensuring that imported food meets the EU's stringent food safety standards. Consumer perceptions of unsafe food tend to focus on acute outbreaks of bacterial or viral origin. In recent years there have been a number of diverse food crises associated with fraudulent activity which may (e.g. melamine in dairy products in China) or may not (e.g. the horse meat scandal in the EU) represent a genuine food safety risk. Well publicized incidents of chronic exposure to chemical contamination in the EU (e.g. dioxins in meat and mycotoxins in nuts) have required robust coordinated policy responses from the Commission. Despite the decreasing incidence of non-compliant residues of veterinary medicinal products and banned substances in animal products, EU consumers are increasingly concerned about the use of such products in food-producing animals, including in the context of the build-up of antimicrobial resistance in animals and transfer to humans. The Commission plays a key role in coordination of the EU member states' responses to such incidents, in risk management, and in preparation for emerging issues. This paper focuses on how the EU as a whole has dealt with a number of food crises, and what can be learned from past incidents. Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Internet Effects in Times of Political Crisis: Online Newsgathering and Attitudes toward the European Union.

PubMed

Baccini, Leonardo; Sudulich, Laura; Wall, Matthew

2016-01-01

This paper evaluates the influence of online news consumption on attitudes toward the European Union in a context of protracted economic crisis. Using data from the 2011 Irish National Election Study, we combine location-specific information on broadband availability with respondent geo-location data, which facilitates causal inference about the effects of online news consumption via instrumental variable models. Results show that Irish citizens who source political information online are more prone to blame the EU for the poor state of the economy than those who do not. There is evidence of preference reinforcement among those with negative predispositions toward the EU, but not among pro-EU citizens. We complement this analysis with a study of voting behavior in the European Fiscal Compact Referendum, employing a similar methodological approach. The results from this second survey confirm the anti-EU influence of online news consumption among Irish citizens, although evidence suggests a pro-EU effect among voters who browsed the website of the politically neutral Irish Referendum Commission. Our paper contributes to the literature on public opinion, the EU, and political attitudes in times of crisis.

EU to review implications of tax

DOE Office of Scientific and Technical Information (OSTI.GOV)

Scott, A.

1997-05-21

The European Council of Ministers has postponed discussion of the European Commission`s proposed energy tax and has authorized a study to reevaluate the technical and legal implications and the costs and benefits of the tax. The reevaluation comes as a ray of hope to European chemical industry officials, who are concerned about the effects of the tax on the industry`s international competitiveness. The commission`s proposal would tax natural gas, electricity, and coal in the European Union (EU) for the first time. It would raise taxes throughout the EU to one level. In its current form the energy tax would devastatemore » the European industry`s competitiveness outside the region, says European Chemical Industry Council (Cefic) counsel Claude Culem. We`re willing to improve emissions to achieve environmental goals - we don`t need energy taxes, Culem tells CW. The whole project is dangerous, not necessarily in the short term, but certainly in the long term. European Parliament ministers are scheduled to debate the issue with the Dutch government, which holds the EU presidency, and hope to wrap up proceedings over the summer. The tax may only be adopted when ministers agree on it unanimously. If it is approved, it would be implemented in two stages, in 2000 and 2002.« less

Highlights: The ETF in 2002.

ERIC Educational Resources Information Center

European Training Foundation, Turin (Italy).

As part of its mandate to help the European Commission (EC) define, provide, monitor, and evaluate support to vocational education and training (VET) in regions outside the European Union (EU), the European Training Foundation (ETF) provided assistance to the following areas in 2002: Central and Eastern Europe; the New Independent States and…

Initial interlaboratory validation of an analytical method for the determination of lead in canned tuna to be used for monitoring and regulatory purposes.

PubMed

Santiago, E C; Bello, F B B

2003-06-01

The Association of Official Analytical Chemists (AOAC) Standard Method 972.23 (dry ashing and flame atomic absorption spectrophotometry (FAAS)), applied to the analysis of lead in tuna, was validated in three selected local laboratories to determine the acceptability of the method to both the Codex Alimentarius Commission (Codex) and the European Union (EU) Commission for monitoring lead in canned tuna. Initial validation showed that the standard AOAC method as performed in the three participating laboratories cannot satisfy the Codex/EU proposed criteria for the method detection limit for monitoring lead in fish at the present regulation level of 0.5 mg x kg(-1). Modification of the standard method by chelation/concentration of the digest solution before FAAS analysis showed that the modified method has the potential to meet Codex/EU criteria on sensitivity, accuracy and precision at the specified regulation level.

Ethical evaluation of research proposals by ethics panels advising the European Commission.

PubMed

Kolar, Roman

2004-06-01

Ethical principles with regard to animal experimentation are referred to in European Union (EU) legislation and other official documents. Therefore, applications for funding of research under the EU's research programme may undergo an ethical review that is carried out by so-called ethics panels, consisting of experts chosen by the European Commission. The work of these panels differs substantially from that of other ethical committees, as they exist on the institutional, local, regional or national level. Their main purpose is not to decide whether a proposed research can be regarded legal, and therefore should be endorsed or licensed; instead, it is to help the Commission in prioritising its funding. The panels may examine other ethical aspects than those of animal experimentation or animal welfare alone, such as the use of human volunteers. This is reflected by the composition of the panels. Their decisions are normally based on consensus. Even though these decisions may refer to EU legislation, the criteria applied are not restricted to those provided by this legislation. Nevertheless, the various aspects of the Commission's ethical evaluation system (e.g. formal and practical basic conditions, information content of applications, type of decisions taken, lacking of any quality control) offers opportunities for improvement.

The European Social Fund: The Commission, the Member State and Levels of Governance

ERIC Educational Resources Information Center

Brine, Jacqueline

2004-01-01

The European Social Fund (ESF) is the European Union structural fund that redistributes funds to facilitate vocational education and training (VET). With the exception of the Common Agricultural Policy it is the EU's largest instrument for redistribution. Currently linked to the European Employment Strategy it match-funds, and through its…

Global health in the European Union--a review from an agenda-setting perspective.

PubMed

Aluttis, Christoph; Krafft, Thomas; Brand, Helmut

2014-01-01

This review attempts to analyse the global health agenda-setting process in the European Union (EU). We give an overview of the European perspective on global health, making reference to the developments that led to the EU acknowledging its role as a global health actor. The article thereby focuses in particular on the European interpretation of its role in global health from 2010, which was formalised through, respectively, a European Commission Communication and European Council Conclusions. Departing from there, and based on Kingdon's multiple streams theory on agenda setting, we identify some barriers that seem to hinder the further establishment and promotion of a solid global health agenda in the EU. The main barriers for creating a strong European global health agenda are the fragmentation of the policy community and the lack of a common definition for global health in Europe. Forwarding the agenda in Europe for global health requires more clarification of the common goals and perspectives of the policy community and the use of arising windows of opportunity.

Safety assessment of genetically modified plants with deliberately altered composition

PubMed Central

Halford, Nigel G; Hudson, Elizabeth; Gimson, Amy; Weightman, Richard; Shewry, Peter R; Tompkins, Steven

2014-01-01

The development and marketing of ‘novel’ genetically modified (GM) crops in which composition has been deliberately altered poses a challenge to the European Union (EU)'s risk assessment processes, which are based on the concept of substantial equivalence with a non-GM comparator. This article gives some examples of these novel GM crops and summarizes the conclusions of a report that was commissioned by the European Food Safety Authority on how the EU's risk assessment processes could be adapted to enable their safety to be assessed. PMID:24735114

Monitoring Forest Condition in Europe: Impacts of Nitrogen and Sulfur Depositions on Forest Ecosystems

Treesearch

M. Lorenz; G. Becher; V. Mues; E. Ulrich

2006-01-01

Forest condition in Europe has been monitored over 19 years jointly by the United Nations Economic Commission for Europe (UNECE) and the European Union (EU). Large-scale variations of forest condition over space and time in relation to natural and anthropogenic factors are assessed on about 6,000 plots systematically spread across Europe. This large-scale monitoring...

Proposal for National Targets in the Framework of the European Reduction Goal for Early School Leaving

ERIC Educational Resources Information Center

Lastra-Bravo, Xavier B.; Tolón-Becerra, Alfredo; Salinas-Andújar, José A.

2013-01-01

According to the European Commission's "Europe 2020" strategy, the early school leaving (ESL) rate in European Union (EU) Member States must be reduced to a maximum of 10 per cent by 2020. This paper proposes a nonlinear distribution method based on dynamic targets for reducing the percentage of early school leavers. The aim of this…

The Politics of Global Value Chains: Import-dependent Firms and EU-Asia Trade Agreements.

PubMed

Eckhardt, Jappe; Poletti, Arlo

2016-01-01

In 2006, the European Commission released its Global Europe Communication, in which it announced a shift from a multilateral to a bilateral trade strategy. One of the key pillars of this new strategy was to strengthen the bilateral trade relations with key Asian countries. In contrast to existing analyses that focus on European Union (EU) decision makers' agency, we propose an explanation for this notable shift in the EU's trade policy that stresses the political role of import-dependent firms. In light of the increasing integration of such firms into global value chains, the article argues that a plausible case can be made, both theoretically and empirically, that import-dependent firms had a clear stake in the signing of preferential trade agreements between the EU and Asian countries and that their lobbying efforts significantly affected the EU's decision to start negotiations with South Korea, India and Vietnam.

Global health in the European Union – a review from an agenda-setting perspective

PubMed Central

Aluttis, Christoph; Krafft, Thomas; Brand, Helmut

2014-01-01

This review attempts to analyse the global health agenda-setting process in the European Union (EU). We give an overview of the European perspective on global health, making reference to the developments that led to the EU acknowledging its role as a global health actor. The article thereby focusses in particular on the European interpretation of its role in global health from 2010, which was formalised through, respectively, a European Commission Communication and European Council Conclusions. Departing from there, and based on Kingdon's multiple streams theory on agenda setting, we identify some barriers that seem to hinder the further establishment and promotion of a solid global health agenda in the EU. The main barriers for creating a strong European global health agenda are the fragmentation of the policy community and the lack of a common definition for global health in Europe. Forwarding the agenda in Europe for global health requires more clarification of the common goals and perspectives of the policy community and the use of arising windows of opportunity. PMID:24560264

EU sales ban on new cosmetics tested on animals: impact on alternative methods, WTO implications and animal welfare aspects.

PubMed

Ruhdel, Irmela W

2004-06-01

In 1993, the European Union (EU) adopted Directive 93/35/EEC, calling for a sales ban on new cosmetic products containing ingredients tested on animals after 1 January, 1998, provided that alternative methods had been developed by then. In May 2000, for the second time, the European Commission postponed that ban. The Commission justified the repeated postponement of the sales ban by saying that no animal-free methods were available, although three in vitro methods were scientifically approved in 1997. With three years delay, these methods have been published and therefore "made available" in the EU. OECD acceptance is still awaited. Another reason for the postponement was the fear of possible World Trade Organisation (WTO) conflicts. However, according to WTO rules, the protection of public morality or animal health could justify a restriction of the free trade principle. From the animal welfare point of view, an unqualified EU sales ban, combined with an animal testing ban, would provide the incentive to further promote the development and acceptance of alternative methods and to prove that ethical standards are legitimate concerns under WTO rules.

The revision of the 2014 European tobacco products directive: an analysis of the tobacco industry's attempts to ‘break the health silo’

PubMed Central

Peeters, Silvy; Costa, Hélia; Stuckler, David; McKee, Martin; Gilmore, Anna B

2016-01-01

Background The 2014 European Union (EU) Tobacco Products Directive (TPD) was negotiated in a changed policy context, following adoption of the EU's ‘Smart Regulation’ agenda, which transnational tobacco companies (TTCs) anticipated would increase their influence on health policy, and the WHO Framework Convention on Tobacco Control (FCTC), which sought to reduce it. This study aims to explore the scale and nature of the TTCs' lobby against the EU TPD and evaluate how these developments have affected their ability to exert influence. Methods Analysis of 581 documents obtained through freedom of information requests, 28 leaked Philip Morris International (PMI) documents, 17 TTC documents from the Legacy Library, web content via Google alerts and searches of the EU institutions' websites, plus four stakeholder interviews. Results The lobby was massive. PMI alone employed over 160 lobbyists. Strategies mainly used third parties. Efforts to 'Push' (amend) or 'Delay' the proposal and block 'extreme policy options' were partially successful, with plain packaging and point of sales display ban removed during the 3-year delay in the Commission. The Smart Regulation mechanism contributed to changes and delays, facilitating meetings between TTC representatives (including ex-Commission employees) and senior Commission staff. Contrary to Article 5.3, these meetings were not disclosed. Conclusions During the legislative process, Article 5.3 was not consistently applied by non-health Directorates of the European Commission, while the tools of the Smart Regulation appear to have facilitated TTC access to, and influence on, the 2014 TPD. The use of third parties undermines Article 5.3. PMID:25713313

First proficiency testing to evaluate the ability of European Union National Reference Laboratories to detect staphylococcal enterotoxins in milk products.

PubMed

Hennekinne, Jacques-Antoine; Gohier, Martine; Maire, Tiphaine; Lapeyre, Christiane; Lombard, Bertrand; Dragacci, Sylviane

2003-01-01

The European Commission has designed a network of European Union-National Reference Laboratories (EU-NRLs), coordinated by a Community Reference Laboratory (CRL), for control of hygiene of milk and milk products (Council Directive 92/46/ECC). As a common contaminant of milk and milk products such as cheese, staphylococcal enterotoxins are often involved in human outbreaks and should be monitored regularly. The main tasks of the EU-CRLs were to select and transfer to the EU-NRLs a reference method for detection of enterotoxins, and to set up proficiency testing to evaluate the competency of the European laboratory network. The first interlaboratory exercise was performed on samples of freeze-dried cheese inoculated with 2 levels of staphylococcal enterotoxins (0.1 and 0.25 ng/g) and on an uninoculated control. These levels were chosen considering the EU regulation for staphylococcal enterotoxins in milk and milk products and the limit of detection of the enzyme-linked immunosorbent assay test recommended in the reference method. The trial was conducted according to the recommendations of ISO Guide 43. Results produced by laboratories were compiled and compared through statistical analysis. Except for data from 2 laboratories for the uninoculated control and cheese inoculated at 0.1 ng/g, all laboratories produced satisfactory results, showing the ability of the EU-NRL network to monitor the enterotoxin contaminant.

The Global Health Policies of the EU and its Member States: A Common Vision?

PubMed Central

Steurs, Lies; Van de Pas, Remco; Delputte, Sarah; Orbie, Jan

2018-01-01

Background: This article assesses the global health policies of the European Union (EU) and those of its individual member states. So far EU and public health scholars have paid little heed to this, despite the large budgets involved in this area. While the European Commission has attempted to define the ‘EU role in Global Health’ in 2010, member states are active in the domain of global health as well. Therefore, this article raises the question to what extent a common ‘EU’ vision on global health exists. Methods: This is examined through a comparative framing analysis of the global health policy documents of the European Commission and five EU member states (France, Germany, the United Kingdom, Belgium, and Denmark). The analysis is informed by a two-layered typology, distinguishing global health from international health and four ‘global health frames,’ namely social justice, security, investment and charity. Results: The findings show that the concept of ‘global health’ has not gained ground the same way within European policy documents. Consequently, there are also differences in how health is being framed. While the European Commission, Belgium, and Denmark clearly support a social justice frame, the global health strategies of the United Kingdom, Germany, and France put an additional focus on the security and investment frames. Conclusion: There are different understandings of global/international health as well as different framings within relevant documents of the EU and its member states. Therefore, the existence of an ‘EU’ vision on global health is questionable. Further research is needed on how this impacts on policy implementation. PMID:29764107

European Training and Research in Peritoneal Dialysis--A Network to Deliver Scientific Peritoneal Dialysis Training to a New Generation of Researchers.

PubMed

Machowska, Anna; van Wier, Tanja; Aufricht, Christoph; Beelen, Rob; Rutherford, Peter

2015-01-01

Peritoneal dialysis (PD) utilization varies across countries, and of the factors that explain the variation, the scientific and clinical knowledge of health care professionals is potentially important. In this paper, we describe a European collaboration--between 8 academic PD research programs, a small-to-medium-sized enterprise, and a large PD product manufacturer--that received significant research funding from the EU commission to establish a training network. European Training and Research in Peritoneal Dialysis (EuTRiPD) is providing training to 12 PhD students who have moved within the European Union and are completing research training. The underlying structure and processes within EuTRiPD (http://www.eutripd. eu) are described, and the benefits of the collaborative approach are discussed. This model could be useful to other research groups and will assist in maintaining and growing scientific expertise in PD research.

Study of natural occurrence of T-2 and HT-2 toxins and their glucosyl derivatives from field barley to malt by high resolution orbitrap mass spectrometry

USDA-ARS?s Scientific Manuscript database

A recent European Union Commission Recommendation (2013/165/EU), asked for collection of more data on the occurrence of T-2 and HT-2 toxins in cereals and cereal products and emphasized that if the method of analysis enables it, it would be appropriate to collect data of the occurrence of masked myc...

Italy in the Eu: Love Affair or Disillusionment? Italian Discontent with the European Integration Past and Present

DTIC Science & Technology

2014-06-01

in the formation of a European monetary union further contributing to the European countries’ political union . Among Italy’s reasons to participate...of abandoning participation in the EU project. 14. SUBJECT TERMS Italy, European Union , European institutions, Mussolini, Hitler, NATO...System EMU European Monetary Union EU European Union GDP gross domestic product Km kilometer IAI Istituto Affari Internazionali [Institute of

Matches and mismatches between conservation investments and biodiversity values in the European Union.

PubMed

Sánchez-Fernández, David; Abellán, Pedro; Aragón, Pedro; Varela, Sara; Cabeza, Mar

2018-02-01

Recently, the European Commission adopted a new strategy to halt the loss of biodiversity. Member states are expected to favor a more effective collection and redistribution of European Union (EU) funds under the current Multiannual Financial Framework for 2014-2020. Because of the large spatial variation in the distribution of biodiversity and conservation needs at the continental scale, EU instruments should ensure that countries with higher biodiversity values get more funds and resources for the conservation than other countries. Using linear regressions, we assessed the association between conservation investments and biodiversity values across member states, accounting for a variety of conservation investment indicators, taxonomic groups (including groups of plants, vertebrates, and invertebrates), and indicators of biodiversity value. In general, we found clear overall associations between conservation investments and biodiversity variables. However, some countries received more or less investment than would be expected based on biodiversity values in those countries. We also found that the extensive use of birds as unique indicators of conservation effectiveness may lead to biased decisions. Our results can inform future decisions regarding funding allocation and thus improve distribution of EU conservation funds. © 2017 Society for Conservation Biology.

Women Physicists in the European Union : how Brussels is moving toward gender equality

NASA Astrophysics Data System (ADS)

Pancheri, Giulia

2008-04-01

The policies of the European Union towards gender equality in science occupation will be discussed along three aspects: 1. Current statistics recently published by the EU will be illustrated with some comparison with similar US statistics. The latest recommendations of the Helsinki group will be presented, together with the conclusions of the Women in Science meetings organized by the EU. 2. The implementation of these recommendations will be illustrated by this speaker's experience both as independent expert for Physics Research Programs for the European Commission for the last 10 years, as well as from the point of view of having been European Coordinator of three Research Networks in Theoretical Physics from 1992 until 2006: the impact of this on young women students will be described. 3. National policies enforced through the Equal Opportunity Committees will be illustrated, with the specific case of the Affirmative Actions of Italian INFN Equal Opportunity Committe and their impact on hiring and promotion of women physicists.

The European Federation of Organisations for Medical Physics Policy Statement No. 6.1: Recommended Guidelines on National Registration Schemes for Medical Physicists.

PubMed

Christofides, Stelios; Isidoro, Jorge; Pesznyak, Csilla; Bumbure, Lada; Cremers, Florian; Schmidt, Werner F O

2016-01-01

This EFOMP Policy Statement is an update of Policy Statement No. 6 first published in 1994. The present version takes into account the European Union Parliament and Council Directive 2013/55/EU that amends Directive 2005/36/EU on the recognition of professional qualifications and the European Union Council Directive 2013/59/EURATOM laying down the basic safety standards for protection against the dangers arising from exposure to ionising radiation. The European Commission Radiation Protection Report No. 174, Guidelines on Medical Physics Expert and the EFOMP Policy Statement No. 12.1, Recommendations on Medical Physics Education and Training in Europe 2014, are also taken into consideration. The EFOMP National Member Organisations are encouraged to update their Medical Physics registration schemes where these exist or to develop registration schemes taking into account the present version of this EFOMP Policy Statement (Policy Statement No. 6.1"Recommended Guidelines on National Registration Schemes for Medical Physicists"). Copyright © 2016. Published by Elsevier Ltd.

Tuberculosis among migrant populations in the European Union and the European Economic Area.

PubMed

Odone, Anna; Tillmann, Taavi; Sandgren, Andreas; Williams, Gemma; Rechel, Bernd; Ingleby, David; Noori, Teymur; Mladovsky, Philipa; McKee, Martin

2015-06-01

Although tuberculosis (TB) incidence has been decreasing in the European Union/European Economic Area (EU/EEA) in the last decades, specific subgroups of the population, such as migrants, remain at high risk of TB. This study is based on the report 'Key Infectious Diseases in Migrant Populations in the EU/EEA' commissioned by The European Centre for Disease Prevention and Control. We collected, critically appraised and summarized the available evidence on the TB burden in migrants in the EU/EEA. Data were collected through: (i) a comprehensive literature review; (ii) analysis of data from The European Surveillance System (TESSy) and (iii) evidence provided by TB experts during an infectious disease workshop in 2012. In 2010, of the 73,996 TB cases notified in the EU/EEA, 25% were of foreign origin. The overall decrease of TB cases observed in recent years has not been reflected in migrant populations. Foreign-born people with TB exhibit different socioeconomic and clinical characteristics than native sufferers. This is one of the first studies to use multiple data sources, including the largest available European database on infectious disease notifications, to assess the burden and provide a comprehensive description and analysis of specific TB features in migrants in the EU/EEA. Strengthened information about health determinants and factors for migrants' vulnerability is needed to plan, implement and evaluate targeted TB care and control interventions for migrants in the EU/EEA. © The Author 2014. Published by Oxford University Press on behalf of the European Public Health Association.

Internet Effects in Times of Political Crisis

PubMed Central

Baccini, Leonardo; Sudulich, Laura; Wall, Matthew

2016-01-01

This paper evaluates the influence of online news consumption on attitudes toward the European Union in a context of protracted economic crisis. Using data from the 2011 Irish National Election Study, we combine location-specific information on broadband availability with respondent geo-location data, which facilitates causal inference about the effects of online news consumption via instrumental variable models. Results show that Irish citizens who source political information online are more prone to blame the EU for the poor state of the economy than those who do not. There is evidence of preference reinforcement among those with negative predispositions toward the EU, but not among pro-EU citizens. We complement this analysis with a study of voting behavior in the European Fiscal Compact Referendum, employing a similar methodological approach. The results from this second survey confirm the anti-EU influence of online news consumption among Irish citizens, although evidence suggests a pro-EU effect among voters who browsed the website of the politically neutral Irish Referendum Commission. Our paper contributes to the literature on public opinion, the EU, and political attitudes in times of crisis. PMID:27274571

New EU legislation for risk assessment of GM food: no scientific justification for mandatory animal feeding trials.

PubMed

Kuiper, Harry A; Kok, Esther J; Davies, Howard V

2013-09-01

This commentary focuses on the potential added value of and need for (sub)-chronic testing of whole genetically modified (GM) foods in rodents to assess their safety. Such routine testing should not be required since, due to apparent weaknesses in the approach, it does not add to current risk assessment of GM foods. Moreover, the demand for routine testing using animals is in conflict with the European Union (EU) Commission's efforts to reduce animal experimentation. Regulating agencies in the EU are invited to respect the sound scientific principles applied to the risk assessment of foods derived from GM plants and not to interfere in the risk assessment by introducing extra requirements based on pseudo-scientific or political considerations. © 2013 Society for Experimental Biology, Association of Applied Biologists and John Wiley & Sons Ltd.

Contaminated Sites in Europe: Review of the Current Situation Based on Data Collected through a European Network

PubMed Central

Van Liedekerke, Marc; Yigini, Yusuf; Montanarella, Luca

2013-01-01

Under the European Union (EU) Thematic Strategy for Soil Protection, the European Commission has identified soil contamination as a priority for the collection of policy-relevant soil data at European scale. In order to support EU soil management policies, soil-related indicators need to be developed which requires appropriate data collection and establishment of harmonized datasets for the EU Member States. In 2011-12, the European Soil Data Centre of the European Commission conducted a project to collect data on contaminated sites from national institutions in Europe using the European Environment Information and Observation Network for soil (EIONET-SOIL). This paper presents the results obtained from analysing the soil contaminated sites data submitted by participating countries. According to the received data, the number of estimated potential contaminated sites is more than 2.5 million and the identified contaminated sites around 342 thousand. Municipal and industrial wastes contribute most to soil contamination (38%), followed by the industrial/commercial sector (34%). Mineral oil and heavy metals are the main contaminants contributing around 60% to soil contamination. In terms of budget, the management of contaminated sites is estimated to cost around 6 billion Euros (€) annually. PMID:23843802

Health consequences of Chernobyl and other radiation accidents. Report on the European Union Cluster Contractors' workshop (San Miniato, Italy, 17-22 June 1997).

PubMed

Karaoglou, A; Chadwick, K H

1998-04-01

The Radiation Protection Research Unit of the European Commission has been supporting collaborative research projects on the radiological consequences of the Chernobyl accident since 1991. However, in the Fourth Framework Programme of the Commission which started in 1996, the collaboration with scientists in the former Soviet Union has been placed on a different footing, and the programme has been expanded to include other regions, especially in Russia and Kazakhstan, where previous nuclear incidents have led to the exposure of workers and the local populations and to widespread radioactive contamination. There are 15 projects on health-related studies in the newly started programme, and in order to improve the collaboration between the different scientists working in these projects a Cluster Contractors' Meeting was organised in San Miniato, Italy, in June 1997 with the participation of some 50 scientists from the European Union (EU) and the Newly Independent States (NIS). This report summarizes the different topics, including molecular biology and treatment of childhood thyroid cancer, various epidemiological studies and dose reconstruction, which were discussed at the meeting and which form the major projects in the new collaborative programme.

DOE Office of Scientific and Technical Information (OSTI.GOV)

Walker, Randy M

Thousands of shipments of radioisotopes developed in the United States (US) are transported domestically and internationally for medical and industrial applications, including to partner laboratories in European Union (EU) countries. Over the past five years, the Environmental Protection Agency (EPA), the Department of Energy (DOE), and Oak Ridge National Laboratory (ORNL) have worked with state regulatory compliance personnel, key private sector shippers and carriers, the Department of Homeland Security (DHS), the Department of Transportation (DOT), the Department of Defense (DoD) and the Nuclear Regulatory Commission (NRC) on Radio Frequency Identification (RFID) tracking and monitoring of medical and industrial radioisotopes inmore » commerce. The EPA Radiological Source Tracking and Monitoring (RadSTraM) project tested, evaluated, and integrated RFID technologies in laboratory settings, and at multiple private-sector shipping and distribution facilities (Perkin Elmer and DHL) using common radioisotopes used in everyday commerce. The RFID tracking was also tested in association with other deployed technologies including radiation detection, chemical/explosives detection, advanced imaging, lasers, and infrared scanning. At the 2007 EU-US Summit, the leaders of the US Department of Commerce (DOC) and EU European Commission (EC) committed to pursue jointly directed Lighthouse Priority Projects. These projects are intended to 'foster cooperation' and 'reduce regulatory burdens' with respect to transatlantic commerce. The Transatlantic Economic Council (TEC) Lighthouse Project on Radio Frequency Identification (RFID) has been directed to 'develop a joint framework for cooperation on identification and development of best practices for Radio Frequency Identification (RFID) technologies.' The RFID Lighthouse Priority Project commits both sides to endeavor to align U.S. and EU regulatory and policy approaches on RFID technologies, including pilot projects in the public sector. The RadSTraM project was specifically cited as a candidate for a RFID Lighthouse Project by the EU/DOC collaboration in meeting their mutual goal of developing a 'joint framework for cooperation on identification and development of best practices for RFID technologies.' Concurrently, the Universal Postal Union (UPU) identified this project as a candidate for radioisotope packages shipped by the postal service between the United State Postal Service (USPS). and European Post Agencies.« less

Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry.

PubMed

Beck, Alain; Reichert, Janice M

2013-01-01

In a defining moment for the European Medicines Agency (EMA) and the biopharmaceutical industry, on June 27, 2013 EMA's Committee for Medicinal Products for Human Use adopted a positive opinion for two biosimilar infliximab products (Celltrion's Remsima® and Hospira's Inflectra®), and recommended that they be approved for marketing in the European Union (EU). The European Commission's decision on an application is typically issued 67 d after an opinion is provided; thus, decisions are expected in early September 2013. If approved, the products will comprise the first biosimilar antibody made available to patients in a highly regulated market, although launch may be delayed due to an extension of the reference product's (Remicade®) patent in the EU.

Impact of cigarette price differences across the entire European Union on cross-border purchase of tobacco products among adult cigarette smokers.

PubMed

Agaku, Israel T; Blecher, Evan; Filippidis, Filippos T; Omaduvie, Uyoyo T; Vozikis, Athanassios; Vardavas, Constantine I

2016-05-01

We investigated the impact of cigarette price differences across the European Union (EU) on cross-border tobacco purchasing because of cheaper price among current cigarette smokers. Individual-level tobacco-related data (including cross-border tobacco purchasing behavior) were from the Special Eurobarometer 385 (V.77.1), a cross-sectional survey of persons aged ≥15 years from 27 EU Member States during 2012. Country-specific weighted average prices (WAP) per 1000 cigarettes (as of 1 July 2012) were obtained from the European Commission, and divided by 50 to yield WAP per cigarette pack. The dispersion in EU cigarette prices was measured with the coefficient of variation. Multivariate logistic regression was applied to measure the relationship between EU-wide cigarette price differential and cross-border tobacco purchasing because of cheaper price among current cigarette smokers (n=6896). The coefficient of variation for cigarette WAP within the EU was 0.39 (mean price=€3.99/pack). Of all current cigarette smokers in the EU, 26.2% (27.5 million persons) engaged in a cross-border tobacco purchase within the past 12 months, of which 56.3% did so because of cheaper price in another country. EU-wide cigarette price differential was significantly associated with making a cross-border tobacco purchase because of cheaper price (adjusted OR=1.34; 95% CI 1.22 to 1.47). Reducing differences in cigarette tax and price within the EU, coupled with a stricter limitation on the quantity of cigarettes that it is possible to carry from one Member State to another, may help reduce cross-border tax avoidance strategies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Pharmacovigilance in pharmaceutical companies: An overview

PubMed Central

Mammì, Maria; Citraro, Rita; Torcasio, Giovanni; Cusato, Gennaro; Palleria, Caterina; di Paola, Eugenio Donato

2013-01-01

Pharmacovigilance is responsible for monitoring the safety of medicines in normal clinical use and during clinical trials. In the light of the experience acquired and following an assessment by the Commission of the Union system of pharmacovigilance, it has become clear that it is necessary to take measures in order to improve the operation of Union law on the pharmacovigilance of medicinal products for human use. Regulation (EU) No 1235/2010 and Directive 2010/84/EU introduced new legislation on pharmacovigilance. The marketing authorization holder should be responsible for continuously monitoring the safety of its medicinal products for human use, for informing the authorities of any changes that might have an impact on the marketing authorization, and for ensuring that the product information is kept up-to-date. Marketing authorization holders (MAH) record all suspected adverse reactions occurring in the European Union or in the third countries, and which are brought to their attention spontaneously by the patients or their health care, or occurring in the context of post-authorization study. For all medicinal products is mandatory to maintain a pharmacovigilance system master file (PSMF). According to the Legislative Decree 219/2006 the MAH must submit to the competent authorities the information on suspected adverse reactions of a medicinal product, in form of a periodic safety update reports (PSURs). PMID:24347978

Pharmacovigilance in pharmaceutical companies: An overview.

PubMed

Mammì, Maria; Citraro, Rita; Torcasio, Giovanni; Cusato, Gennaro; Palleria, Caterina; di Paola, Eugenio Donato

2013-12-01

Pharmacovigilance is responsible for monitoring the safety of medicines in normal clinical use and during clinical trials. In the light of the experience acquired and following an assessment by the Commission of the Union system of pharmacovigilance, it has become clear that it is necessary to take measures in order to improve the operation of Union law on the pharmacovigilance of medicinal products for human use. Regulation (EU) No 1235/2010 and Directive 2010/84/EU introduced new legislation on pharmacovigilance. The marketing authorization holder should be responsible for continuously monitoring the safety of its medicinal products for human use, for informing the authorities of any changes that might have an impact on the marketing authorization, and for ensuring that the product information is kept up-to-date. Marketing authorization holders (MAH) record all suspected adverse reactions occurring in the European Union or in the third countries, and which are brought to their attention spontaneously by the patients or their health care, or occurring in the context of post-authorization study. For all medicinal products is mandatory to maintain a pharmacovigilance system master file (PSMF). According to the Legislative Decree 219/2006 the MAH must submit to the competent authorities the information on suspected adverse reactions of a medicinal product, in form of a periodic safety update reports (PSURs).

Information technology law and health systems in the European Union.

PubMed

Mossialos, Elias; Thomson, Sarah; Ter Linden, Annemarie

2004-01-01

This study aims to examine the impact of European Union (EU) law relating to information technology (IT) on health systems. The study identifies EU directives relating to IT, analyzes them in terms of their impact on the use of IT in health systems, and outlines their implications for health technology assessment (HTA). Analysis is based on a review of literature identified through relevant databases and Internet searches. Developments in IT have serious implications for EU health systems, presenting policy makers with new challenges. The European Commission has adopted a range of legal measures to protect consumers in the "information society" However, as few of them are health-specific, it is not evident that they have implications for health, health systems, or HTA, and they may not be effective in protecting consumers in the health sector. In light of the growing importance of IT in the health sector, legal and nonlegal measures need to be further developed at EU and international level. Where possible, future initiatives should pay attention to the particular characteristics of health goods and services and health systems. Although definitions of HTA usually recognize the importance of evaluating both the indirect, unintended consequences of health technologies and the legal aspects of their application, it seems that, in practice, HTA often overlooks or underestimates legislative matters. Those involved in HTA should be aware of the legal implications of using IT to provide health goods and services and compile, store, transfer, and disseminate health information electronically.

Responsible decision-making for plant research and breeding innovations in the European Union.

PubMed

Eriksson, Dennis; Chatzopoulou, Sevasti

2018-01-02

Plant research and breeding has made substantial technical progress over the past few decades, indicating a potential for tremendous societal impact. Due to this potential, the development of policies and legislation on plant breeding and the technical progress should preferably involve all relevant stakeholders. However, we argue here that there is a substantial imbalance in the European Union (EU) regarding the influence of the various stakeholder groups on policy makers. We use evidence from three examples in order to show that the role of science is overlooked: 1) important delays in the decision process concerning the authorization of genetically modified (GM) maize events, 2) the significance attributed to non-scientific reasons in new legislation concerning the prohibition of GM events in EU member states, and 3) failure of the European Commission to deliver legal guidance to new plant breeding techniques despite sufficient scientific evidence and advisory reports. We attribute this imbalance to misinformation and misinterpretation of public perceptions and a disproportionate attention to single outlier reports, and we present ideas on how to establish a better stakeholder balance within this field.

Turkey’s Membership in the European Union: Analyzing Potential Benefits and Drawbacks

DTIC Science & Technology

2008-12-01

THE EUROPEAN UNION: ANALYZING POTENTIAL BENEFITS AND DRAWBACKS by Abdi Pehlivan December 2008 Thesis Co-Advisors: David S. Yost...DATES COVERED Master’s Thesis 4. TITLE AND SUBTITLE Turkey’s Membership in the European Union: Analyzing Potential Benefits and Drawbacks 6...EU. This thesis analyzes the potential advantages and drawbacks of Turkey’s EU membership for both Turkey and the EU. It considers economic, social

Soft Power and Hard Measures: Large-Scale Assessment, Citizenship and the European Union

ERIC Educational Resources Information Center

Rutkowski, David; Engel, Laura C.

2010-01-01

This article explores the International Civic and Citizenship Education Study (ICCS) with particular emphasis on the European Union's (EU's) involvement in the regional portion. Using the ICCS, the EU actively combines hard measures with soft power, allowing the EU to define and steer cross-national rankings of values of EU citizenship. The…

Mutatis Mutandis? The Court of Justice of the European Union Rules that Member States May Be Allowed to Impose Non-Resident Student Quotas

ERIC Educational Resources Information Center

Observatory on Borderless Higher Education, 2010

2010-01-01

Earlier this month, the Court of Justice of the European Union (the Court), ruled that European Union (EU) member states can impose non-resident student quotas in certain circumstances. The Court, whose job is to ensure that all EU member states interpret and apply EU legislation in the same way, recently made the ruling in response to a…

EU Funded Research Activities on NPPS Operational Safety

DOE Office of Scientific and Technical Information (OSTI.GOV)

Manolatos, P.; Van Goethem, G.

2002-07-01

The 5. framework programme (FP-5), the pluri-annual research programme of the European Union (EU), covers the period 1998-2002. Research on nuclear energy, fusion and fission, is covered by the EURATOM part of the FP-5. An overview of the Euratom's research on Nuclear Reactor Safety, managed by the DG-RTD of the European Commission (EC), is presented. This concerns 70 multi-partner projects of approximately euro 82.5 million total contract value that have been selected and co-financed during the period 1999-2001. They form the three clusters of projects dealing with the 'Operational Safety of Existing Installations'. 'Plant Life Extension and Management' (PLEM), 'Severemore » Accident Management' (SAM) and 'Evolutionary concepts' (EVOL). Emphasis is given here to the projects of the PLEM cluster. (authors)« less

Underlying Paradox in the European Union's Multilingualism Policies

ERIC Educational Resources Information Center

Johnson, Fern L.

2013-01-01

The European Union (EU) has developed comprehensive policies in recent years to promote multilingualism. In this article, major EU policy statements on multilingualism are analyzed to demonstrate how their underlying language ideology produces paradox by both encouraging multilingualism and regulating its definition within the EU. The first…

Public health research systems in the European union

PubMed Central

2011-01-01

Background Strengthening health research is an important objective for international health organisations, but there has been less attention to support for health research in Europe. We describe the public-health (population and organisational level) research systems in the 27 European Union countries. Methods We developed a typology for describing health research structures based on funding streams and strategies. We drew data from internet sources and asked country informants to review these for consistency and completeness. The structures were described as organograms and narratives in country profiles for each of the 27 EU member states. National public-health research structures included public and independent funding organisations, 'mixed' institutions (which receive funds, and both use and allocate them) and provider institutions. Results Most health research is funded through ministries of science or science councils (and sometimes foundations), while parliaments and regions may also contribute. National institutes of public health are usually funded by ministries of health. Many national research organisations both determine research programmes and undertake health research, but there is a move towards public-health sciences within the universities, and a transition from internal grants to competitive funding. Of 27 national research strategies, 17 referred to health and 11 to public health themes. Although all countries had strategies for public health itself, we found little coherence in public-health research programmes. The European Commission has country contact points for both EU research and health programmes, but they do not coordinate with national health-research programmes. Conclusions Public-health research is broadly distributed across programmes in EU countries. Better understanding of research structures, programmes and results would improve recognition for public health in Europe, and contribute to practice. EU ministries of health should give greater attention to national public-health research strategies and programmes, and the European Union and the World Health Organisation can provide coordination and support. PMID:21970897

Twentieth anniversary of the European Union health mandate: taking stock of perceived achievements, failures and missed opportunities - a qualitative study.

PubMed

Rosenkötter, Nicole; Clemens, Timo; Sørensen, Kristine; Brand, Helmut

2013-11-14

The European Union (EU) health mandate was initially defined in the Maastricht Treaty in 1992. The twentieth anniversary of the Treaty offers a unique opportunity to take stock of EU health actions by giving an overview of influential public health related EU-level policy outputs and a summary of policy outputs or actions perceived as an achievement, a failure or a missed opportunity. Semi-structured expert interviews (N = 20) were conducted focusing on EU-level actions that were relevant for health. Respondents were asked to name EU policies or actions that they perceived as an achievement, a failure or a missed opportunity. A directed content analysis approach was used to identify expert perceptions on achievements, failures and missed opportunities in the interviews. Additionally, a nominal group technique was applied to identify influential and public health relevant EU-level policy outputs. The ranking of influential policy outputs resulted in top positions of adjudications and legislations, agencies, European Commission (EC) programmes and strategies, official networks, cooperative structures and exchange efforts, the work on health determinants and uptake of scientific knowledge. The assessment of EU health policies as being an achievement, a failure or a missed opportunity was often characterized by diverging respondent views. Recurring topics that emerged were the Directorate General for Health and Consumers (DG SANCO), EU agencies, life style factors, internal market provisions as well as the EU Directive on patients' rights in cross-border healthcare. Among these recurring topics, expert perceptions on the establishment of DG SANCO, EU public health agencies, and successes in tobacco control were dominated by aspects of achievements. The implementation status of the Health in All Policy approach was perceived as a missed opportunity. When comparing the emerging themes from the interviews conducted with the responsibilities defined in the EU health mandate, one can identify that these responsibilities were only partly fulfilled or acknowledged by the respondents. In general, the EU is a recognized public health player in Europe which over the past two decades, has begun to develop competencies in supporting, coordinating and supplementing member state health actions. However, the assurance of health protection in other European policies seems to require further development.

Twentieth anniversary of the European Union health mandate: taking stock of perceived achievements, failures and missed opportunities – a qualitative study

PubMed Central

2013-01-01

Background The European Union (EU) health mandate was initially defined in the Maastricht Treaty in 1992. The twentieth anniversary of the Treaty offers a unique opportunity to take stock of EU health actions by giving an overview of influential public health related EU-level policy outputs and a summary of policy outputs or actions perceived as an achievement, a failure or a missed opportunity. Methods Semi-structured expert interviews (N = 20) were conducted focusing on EU-level actions that were relevant for health. Respondents were asked to name EU policies or actions that they perceived as an achievement, a failure or a missed opportunity. A directed content analysis approach was used to identify expert perceptions on achievements, failures and missed opportunities in the interviews. Additionally, a nominal group technique was applied to identify influential and public health relevant EU-level policy outputs. Results The ranking of influential policy outputs resulted in top positions of adjudications and legislations, agencies, European Commission (EC) programmes and strategies, official networks, cooperative structures and exchange efforts, the work on health determinants and uptake of scientific knowledge. The assessment of EU health policies as being an achievement, a failure or a missed opportunity was often characterized by diverging respondent views. Recurring topics that emerged were the Directorate General for Health and Consumers (DG SANCO), EU agencies, life style factors, internal market provisions as well as the EU Directive on patients’ rights in cross-border healthcare. Among these recurring topics, expert perceptions on the establishment of DG SANCO, EU public health agencies, and successes in tobacco control were dominated by aspects of achievements. The implementation status of the Health in All Policy approach was perceived as a missed opportunity. Conclusions When comparing the emerging themes from the interviews conducted with the responsibilities defined in the EU health mandate, one can identify that these responsibilities were only partly fulfilled or acknowledged by the respondents. In general, the EU is a recognized public health player in Europe which over the past two decades, has begun to develop competencies in supporting, coordinating and supplementing member state health actions. However, the assurance of health protection in other European policies seems to require further development. PMID:24225055

Popular universities: An alternative vision for lifelong learning in Europe

NASA Astrophysics Data System (ADS)

Stromquist, Nelly P.; da Costa, Romina B.

2017-10-01

At its inception in 1993, the European Union (EU) did not consider education one of the pillars of its regional cohesiveness and identity. As time went by, recognition of the potential role of education at individual and social levels increased. This concern for education, however, is much more centred on the acquisition of knowledge and skills towards developing a competitive labour force than towards facilitating the integration of all citizens in the European community - a bias which is reflected in EU policies and recommendations. At local levels, communities need to offer educational opportunities to all members of society, irrespective of their social, cultural and linguistic background and their level of education. In many EU member countries, this kind of learning is offered by popular universities (PUs), which are not state-funded and run in close collaboration with their respective local communities. The authors of this paper carried out a qualitative survey, collecting data on PUs in Spain and France. Their purpose was to examine how European PU offerings align with community needs, and to what extent they address emerging issues such as immigration, the refugee crisis, an aging population and youth unemployment. In the evaluation of their comparative survey, the authors link the grassroots approaches of PUs in Spain and France to the broader European Union (EU) discourse on lifelong learning (LLL) as seen in policy documents such as the European Commission's Memorandum on Lifelong Learning. Finally, they examine the ways in which PUs' approach to LLL works to contest the dominant consensus on the meaning and scope of lifelong learning, offering an alternative way forward.

Good practices and challenges in addressing poliomyelitis and measles in the European Union.

PubMed

Kinsman, John; Stöven, Svenja; Elgh, Fredrik; Murillo, Pilar; Sulzner, Michael

2018-04-06

All European Union (EU) and European Economic Area (EEA) Member States have pledged to ensure political commitment towards sustaining the region's poliomyelitis-free status and eliminating measles. However, there remain significant gaps between policy and practice in many countries. This article reports on an assessment conducted for the European Commission that aimed to support improvements in preparedness and response to poliomyelitis and measles in Europe. A documentary review was complemented by qualitative interviews with professionals working in International and EU agencies, and in at-risk or recently affected EU/EEA Member States (six each for poliomyelitis and measles). Twenty-six interviews were conducted on poliomyelitis and 24 on measles; the data were subjected to thematic analysis. Preliminary findings were then discussed at a Consensus Workshop with 22 of the interviewees and eight other experts. Generic or disease-specific plans exist in the participating countries and cross-border communications during outbreaks were generally reported as satisfactory. However, surveillance systems are of uneven quality, and clinical expertise for the two diseases is limited by a lack of experience. Serious breaches of protocol have recently been reported from companies producing poliomyelitis vaccines, and vaccine coverage rates for both diseases were also sub-optimal. A set of suggested good practices to address these and other challenges is presented. Poliomyelitis and measles should be brought fully onto the policy agendas of all EU/EEA Member States, and adequate resources provided to address them. Each country must abide by the relevant commitments that they have already made.

Estimating the soil organic carbon content for European NUTS2 regions based on LUCAS data collection.

PubMed

Panagos, Panos; Ballabio, Cristiano; Yigini, Yusuf; Dunbar, Martha B

2013-01-01

Under the European Union Thematic Strategy for Soil Protection, the European Commission Directorate-General for the Environment and the European Environmental Agency (EEA) identified a decline in soil organic carbon and soil losses by erosion as priorities for the collection of policy relevant soil data at European scale. Moreover, the estimation of soil organic carbon content is of crucial importance for soil protection and for climate change mitigation strategies. Soil organic carbon is one of the attributes of the recently developed LUCAS soil database. The request for data on soil organic carbon and other soil attributes arose from an on-going debate about efforts to establish harmonized datasets for all EU countries with data on soil threats in order to support modeling activities and display variations in these soil conditions across Europe. In 2009, the European Commission's Joint Research Centre conducted the LUCAS soil survey, sampling ca. 20,000 points across 23 EU member states. This article describes the results obtained from analyzing the soil organic carbon data in the LUCAS soil database. The collected data were compared with the modeled European topsoil organic carbon content data developed at the JRC. The best fitted comparison was performed at NUTS2 level and showed underestimation of modeled data in southern Europe and overestimation in the new central eastern member states. There is a good correlation in certain regions for countries such as the United Kingdom, Slovenia, Italy, Ireland, and France. Here we assess the feasibility of producing comparable estimates of the soil organic carbon content at NUTS2 regional level for the European Union (EU27) and draw a comparison with existing modeled data. In addition to the data analysis, we suggest how the modeled data can be improved in future updates with better calibration of the model. Copyright © 2012 Elsevier B.V. All rights reserved.

European Union Policies in Education and Training: The Lisbon Agenda as a Turning Point?

ERIC Educational Resources Information Center

Ertl, Hubert

2006-01-01

This paper investigates European Union (EU) education and training policies in the light of the evolving Lisbon agenda on improving the competitiveness of the EU. It examines the ways in which EU policies have developed over time, focusing on their legal basis, underlying principles, main forms of implementation and their impact on national…

European commission research on stratospheric ozone depletion

NASA Astrophysics Data System (ADS)

Amanatidis, G. T.; Ott, H.

1995-02-01

The research policy of the European Commission (EC) on the stratospheric ozone depletion, which is implemented through the ENVIRONMENT Programme is described. The strategy of this stratospheric ozone research, which is developed to address the open scientific questions, requires a coordinated and balanced programme which is based on long term measurements, process studies at regional or global scale, laboratory studies, continuous and accurate measurements of ultraviolet (UV) radiation and development of instrumentation. These research activities, whenever necessary, take form of extensive and coordinated experiments (EASOE 1991/92, SESAME 1994-95), while the overall objective is to provide a firm scientific basis for future European Union (EU) policy actions in this area. Finally, priorities which have been identified for future research in the ENVIRONMENT and CLIMATE Programme (1994-1998) are also detailed.

Land Recycling: from Science to Practice - A Sustainable Development of Urban Areas

NASA Astrophysics Data System (ADS)

Romanowicz, A.

2015-12-01

Member States (MS) of the European Union have experience significant urban sprawl in the last 3 decades. The urban sprawl was driven mainly by internal (MS or EU) or external migration but also by EU policies (including funds and projects) and by changes in life style (e.g. moving away from cities; second homes). This presentation will aim at showing a number of EU wide analysis on: aging population, depopulation of some of the EU regions; agricultural production and scenarios projections of thereof. Various EU funded projects and programs have analyzed ways how future cities and how EU future land use could developed. Number of those solutions where further investigated with case studies/small scale implementations. However, in recent years the 2012 EU road map to resource efficiency and UN Sustainable Development Goals have called respectively for 'no net land take by 2050' and land neutrality. Thus, the process of implementing innovative solutions for land use has started and some of the cities and regions are well ahead in moving towards XXI century society. In order to streamline/share knowledge and steer EU wide discussion on this the European Commission in its road map to resource efficiency announced a Communication on land as a resource. This presentation will attempt to synthesize current discussion on the topic of 'land as a resource' and include examples of implemented innovative solutions for aging population, land recycling for urban developments and green spaces within the current EU policy context. Finally, some appreciation of the adopted UN Sustainable Development Goals regarding land and soil from the EU perspective will be given.

Regulatory landscape for cell therapy--EU view.

PubMed

McBlane, James W

2015-09-01

This article addresses regulation of cell therapies in the European Union (EU), covering cell sourcing and applications for clinical trials and marketing authorisation applications. Regulatory oversight of cell sourcing and review of applications for clinical trials with cell therapies are handled at national level, that is, separately with each country making its own decisions. For clinical trials, this can lead to different decisions in different countries for the same trial. A regulation is soon to come into force that will address this and introduce a more efficient clinical trial application process. However, at the marketing authorisation stage, the process is pan-national: the Committee for Human Medicinal Products (CHMP) is responsible for giving the final scientific opinion on all EU marketing authorisation applications for cell therapies: favourable scientific opinions are passed to the European Commission (EC) for further consultation and, if successful, grant of a marketing authorisation valid in all 28 EU countries. In its review of applications for marketing authorisations (MAAs) for cell therapies, the CHMP is obliged to consult the Committee for Advanced Therapies (CAT), who conduct detailed scientific assessments of these applications, with assessment by staff from national regulatory authorities and specialist advisors to the regulators. Copyright © 2015.

The role of the concept of "history of safe use" in the safety assessment of novel foods and novel food ingredients. Opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG).

PubMed

Engel, Karl-Heinz; Vogel, Rudi F; Knorr, Dietrich; Habermeyer, Michael; Kochte-Clemens, Barbara; Eisenbrand, Gerhard

2011-06-01

The Council of the European Union has proposed a revision on the EU regulation on novel foods and novel food ingredients concerning safety assessment of traditional foods from non-EU countries and their introduction onto the EU market. The proposal stipulates that such foods may be placed on the EU market if their history of safe use in the country of origin is appropriately documented. The present statement of the SKLM gives an overview on current discussions on practical implementation of the "history of safe use" concept as well as examples of its application. The SKLM, in principle, agrees with these concepts, underscores, however, in connection with convincing evidence for a "history of safe use" the need for a range of additional information to achieve a comprehensive risk assessment. In the opinion of the SKLM such information must comprise compositional data as well as experience on adverse effects. A list of questions considered essential is presented. The following opinion was adopted on December 23rd 2010. Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

A System of Systems (SoS) Approach to transforming to a low carbon resource-efficient energy system: Insights for the European Union (EU)

NASA Astrophysics Data System (ADS)

Madani, K.; Jess, T.; Mahlooji, M.; Ristic, B.

2015-12-01

The world's energy sector is experiencing a serious transition from reliance on fossil fuel energy sources to extensive reliance on renewable energies. Europe is leading the way in this transition to a low carbon economy in an attempt to keep climate change below 2oC. Member States have committed themselves to reducing greenhouse gas emissions by 20% and increasing the share of renewables in the EU's energy mix to 20% by 2020. The EU has now gone a step further with the objective of reducing greenhouse gas emissions by 80-95% by 2050. Nevertheless, the short-term focus of the European Commission is at "cost-efficient ways" to cut its greenhouse gas emissions which forgoes the unintended impacts of a large expansion of low-carbon energy technologies on major natural resources such as water and land. This study uses the "System of Systems (SoS) Approach to Energy Sustainability Assessment" (Hadian and Madani, 2015) to evaluate the Relative Aggregate Footprint (RAF) of energy sources in different European Union (EU) member states. RAF reflects the overall resource-use efficiency of energy sources with respect to four criteria: carbon footprint, water footprint, land footprint, and economic cost. Weights are assigned to the four resource use efficiency criteria based on each member state's varying natural and economic resources to examine the changes in the desirability of energy sources based on regional resource availability conditions, and to help evaluating the overall resource use efficiency of the EU's energy portfolio. A longer-term strategy in Europe has been devised under the "Resource Efficient Europe" flagship imitative intended to put the EU on course to using resources in a sustainable way. This study will highlight the resource efficiency of the EU's energy sector in order to assist in a sustainable transition to a low carbon economy in Europe. ReferenceHadian S, Madani K (2015) A System of Systems Approach to Energy Sustainability Assessment: Are All Renewables Really Green? Ecological Indicators, 52, 194-206.

The Politics of Global Value Chains: Import-dependent Firms and EU–Asia Trade Agreements

PubMed Central

Eckhardt, Jappe; Poletti, Arlo

2015-01-01

In 2006, the European Commission released its Global Europe Communication, in which it announced a shift from a multilateral to a bilateral trade strategy. One of the key pillars of this new strategy was to strengthen the bilateral trade relations with key Asian countries. In contrast to existing analyses that focus on European Union (EU) decision makers’ agency, we propose an explanation for this notable shift in the EU’s trade policy that stresses the political role of import-dependent firms. In light of the increasing integration of such firms into global value chains, the article argues that a plausible case can be made, both theoretically and empirically, that import-dependent firms had a clear stake in the signing of preferential trade agreements between the EU and Asian countries and that their lobbying efforts significantly affected the EU’s decision to start negotiations with South Korea, India and Vietnam. PMID:28018131

Advertising of medical devices: foreign experience and Ukrainian practice.

PubMed

Pashkov, Vitalii; Harkusha, Andrii; Bytiak, Oleksii

Chosen European foreign policy vector for Ukraine establishes its obligation to enforce the process of adaptation of the EU law regulations in the internal legal policy. The approximation of Ukrainian law to the European Union (EU) "acquis communautaire" is not only the instrument for deepening our economic cooperation with the European Union, but also the important measure to enhance further development of Ukraine in general. National legislation, which regulate advertising and promotion of medical devices (MD), is not an exception. Some key points on legal regulation of abovementioned sphere is a base of this study. Ukrainian legislation, European Union`s Law Acts, EU's member-states law, WHO Acts and Recommendations, European Medical Technology Industry Association (EUCOMED) Acts. Article is based on dialectical, comparative, analytic, synthetic and comprehensive research methods. In accordance with Ukrainian legislation, there is no special law that concerns advertising on MD in Ukraine, this sphere is regulated by general law that named ≪About advertisement≫, but it doesn't take into account even main characteristics of such a special object as medical devices (MD). Moreover, the law ≪About advertisement≫ contain discrepancies in terms that are used, these contradictions, in our opinion, must be eliminated by appropriate law reforms. The advertising and promotion of MD in EU is regulated by a combination of EU and national legislation of EU Member States, national advertising and promotion of MD are not harmonized with the EU MDD for now, resulting in a fragmented legal landscape that differs from one EU Member State to the other. Practice of adopting different codes and guides that regulate advertising, including advertising of MD, is widespread in EU and EU Member States and thus must be used in Ukraine with appropriate reformation of national law.

Report on the Joint EU-US Workshop on Microbial Community Dynamics: Cooperation and Competition

DOE Office of Scientific and Technical Information (OSTI.GOV)

Wall, Judy D.

2013-07-01

The European Commission (EC)-United States (US) Task Force on Biotechnology Research has a longstanding joint Working Group on Biotechnology for the Environment whose mission is to foster collaborations between researchers in the European Union (EU) and US in the field of environmental biotechnology. A special focus of the Working Group is to increase scientific interchange between early career scientists in the US and EU. Such interactions initiate a foundation of respect and trust needed to develop long-term collaborations. In order to realize the full potential for the application of modern technologies to obtain a sustainable biosphere, it is vital tomore » create conduits for knowledge exchange among scientists worldwide engaged in environmental microbial biotechnology research. Since its formation in 1994, the Working Group has organized many activities for early career scientists designed to promote this scientific exchange, including two week courses with hands-on research experience, intensive workshops of two or three days, and research scholar exchanges of one to six months. These interactions are focused on environmental problems that respect no international boundaries.« less

Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union.

PubMed

Pignatti, Francesco; Ehmann, Falk; Hemmings, Robert; Jonsson, Bertil; Nuebling, Micha; Papaluca-Amati, Marisa; Posch, Martin; Rasi, Guido

2014-03-15

The European Union (EU) legal framework for medical device regulation is currently under revision. The European Commission has proposed a new framework to ensure that medical devices serve the needs and ensure the safety of European citizens, aiming for a framework that is fit for purpose, more transparent, and better adapted to scientific and technological progress. The proposed new framework is described as an evolution of the current regime keeping the same legal approach. An important proposed change is that companion diagnostics will no longer be considered as low risk and subject to self-certification by the manufacturer. According to the new proposal, companion diagnostics will be classified as high individual risk or moderate public health risk (category C) and require conformity assessment by a notified body. It has also been proposed that evidence of the clinical utility of the device for the intended purpose should be required for companion diagnostics. In this article, we review the EU legal framework relevant for companion diagnostics, describe the proposed changes, and summarize the available scientific guidance from the European Medicines Agency and its regulatory experience with cancer drug development including companion diagnostics. See all articles in this CCR Focus section, "The Precision Medicine Conundrum: Approaches to Companion Diagnostic Co-development." ©2014 AACR.

Distance Training in the European Union. ZIFF Papiere 96.

ERIC Educational Resources Information Center

Keegan, Desmond

A study examined distance training in the European Union (EU) countries. First, recent literature on the following topics was reviewed: technology-supported learning, flexible and distance learning, development of open distance learning, and teleconferencing and distance learning. Next, enrollments and trends in distance learning in the EU as a…

Solving employment problems in the European Union: The role of energy efficiency

DOE Office of Scientific and Technical Information (OSTI.GOV)

Wiltshire, V.

1998-07-01

This paper is based on a project funded under the European Commission's SAVE (Specific Actions for Vigorous Energy Efficiency) program. The project is looking at the employment implications of energy efficiency programs, using a large number of case studies throughout the nine European Union (EU) countries participating in the project. Various modeling techniques are being used to investigate policy scenarios. The EU is particularly interested in looking at employment potential of energy efficiency at the present time. Traditionally, jobs in the environmental sector have only been seen as occurring in end-of-pipe type industries, such as pollution control; but a largemore » potential for employment opportunities has now been recognized in the energy efficiency sector. Included in the study will be a detailed discussion of the quality, as well as the quantity, of jobs created, i.e. what skill levels will be required and the types of people who would wish to undertake the work. The qualitative aspect of jobs will be looked at for their suitability for solving EU and country specific problems, such as long term unemployment of unskilled workers. This paper will present some initial results from the study and discuss the issues raised by it and by other recent work in this area. Such issues include not only the types and numbers of jobs directly created through the programs, but also indirect effects on the local, national and international economies. The negative effects, such as the reduced energy usage effect on the supply industry will also be examined.« less

Fuel switching in the electricity sector under the EU ETS: Review and prospective

DOE Office of Scientific and Technical Information (OSTI.GOV)

Delarue, E.; Voorspools, K.; D'haeseleer, W.

2008-06-15

The European Union has implemented the European Union emission trading scheme (EU ETS) as an instrument to facilitate greenhouse gas (GHG) emission abatement stipulated in the Kyoto protocol. Empirical data show that in the early stages of the EU ETS, the value of a ton of CO{sub 2} has already led to emission abatement through switching from coal to gas in the European electric power sector. In the second part of this paper, an electricity generation simulation model is used to perform simulations on the switching behavior in both the first and the second trading periods of the EU ETS.more » In 2005, the reduction in GHG emissions in the electric power sector due to EU ETS is estimated close to 88 Mton. For the second trading period, a European Union allowance (EUA) price dependent GHG reduction curve has been determined. The obtained switching potential turns out to be significant, up to 300 Mton/year, at sufficiently high EUA prices.« less

EuCARD 2010: European coordination of accelerator research and development

NASA Astrophysics Data System (ADS)

Romaniuk, Ryszard S.

2010-09-01

Accelerators are basic tools of the experimental physics of elementary particles, nuclear physics, light sources of the fourth generation. They are also used in myriad other applications in research, industry and medicine. For example, there are intensely developed transmutation techniques for nuclear waste from nuclear power and atomic industries. The European Union invests in the development of accelerator infrastructures inside the framework programs to build the European Research Area. The aim is to build new accelerator research infrastructures, develop the existing ones, and generally make the infrastructures more available to competent users. The paper summarizes the first year of activities of the EU FP7 Project Capacities EuCARD -European Coordination of Accelerator R&D. EuCARD is a common venture of 37 European Accelerator Laboratories, Institutes, Universities and Industrial Partners involved in accelerator sciences and technologies. The project, initiated by ESGARD, is an Integrating Activity co-funded by the European Commission under Framework Program 7 - Capacities for a duration of four years, starting April 1st, 2009. Several teams from this country participate actively in this project. The contribution from Polish research teams concerns: photonic and electronic measurement - control systems, RF-gun co-design, thin-film superconducting technology, superconducting transport infrastructures, photon and particle beam measurements and control.

Naval War College Review. Volume 64, Number 1, Winter 2011

DTIC Science & Technology

2011-01-01

2010, a Chinese delegation headed by Major General Li Ning, the defense counselor for the Chinese mission to the European Union , visited the...headquarters of European Union Naval Force (EU NAVFOR) Somalia in Djibouti.52 Djibouti would be an excellent choice as a place for the PLAN, and it should...France’s Base Aérienne 188 is home to the headquarters of EU NAVFOR Somalia/Operation ATALANTA, the European Union naval force tasked with

Final report of coordination and cooperation with the European Union on embankment failure analysis

USDA-ARS?s Scientific Manuscript database

There has been an emphasis in the European Union (EU) community on the investigation of extreme flood processes and the uncertainties related to these processes. Over a 3-year period, the EU and the U.S. dam safety community (1) coordinated their efforts and collected information needed to integrate...

Latvia Country Analysis Brief

EIA Publications

2014-01-01

Latvia, which regained its independence from Soviet Union in 1991 and joined the European Union (EU) in 2004, is not a notable energy producer or consumer. The country produced 30 trillion British thermal units (Btus) and consumed 163 trillion Btus of total energy in 2011, which places it in the bottom five among the EU countries on both measures.

Data Resource Profile: The European Union Statistics on Income and Living Conditions (EU-SILC).

PubMed

Arora, Vishal S; Karanikolos, Marina; Clair, Amy; Reeves, Aaron; Stuckler, David; McKee, Martin

2015-04-01

Social and economic policies are inextricably linked with population health outcomes in Europe, yet few datasets are able to fully explore and compare this relationship across European countries. The European Union Statistics on Income and Living Conditions (EU-SILC) survey aims to address this gap using microdata on income, living conditions and health. EU-SILC contains both cross-sectional and longitudinal elements, with nationally representative samples of individuals 16 years and older in 28 European Union member states as well as Iceland, Norway and Switzerland. Data collection began in 2003 in Belgium, Denmark, Ireland, Greece, Luxembourg and Austria, with subsequent expansion across Europe. By 2011, all 28 EU member states, plus three others, were included in the dataset. Although EU-SILC is administered by Eurostat, the data are output-harmonized so that countries are required to collect specified data items but are free to determine sampling strategies for data collection purposes. EU-SILC covers approximately 500,000 European residents for its cross-sectional survey annually. Whereas aggregated data from EU-SILC are publicly available [http://ec.europa.eu/eurostat/web/income-and-living-conditions/data/main-tables], microdata are only available to research organizations subject to approval by Eurostat. Please refer to [http://epp.eurostat.ec.europa.eu/portal/page/portal/microdata/eu_silc] for further information regarding microdata access. © The Author 2015; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

[European Union regulatory and quality requirements for botanical drugs and their implications for Chinese herbal medicinal products development].

PubMed

Zhu, You-Ping

2017-06-01

This paper introduces regulatory pathways and characteristic quality requirements for marketing authorization of herbal medicinal products in the European Union（EU）, and the legal status and applications of "European Union list of herbal substances, preparations and combinations" and "European Union herbal monographs". Also introduced are Chinese herbs that have been granted the EU list entry, those with EU herbal monographs, and registered EU traditional herbal medicinal products with Chinese herbs as active ingredients. Special attention is paid to the technical details of three authorized EU herbal medicinal products (Veregen, Sativex and Episalvan) in comparison with Andrographis paniculata extract HMPL-004 that failed the phase Ⅲ clinical trial for ulcerative colitis. The paper further emphasizes the importance of enriching active fractions of herbal extracts and taking regulatory and quality considerations into account in early stage of botanical drug development. Copyright© by the Chinese Pharmaceutical Association.

Proficiency testing to detect Trichinella larvae in meat in the European Union.

PubMed

Marucci, G; Tonanzi, D; Cherchi, S; Galati, F; Bella, A; Interisano, M; Ludovisi, A; Amati, A; Pozio, E

2016-11-15

According to the Commission Implementing Regulation (EU) 2015/1375 (replacing the Commission Regulation (EC) No 2075/2005), all animals, which are potential carriers of Trichinella spp. larvae, should be tested at the slaughterhouse or game-handling establishments according to one of the approved tests. One of the core duties of the European Union Reference Laboratory for Parasites is to organize proficiency testing (PT), as stated in the Commission Regulation (EC) No. 882/2004 of the European Parliament and of the Council. The aim of this work was to evaluate the results of PTs of the digestion method carried out by the National Reference Laboratories for Parasites (NRLPs) over a nine year period (2007-2015). Participating laboratories received a panel of samples consisting in 35g or 100g of minced pork or horse meat spiked with Trichinella spiralis live larvae. The number of spiked samples varied from 2 to 9 over the years. A negative control was also included in the panel, except during the 2015 PT, when only positive samples were used. The percentage of NRLPs, which passed the PT, increased from 83.3% in 2007 to 100% in 2014. Considering the number of recovered larvae, the heterogeneity in participant's results reduced overtime. The values of the overall mean difference between spiked and recovered larvae decreased during the study period, witnessing a general improvement of NRLPs performance and confirming the effectiveness of PT for a good performance of this test. Copyright © 2016 Elsevier B.V. All rights reserved.

European union standards for tuberculosis care.

PubMed

Migliori, G B; Zellweger, J P; Abubakar, I; Ibraim, E; Caminero, J A; De Vries, G; D'Ambrosio, L; Centis, R; Sotgiu, G; Menegale, O; Kliiman, K; Aksamit, T; Cirillo, D M; Danilovits, M; Dara, M; Dheda, K; Dinh-Xuan, A T; Kluge, H; Lange, C; Leimane, V; Loddenkemper, R; Nicod, L P; Raviglione, M C; Spanevello, A; Thomsen, V Ø; Villar, M; Wanlin, M; Wedzicha, J A; Zumla, A; Blasi, F; Huitric, E; Sandgren, A; Manissero, D

2012-04-01

The European Centre for Disease Prevention and Control (ECDC) and the European Respiratory Society (ERS) jointly developed European Union Standards for Tuberculosis Care (ESTC) aimed at providing European Union (EU)-tailored standards for the diagnosis, treatment and prevention of tuberculosis (TB). The International Standards for TB Care (ISTC) were developed in the global context and are not always adapted to the EU setting and practices. The majority of EU countries have the resources and capacity to implement higher standards to further secure quality TB diagnosis, treatment and prevention. On this basis, the ESTC were developed as standards specifically tailored to the EU setting. A panel of 30 international experts, led by a writing group and the ERS and ECDC, identified and developed the 21 ESTC in the areas of diagnosis, treatment, HIV and comorbid conditions, and public health and prevention. The ISTCs formed the basis for the 21 standards, upon which additional EU adaptations and supplements were developed. These patient-centred standards are targeted to clinicians and public health workers, providing an easy-to-use resource, guiding through all required activities to ensure optimal diagnosis, treatment and prevention of TB. These will support EU health programmes to identify and develop optimal procedures for TB care, control and elimination.

Gender, Jobs and Working Conditions in the European Union.

ERIC Educational Resources Information Center

Fagan, Colette; Burchell, Brendan

Trends in gender, jobs, and working conditions in the European Union (EU) were examined. In 2000, representative samples of approximately 1,500 workers in each of the EU member states (500 in Luxembourg) were surveyed. To identify trends, the survey findings were compared with those of similar surveys conducted in 1991 and 1996. The comparison…

Is the European (Active) Citizenship Ideal Fostering Inclusion within the Union? A Critical Review

ERIC Educational Resources Information Center

Milana, Marcella

2008-01-01

This article reviews: (1) the establishment and functioning of EU citizenship: (2) the resulting perception of education for European active citizenship; and (3) the question of its adequacy for enhancing democratic values and practices within the Union. Key policy documents produced by the EU help to unfold the basic assumptions on which…

Multi-Level Steering and Institution Building: The European Union's Approach to Research Policy

ERIC Educational Resources Information Center

Young, Mitchell

2012-01-01

Adopting the conception of the university as a primary driver of innovation and economic growth has brought increased pressure for the European Union (EU) to actively steer university-based research policy, despite its being outside of the EU's direct jurisdiction. While the open method of coordination (OMC) was developed for such situations, the…

Rapid and selective determination of multi-sulfonamides by high-performance thin layer chromatography coupled to fluorescent densitometry and electrospray ionization mass detection.

PubMed

Chen, Yisheng; Schwack, Wolfgang

2014-02-28

In the European Union (EU), sulfonamides are among the most widely administrated groups of antibiotics in animal husbandry. Therefore, monitoring their residues in edible animal tissues plays an important role in the EU food safety framework. In this work, a simple and efficient method for the rapid screening of twelve prior sulfonamides frequently prescribed as veterinary drugs by high-performance thin-layer chromatography (HPTLC) was established. Sample extracts obtained with acetonitrile were tenfold concentrated and applied to HPTLC without any further cleanup. Following separation and fluram derivatization, sensitive and selective quantitation of the analytes can readily be accomplished with fluorescent densitometry. Limits of detection and quantitation were 15-40 and 35-70μg/kg, respectively. Additionally, a confirmative detection by HPTLC-electrospray ionization mass spectrometry (HPTLC-ESI/MS) was optimized, offering straightforward identification of target zones. Therefore, the risk of potential false positive findings can efficiently be reduced. The method was validated to meet the enforced commission regulation (EU) No. 37/2010, regarding different matrix complexities (bovine milk, porcine liver and kidney). Copyright © 2014 Elsevier B.V. All rights reserved.

Healthcare access and mobility between the UK and other European Union states: an 'implementation surplus'.

PubMed

Sheaff, R

1997-12-01

European Union (EU) policy on mobility requires ensuring healthcare access for EU residents who travel between EU states. This case-study investigates how this policy has been implemented in respect of EU visitors to the UK. EU visitors to the UK have similar access to 'immediately needed' National Health Service (NHS) healthcare to UK residents. For non-urgent healthcare, the NHS has official systems to discourage 'medical tourism' and divert such patients to the private sector or to reclaim the costs of NHS hospital treatment for EU visitors. Yet these official systems contrast with the flexibility and liberality of actual NHS practice towards EU visitors. Research on health policy implementation mostly examines reasons for 'implementation failure'. However, the present study indicates a health policy being implemented more fully than policy-makers may have anticipated. In the case of healthcare access for EU visitors to the UK, an implementation surplus is evident rather than an implementation deficit.

HELCOM Baltic Sea Action Plan--a regional programme of measures for the marine environment based on the Ecosystem Approach.

PubMed

Backer, Hermanni; Leppänen, Juha-Markku; Brusendorff, Anne Christine; Forsius, Kaj; Stankiewicz, Monika; Mehtonen, Jukka; Pyhälä, Minna; Laamanen, Maria; Paulomäki, Hanna; Vlasov, Nikolay; Haaranen, Tarja

2010-05-01

The Helsinki Commission (HELCOM) Baltic Sea Action Plan, adopted by the coastal countries of the Baltic Sea and the European Community in November 2007, is a regional intergovernmental programme of measures for the protection and management of the marine environment explicitly based on the Ecosystem Approach. The Action Plan is structured around a set of Ecological Objectives used to define indicators and targets, including effect-based nutrient input ceilings, and to monitor implementation. The Action Plan strongly links Baltic marine environmental concerns to important socio-economic fields such as agriculture and fisheries and promotes cross-sectoral tools including marine spatial planning. Due to complementarities with the European Union (EU) Marine Strategy Framework Directive, the Action Plan is in essence a pilot for this process without neglecting the important role of the Russian Federation - the only Baltic coastal country not a member of the EU. (c) 2009 Elsevier Ltd. All rights reserved.

Policy needs and options for a common transatlantic approach towards measuring adoption, usage and benefits of eHealth.

PubMed

Stroetmann, Karl A; Middleton, Blackford

2011-01-01

The European Union (EU) sponsored ARGOS project analysed current eHealth policy thinking in both the EU and the USA, compared strategic challenges and outcomes in selected fields, and drafted roadmaps towards developing advanced global approaches for these issues. This policy brief focuses on better understanding the benefits and costs of eHealth investments, assessing their overall socio-economic impact, identifying challenges and success factors, as well as measuring and globally benchmarking the concrete usage of eHealth solutions. These are by now key policy priorities not only of national governments and the European Commission, but also of international institutions like WHO or OECD. There is a strong felt transatlantic need for stocktaking, identifying lessons learned, sharing of experience, and working together to advance these issues for the benefit of health systems. A growing number of national and international activities can be taken advantage of. Recommendations on how to proceed with such transatlantic activities are proposed.

Old wine in new bottles: Tobacco industry's submission to European Commission tobacco product directive public consultation

PubMed Central

Hiilamo, Heikki; Glantz, Stanton A.

2015-01-01

Between September and December 2010 the European Commission Health & Consumer Protection Directorate-General (DGSANCO) held a public consultation on a possible revision of the European Union Tobacco Products Directive (2001/37/EC). We used content analysis of the tobacco industry's and related parties' 300 submissions to the public consultation to determine if tobacco industry and its allies in Europe are prepared to reduce harm of the tobacco products as their public statements assert. The industry submission resorted to traditional tobacco industry arguments where illicit trade and freedom of choice were emphasized and misrepresented the conclusions of a DGSANCO-commissioned scientific report on smokeless tobacco products. Retailers and wholesalers referred to employment and economic growth more often than respondents from other categories. The pattern of responses in the submission differed dramatically from independent public opinion polls of EU citizens' support for tobacco control policies. None of the major tobacco manufacturers or their lobbying organizations supported any of the DGSANCO's proposed evidence based interventions (pictorial health warnings, plain packaging or point-of-sale display bans) to reduce harms caused by cigarette smoking. PMID:25467283

Economic efficiency versus social equality? The U.S. liberal model versus the European social model.

PubMed

Navarro, Vicente; Schmitt, John

2005-01-01

This article begins by challenging the widely held view in neoliberal discourse that there is a necessary trade-off between higher efficiency and lower reduction of inequalities: the article empirically shows that the liberal, U.S. model has been less efficient economically (slower economic growth, higher unemployment) than the social model in existence in the European Union and in the majority of its member states. Based on the data presented, the authors criticize the adoption of features of the liberal model (such as deregulation of their labor markets, reduction of public social expenditures) by some European governments. The second section analyzes the causes for the slowdown of economic growth and the increase of unemployment in the European Union--that is, the application of monetarist and neoliberal policies in the institutional frame of the European Union, including the Stability Pact, the objectives and modus operandi of the European Central Bank, and the very limited resources available to the European Commission for stimulating and distributive functions. The third section details the reasons for these developments, including (besides historical considerations) the enormous influence of financial capital in the E.U. institutions and the very limited democracy. Proposals for change are included.

Health impact assessment: assessing opportunities and barriers to intersectoral health improvement in an expanded European Union

PubMed Central

Lock, K.; McKee, M.

2005-01-01

On 1 May 2004 the European Union (EU) underwent unprecedented enlargement, from 15 to 25 countries, increasing its population by 20% to over 450 million. Although EU law has limited specific competence in the area of health, its influence on other policy sectors such as agriculture, trade, and employment has wide ranging implications for health. Yet with the exception of provisions on communicable disease control and food safety, public health considerations have played little part in negotiations on EU accession. This paper argues for an intersectoral public health approach in the expanded EU. It reviews the legal basis for assessing the health impacts of policy in the EU and, using health impact assessment as a case study, it examines how well the new member states may be prepared to tackle intersectoral public health action within the constraints imposed by EU policy. PMID:15831682

Land of the free, home of the (un)regulated: A look at market-building and liberalization in the EU and the US

NASA Astrophysics Data System (ADS)

Hoffmann, Leif Soren Birger Per Ove Holm

In my dissertation I argue that because the European Union and the United States of America have been largely treated as unique or at least special cases, both the literature on American-state building and that on European market integration have missed how close comparison alters both our descriptive views and social-scientific explanations of the shape of each polity. In particular, scholars have not sufficiently recognized that the European Union has gone further than the United States in many elements of the creation of a centralized, liberalized single market, nor have they produced explanations that account well for this development. This study challenges the dominant assumption that the United States is generally more hierarchical and centralized than the European Union and more of a single free market in the sense of fewer allowable trade barriers. By analyzing the rules of market integration in services (over 70% of GDP), public procurement (15 -- 20% GDP) and the regulated goods markets (goods like elevators with their own regulatory regimes), I demonstrate that in all these major cases the European Union has adopted rules that open exchange to competition more than the United States. While the actual integration of flows on the ground is still generally less across European states than American ones, the political rules are more - and more liberally - integrated in Europe. I offer an institutional and ideational argument to explain these differences, with two main parts. First, there is no American parallel to the institution of the European Commission, which is mandated to continually push liberalization forward. My research shows that Commission leadership has been critical to each of the examined cases. Second, broader norms of legitimate governance favor centralized authority - including liberalizing central authority - more in the European Union than in the United States. Despite all the criticism we hear of the European Union, the basic notion of federal governance of market integration is far more strongly accepted across Europe at both elite and mass levels than in the United States. As interview evidence in this study displays, many Americans consistently object to any role for the federal government.

Political legitimacy and European monetary union: contracts, constitutionalism and the normative logic of two-level games

PubMed Central

Bellamy, Richard; Weale, Albert

2015-01-01

ABSTRACT The crisis of the euro area has severely tested the political authority of the European Union (EU). The crisis raises questions of normative legitimacy both because the EU is a normative order and because the construction of economic and monetary union (EMU) rested upon a theory that stressed the normative value of the depoliticization of money. However, this theory neglected the normative logic of the two-level game implicit in EMU. It also neglected the need for an impartial and publically acceptable constitutional order to acknowledge reasonable disagreements. By contrast, we contend that any reconstruction of the EU's economic constitution has to pay attention to reconciling a European monetary order with the legitimacy of member state governance. The EU requires a two-level contract to meet this standard. Member states must treat each other as equals and be representative of and accountable to their citizens on an equitable basis. These criteria entail that the EU's political legitimacy requires a form of demoicracy that we call ‘republican intergovernmentalism’. Only rules that could be acceptable as the product of a political constitution among the peoples of Europe can ultimately meet the required standards of political legitimacy. Such a political constitution could be brought about through empowering national parliaments in EU decision-making. PMID:26924935

Political legitimacy and European monetary union: contracts, constitutionalism and the normative logic of two-level games.

PubMed

Bellamy, Richard; Weale, Albert

2015-02-07

The crisis of the euro area has severely tested the political authority of the European Union (EU). The crisis raises questions of normative legitimacy both because the EU is a normative order and because the construction of economic and monetary union (EMU) rested upon a theory that stressed the normative value of the depoliticization of money. However, this theory neglected the normative logic of the two-level game implicit in EMU. It also neglected the need for an impartial and publically acceptable constitutional order to acknowledge reasonable disagreements. By contrast, we contend that any reconstruction of the EU's economic constitution has to pay attention to reconciling a European monetary order with the legitimacy of member state governance. The EU requires a two-level contract to meet this standard. Member states must treat each other as equals and be representative of and accountable to their citizens on an equitable basis. These criteria entail that the EU's political legitimacy requires a form of demoi cracy that we call 'republican intergovernmentalism'. Only rules that could be acceptable as the product of a political constitution among the peoples of Europe can ultimately meet the required standards of political legitimacy. Such a political constitution could be brought about through empowering national parliaments in EU decision-making.

European Union Standards for Tuberculosis Care

PubMed Central

Migliori, G.B.; Zellweger, J.P.; Abubakar, I.; Ibraim, E.; Caminero, J.A.; De Vries, G.; D'Ambrosio, L.; Centis, R.; Sotgiu, G.; Menegale, O.; Kliiman, K.; Aksamit, T.; Cirillo, D.M.; Danilovits, M.; Dara, M.; Dheda, K.; Dinh-Xuan, A.T.; Kluge, H.; Lange, C.; Leimane, V.; Loddenkemper, R.; Nicod, L.P.; Raviglione, M.C.; Spanevello, A.; Thomsen, V.Ø.; Villar, M.; Wanlin, M.; Wedzicha, J.A.; Zumla, A.; Blasi, F.; Huitric, E.; Sandgren, A.; Manissero, D.

2012-01-01

The European Centre for Disease Prevention and Control (ECDC) and the European Respiratory Society (ERS) jointly developed European Union Standards for Tuberculosis Care (ESTC) aimed at providing European Union (EU)-tailored standards for the diagnosis, treatment and prevention of tuberculosis (TB). The International Standards for TB Care (ISTC) were developed in the global context and are not always adapted to the EU setting and practices. The majority of EU countries have the resources and capacity to implement higher standards to further secure quality TB diagnosis, treatment and prevention. On this basis, the ESTC were developed as standards specifically tailored to the EU setting. A panel of 30 international experts, led by a writing group and the ERS and ECDC, identified and developed the 21 ESTC in the areas of diagnosis, treatment, HIV and comorbid conditions, and public health and prevention. The ISTCs formed the basis for the 21 standards, upon which additional EU adaptations and supplements were developed. These patient-centred standards are targeted to clinicians and public health workers, providing an easy-to-use resource, guiding through all required activities to ensure optimal diagnosis, treatment and prevention of TB. These will support EU health programmes to identify and develop optimal procedures for TB care, control and elimination. PMID:22467723

Scientific collaboration between 'old' and 'new' member states: Did joining the European Union make a difference?

PubMed

Makkonen, Teemu; Mitze, Timo

This paper provides new insights on the effects of the enlargement of the European Union (EU) and European integration by investigating the issue of scientific collaboration within the new EU member states vis - à - vis the old EU member states. The question addressed is whether the EU membership following the two enlargement waves 2004 and 2007 has significantly increased the co-publication intensity of the new member states with other member countries. The empirical results based on data collected from the Web of Science database and Difference-in-Difference estimations point towards a conclusion that joining the EU indeed has had an additional positive impact on the co-publication intensity between the new and old member states and, in particular, within the new member states themselves. These results give tentative support for the successfulness of the EU's science policies in achieving a common 'internal market' in research. We also find evidence for early anticipation effects of the consecutive EU accession.

Changes in Estonian General Education from the Collapse of the Soviet Union to EU Entry

ERIC Educational Resources Information Center

Krull, Edgar; Trasberg, Karmen

2006-01-01

This article introduces and discusses the nature and development of Estonian system of general education in the period of last thirty years. The main focus is paid on the changes resulting from the collapse of the Soviet Union and the period of integration leading up to EU entry. Also changes in other spheres of education and social life are…

A Comparative Analysis of E-Learning Policy Formulation in the European Union and the United States: Discursive Convergence and Divergence

ERIC Educational Resources Information Center

Erichsen, Elizabeth Roumell; Salajan, Florin D.

2014-01-01

This study developed a framework that compares the content and purposes of "federal" level European Union (EU) and United States (US) e-learning policy to ascertain trends, patterns, and points of convergence and divergence across the years 1994-2010. It reveals that the EU and US are applying similar rhetoric for policy framing,…

European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health

PubMed Central

Bates, C; Fagerstrom, K; Jarvis, M; Kunze, M; McNeill, A; Ramstrom, L

2003-01-01

Rationale: This statement is an updated version of one released by the same authors in February 2003. The statement was produced to follow up the Royal College of Physicians (RCP) Tobacco Advisory Group report "Protecting smokers, saving lives: the case for a tobacco and nicotine regulatory authority",1 which argued for an evidence based regulatory approach to smokeless tobacco and harm reduction and posed a series of questions that regulators must address in relation to smokeless tobacco. The purpose of this statement is to provide arguments of fact and principle to follow the RCP's report and to outline the public health case for changing existing European Union (EU) regulation in this area. A review of regulation in relation to harm reduction and regulation of tobacco products other than cigarettes is required in Article 11 of EU directive 2001/37/EC,2 and this is a contribution towards forming a consensus in the European public health community about what policy the EU should adopt in the light of this review, or following ongoing legal action that may potentially strike out the existing regulation altogether. Public health case: We believe that the partial ban applied to some forms of smokeless tobacco in the EU should be replaced by regulation of the toxicity of all smokeless tobacco. We hold this view for public health reasons: smokeless tobacco is substantially less harmful than smoking and evidence from Sweden suggests it is used as a substitute for smoking and for smoking cessation. To the extent there is a "gateway" it appears not to lead to smoking, but away from it and is an important reason why Sweden has the lowest rates of tobacco related disease in Europe. We think it is wrong to deny other Europeans this option for risk reduction and that the current ban violates rights of smokers to control their own risks. For smokers that are addicted to nicotine and cannot or will not stop, it is important that they can take advantage of much less hazardous forms of nicotine and tobacco—the alternative being to "quit or die"... and many die. While nicotine replacement therapies (NRT) may have a role in harm reduction, tobacco based harm reduction options may reach more smokers and in a different, market based, way. Chewing tobacco is not banned or regulated in the EU but is often highly toxic, and our proposal could remove more products from the market than it permitted. Regulatory options: We believe that the EU policy on smokeless tobacco should adapt to new scientific knowledge and that the European Commission should bring forward proposals to amend or replace Article 8 of directive 2001/37/EC with a new regulatory framework. Canada has developed testing regimens for tobacco constituents and these could be readily adapted to the European situation. A review of EU policy in this area is required no later than December 2004, and we believe the Commission should expedite the part of its review that deals with harm reduction and regulation of tobacco products other than cigarettes so as to reconsider its policy on smokeless tobacco. We held this view before Swedish Match brought its legal proceedings to challenge EU legislation and we will continue to hold these views if its action fails. PMID:14660767

E-Learning and Training in Europe: A Survey into the Use of e-Learning in Training and Professional Development in the European Union. CEDEFOP Reference Series.

ERIC Educational Resources Information Center

European Centre for the Development of Vocational Training, Thessaloniki (Greece).

A study investigated the extent of e-learning learning supported by information and communication technologies (ICT) methods in vocational education and training (VET) in the European Union (EU). The survey conducted via the Internet received 653 replies from organizations in the EU. Just over 80 percent of respondents were suppliers or users of…

Cancer research performance in the European Union: a study of published output from 2000 to 2008.

PubMed

Micheli, Andrea; Di Salvo, Francesca; Lombardo, Claudio; Ugolini, Donatella; Baili, Paolo; A Pierotti, Marco

2011-01-01

Although several studies have assessed cancer research performance in individual European countries, comparisons of European Union (EU27) performance with countries of similar population size are not available. We compared cancer research performance in 2000-2008 between EU27 and 11 countries with over 100 million inhabitants. Performance should not have been affected by the 2007-2009 recession. We examined 143 journals considered oncology journals by Journal Citation Reports, accessing them via Scopus. Publications were attributed to countries using a published counting procedure. For number of publications, the USA held a clear lead in 2006-2008 (yearly averages: 10,293 USA vs 9,962 EU27), whereas the EU27 held the lead previously. EU27 was also second to the USA for total impact factor. China markedly improved its cancer publications record over the period. Compared to the USA, EU27 and Japan, the other countries (all developing) had a poor publications record. Comparative cancer research spending data are not available. However from 2002 to 2007, gross domestic expenditure on research and development (UNESCO data) increased by 34% in North America, 161% in China and only 28% in EU27. Thus the European Union is lagging behind North America and may well be eclipsed by China in research and development spending in the near future. We suggest that these new findings should be considered by policymakers in Europe and other countries when developing policies for cancer control.

EU Rural Development Policy in the New Member States: Promoting Multifunctionality?

ERIC Educational Resources Information Center

Ramniceanu, Irina; Ackrill, Robert

2007-01-01

European Union (EU) enlargement has seen 10 new member states (NMS) adopt the full range of EU policies. Within this, the rural development arm of the Common Agricultural Policy offers particular points of interest. Member states chose from an extensive list of policy measures developed within the EU15 and intended, in particular, to…

DOE Office of Scientific and Technical Information (OSTI.GOV)

Verstraete, Frans, E-mail: Frans.Verstraete@ec.europa.eu

Directive 2002/32/EC of 7 May 2002 of the European Parliament and of the Council on undesirable substances in animal feed is the framework for the EU action on undesirable substances in feed. This framework Directive provides: ⁎that products intended for animal feed may enter for use in the Union from third countries, be put into circulation and/or used in the Union only if they are sound, genuine and of merchantable quality and therefore when correctly used do not represent any danger to human health, animal health or to the environment or could adversely affect livestock production. ⁎that in order tomore » protect animal and public health and the environment, maximum levels for specific undesirable substances shall be established where necessary. ⁎for mandatory consultation of a scientific body (EFSA) for all provisions which may have an effect upon public health or animal health or on the environment. ⁎that products intended for animal feed containing levels of an undesirable substance that exceed the established maximum level may not be mixed for dilution purposes with the same, or other, products intended for animal feed and may not be used for the production of compound feed. Based on the provisions and principles laid down in this framework Directive, maximum levels for a whole range of undesirable substances have been established at EU level. During the discussions in view of the adoption of Directive 2002/32/EC, the European Commission made the commitment to review all existing provisions on undesirable substances on the basis of updated scientific risk assessments. Following requests of the European Commission, the Panel on Contaminants in the Food Chain (CONTAM) from the European Food Safety Authority (EFSA) has completed a series of 30 risk assessments undertaken over the last 5 years on undesirable substances in animal feed reviewing the possible risks for animal and human health due to the presence of these substances in animal feed. EU legislation on undesirable substances has undergone recently several changes to take account of these most recent scientific opinions. Furthermore EFSA has assessed the risks for public and animal health following the unavoidable carry-over of coccidiostats into non target feed. Maximum levels for the unavoidable carry-over have been established for the non-target feed and the food of animal origin from non-target animal species.« less

European Union pharmacovigilance capabilities: potential for the new legislation

PubMed Central

Tanti, Amy; Kouvelas, Dimitrios; Lungu, Calin; Pirozynski, Michal; Serracino-Inglott, Anthony; Aislaitner, George

2015-01-01

European Directives and Regulations introduced between late 2010 and 2012 have substantially overhauled pharmacovigilance processes across the European Union (EU). In this review, the implementation of the pharmacovigilance legislative framework by EU regulators is examined with the aim of mapping Directive 2010/84/EU and Regulation EC No. 1235/2010 against their aspired objectives of strengthening and rationalizing pharmacovigilance in the EU. A comprehensive review of the current state of affairs of the progress made by EU regulators is presented in this paper. Our review shows that intense efforts by regulators and industry to fulfil legislative obligations have resulted in major positive shifts in pharmacovigilance. Harmonized decision making, transparency in decision processes with patient involvement, information accessibility to the public, patient adverse drug reaction reporting, efforts in communication and enhanced cooperation between member states to maximize resource utilization and minimize duplication of efforts are observed. PMID:26301067

[Analysis of difficult problems on European Union laws and regulations of traditional herbal medicinal products].

PubMed

Qu, Li-Ping; Zhang, Xiao-Qun; Xiong, Yan; Wang, Yi-Tao; Zou, Wen-Jun

2017-10-01

Registration of Chinese patent medicine in European Union (EU) is of great significance to the internationalization of traditional Chinese medicine as EU market acts as an important position in the global botanical market. In retrospect, the domestic studies on EU regulations of traditional herbal medicinal products have been conducted for more than 10 years, but there is still some cognitive bias and lack of research. In this paper, a review of the relevant research progress and the main misunderstanding problems about Directive 2004/24/EC, like the centralized and decentralized supervision system of traditional herbal medicinal products in the EU, marketing authorization procedures for traditional herbal medicinal products, Community Herbal Monograph and List Entries, would be systematically analyzed, so as to provide reference for the registration of Chinese patent medicine in EU. Copyright© by the Chinese Pharmaceutical Association.

The implementation of the Strategy Europe 2020 objectives in European Union countries: the concept analysis and statistical evaluation.

PubMed

Stec, Małgorzata; Grzebyk, Mariola

2018-01-01

The European Union (EU), striving to create economic dominance on the global market, has prepared a comprehensive development programme, which initially was the Lisbon Strategy and then the Strategy Europe 2020. The attainment of the strategic goals included in the prospective development programmes shall transform the EU into the most competitive economy in the world based on knowledge. This paper presents a statistical evaluation of progress being made by EU member states in meeting Europe 2020. For the basis of the assessment, the authors proposed a general synthetic measure in dynamic terms, which allows to objectively compare EU member states by 10 major statistical indicators. The results indicate that most of EU countries show average progress in realisation of Europe's development programme which may suggest that the goals may not be achieved in the prescribed time. It is particularly important to monitor the implementation of Europe 2020 to arrive at the right decisions which will guarantee the accomplishment of the EU's development strategy.

A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document.

PubMed

Cornel, Martina C; Rigter, Tessel; Weinreich, Stephanie S; Burgard, Peter; Hoffmann, Georg F; Lindner, Martin; Gerard Loeber, J; Rupp, Kathrin; Taruscio, Domenica; Vittozzi, Luciano

2014-01-01

The European Union (EU) Council Recommendation on rare diseases urged the member states to implement national and EU collaborative actions to improve the health care of rare disease patients. Following this recommendation, the European Commission launched a tender on newborn screening (NBS) to report on current practices of laboratory testing, form a network of experts and provide guidance on how to further implement NBS screening in a responsible way, the latter of which was provided in an Expert Opinion document. After consultation of experts from EU member states, (potential) candidate member states and European Free Trade Association countries, in a consensus meeting in June 2011, 70 expert opinions were finalized. They included the need to develop case definitions for all disorders screened for to facilitate assessment and international outcome studies. Decision whether a screening program should be performed can be based on screening criteria updated from the traditional Wilson and Jungner (1968) criteria, relating to disease, treatment, test and cost. The interest of the child should be central in the assessment of pros and cons. A European NBS body should assess evidence on (new) screening candidate disorders. For rare conditions, best level evidence should be used. The health system should ensure treatment to cases diagnosed by screening, controlled and revised by follow-up outcome studies. Screening methodology should aim to avoid unintended findings, such as mild forms and carrier status information, as much as possible. Activities to improve NBS in Europe, such as training and scientific evaluation, could benefit from collaboration at EU level and beyond.

Public health impacts of combustion emissions in the United Kingdom.

PubMed

Yim, Steve H L; Barrett, Steven R H

2012-04-17

Combustion emissions are a major contributor to degradation of air quality and pose a risk to human health. We evaluate and apply a multiscale air quality modeling system to assess the impact of combustion emissions on UK air quality. Epidemiological evidence is used to quantitatively relate PM(2.5) exposure to risk of early death. We find that UK combustion emissions cause ∼13,000 premature deaths in the UK per year, while an additional ∼6000 deaths in the UK are caused by non-UK European Union (EU) combustion emissions. The leading domestic contributor is transport, which causes ∼7500 early deaths per year, while power generation and industrial emissions result in ∼2500 and ∼830 early deaths per year, respectively. We estimate the uncertainty in premature mortality calculations at -80% to +50%, where results have been corrected by a low modeling bias of 28%. The total monetized life loss in the UK is estimated at £6-62bn/year or 0.4-3.5% of gross domestic product. In Greater London, where PM concentrations are highest and are currently in exceedance of EU standards, we estimate that non-UK EU emissions account for 30% of the ∼3200 air quality-related deaths per year. In the context of the European Commission having launched infringement proceedings against the UK Government over exceedances of EU PM air quality standards in London, these results indicate that further policy measures should be coordinated at an EU-level because of the strength of the transboundary component of PM pollution.

The 2011 PHARMINE report on pharmacy and pharmacy education in the European Union

PubMed Central

Atkinson, Jeffrey; Rombaut, Bart

The PHARMINE consortium consists of 50 universities from European Union member states or other European countries that are members of the European Association of Faculties of Pharmacy (EAFP). EU partner associations representing community (PGEU), hospital (EAHP) and industrial pharmacy (EIPG), together with the European Pharmacy Students’ Association (EPSA) are also part of the consortium. The consortium surveyed pharmacies and pharmacists in different settings: community, hospital, industry and other sectors. The consortium also looked at how European Union higher education institutions and courses are organised. The PHARMINE survey of pharmacy and pharmacy education in Europe produced country profiles with extensive information for EU member states and several other European countries. These data are available at: http://www.pharmine.org/losse_paginas/Country_Profiles/. This 2011 PHARMINE report presents the project and data, and some preliminary analysis on the basic question of how pharmacy education is adapted to pharmacy practice in the EU. PMID:24198854

The potential of transnational language policy to promote social inclusion of immigrants: An analysis and evaluation of the European Union's INCLUDE project

NASA Astrophysics Data System (ADS)

Bian, Cui

2017-08-01

Language issues and social inclusion consistently remain two major concerns for member countries of the European Union (EU). Despite an increasing awareness of the importance of language learning in migrants' social inclusion, and the promotion of language policies at European and national levels, there is still a lack of common actions at the European level. Challenged by questions as to whether language learning should be prioritised as a human right or as human capital building, how host/mainstream language learning can be reinforced while respecting language diversity, and other problems, member countries still need to find solutions. Confronting these dilemmas, this study analyses the relationship and interactions between language learning and immigrants' social inclusion in different contexts. It explores the potential of enhancing the effectiveness of language policies via a dialogue between policies and practices in different national contexts and research studies in the field of language and social inclusion. The research data are derived from two databases created by a European policy for active social inclusion project called INCLUDE. This project ran from 2013 to 2016 under the EU's lifelong learning programme, with funding support from the European Commission. Through an analysis of these two project databases, the paper reviews recent national language policies and their effect on the social inclusion of migrants. In the second part of her article, the author interprets the process of language learning and social inclusion using poststructuralist theories of language and identity.

Fungicide control of Phytophthora ramorum on rhododendron

Treesearch

Kurt Heungens; Isabelle De Dobbelaere; Martine Maes

2006-01-01

Commercial rhododendron plants have been the most important hosts of Phytophthora ramorum in Europe. As part of the European Union (EU) emergency phytosanitary measures 2002/757/EU and 2004/426/EU all commercial rhododendron-growing premises are surveyed for P. ramorum. Detection of P. ramorum leads to quarantine...

European activities in radiation protection in medicine.

PubMed

Simeonov, Georgi

2015-07-01

The recently published Council Directive 2013/59/Euratom ('new European Basic Safety Standards', EU BSS) modernises and consolidates the European radiation protection legislation by taking into account the latest scientific knowledge, technological progress and experience with implementing the current legislation and by merging five existing Directives into a single piece of legislation. The new European BSS repeal previous European legislation on which the national systems for radiation protection in medicine of the 28 European Union (EU) Member States are based, including the 96/29/Euratom 'BSS' and the 97/43/Euratom 'Medical Exposure' Directives. While most of the elements of the previous legislation have been kept, there are several legal changes that will have important influence over the regulation and practice in the field all over Europe-these include, among others: (i) strengthening the implementation of the justification principle and expanding it to medically exposed asymptomatic individuals, (ii) more attention to interventional radiology, (iii) new requirements for dose recording and reporting, (iv) increased role of the medical physics expert in imaging, (v) new set of requirements for preventing and following up on accidents and (vi) new set of requirements for procedures where radiological equipment is used on people for non-medical purposes (non-medical imaging exposure). The EU Member States have to enforce the new EU BSS before January 2018 and bring into force the laws, regulations and administrative provisions necessary to comply with it. The European Commission has certain legal obligations and powers to verify the compliance of the national measures with the EU laws and, wherever necessary, issue recommendations to, or open infringement cases against, national governments. In order to ensure timely and coordinated implementation of the new European legal requirements for radiation protection, the Commission is launching several actions including promotion and dissemination activities, exchange and discussion fora and provision of guidance. These actions will be based on previous experiences and will rely on the results of recent and ongoing EU-funded projects. Important stakeholders including the Euratom Article 31 Group, the association of the Heads of European Radiological protection Competent Authorities (HERCA) and different European professional and specialty organisations will be involved. © The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Science and alcohol policy: a case study of the EU Strategy on Alcohol.

PubMed

Gordon, Rebecca; Anderson, Peter

2011-03-01

To describe the extent to which the content of the European Commission's Communication on alcohol reflects public health-based scientific evidence. Document retrieval and content analysis. European Union. Background documents leading up to the European Commission's Communication on alcohol, the Communication itself and implementation actions following the Communication. Documents were read and analyzed for evidence-based alcohol policy content. Although the Communication acknowledges and supports existing interventions which have high evidence for effectiveness, such as enforcing blood alcohol concentration (BAC) limits for drivers, it extensively promotes other interventions which have been shown to be ineffective; for example, recommending education and persuasion strategies as a measure across all its five priority areas. Measures to influence price are mentioned only once in relation to sales in drinking venues limiting two-for-one drinks offers. Measures to control physical availability are mentioned infrequently. The Communication reflects the science, in that it acknowledges the significance of alcohol as a social and health determinant in Europe. However, it places more emphasis on policy actions with less evidence for effectiveness than on those with strong evidence. It also focuses its efforts more on mapping member state actions and coordinating knowledge exchange than on providing concrete recommendations for action or developing Europe-wide policy measures. This may be a compromise between the rights of Member States to develop national policy and legislation and the obligation of the European Union as a collaborative body to protect health. Furthermore, it has been suggested that the European Union's roots as a trading block emphasizes collaboration with industry stakeholders and this influences the ability to prioritize health over trade considerations. © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction.

Teaching Citizenship: What if the EU Is Part of the Solution and Not the Problem?

ERIC Educational Resources Information Center

Lödén, Hans; McCallion, Malin Stegmann; Wall, Peter

2014-01-01

We propose that the European Union (EU) should be used in citizenship education as a possible vehicle for citizens' influence on issues outside the reach of the nation-state. Citizenship education thus ought to include the EU as an arena for political action and relevant "EU knowledge" ought to be part of the curriculum. Concepts from…

Conjunctive Cohesion in English Language EU Documents--A Corpus-Based Analysis and Its Implications

ERIC Educational Resources Information Center

Trebits, Anna

2009-01-01

This paper reports the findings of a study which forms part of a larger-scale research project investigating the use of English in the documents of the European Union (EU). The documents of the EU show various features of texts written for legal, business and other specific purposes. Moreover, the translation services of the EU institutions often…

78 FR 38541 - Increase in Fees for Voluntary Federal Dairy Grading and Inspection Services

Federal Register 2010, 2011, 2012, 2013, 2014

2013-06-27

... 10 percent effective February 2014. The fees applicable to European Union Health Certification... European Union Health Certification Program derogation process. These actions will equally affect all...-resident service per European Union (EU) Health Certification Program derogation for somatic cell count and...

An Assessment of Coherence Between Early Warning and Response Systems and Serious Cross-Border Health Threats in the European Union and Turkey

PubMed Central

Elif Ekmekci, Perihan

2017-01-01

Disease outbreaks have attracted the attention of the public health community to early warning and response systems (EWRS) for communicable diseases and other cross-border threats to health. The European Union (EU) and the World Health Organization (WHO) have published regulations in this area. Decision 1082/2013/EU brought a new approach the management of public health threats in EU member states. Decision 1082/2013/EU brought several innovations, which included establishing a Health Security Committee; preparedness and response planning; joint procurement of medical countermeasures; ad hoc monitoring for biological, chemical, and environmental threats; EWRS; and recognition of an emergency situation and interoperability between various sectors. Turkey, as an acceding country to the EU and a member of the WHO, has been improving its national public health system to meet EU legislations and WHO standards. This article first explains EWRS as defined in Decision 1082/2013/EU and Turkey’s obligations to align its public health laws to the EU acquis. EWRS in Turkey are addressed, particularly their coherence with EU policies regarding preparedness and response, alert notification, and interoperability between health and other sectors. Finally, the challenges and limitations of the current Turkish system are discussed and further improvements are suggested. PMID:27511433

Nonreferral Unions and Equal Employment Opportunity. A Report of the United States Commission on Civil Rights.

ERIC Educational Resources Information Center

Davis, Barbara; And Others

In an effort to examine the role of international and local nonreferral unions in advancing the job status of minorities and women, the Equal Employment Opportunity Commission (EEOC) conducted a national survey of unions and employers and completed a legal analysis of the duty of unions to represent their members fairly. Among the key findings of…

Implementation of the Directive 2011/24/EU in the Czech Republic.

PubMed

Prudil, Lukás

2014-03-01

The article describes implementation of the Directive 2011/24/EU in the Czech Republic, its consequences with individual patient's rights and financing of healthcare for citizens of the European Union.

EU Employment and Social Policy, 1999-2001: Jobs, Cohesion, Productivity.

ERIC Educational Resources Information Center

Commission of the European Communities, Brussels (Belgium). Directorate-General for Employment and Social Affairs.

This document examines employment and social policy in the European Union in 1999-2001. The document begins with an interview with Anna Diamantopoulou, the European Union's commissioner for employment and social affairs and the paper "Balancing Jobs, Cohesion, and Productivity" by Odile Quintin, the European Union's director-general for…

Germany in Europe: Enduring Issues. Social Studies Grades 6-12. Update 2002.

ERIC Educational Resources Information Center

Blankenship, Glen; Moffitt, Louisa

This instructional package, consisting of a text and 27 transparencies, is designed for the middle and secondary school classroom. The unit focuses on three topics: (1) "Germany in the European Union (EU)" (four lessons focusing on history of the EU, characteristics of member states, and EU governance); (2) "Economic Issues in…

Export competitiveness of dairy products on global markets: the case of the European Union countries.

PubMed

Bojnec, Š; Fertő, I

2014-10-01

This paper analyzed the export competitiveness of dairy products of the European Union (EU) countries (EU-27) on intra-EU, extra-EU, and global markets, using the revealed comparative advantage index over the 2000-2011 period. The results indicated that about half of the EU-27 countries have had competitive exports in a certain segment of dairy products. The results differed by level of milk processing and for intra-EU and extra-EU markets, and did so over the analyzed years. Belgium, Denmark, France, Ireland, and the Netherlands are old EU-15 countries with competitive dairy exports (from the lowest to the highest according to the level of milk processing). The majority of the new EU-12 countries have faced difficulties in maintaining their level of export competitiveness, at least for some dairy products and market segments. The more competitive EU-12 countries in dairy exports were the Baltic States (Estonia, Latvia, and Lithuania) and Poland. The duration of export competitiveness differed across the dairy groups of products according to the level of milk processing, indicating the importance of dairy chain product differentiation for export competitiveness and specialization. The export competitiveness of the higher level of processed milk products for final consumption can be significant for export dairy chain competitiveness on global markets. Copyright © 2014 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Pharmacology and Therapeutics Education in the European Union Needs Harmonization and Modernization: A Cross‐sectional Survey Among 185 Medical Schools in 27 Countries

PubMed Central

Tichelaar, J; Okorie, M; Bissell, L; Christiaens, T; Likic, R; Mačìulaitis, R; Costa, J; Sanz, EJ; Tamba, BI; Maxwell, SR; Richir, MC; van Agtmael, MA

2017-01-01

Effective teaching in pharmacology and clinical pharmacology and therapeutics (CPT) is necessary to make medical students competent prescribers. However, the current structure, delivery, and assessment of CPT education in the European Union (EU) is unknown. We sent an online questionnaire to teachers with overall responsibility for CPT education in EU medical schools. Questions focused on undergraduate teaching and assessment of CPT, and students' preparedness for prescribing. In all, 185 medical schools (64%) from 27 EU countries responded. Traditional learning methods were mainly used. The majority of respondents did not provide students with the opportunity to practice real‐life prescribing and believed that their students were not well prepared for prescribing. There is a marked difference in the quality and quantity of CPT education within and between EU countries, suggesting that there is considerable scope for improvement. A collaborative approach should be adopted to harmonize and modernize the undergraduate CPT education across the EU. PMID:28295236

Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.

PubMed

Fears, Robin; Kaufmann, Stefan; Ter Meulen, Volker; Zumla, Alimuddin

2010-05-01

Tuberculosis (TB) is a leading cause of death globally. TB had been considered conquered in Europe but has re-emerged as a significant problem, partly because of poor TB control programs and the link with HIV infection, migrants and other vulnerable populations, but also because a mood of complacency led to declining investment in research and public health infrastructure. In the European Union (EU), efforts initiated by the European Academies Science Advisory Council (EASAC) now assess how research can better inform policy development and indicate the gaps and uncertainties in the scientific evidence base. A growing number of Mycobacterium tuberculosis (Mtb) strains are now resistant to the first-line anti-TB drugs, necessitating use of second-line drugs which are more expensive, less effective and more toxic. The presence of extensively drug-resistant (XDR) TB in the EU illustrates that there are problems with TB management and control. In the EU, the aggregated rate of notified TB is approximately 18 cases per 100,000 population (range 4-120 cases/100,000 in different Member States). The highest rates are found in Eastern European countries. Only about half of EU countries routinely perform drug susceptibility testing linked to notification of TB cases. It is important for the European Commission (EC) to network regional reference laboratories to support molecular epidemiology and exchange of data via creation of interactive international databases of Mtb genotypic and phenotypic information. EU countries should help develop TB laboratory services by investing in training and provision of assistance to maintain quality control in neighbouring Eastern European countries. Improved TB care necessitates research across the spectrum to include fundamental and epidemiological science, research and development (R&D) for new drugs, diagnostics, vaccines, and operational research. Total R&D investment in TB by the EC and Member States is low by comparison with the USA despite Europe being on the frontline of the epidemic. Thus, alternative funding models for targeting TB research priorities by the EU are required. Increasing the visibility of TB as a priority issue for the EU requires the scientific community, with the academies of science, as appropriate, to communicate to politicians, healthcare providers, funders and the public at large about the current threat posed by drug-resistant TB. Any global strategy for TB control must also take into account measures to address the social, environmental and economic issues which are inextricably linked with TB. The academies conclude that, overall, the EU has failed so far to respond sufficiently to the global TB threat but can still draw on considerable strengths in its science. The EU also has a humanitarian responsibility to support TB control in developing countries. It remains very important for the EC that neither biomedical research nor investment in health services should become a casualty of the current economic recession. Copyright 2010 Elsevier Ltd. All rights reserved.

Modeling the Impacts of EU Bioenergy Demand on the Forest Sector of the Southeast U.S.

Treesearch

Rafal Chudy; Robert C. Abt; Frederick W. Cubbage; Ragnar Jonsson; Jeffrey P. Prestemon

2013-01-01

The wood-pellet trade between the U.S. (United States) and the EU (European Union) has increased substantially recently. This research analyzes the effects of EU biomass imports from the Southeast U.S. on Southeast U.S. timber prices, inventories and production and on EU imports of feedstock. The SRTS (sub-regional timber supply model) was used to simulate market...

Inequalities in suicide rates in the European Union's elderly: trends and impact of macro-socioeconomic factors between 1980 and 2006.

PubMed

Innamorati, Marco; Tamburello, Antonino; Lester, David; Amore, Mario; Girardi, Paolo; Tatarelli, Roberto; Pompili, Maurizio

2010-04-01

To study suicide rates in elderly people in the former European Community, known as the European Union (EU) since late 1993, to identify differences between early members (admitted to the EU before 2004) and new members (admitted after 2004), and to evaluate the association between macro-socioeconomic variables and suicide rates. We explored temporal trends in age-adjusted suicide rates for people aged 65 years and older residing in the EU from 1980 to 2006. In the years examined in the study, there has been a general decrease in suicide rates in new and early members of the EU, although more slowly for elderly men than for women. The decrease in suicide rates of citizens aged 65 years and older was associated with a small but significant difference between new and early members of the EU (RR = 1.04, 95% CI 1.03 to 1.05; z = 11.95, P < 0.001). The macro-socioeconomic indices were strongly associated with age-adjusted suicide rates in EU senior citizens, except unemployment rates. Deaths by suicide in elderly people are declining in all EU nations, but inequalities in the suicide rates of men and women remain, especially in new EU members.

Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union

PubMed Central

Samoliński, B; Fronczak, A; Kuna, P; Akdis, C A; Anto, J M; Bialoszewski, A Z; Burney, P G; Bush, A; Czupryniak, A; Dahl, R; Flood, B; Galea, G; Jutel, M; Kowalski, M L; Palkonen, S; Papadopoulos, N; Raciborski, F; Sienkiewicz, D; Tomaszewska, A; Mutius, E; Willman, D; Włodarczyk, A; Yusuf, O; Zuberbier, T; Bousquet, J; Niggemann, Bodo

2012-01-01

The leading priority for the Polish Presidency of the Council of the European Union was to reduce health inequalities across European societies, and, within its framework, prevention and control of respiratory diseases in children. This very important paper contain proposal of international cooperation on the prevention, early detection and monitoring of asthma and allergic diseases in childhood which will be undertaken by the EU member countries as a result of EU conclusion developed during the Polish Presidency of the Council of the European Union. This will result in collaboration in the field of chronic diseases, particularly respiratory diseases, together with the activity of the network of national institutions and NGOs in this area. Paper also contains extensive analysis of the socio-economic, political, epidemiological, technological and medical factors affecting the prevention and control of childhood asthma and allergy presented during Experts presidential conference organized in Warsaw-Ossa 21–22 September 2011. PMID:22540290

75 FR 62502 - Proposed Information Collection; Comment Request; Information for Self-Certification Under FAQ 6...

Federal Register 2010, 2011, 2012, 2013, 2014

2010-10-12

... Request; Information for Self-Certification Under FAQ 6 of the United States--European Union Safe Harbor.... SUPPLEMENTARY INFORMATION: I. Abstract In response to the European Union Directive on Data Protection that... framework bridges the differences between the European Union (EU) and U.S. approaches to privacy protection...

78 FR 60368 - Determination Regarding Waiver of Discriminatory Purchasing Requirements With Respect to Goods...

Federal Register 2010, 2011, 2012, 2013, 2014

2013-10-01

... Purchasing Requirements With Respect to Goods and Services of a New Member State of the European Union...-9646. SUPPLEMENTARY INFORMATION: The European Union (``EU'') is a party to the World Trade Organization....S. obligations under the GPA, I hereby determine that: 1. The European Union, including the Republic...

The North Atlantic Treaty Organization and the European Union’s Common Security and Defense Policy: Intersecting Trajectories

DTIC Science & Technology

2011-07-01

www.consilium.europa.eu/uedocs/cmsUpload/78367.pdf. 23. Gustav Lindstrom , “Enter the EU Battlegroups,” Chaillot Paper, No. 97, February 2007, Paris, France: EU...individual human be- ing is our Benchmark. U.S. ARMY WAR COLLEGE Major General Gregg F. Martin Commandant ***** STRATEGIC STUDIES INSTITUTE Director

EU Strategies to Encourage Youth Entrepreneurship: Evidence from Higher Education in Greece

ERIC Educational Resources Information Center

Karanassios, Nikolaos; Pazarskis, Michail; Mitsopoulos, Konstantinos; Christodoulou, Petros

2006-01-01

The authors present and discuss significant aspects of youth entrepreneurship in the European Union (EU) and, especially, in higher education institutions in Greece. The structure of this paper is as follows. First, the study introduces a conceptual basis for entrepreneurship as defined in the EU and looks at entrepreneurship in the context of…

The Integration of Immigrants Into the Labour Markets of the EU. IAB Labour Market Research Topics.

ERIC Educational Resources Information Center

Werner, Heinz

Integration of foreign workers into European Union (EU) labor markets was evaluated. Three indicators of labor market integration were analyzed: unemployment rate, employment rate, and self- employment rate. Results were drawn from the Labor Force Survey data compiled by Eurostat. Findings indicated that, in all EU countries, the unemployment rate…

Bulletin on Women and Employment in the EU. 1994-1996.

ERIC Educational Resources Information Center

Bulletin on Women and Employment in the EU, 1996

1996-01-01

These six bulletins examine various aspects of women's employment in the European Union (EU). In the first bulletin, the different positions of women in the labor markets of the individual EU member countries are demonstrated to mirror the roles of women in each country's family and welfare system. The problems of unemployment and underemployment…

Selective Prevention: Addressing Vulnerability to Problem Drug Use in Europe

ERIC Educational Resources Information Center

Burkhart, Gregor; Gyarmathy, V. Anna; Bo, Alessandra

2011-01-01

Following the 2003 publication of the European Union (EU) Council Recommendations and the 2005-2008 and 2009-2012 EU Drugs Action Plans, increasing attention has been given in EU member states' drug policies to populations that are vulnerable to problem drug use (PDU). Monitoring data reported to the EMCDDA by designated agencies from 30 countries…

An Assessment of Coherence Between Early Warning and Response Systems and Serious Cross-Border Health Threats in the European Union and Turkey.

PubMed

Ekmekci, Perihan Elif

2016-12-01

Disease outbreaks have attracted the attention of the public health community to early warning and response systems (EWRS) for communicable diseases and other cross-border threats to health. The European Union (EU) and the World Health Organization (WHO) have published regulations in this area. Decision 1082/2013/EU brought a new approach the management of public health threats in EU member states. Decision 1082/2013/EU brought several innovations, which included establishing a Health Security Committee; preparedness and response planning; joint procurement of medical countermeasures; ad hoc monitoring for biological, chemical, and environmental threats; EWRS; and recognition of an emergency situation and interoperability between various sectors. Turkey, as an acceding country to the EU and a member of the WHO, has been improving its national public health system to meet EU legislations and WHO standards. This article first explains EWRS as defined in Decision 1082/2013/EU and Turkey's obligations to align its public health laws to the EU acquis. EWRS in Turkey are addressed, particularly their coherence with EU policies regarding preparedness and response, alert notification, and interoperability between health and other sectors. Finally, the challenges and limitations of the current Turkish system are discussed and further improvements are suggested. (Disaster Med Public Health Preparedness. 2016;10:883-892).

Low‐pathogenic notifiable avian influenza serosurveillance and the risk of infection in poultry – a critical review of the European Union active surveillance programme (2005–2007)

PubMed Central

Gonzales, J. L.; Elbers, A. R. W.; Bouma, A.; Koch, G.; De Wit, J. J.; Stegeman, J. A.

2010-01-01

Please cite this paper as: Gonzales et al. (2010) Low‐pathogenic notifiable avian influenza serosurveillance and the risk of infection in poultry – a critical review of the European Union active surveillance programme (2005–2007). Influenza and Other Respiratory Viruses 4(2), 91–99. Background  Since 2003, Member States (MS) of the European Union (EU) have implemented serosurveillance programmes for low pathogenic notifiable avian influenza (LPNAI) in poultry. To date, there is the need to evaluate the surveillance activity in order to optimize the programme’s surveillance design. Objectives  To evaluate MS sampling operations [sample size and targeted poultry types (PTs)] and its relation with the probability of detection and to estimate the PTs relative risk (RR) of being infected. Methods  Reported data of the surveillance carried out from 2005 to 2007 were analyzed using: (i) descriptive indicators to characterize both MS sampling operations and its relation with the probability of detection and the LPNAI epidemiological situation, and (ii) multivariable methods to estimate each PTs RR of being infected. Results  Member States sampling a higher sample size than that recommended by the EU had a significantly higher probability of detection. Poultry types with ducks & geese, game‐birds, ratites and “others” had a significant higher RR of being seropositive than chicken categories. The seroprevalence in duck & geese and game‐bird holdings appears to be higher than 5%, which is the EU‐recommended design prevalence (DP), while in chicken and turkey categories the seroprevalence was considerably lower than 5% and with that there is the risk of missing LPNAI seropositive holdings. Conclusion  It is recommended that the European Commission discusses with its MS whether the results of our evaluation calls for refinement of the surveillance characteristics such as sampling frequency, the between‐holding DP and MS sampling operation strategies. PMID:20167049

The PHARMINE study on the impact of the European Union directive on sectoral professions and of the Bologna declaration on pharmacy education in Europe

PubMed Central

Atkinson, Jeffrey; Rombaut, Bart

The Bologna declaration and the European Union (EU) directive 2005/36/EC on the recognition of professional qualifications influence the mobility of pharmacy students and pharmacy professionals, respectively. In addition the Bologna declaration aims at tuning higher education degrees including pharmacy throughout the EU in order to prepare for a harmonised European Higher Education Area. The directive outlines the knowledge, skills and qualifications required for the pursuit of the professional activity of a pharmacy in the EU. The PHARMINE project (Pharmacy Education in Europe, www.pharmine.org) looked at how the Bologna declaration and the directive influence modern-day pharmacy education and training in Europe. PMID:24198855

Actions for prevention and control of health threats related to maritime transport in European Union.

PubMed

Hadjichristodoulou, Christos; Mouchtouri, Varvara A; Guglielmetti, Paolo; Lemos, Cinthia Menel; Nichols, Gordon; Paux, Thierry; Schlaich, Clara; Cornejo, Miguel Davila; Martinez, Carmen Varela; Dionisio, Mauro; Rehmet, Sybille; Jaremin, Bogdan; Kremastinou, Jenny

2013-01-01

Actions at European Union level for International Health Regulations (IHR) 2005 implementation and maritime transport were focused on two European projects implemented between 2006 and 2011. Situation analysis and needs assessment were conducted, a Manual including European standards and best practice and training material was developed and training courses were delivered. Ship-to-port and port-to-port communication web-based network and database for recording IHR Ship Sanitation Certificates (SSC) were established. Fifty pilot inspections based on the Manual were conducted on passenger ships. A total of 393 corrective actions were implemented according to recommendations given to Captains during pilot inspections. The web-based communication network of competent authorities at ports in EU Member States was used to manage 13 events/outbreaks (dengue fever, Legionnaires' disease, gastroenteritis, meningitis, varicella and measles). The European information database system was used for producing and recording 1018 IHR SSC by 156 inspectors in 6 countries in accordance with the WHO Handbook for inspection of ships and issuance of SSC. Implementation of corrective actions after pilot inspections increased the level of compliance with the hygiene standards in passenger ships sailing within the EU waters and improved hygiene conditions. The communication tool contributed to improvement of outbreak identification and better management through rapid sharing of public health information, allowing a more timely and coordinated response. After the implementation of actions on passenger ships, the European Commission co-funded a Joint action that will expand the activities to all types of ships and chemical, biological and radio-nuclear threats (deliberate acts/accidental). Copyright © 2013 Elsevier Ltd. All rights reserved.

Socioeconomic impact assessment in ex ante evaluations: a case study on the rural development programs of the European Union.

PubMed

Vidueira, Pablo; Díaz-Puente, José M; Rivera, María

2014-08-01

Ex ante impact assessment has become a fundamental tool for effective program management, and thus, a compulsory task when establishing a new program in the European Union (EU). This article aims to analyze benefits from ex ante impact assessment, methodologies followed, and difficulties encountered. This is done through the case study on the rural development programs (RDPs) in the EU. Results regarding methodologies are then contrasted with the international context in order to provide solid insights to evaluators and program managing authorities facing ex ante impact assessment. All European RDPs from the period 2007 through 2013 (a total of 88) and their corresponding available ex ante evaluations (a total of 70) were analyzed focusing on the socioeconomic impact assessment. Only 46.6% of the regions provide quantified impact estimations on socioeconomic impacts in spite of it being a compulsory task demanded by the European Commission (EC). Recommended methods by the EC are mostly used, but there is a lack of mixed method approaches since qualitative methods are used in substitution of quantitative ones. Two main difficulties argued were the complexity of program impacts and the lack of needed program information. Qualitative approaches on their own have been found as not suitable for ex ante impact assessment, while quantitative approaches-such as microsimulation models-provide a good approximation to actual impacts. However, time and budgetary constraints make that quantitative and mixed methods should be mainly applied on the most relevant impacts for the program success. © The Author(s) 2014.

The use of existing environmental networks for the post-market monitoring of GM crop cultivation in the EU.

PubMed

Smets, G; Alcalde, E; Andres, D; Carron, D; Delzenne, P; Heise, A; Legris, G; Martinez Parrilla, M; Verhaert, J; Wandelt, C; Ilegems, M; Rüdelsheim, P

2014-07-01

The European Union (EU) Directive 2001/18/EC on the deliberate release of genetically modified organisms (GMOs) into the environment requires that both Case-Specific Monitoring (CSM) and General Surveillance (GS) are considered as post-market implementing measures. Whereas CSM is directed to monitor potential adverse effects of GMOs or their use identified in the environmental risk assessment, GS aims to detect un-intended adverse effects of GMOs or their use on human and animal health or the environment. Guidance documents on the monitoring of genetically modified (GM) plants from the Commission and EFSA clarify that, as appropriate, GS can make use of established routine surveillance practices. Networks involved in routine surveillance offer recognised expertise in a particular domain and are designed to collect information on important environmental aspects over a large geographical area. However, as the suitability of existing monitoring networks to provide relevant data for monitoring impacts of GMOs is not known, plant biotechnology companies developed an approach to describe the processes and criteria that will be used for selecting and evaluating existing monitoring systems. In this paper, the availability of existing monitoring networks for this purpose is evaluated. By cataloguing the existing environmental monitoring networks in the EU, it can be concluded that they can only be used, in the context of GMO cultivation monitoring, as secondary tools to collect baseline information.

Is tuberculosis crossing borders at the Eastern boundary of the European Union?

PubMed Central

van der Werf, Marieke J.; Hollo, Vahur; Noori, Teymur

2013-01-01

Background: The Eastern border of the European Union (EU) consists of 10 countries after the expansion of the EU in 2004 and 2007. These 10 countries border to the East to countries with high tuberculosis (TB) notification rates. We analyzed the notification data of Europe to quantify the impact of cross-border TB at the Eastern border of the EU. Methods: We used TB surveillance data of 2010 submitted by 53 European Region countries to the European Centre for Disease Prevention and Control and the World Health Organization Regional Office for Europe. Notified TB cases were stratified by origin of the case (national/foreign). We calculated the contribution of foreign to overall TB notification. Results: In the 10 EU countries located at the EU Eastern border, 618 notified TB cases (1.7% of all notified TB cases) were of foreign origin. Of those 618 TB cases, 173 (28.0%) were from countries bordering the EU to the East. More specifically, 90 (52.0%) were from Russia, 33 (19.1%) from Belarus, 33 (19.1%) from Ukraine, 13 (7.5%) from Moldova and 4 (2.3%) from Turkey. Conclusions: Currently, migrants contribute little to TB notifications in the 10 EU countries at the Eastern border of the EU, but changes in migration patterns may result in an increasing contribution. Therefore, EU countries at the Eastern border of the EU should strive to provide prompt diagnostic services and adequate treatment of migrants. PMID:23813718

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States.

PubMed

Vogler, Sabine; Habl, Claudia; Bogut, Martina; Voncina, Luka

2011-04-15

To perform a comparative analysis of the pharmaceutical pricing and reimbursement systems in Croatia and the 27 European Union (EU) Member States. Knowledge about the pharmaceutical systems in Croatia and the 27 EU Member States was acquired by literature review and primary research with stakeholders. Pharmaceutical prices are controlled at all levels in Croatia, which is also the case in 21 EU Member States. Like many EU countries, Croatia also applies external price referencing, i.e., compares prices with other countries. While the wholesale remuneration by a statutorily regulated linear mark-up is applied in Croatia and in several EU countries, the pharmacy compensation for dispensing reimbursable medicines in the form of a flat rate service fee in Croatia is rare among EU countries, which usually apply a linear or regressive pharmacy mark-up scheme. Like in most EU countries, the Croatian Social Insurance reimburses specific medicines at 100%, whereas patients are charged co-payments for other reimbursable medicines. Criteria for reimbursement include the medicine's importance from the public health perspective, its therapeutic value, and relative effectiveness. In Croatia and in many EU Member States, reimbursement is based on a reference price system. The Croatian pharmaceutical system is similar to those in the EU Member States. Key policies, like external price referencing and reference price systems, which have increasingly been introduced in EU countries are also applied in Croatia and serve the same purpose: to ensure access to medicines while containing public pharmaceutical expenditure.

DOE Office of Scientific and Technical Information (OSTI.GOV)

Walker, Randy M.; Kopsick, Deborah A.; Gorman, Bryan L.

Background Thousands of shipments of radioisotopes developed in the United States (U.S.) are transported domestically and internationally for medical and industrial applications, including to partner laboratories in European Union (EU) countries. Over the past five years, the Environmental Protection Agency (EPA), the Department of Energy (DOE), and Oak Ridge National Laboratory (ORNL)1 have worked with state first responder personnel, key private sector supply chain stakeholders, the Department of Homeland Security (DHS), the Department of Transportation (DOT), the Department of Defense (DoD) and the Nuclear Regulatory Commission (NRC) on Radio Frequency Identification (RFID) tracking and monitoring of medical, research and industrialmore » radioisotopes in commerce. ORNL was the pioneer of the international radioisotope shipping and production business. Most radioisotopes made and used today were either made or discovered at ORNL. While most of the radioisotopes used in the commercial sector are now produced and sold by the private market, ORNL still leads the world in the production of exotic, high-value and/or sensitive industrial, medical and research isotopes. The ORNL-EPA-DOE Radiological Source Tracking and Monitoring (RadSTraM) project tested, evaluated, and integrated RFID technologies in laboratory settings and at multiple private-sector shipping and distribution facilities (Perkin Elmer and DHL) to track and monitor common radioisotopes used in everyday commerce. The RFID tracking capability was also tested in association with other deployed technologies including radiation detection, chemical/explosives detection, advanced imaging, lasers, and infrared scanning. At the 2007 EU-U.S. Summit, the leaders of the US Department of Commerce (DOC) and EU European Commission (EC) committed to pursue jointly directed Lighthouse Priority Projects. These projects are intended to foster cooperation and reduce regulatory burdens with respect to transatlantic commerce. The Transatlantic Economic Council (TEC) Lighthouse Project on Radio Frequency Identification (RFID) has been directed to develop a joint framework for cooperation on identification and development of best practices for Radio Frequency Identification (RFID) technologies The RFID Lighthouse Priority Project commits both sides to endeavor to align U.S. and EU regulatory and policy approaches on RFID technologies, including pilot projects in the public sector.« less

Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016.

PubMed

van Sighem, Ard; Pharris, Anastasia; Quinten, Chantal; Noori, Teymur; Amato-Gauci, Andrew J

2017-11-01

It is well-documented that early HIV diagnosis and linkage to care reduces morbidity and mortality as well as HIV transmission. We estimated the median time from HIV infection to diagnosis in the European Union/European Economic Area (EU/EEA) at 2.9 years in 2016, with regional variation. Despite evidence of a decline in the number of people living with undiagnosed HIV in the EU/EEA, many remain undiagnosed, including 33% with more advanced HIV infection (CD4 < 350 cells/mm3).

Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016

PubMed Central

van Sighem, Ard; Pharris, Anastasia; Quinten, Chantal; Noori, Teymur; Amato-Gauci, Andrew J

2017-01-01

It is well-documented that early HIV diagnosis and linkage to care reduces morbidity and mortality as well as HIV transmission. We estimated the median time from HIV infection to diagnosis in the European Union/European Economic Area (EU/EEA) at 2.9 years in 2016, with regional variation. Despite evidence of a decline in the number of people living with undiagnosed HIV in the EU/EEA, many remain undiagnosed, including 33% with more advanced HIV infection (CD4 < 350 cells/mm3). PMID:29208159

Municipal solid waste development phases: Evidence from EU27.

PubMed

Vujić, Goran; Gonzalez-Roof, Alvaro; Stanisavljević, Nemanja; Ragossnig, Arne M

2015-12-01

Many countries in the European Union (EU) have very developed waste management systems. Some of its members have managed to reduce their landfilled waste to values close to zero during the last decade. Thus, European Union legislation is very stringent regarding waste management for their members and candidate countries, too. This raises the following questions: Is it possible for developing and developed countries to comply with the European Union waste legislation, and under what conditions? How did waste management develop in relation to the economic development in the countries of the European Union? The correlation between waste management practices and economic development was analysed for 27 of the European Union Member States for the time period between 1995 and 2007. In addition, a regression analysis was performed to estimate landfilling of waste in relation to gross domestic product for every country. The results showed a strong correlation between the waste management variables and the gross domestic product of the EU27 members. The definition of the municipal solid waste management development phases followed a closer analysis of the relation between gross domestic product and landfilled waste. The municipal solid waste management phases are characterised by high landfilling rates at low gross domestic product levels, and landfilling rates near zero at high gross domestic product levels. Hence the results emphasize the importance of wider understanding of what is required for developing countries to comply with the European Union initiatives, and highlight the importance of allowing developing countries to make their own paths of waste management development. © The Author(s) 2015.

76 FR 8337 - Proposed Information Collection; Comment Request; Survey of Participating Companies in the U.S...

Federal Register 2010, 2011, 2012, 2013, 2014

2011-02-14

... Request; Survey of Participating Companies in the U.S.-European Union and U.S.-Swiss Safe Harbor... Trade Administration (ITA) administers the U.S.-European Union (EU) and U.S.- Swiss Safe Harbor Frameworks. These Frameworks allow U.S. companies to meet the requirements of the European Union's Data...

Regulatory Regionalism and Education: The European Union in Central Asia

ERIC Educational Resources Information Center

Jones, Peter

2010-01-01

This paper investigates the purchase which Jayasuriya's regulatory regionalism approach offers for an analysis of the European Union's engagement in Central Asia. The European Union has a clearly articulated strategy through which to pursue what it sees as its interests in Central Asia and the development of a range of EU-Central Asia education…

Reluctant to Learn? The Use of Evaluation to Improve EU Cohesion Policy Implementation in Polish and Spanish Regions

ERIC Educational Resources Information Center

Wojtowicz, Dominika Maria; Kupiec, Tomasz

2018-01-01

For many European Union (EU) member states, the Cohesion Policy (CP) was the channel through which the practice of evaluation was transmitted into domestic administration. Studies have shown that the EU member countries differ in terms of their evaluation capacity and activity. None of those studies, however, addresses regional governments, which…

Quantitative risk assessment for the introduction of African swine fever virus into the European Union by legal import of live pigs.

PubMed

Mur, L; Martínez-López, B; Martínez-Avilés, M; Costard, S; Wieland, B; Pfeiffer, D U; Sánchez-Vizcaíno, J M

2012-04-01

The recent incursion and spread of African swine fever virus (ASFV) in the Russian Federation and Caucasus region, close to European Union (EU) borders, have increased the concerns regarding the probability of ASFV introduction into the EU. There are many potential routes of ASFV entry into EU, but here we specifically aimed to assess the probability of ASFV introduction by legal trade of pigs, which historically has been one of the most important ways of exotic diseases introduction into the EU. A stochastic model was used to estimate the monthly probability of ASFV introduction for each country of the EU. Results of this model suggest an annual probability for ASFV introduction in the whole EU by this way of 5.22*10(-3) , which approximately corresponds with one outbreak in 192years. The risk of ASFV introduction via live pigs was highest in Poland (69%), particularly during the months of November and December. As expected, Russian Federation is the country that most contributes to this risk, representing 68% of the overall annual risk. Methods and results presented here may be useful for informing risk-based surveillance and control programmes and, ultimately, for prevention and control of potential ASFV incursions into the EU. © 2011 Blackwell Verlag GmbH.

Legal frameworks and key concepts regulating diversion and treatment of mentally disordered offenders in European Union member states.

PubMed

Dressing, Harald; Salize, Hans Joachim; Gordon, Harvey

2007-10-01

There is only limited research on the various legal regulations governing assessment, placement and treatment of mentally ill offenders in European Union member states (EU-member states). To provide a structured description and cross-boundary comparison of legal frameworks regulating diversion and treatment of mentally disordered offenders in EU-member states before the extension in May 2004. A special focus is on the concept of criminal responsibility. Information on legislation and practice concerning the assessment, placement and treatment of mentally ill offenders was gathered by means of a detailed, structured questionnaire which was filled in by national experts. The legal regulations relevant for forensic psychiatry in EU-member states are outlined. Definitions of mental disorders given within these acts are introduced and compared with ICD-10 diagnoses. Finally the application of the concept of criminal responsibility by the law and in routine practice is presented. Legal frameworks for the processing and placement of mentally disordered offenders varied markedly across EU-member states. Since May 2004 the European Union has expanded to 25 member states and in January 2007 it will reach 27. With increasing mobility across Europe, the need for increasing trans-national co-operation is becoming apparent in which great variation in legal tradition pertains.

Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007.

PubMed

Gouveia, Joaquim; Coleman, Michel P; Haward, Robert; Zanetti, Roberto; Hakama, Matti; Borras, Josep Maria; Primic-Zakelj, Maja; de Koning, Harry J; Travado, Luzia

2008-07-01

Cancer is a major cause of morbidity and mortality in the European Union (EU), and a public health burden. Improving cancer control in the EU will require implementation of efficient strategies within Member States and better policy coordination between them. In cooperation between the rotating EU Presidencies of Germany (2007), Portugal (2007) and Slovenia (2008), special attention was devoted to an integrated approach to cancer control in EU policies and programmes. A round-table focussed on national cancer plans, population-based cancer registries and cancer screening programmes was held during the Health Strategies in Europe meeting in Lisbon in July 2007, under the Portuguese Presidency. These three topics were selected as critical for improving cancer control at both national and European levels. The round-table was designed to produce a set of recommendations to inform EU cancer policy. This paper provides a résumé of the conclusions and recommendations, to stimulate wider discussion and policy development. The conclusions of the meeting were presented at the Employment, Social Policy, Health and Consumer Affairs Council in December 2007 and cancer was included in the Council Conclusions for the new European Health Strategy. Success in cancer control will require consistent attention from future EU Presidencies, such as the initiative of the Slovenian EU Presidency in early 2008.

Legal strategies to protect sexual and reproductive health and rights in the context of the refugee crisis in Europe: a complaint before the European Ombudsperson.

PubMed

Laporta Hernández, Elena

2017-11-01

In the context of the refugee crisis in Europe, the measures taken by the institutions and bodies of the European Union as they relate to respecting, protecting, and ensuring human rights have proven to be woefully inadequate. The development of a restrictive, defensive, security-based immigration policy has led to failure by European countries and the European Union to fulfil their human rights obligations. Specifically, the Agreement struck between the European Union and Turkey on 18 March 2016, in addition to externalising borders, placed economic and political considerations centre stage, leading to serious violations of the human rights of refugees and migrants, including their sexual and reproductive rights. In an effort to identify the failures and the institutions responsible for promoting the necessary measures to mitigate the negative impacts these policies have had, the international human rights organisation Women's Link Worldwide lodged a complaint with the European Ombudsperson. In its complaint, Women's Link alleges maladministration by the European Commission for its failure to carry out a human rights impact assessment of the 18 March 2016 EU-Turkey Agreement and the reports on its implementation. Such an assessment should include a gender perspective and a children's rights approach, and its omission is not only a failure to comply with international human rights standards, but also directly and negatively affects women's and children's rights.

Pharmacology and Therapeutics Education in the European Union Needs Harmonization and Modernization: A Cross-sectional Survey Among 185 Medical Schools in 27 Countries.

PubMed

Brinkman, D J; Tichelaar, J; Okorie, M; Bissell, L; Christiaens, T; Likic, R; Mačìulaitis, R; Costa, J; Sanz, E J; Tamba, B I; Maxwell, S R; Richir, M C; van Agtmael, M A

2017-11-01

Effective teaching in pharmacology and clinical pharmacology and therapeutics (CPT) is necessary to make medical students competent prescribers. However, the current structure, delivery, and assessment of CPT education in the European Union (EU) is unknown. We sent an online questionnaire to teachers with overall responsibility for CPT education in EU medical schools. Questions focused on undergraduate teaching and assessment of CPT, and students' preparedness for prescribing. In all, 185 medical schools (64%) from 27 EU countries responded. Traditional learning methods were mainly used. The majority of respondents did not provide students with the opportunity to practice real-life prescribing and believed that their students were not well prepared for prescribing. There is a marked difference in the quality and quantity of CPT education within and between EU countries, suggesting that there is considerable scope for improvement. A collaborative approach should be adopted to harmonize and modernize the undergraduate CPT education across the EU. © 2017 The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.

Extraction and Validation of Geomorphological Features from EU-DEM in The Vicinity of the Mygdonia Basin, Northern Greece

NASA Astrophysics Data System (ADS)

Mouratidis, Antonios; Karadimou, Georgia; Ampatzidis, Dimitrios

2017-12-01

The European Union Digital Elevation Model (EU-DEM) is a relatively new, hybrid elevation product, principally based on SRTM DEM and ASTER GDEM data, but also on publically available Russian topographic maps for regions north of 60° N. More specifically, EU-DEM is a Digital Surface Model (DSM) over Europe from the Global Monitoring for Environment and Security (GMES) Reference Data Access (RDA) project - a realisation of the Copernicus (former GMES) programme, managed by the European Commission/DG Enterprise and Industry. Even if EU-DEM is indeed more reliable in terms of elevation accuracy than its constituents, it ought to be noted that it is not representative of the original elevation measurements, but is rather a secondary (mathematical) product. Therefore, for specific applications, such as those of geomorphological interest, artefacts may be induced. To this end, the purpose of this paper is to investigate the performance of EU-DEM for geomorphological applications and compare it against other available datasets, i.e. topographic maps and (almost) global DEMs such as SRTM, ASTER-GDEM and WorldDEM™. This initial investigation is carried out in Central Macedonia, Northern Greece, in the vicinity of the Mygdonia basin, which corresponds to an area of particular interest for several geoscience applications. This area has also been serving as a test site for the systematic validation of DEMs for more than a decade. Consequently, extensive elevation datasets and experience have been accumulated over the years, rendering the evaluation of new elevation products a coherent and useful exercise on a local to regional scale. In this context, relief classification, drainage basin delineation, slope and slope aspect, as well as extraction and classification of drainage network are performed and validated among the aforementioned elevation sources. The achieved results focus on qualitative and quantitative aspects of automatic geomorphological feature extraction from EU-DEM at a water basin level, with the use of Geographical Information Systems (GIS).

77 FR 68196 - Notice of Applications for Certificates of Public Convenience and Necessity and Foreign Air...

Federal Register 2010, 2011, 2012, 2013, 2014

2012-11-15

... carrier permit to enable GSS, consistent with the open skies, U.S.-European Union (``EU'') Air Transport... point or points behind any Member State of the European Union, via any point or points in any Member... European Union carriers in the future. GSS also requests (i) exemption authority, to the extent necessary...

Political Strategies and Language Policies: The European Union Lisbon Strategy and Its Implications for the EU's Language and Multilingualism Policy

ERIC Educational Resources Information Center

Krzyzanowski, Michal; Wodak, Ruth

2011-01-01

This paper explores the interplay between the politics and policies of multilingualism by looking at the role of political macro-strategies in shaping language and multilingualism policies within the European Union. The paper focuses on the relationship between the European Union's 2000-2010 Lisbon Strategy on the European Knowledge-Based Economy…

The European Charter for Regional or Minority Languages: A "Magnum Opus" or an Incomplete "Modus Vivendi?"

ERIC Educational Resources Information Center

Soldat-Jaffe, Tatjana

2015-01-01

This article investigates to what extent the European Union (EU) has the means to protect minority and regional languages in the EU, looking at the ways three different bodies of the EU, the European Parliament (EP), the Council of Europe (CoE) and the European Charter for Regional or Minority Languages (ECRML) differ in handling language…

Human Resources Policies Compared: What Can the EU and the USA Learn from Each Other?

ERIC Educational Resources Information Center

Tome, Eduardo

2005-01-01

Purpose: To compare in a fruitful way the human resources (HR) policies that exist in the European Union (EU) and in the United States of America (USA). Nowadays, the world is evolving to a situation in which big economic spaces like Brazil, Russia, India, China, Japan, the EU and the USA are becoming dominant. Those spaces can learn from one…

IPTS/ESTO Studies on Reforms of Agriculture, Education and Social Systems within the Context of Enlargement and Demographic Change in the EU. Final Report.

ERIC Educational Resources Information Center

2002

This document summarizes a comparative analysis of the interconnections between technological and socioeconomic developments in agriculture and rural development, human capital formation, and social systems in the 13 candidate countries (CCs) for admission into the European Union (EU) and in the 15 countries of the EU. Specific topics considered…

Economic Burden of Bladder Cancer Across the European Union.

PubMed

Leal, Jose; Luengo-Fernandez, Ramon; Sullivan, Richard; Witjes, J Alfred

2016-03-01

More than 120,000 people are diagnosed annually with bladder cancer in the 28 countries of the European Union (EU). With >40,000 people dying of it each year, it is the sixth leading cause of cancer. However, to date, no systematic cost-of-illness study has assessed the economic impact of bladder cancer in the EU. To estimate the annual economic costs of bladder cancer in the EU for 2012. Country-specific cancer cost data were estimated using aggregate data on morbidity, mortality, and health care resource use, obtained from numerous international and national sources. Health care costs were estimated from expenditures on primary, outpatient, emergency, and inpatient care, as well as medications. Costs of unpaid care and lost earnings due to morbidity and early death were estimated. Bladder cancer cost the EU €4.9 billion in 2012, with health care accounting for €2.9 billion (59%) and representing 5% of total health care cancer costs. Bladder cancer accounted for 3% of all cancer costs in the EU (€143 billion) in 2012 and represented an annual health care cost of €57 per 10 EU citizens, with costs varying >10 times between the country with the lowest cost, Bulgaria (€8 for every 10 citizens), and highest cost, Luxembourg (€93). Productivity losses and informal care represented 23% and 18% of bladder cancer costs, respectively. The quality and availability of comparable cancer-related data across the EU need further improvement. Our results add to essential public health and policy intelligence for delivering affordable bladder cancer care systems and prioritising the allocation of public research funds. We looked at the economic costs of bladder cancer across the European Union (EU). We found bladder cancer to cost €4.9 billion in 2012, with health care accounting for €2.9 billion. Our study provides data that can be used to inform affordable cancer care in the EU. Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States

PubMed Central

Vogler, Sabine; Habl, Claudia; Bogut, Martina; Vončina, Luka

2011-01-01

Aim To perform a comparative analysis of the pharmaceutical pricing and reimbursement systems in Croatia and the 27 European Union (EU) Member States. Methods Knowledge about the pharmaceutical systems in Croatia and the 27 EU Member States was acquired by literature review and primary research with stakeholders. Results Pharmaceutical prices are controlled at all levels in Croatia, which is also the case in 21 EU Member States. Like many EU countries, Croatia also applies external price referencing, ie, compares prices with other countries. While the wholesale remuneration by a statutorily regulated linear mark-up is applied in Croatia and in several EU countries, the pharmacy compensation for dispensing reimbursable medicines in the form of a flat rate service fee in Croatia is rare among EU countries, which usually apply a linear or regressive pharmacy mark-up scheme. Like in most EU countries, the Croatian Social Insurance reimburses specific medicines at 100%, whereas patients are charged co-payments for other reimbursable medicines. Criteria for reimbursement include the medicine’s importance from the public health perspective, its therapeutic value, and relative effectiveness. In Croatia and in many EU Member States, reimbursement is based on a reference price system. Conclusion The Croatian pharmaceutical system is similar to those in the EU Member States. Key policies, like external price referencing and reference price systems, which have increasingly been introduced in EU countries are also applied in Croatia and serve the same purpose: to ensure access to medicines while containing public pharmaceutical expenditure. PMID:21495202

Implications of the accession of the Republic of Croatia to the European Union for Croatian health care system.

PubMed

Ostojić, Rajko; Bilas, Vlatka; Franc, Sanja

2012-09-01

The Republic of Croatia's accession to the European Union (EU) will affect all segments of economy and society, including the health care system. The aim of this paper is to establish the potential effects of joining the EU on Croatian health care, as well as to assess its readiness to enter this regional economic integration. The paper identifies potential areas of impact of EU accession on Croatian health care and analyzes the results of the conducted empirical research. In this research, a method of in-depth interviews was applied on a sample of 49 subjects; health professionals from public and private sectors, health insurance companies, pharmaceutical companies, drug wholesalers, and non-governmental organisations (patient associations). Once Croatia joins the EU, it will face: new rules and priorities in line with the current European health strategy; the possibilities of drawing funds from European cohesion funds; labour migrations; new guidelines on patient safety and mobility. From the aspect of harmonising national regulations with EU regulations in the area of health care, Croatian system can be assessed as ready to enter the EU. Croatia's accession to the EU can result in a better information flow, growth of competitiveness of Croatian health care system, enhanced quality, inflow of EU funds, development of health tourism, but also in increased migration of health care professionals, and potential increase in the cost of health care services. Functioning within the EU framework might result in adaptation to the EU standards, but it could also result in the concentration of staff and institutions in larger cities.

Health law and policy in the European Union.

PubMed

Greer, Scott L; Hervey, Tamara K; Mackenbach, Johan P; McKee, Martin

2013-03-30

From its origins as six western European countries coming together to reduce trade barriers, the European Union (EU) has expanded, both geographically and in the scope of its actions, to become an important supranational body whose policies affect almost all aspects of the lives of its citizens. This influence extends to health and health services. The EU's formal responsibilities in health and health services are limited in scope, but, it has substantial indirect influence on them. In this paper, we describe the institutions of the EU, its legislative process, and the nature of European law as it affects free movement of the goods, people, and services that affect health or are necessary to deliver health care. We show how the influence of the EU goes far beyond the activities that are most visible to health professionals, such as research funding and public health programmes, and involves an extensive body of legislation that affects almost every aspect of health and health care.

Evidence based policy making in the European Union: the role of the scientific community.

PubMed

Majcen, Špela

2017-03-01

In the times when the acquis of the European Union (EU) has developed so far as to reach a high level of technical complexity, in particular in certain policy fields such as environmental legislation, it is important to look at what kind of information and data policy decisions are based on. This position paper looks at the extent to which evidence-based decision-making process is being considered in the EU institutions when it comes to adopting legislation in the field of environment at the EU level. The paper calls for closer collaboration between scientists and decision-makers in view of ensuring that correct data is understood and taken into consideration when drafting, amending, negotiating and adopting new legal texts at all levels of the EU decision-making process. It concludes that better awareness of the need for such collaboration among the decision-makers as well as the scientific community would benefit the process and quality of the final outcomes (legislation).

[Genetically modified food and allergies - an update].

PubMed

Niemann, Birgit; Pöting, Annette; Braeuning, Albert; Lampen, Alfonso

2016-07-01

Approval by the European Commission is mandatory for placing genetically modified plants as food or feed on the market in member states of the European Union (EU). The approval is preceded by a safety assessment based on the guidance of the European Food Safety Authority EFSA. The assessment of allergenicity of genetically modified plants and their newly expressed proteins is an integral part of this assessment process. Guidance documents for the assessment of allergenicity are currently under revision. For this purpose, an expert workshop was conducted in Brussels on June 17, 2015. There, methodological improvements for the assessment of coeliac disease-causing properties of proteins, as well as the use of complex models for in vitro digestion of proteins were discussed. Using such techniques a refinement of the current, proven system of allergenicity assessment of genetically modified plants can be achieved.

One WEEE, many species: lessons from the European experience.

PubMed

Deepali Sinha Khetriwal; Widmer, Rolf; Kuehr, Ruediger; Huisman, Jaco

2011-09-01

Electrical and electronic equipment (EEE) pervades modern lifestyles, but its quick obsolescence is resulting in huge quantities of EEE to be disposed of. This fast-growing waste stream has been recognized for its hazard potential. The European Union's (EU) Waste Electrical and Electronic Equipment (WEEE) Directive was essentially in response to the toxicity of e-waste - to ensure that it was collected and treated in an environmentally sound manner. Since then, the WEEE Directive has expanded its aims to include recovery of valuable resources as a means to reduce raw material extraction. With these objectives in mind, the Directive sets a common minimum legislative framework for all EU member states. However, the transposition of the Directive into national legislations has meant many differences in actual implementation models. There are 27 national transpositions of the Directive with different definitions, provisions and agreements. Each legislation reflects national situations, whether they are geographical considerations, legislative history, the influence of lobby groups and other national priorities. Although this diversity in legislations has meant massive problems in compliance and enforcement, it provides an opportunity to get an insight into the possible operational models of e-waste legislation. Building on the study by the United Nations University commissioned by the European Commission as part of its 2008 Review of the WEEE Directive, the paper identifies some key features of the Directive as well as legislative and operational differences in transposition and implementation in the various members states. The paper discusses the successes and challenges of the Directive and concludes with lessons learnt from the European experience.

Interpretation of aged sorption studies for pesticides and their use in European Union regulatory leaching assessments.

PubMed

Beulke, Sabine; van Beinum, Wendy; Suddaby, Laura

2015-04-01

First-tier regulatory exposure assessments for pesticides assume that pesticide sorption is instantaneous and fully reversible. In European Union (EU) regulatory guidance, an increase in sorption over time ("aged sorption") can be considered at the higher tier to refine predicted environmental concentrations in groundwater. Research commissioned by the UK Chemicals Regulation Directorate (CRD), funded by the Department for Environment Food & Rural Affairs (Defra), formed the basis of a draft regulatory guidance document proposing 1) a protocol on how to measure aged sorption of parent compounds in laboratory studies, 2) procedures to fit kinetic models to the experimental data, 3) criteria to test the reliability of the parameters, and 4) procedures for use of the parameters in the groundwater exposure assessment. The draft guidance was revised after feedback from stakeholders and testing of the guidance was performed against real data sets by an independent consultancy. The Chemicals Regulation Directorate submitted the revised document to the European Food Safety Authority (EFSA) for scrutiny. This article gives an overview of the draft guidance and explains the reasoning behind the recommendations made. 2015 Crown Copyright; Published 2015 SETAC.

How online sales and promotion of snus contravenes current European Union legislation.

PubMed

Peeters, Silvy; Gilmore, Anna B

2013-07-01

The European Union (EU) Tobacco Products Directive that bans sales of snus (a form of oral tobacco) in EU countries other than Sweden is currently under review. Major tobacco companies favour the ban being overturned. This study aims to explore compliance with the current ban on snus sales and examines the conduct of online snus vendors, including their compliance with two other EU Directives on excise and tobacco advertising and Swedish legislation banning sales of snus outside Sweden. To determine who is currently distributing snus via the internet in the EU, searches were carried out in Google, followed by searches in the WHOIS and Amadeus databases. Five online test purchases of snus were made in each of 10 EU Member States using a standardised protocol. Feedback from the test purchases and further analysis of the websites accessed for test purchases were used to critically examine snus retailers' conduct. The majority of online vendors operate from Sweden and target non-Swedish EU citizens. Test purchases were successfully made in all 10 EU Member States; of 43 orders placed, only two failed. Age verification relied only on self-report. The majority of sales applied Swedish taxes, contrary to EU requirements. Copious sales promotion activities, many price based, are incorporated in these websites contravening the EU regulation, and three test purchases were delivered with gifts. Snus is currently being sold on the single market via the internet in contravention of Swedish legislation and three EU Directives. The apparent willingness of the tobacco industry to contravene EU and Swedish legislation and profit from unlawful sales raises questions about their status as stakeholders in consultations on future policy developments. The findings highlight how national and regional tobacco control legislation can be undermined in an increasingly globalised world.

Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis

PubMed Central

Kelly, Ruth; Zoubiane, Ghada; Walsh, Desmond; Ward, Rebecca; Goossens, Herman

2016-01-01

Summary Background Antibacterial resistant infections are rising continuously, resulting in increased morbidity and mortality worldwide. With no new antibiotic classes entering the market and the possibility of returning to the pre-antibiotic era, the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) was established to address this problem. We aimed to quantify the scale and scope of publicly funded antibacterial resistance research across JPIAMR countries and at the European Union (EU) level to identify gaps and future opportunities. Methods We did a systematic observational analysis examining antibacterial resistance research funding. Databases of funding organisations across 19 countries and at EU level were systematically searched for publicly funded antibacterial resistance research from Jan 1, 2007, to Dec 31, 2013. We categorised studies on the basis of the JPIAMR strategic research agenda's six priority topics (therapeutics, diagnostics, surveillance, transmission, environment, and interventions) and did an observational analysis. Only research funded by public funding bodies was collected and no private organisations were contacted for their investments. Projects in basic, applied, and clinical research, including epidemiological, public health, and veterinary research and trials were identified using keyword searches by organisations, and inclusion criteria were based on the JPIAMR strategic research agenda's six priority topics, using project titles and abstracts as filters. Findings We identified 1243 antibacterial resistance research projects, with a total public investment of €1·3 billion across 19 countries and at EU level, including public investment in the Innovative Medicines Initiative. Of the total amount invested in antibacterial resistance research across the time period, €646·6 million (49·5%) was invested at the national level and €659·2 million (50·5%) at the EU level. When projects were classified under the six priority topics we found that 763 (63%) of 1208 projects funded at national level were within the area of therapeutics, versus 185 (15%) in transmission, 131 (11%) in diagnostics, 53 (4%) in interventions, and only 37 (3%) in environment and 39 (3%) in surveillance. Interpretation This was the first systematic analysis of research funding of antibacterial resistance of this scale and scope, which relied on the availability and accuracy of data from organisations included. Large variation was seen between countries both in terms of number of projects and associated investment and across the six priority topics. To determine the future direction of JPIAMR countries a clear picture of the funding landscape across Europe and Canada is needed. Countries should work together to increase the effect of research funding by strengthening national and international coordination and collaborations, harmonising research activities, and collectively pooling resources to fund multidisciplinary projects. The JPIAMR have developed a publicly available database to document the antibacterial resistance research collected and can be used as a baseline to analyse funding from 2014 onwards. Funding JPIAMR and the European Commission. PMID:26708524

ETF Work Programme, 2003.

ERIC Educational Resources Information Center

European Training Foundation, Turin (Italy).

This document describes the proposed 2003 activities of the European Training Foundation (ETF) to support vocational education and training reform in non-European Union (EU) countries in the context of the EU's external relations program. The activities listed cover these four main groups of countries across three continents: the Mediterranean…

EU alerting and reporting systems for potential chemical public health threats and hazards.

PubMed

Orford, R; Crabbe, H; Hague, C; Schaper, A; Duarte-Davidson, R

2014-11-01

A number of European and international IT platforms are used to notify competent authorities of new potential chemical exposures. Recently the European Parliament and the Council of European Union adopted new legislation that aims to improve the co-ordinated response to cross border health threats (Decision 1082/2013/EU). The Decision, inter alia, sets provisions on notification, ad hoc monitoring and coordination of public health measures following serious cross border threats to health from biological, chemical and environmental events as well as events that have an unknown origin. The legal instrument applies to all European Union Member States and is comparable to the International Health Regulations in its content, requirements and adoption of a multiple hazards approach. An inter-sectoral and multidisciplinary response to events with potentially dangerous cross border exposure pathways is often required. For example, European Poisons Centres may be aware of cases of toxic exposure to a product and, in parallel, trading standards may be aware of the same product due to a breach of consumer product standards. Whilst both cases would have been recorded for separate purposes in different alerting systems, they relate to the same exposure pathway; therefore a process for linking these records would allow a more robust approach to risk assessment and risk mitigation. The Decision seeks to reconcile this issue for serious threats by linking relevant platforms into one overarching higher level risk management IT platform called the Early Warning Response System (EWRS). This system will serve to link other sectors within the European Commission (EC) to public health (e.g. medicines), as well as other EU agencies and international bodies via co-notification features. Other European alert systems will be linked to EWRS to facilitate information sharing at both the assessment and management levels. This paper provides a timely overview of the main systems run by the EC and other international organisations that provide alerts following chemical incidents that have, or may have, the potential to affect public health. The advantages and further considerations of linking these different systems and sectors are also highlighted. Recommendations are made with the purpose of ensuring that modifications to these systems made to satisfy with EU legislation enable a more timely coordinated response and greater awareness of events in Europe, thereby reducing the public health impact from chemical exposures. Copyright © 2014 Elsevier Ltd. All rights reserved.

Health professional mobility in the European Union: Exploring the equity and efficiency of free movement.

PubMed

Glinos, Irene A

2015-12-01

The WHO Global Code of Practice on the International Recruitment of Health Personnel is a landmark in the health workforce migration debate. Yet its principles apply only partly within the European Union (EU) where freedom of movement prevails. The purpose of this article is to explore whether free mobility of health professionals contributes to "equitably strengthen health systems" in the EU. The article proposes an analytical tool (matrix), which looks at the effects of health professional mobility in terms of efficiency and equity implications at three levels: for the EU, for destination countries and for source countries. The findings show that destinations as well as sources experience positive and negative effects, and that the effects of mobility are complex because they change, overlap and are hard to pin down. The analysis suggests that there is a risk that free health workforce mobility disproportionally benefits wealthier Member States at the expense of less advantaged EU Member States, and that mobility may feed disparities as flows redistribute resources from poorer to wealthier EU countries. The article argues that the principles put forward by the WHO Code appear to be as relevant within the EU as they are globally. Copyright © 2015. Published by Elsevier Ireland Ltd.

Tuberculosis treatment outcome monitoring in European Union countries: systematic review

PubMed Central

van Hest, Rob; Ködmön, Csaba; Verver, Suzanne; Erkens, Connie G.M.; Straetemans, Masja; Manissero, Davide; de Vries, Gerard

2013-01-01

Treatment success measured by treatment outcome monitoring (TOM) is a key programmatic output of tuberculosis (TB) control programmes. We performed a systematic literature review on national-level TOM in the 30 European Union (EU)/European Economic Areas (EEA) countries to summarise methods used to collect and report data on TOM. Online reference bibliographic databases PubMed/MEDLINE and EMBASE were searched to identify relevant indexed and non-indexed literature published between January 2000 and August 2010. The search strategy resulted in 615 potentially relevant indexed citations, of which 27 full-text national studies (79 data sets) were included for final analysis. The selected studies were performed in 10 EU/EEA countries and gave a fragmented impression of TOM in the EU/EEA. Publication year, study period, sample size, databases, definitions, variables, patient and outcome categories, and population subgroups varied widely, portraying a very heterogeneous picture. This review confirmed previous reports of considerable heterogeneity in publications of TOM results across EU/EEA countries. PubMed/MEDLINE and EMBASE indexed studies are not a suitable instrument to measure representative TOM results for the 30 EU/EEA countries. Uniform and complete reporting to the centralised European Surveillance System will produce the most timely and reliable results of TB treatment outcomes in the EU/EEA. PMID:22790913

Freedom of movement vs. exclusion: a reinterpretation of the "insider"-"outsider" divide in the European Union.

PubMed

Ugur, M

1995-01-01

"This article argues that the question of free movement vs. exclusion within the European Union (EU) can be addressed satisfactorily only if we move away from the narrow state-centrism inherent in the current debate. What is required is to 'open' the state concept and examine the implications of state-society relations for EU policy making. Once this is done, it can be seen that the exclusionist stance of the immigration policy and the essentially intergovernmental nature of the policy making are due to an implicit contract between states and constituents implied by the concepts of nationality and citizenship. According to this perspective, the focus on the state or the political elite alone is too one-sided and misses the more complex factors bearing upon EU policy making in this area." excerpt

Tracking uptake of innovations from the European Union Public Health Programme.

PubMed

Voss, Margaretha; Alexanderson, Kristina; McCarthy, Mark

2013-11-01

The European Commission developed the Public Health Programme to enable cross-national innovation and transfer in fields of health information, health threats and health promotion. PHIRE (Public Health Innovation and Research in Europe), a collaboration of the European Public Health Association (EUPHA) with seven partners, addressed the uptake of these public health innovation projects at country level. EUPHA thematic sections lead on areas of public health practice and research and experts can choose to be section members. The section presidents of seven sections chose eight European public health projects, starting in the EU Public Health Programme in 2003-05, that provided new knowledge for practice and covered a majority of the EU countries. A web-based questionnaire recorded country informants' (CIs) perceptions of uptake, assessed as relevance and dissemination to a range of public and non-governmental organizations. 108 CIs individually described the eight innovations in an average of 14 (46%) of the 30 European countries. Three of the eight innovations were considered of high relevance by >60% of respondents and at least 70% of informants considered seven of the eight innovation projects as of high or moderate relevance. Dissemination was noted across governmental, professional and academic settings, with high impact on knowledge/awareness for at least 30% of CIs. Some projects had uptake within the policy cycle in particular countries and connected strongly with academics and professionals. Projects working at local level had less visibility nationally and some projects were unknown to national respondents. European Union funding for public health can contribute to cross-national knowledge transfer and uptake of innovations. More attention is needed to classify, characterize and identify public health innovations and to demonstrate their direct contribution to European health and well-being.

The European Union's emissions trading system in perspective

DOE Office of Scientific and Technical Information (OSTI.GOV)

A. Denny Ellerman; Paul L. Joskow

2008-05-15

The performance of the European Union's Emissions Trading System (EU ETS) to date cannot be evaluated without recognizing that the first three years from 2005 through 2007 constituted a 'trial' period and understanding what this trial period was supposed to accomplish. Its primary goal was to develop the infrastructure and to provide the experience that would enable the successful use of a cap-and-trade system to limit European GHG emissions during a second trading period, 2008-12, corresponding to the first commitment period of the Kyoto Protocol. The trial period was a rehearsal for the later more serious engagement and it wasmore » never intended to achieve significant reductions in CO{sub 2} emissions in only three years. In light of the speed with which the program was developed, the many sovereign countries involved, the need to develop the necessary data, information dissemination, compliance and market institutions, and the lack of extensive experience with emissions trading in Europe, we think that the system has performed surprisingly well. Although there have been plenty of rough edges, a transparent and widely accepted price for tradable CO{sub 2} emission allowances emerged by January 1, 2005, a functioning market for allowances has developed quickly and effortlessly without any prodding by the Commission or member state governments, the cap-and-trade infrastructure of market institutions, registries, monitoring, reporting and verification is in place, and a significant segment of European industry is incorporating the price of CO{sub 2} emissions into their daily production decisions. The development of the EU ETS and the experience with the trial period provides a number of useful lessons for the U.S. and other countries. 27 refs., 7 figs., 5 tabs.« less

75 FR 40829 - Agency Information Collection Activities: Existing Collection; Emergency Extension

Federal Register 2010, 2011, 2012, 2013, 2014

2010-07-14

... produce reports from the data. The EEOC issued regulations requiring referral local unions with 100 or... with the Paperwork Reduction Act, the Equal Employment Opportunity Commission (EEOC or Commission... (TTY). SUPPLEMENTARY INFORMATION: The EEOC has collected information from local unions on the EEO-3...

75 FR 6392 - Agency Information Collection Activities: Existing Collection; Emergency Extension

Federal Register 2010, 2011, 2012, 2013, 2014

2010-02-09

... produce reports from the data. The EEOC issued regulations requiring referral local unions with 100 or... with the Paperwork Reduction Act, the Equal Employment Opportunity Commission (EEOC or Commission... (TTY). SUPPLEMENTARY INFORMATION: The EEOC has collected information from local unions on the EEO-3...

Development of an online SPE-UHPLC-MS/MS method for the multiresidue analysis of the 17 compounds from the EU "Watch list".

PubMed

Gusmaroli, Lucia; Insa, Sara; Petrovic, Mira

2018-04-24

During the last decades, the quality of aquatic ecosystems has been threatened by increasing levels of pollutions, caused by the discharge of man-made chemicals, both via accidental release of pollutants as well as a consequence of the constant outflow of inadequately treated wastewater effluents. For this reason, the European Union is updating its legislations with the aim of limiting the release of emerging contaminants. The Commission Implementing Decision (EU) 2015/495 published in March 2015 drafts a "Watch list" of compounds to be monitored Europe-wide. In this study, a methodology based on online solid-phase extraction (SPE) ultra-high-performance liquid chromatography coupled to a triple-quadrupole mass spectrometer (UHPLC-MS/MS) was developed for the simultaneous determination of the 17 compounds listed therein. The proposed method offers advantages over already available methods, such as versatility (all 17 compounds can be analyzed simultaneously), shorter time required for analysis, robustness, and sensitivity. The employment of online sample preparation minimized sample manipulation and reduced dramatically the sample volume needed and time required, dramatically the sample volume needed and time required, thus making the analysis fast and reliable. The method was successfully validated in surface water and influent and effluent wastewater. Limits of detection ranged from sub- to low-nanogram per liter levels, in compliance with the EU limits, with the only exception of EE2. Graphical abstract Schematic of the workflow for the analysis of the Watch list compounds.

Essential levels of health information in Europe: an action plan for a coherent and sustainable infrastructure.

PubMed

Carinci, Fabrizio

2015-04-01

The European Union needs a common health information infrastructure to support policy and governance on a routine basis. A stream of initiatives conducted in Europe during the last decade resulted into several success stories, but did not specify a unified framework that could be broadly implemented on a continental level. The recent debate raised a potential controversy on the different roles and responsibilities of policy makers vs the public health community in the construction of such a pan-European health information system. While institutional bodies shall clarify the statutory conditions under which such an endeavour is to be carried out, researchers should define a common framework for optimal cross-border information exchange. This paper conceptualizes a general solution emerging from past experiences, introducing a governance structure and overarching framework that can be realized through four main action lines, underpinned by the key principle of "Essential Levels of Health Information" for Europe. The proposed information model is amenable to be applied in a consistent manner at both national and EU level. If realized, the four action lines outlined here will allow developing a EU health information infrastructure that would effectively integrate best practices emerging from EU public health initiatives, including projects and joint actions carried out during the last ten years. The proposed approach adds new content to the ongoing debate on the future activity of the European Commission in the area of health information. Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

European Union emission inventory report 1990-2008 : under the UNECE Convention on Long-range Transboundary Air Pollution (LRTAP)

DOT National Transportation Integrated Search

2010-07-01

This report describes the EU27 emission trends for : a number of air pollutants for the period 19902008. : An improved gap-filling methodology used in : compiling this year's EU27 emission inventory : means that for the first time a complete...

European Industrial Doctorates: Marie Curie Actions

ERIC Educational Resources Information Center

European Commission, 2012

2012-01-01

European industrial doctorates are joint doctoral training projects funded by the European Union (EU) and open to all research fields. The project brings together an academic participant (university, research institution, etc.) and a company. They have to be established in two different EU Member States or associated countries. Associated partners…

An update on Phytophthora ramorum in European nurseries

Treesearch

David Slawson; Jennie Blackburn; Lynne Bennett

2008-01-01

Emergency phytosanitary measures to prevent the introduction into and spread within the European Union (EU) of Phytophthora ramorum Werres, De Cock & Man in 't Veld. have been in place since 2002. Surveillance across the EU, has confirmed the presence of P. ramorum on nurseries and retailers in 15 member states. ...

Multilingualism among Brussels-Based Civil Servants and Lobbyists: Perceptions and Practices

ERIC Educational Resources Information Center

Krizsán, Attila; Erkkilä, Tero

2014-01-01

This article explores the multilingual and multicultural aspects of community-building, networking and communication in the European Union's (EU) political and administrative system. We investigated the networking and communicative preferences of EU civil servants and lobbyists using survey data and thematic interviews. Our aim was to gain a…

Quantitative risk assessment model of canine rabies introduction: application to the risk to the European Union from Morocco.

PubMed

Napp, S; Casas, M; Moset, S; Paramio, J L; Casal, J

2010-11-01

Although rabies incidence in humans in Western Europe is low, the repeated importation of rabid animals from enzootic areas threatens the rabies-free status of terrestrial animals and challenges the public health systems in this area. Most rabid animals imported into the European Union (EU) in recent years came from Morocco. The aim of this study was to develop a probabilistic risk assessment model to estimate the probability of rabies introduction, which was applied to the risk to the EU from dogs coming from Morocco. The mean annual probability of rabies introduction was 0.21 (90% CI 0.02-0.65). The pathways that contributed the most to this probability were: (a) EU citizens who adopted a dog in Morocco (59% of the total probability) and (b) EU citizens who travelled with their dog to Morocco by ferry (34% of the total probability). The model showed a marked seasonality in the risk of rabies with almost 40% of the annual probability occurring during the months of July and August. The application of stricter border controls (assuming 100% compliance) would result in a >270-fold reduction in the likelihood of rabies introduction into the EU from Morocco.

Herbal medicines: challenges in the modern world. Part 2. European Union and Russia.

PubMed

Sammons, Helen M; Gubarev, Michael I; Krepkova, Lubov V; Bortnikova, Valentina V; Corrick, Fenella; Job, Kathleen M; Sherwin, Catherine Mt; Enioutina, Elena Y

2016-08-01

Herbal medicines (HMs) have been well known to people of the European Union (EU) and Russia for centuries. Currently, Western HMs can be classified into two categories, plant-derived conventional medicines and dietary supplements. Interest to HMs has grown rapidly in all countries during the past two decades. The main goal of this review article is to present the history of HMs in the EU and Russia, forms of modern HMs, including Oriental Medicines that are popular among consumers of both countries. Additional discussion points comprise safety and adulteration issues associated with HMs, including regulatory changes and new legislative measures undertaken by the authorities. Materials available from legislative and governmental websites, PubMed and news media were used. Expert commentary: Due to cultural diversities in the EU and Russia, traditional HMs of other regions, particularly Chinese Traditional and Ayurvedic medicines, are also popular. Recently, dietary supplements containing multiple herbal and other natural products have flooded the EU and Russian markets. Pharmacovigilance in these markets is challenging in terms of establishing quality and safety of ingredients, determining efficacy, and defining risks of herb-herb and herb-drug interactions. Both the EU and Russia have introduced new legislation aimed to overcome these deficiencies.

Human migration and pig/pork import in the European Union: What are the implications for Taenia solium infections?

PubMed

Gabriël, S; Johansen, M V; Pozio, E; Smit, G S A; Devleesschauwer, B; Allepuz, A; Papadopoulos, E; van der Giessen, J; Dorny, P

2015-09-30

Taenia solium taeniasis/cysticercosis is a neglected zoonotic disease complex occurring primarily in developing countries. Though claimed eradicated from the European Union (EU), an increasing number of human neurocysticercosis cases is being detected. Risk factors such as human migration and movement of pigs/pork, as well as the increasing trend in pig rearing with outside access are discussed in this review. The entry of a tapeworm carrier into the EU seems a lot more plausible than the import of infected pork. The establishment of local transmission in the EU is presently very unlikely. However, considering the potential changes in risk factors, such as the increasing trend in pig farming with outdoor access, the increasing human migration from endemic areas into the EU, this situation might change, warranting the establishment of an early warning system, which should include disease notification of taeniasis/cysticercosis both in human and animal hosts. As currently human-to-human transmission is the highest risk, prevention strategies should focus on the early detection and treatment of tapeworm carriers, and should be designed in a concerted way, across the EU and across the different sectors. Copyright © 2015 Elsevier B.V. All rights reserved.

Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement.

PubMed

van Hest, N A; Aldridge, R W; de Vries, G; Sandgren, A; Hauer, B; Hayward, A; Arrazola de Oñate, W; Haas, W; Codecasa, L R; Caylà, J A; Story, A; Antoine, D; Gori, A; Quabeck, L; Jonsson, J; Wanlin, M; Orcau, Å; Rodes, A; Dedicoat, M; Antoun, F; van Deutekom, H; Keizer, St; Abubakar, I

2014-03-06

In low-incidence countries in the European Union (EU), tuberculosis (TB) is concentrated in big cities, especially among certain urban high-risk groups including immigrants from TB high-incidence countries, homeless people, and those with a history of drug and alcohol misuse. Elimination of TB in European big cities requires control measures focused on multiple layers of the urban population. The particular complexities of major EU metropolises, for example high population density and social structure, create specific opportunities for transmission, but also enable targeted TB control interventions, not efficient in the general population, to be effective or cost effective. Lessons can be learnt from across the EU and this consensus statement on TB control in big cities and urban risk groups was prepared by a working group representing various EU big cities, brought together on the initiative of the European Centre for Disease Prevention and Control. The consensus statement describes general and specific social, educational, operational, organisational, legal and monitoring TB control interventions in EU big cities, as well as providing recommendations for big city TB control, based upon a conceptual TB transmission and control model.

Blood Versus Land: The Comparative Foundations for Citizenship and Voting Rights in Germany and Sweden

DTIC Science & Technology

2010-03-01

the political process. This thesis will examine how two major immigrant destination states within the European Union extend voting rights to...PAGES 77 14. SUBJECT TERMS Germany, Sweden, European Union , Voting rights, Franchise, Citizenship, Immigration, Immigrant, Migration, Nationalism 16...within the European Union extend voting rights to immigrants from outside the EU. These will be Germany and Sweden. The thesis concludes that the

75 FR 63179 - Agency Information Collection Activities: Existing Collection; Emergency Extension

Federal Register 2010, 2011, 2012, 2013, 2014

2010-10-14

... EEOC issued regulations requiring referral local unions with 100 or more members to submit EEO-3... with the Paperwork Reduction Act, the Equal Employment Opportunity Commission (EEOC or Commission...). SUPPLEMENTARY INFORMATION: The EEOC has collected information from local unions on the EEO-3 form since 1966...

75 FR 18833 - Agency Information Collection Activities: Existing Collection; Emergency Extension

Federal Register 2010, 2011, 2012, 2013, 2014

2010-04-13

... EEOC issued regulations requiring referral local unions with 100 or more members to submit EEO-3... with the Paperwork Reduction Act, the Equal Employment Opportunity Commission (EEOC or Commission...). SUPPLEMENTARY INFORMATION: The EEOC has collected information from local unions on the EEO-3 form since 1966...

EU Failing FAO Challenge to Improve Global Food Security.

PubMed

Smyth, Stuart J; Phillips, Peter W B; Kerr, William A

2016-07-01

The announcement that the European Union (EU) had reached an agreement allowing Member States (MS) to ban genetically modified (GM) crops confirms that the EU has chosen to ignore the food security challenge issued to the world by the Food and Agriculture Organization of the United Nations (FAO) in 2009. The FAO suggests that agricultural biotechnology has a central role in meeting the food security challenge. Copyright © 2016 Elsevier Ltd. All rights reserved.

Knowledge transfer within EU-funded marine science research - a viewpoint

NASA Astrophysics Data System (ADS)

Bayliss-Brown, Georgia; Cheallachaín, Cliona Ní

2016-04-01

Knowledge transfer, in its most inherent form, can be tracked back to the earliest phase of the Neolithic Revolution, 10,000 years ago, at a time when innovators shared their thoughts on crop cultivation and livestock farming (Bellwood, 2004). Not to be mistaken for science transfer - the export of modern science to non-scientific audiences - it was in the 1960s, that modern knowledge transfer was initiated, when reporting research achievements shifted towards having institutional and political agendas (Lipphardt & Ludwig, 2011). Albeit that the economic contribution of scientific research has been scrutinised for decades; today, there is a pronounced need for the evaluation of its social, cultural and ecological impact. To have impact, it is essential that scientific knowledge is clear and accessible, as well as robust and credible, so that it can be successfully transferred and applied by those identifying solutions for today's societal and environmental challenges. This phenomenon is receiving growing academic interest, where publications including "knowledge transfer" in the title have increased near exponentially for 60 years. Furthermore, we are seeing a definite shift towards embedding a mission of knowledge transfer in Public Research Organisations. This new approach is rewarding researchers whom deliver on all three institutional missions: teaching, research and knowledge transfer. In addition, the European Commission (2008) recommends that "knowledge transfer between universities and industry is made a permanent political and operational priority" and that "sufficient resources and incentives [be] available to public research organisations and their staff to engage in knowledge transfer activities". It is also anticipated that funding agencies will soon make pathways-to-impact statements, also known as knowledge transfer plans, a mandatory requirement of all project proposals. AquaTT is a leader in scientific knowledge management, including knowledge transfer and dissemination. This Dublin-based SME has an ever-growing portfolio of FP7 and Horizon 2020 projects where they hold knowledge management responsibilities. In this session, we will present AquaTT's experiences in knowledge management for several European Union-funded marine research projects; including MarineTT (http://marinett.eu/) that was recognised as an exemplar project in the ex post evaluation of FP7 to the European Commission. These insights will be supplemented with an overview of the AquaTT-developed step-by-step knowledge transfer methodology, as used by the COLUMBUS project - the EU's flagship Blue Growth and Knowledge Transfer initiative (http://www.columbusproject.eu/). This session will provide a platform to launch AquaTT's European knowledge transfer network, established to support the research community in fostering a culture that recognises and rewards knowledge transfer between scientists and end-users (industry, policy, and wider society), thereby ensuring that research achieves its maximum potential impact. References Bellwood, P. (2004) The First Farmers: Origins of Agricultural Societies. Malden, MA. European Commission (2008) recommendation on the management of intellectual property in knowledge transfer activities and code of practice for universities and other public research organisations http://ec.europa.eu/invest-in-research/pdf/ip_recommendation_en.pdf Lipphardt, V. and D. Ludwig (2011) Knowledge transfer and science transfer. http://ieg-ego.eu/en/threads/theories-and-methods/knowledge-transfer/veronika-lipphardt-david-ludwig-knowledge-transfer-and-science-transfer

Equal Employment Opportunity Commission v. University of Detroit, 13 December 1988.

PubMed

1988-01-01

The plaintiffs were the Equal Employment Opportunity Commission and a former faculty member, who was discharged after refusing to pay union fees because the union supported a pro-choice view on abortion, which conflicted with the faculty member's religious beliefs. They alleged discrimination on the basis of religion in violation of Title VII of the US Civil Rights Act of 1964. The Court held that there was no Title VII violation since the Union had made a reasonable accommodation by offering to refund that portion of the fees representing the union's activities with respect to abortion. It concluded that the union did not have to accept the faculty member's proposed accommodation of letting him contribute his fees to a charity rather than pay them to the union. full text

76 FR 33703 - Submission for OMB Review; Comment Request

Federal Register 2010, 2011, 2012, 2013, 2014

2011-06-09

...) administers the U.S.-European Union (EU) and U.S.- Swiss Safe Harbor Frameworks (Frameworks). These Frameworks allow U.S. companies to meet the requirements of the European Union's Data Protection Directive and the...: International Trade Administration. Title: Survey of Participating Companies in the United States- European...

Integration and Disintegration: A Political Geography of the European Union.

ERIC Educational Resources Information Center

Davidson, Fiona M.

1997-01-01

Describes the somewhat contradictory movements towards political and economic integration and political decentralization in the European Union (EU). Discusses the implications of those trends for the future of the sovereign state, specifically for Spain, France, and the United Kingdom. Maintains that political power is being wrested away from core…

A revaluation of the cultural dimension of disability policy in the European Union: the impact of digitization and web accessibility.

PubMed

Ferri, Delia; Giannoumis, G Anthony

2014-01-01

Reflecting the commitments undertaken by the EU through the conclusion of the United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), the European Disability Strategy 2010–2020 not only gives a prominent position to accessibility, broadly interpreted, but also suggests an examination of the obligations for access to cultural goods and services. The European Disability Strategy 2010–2020 expressly acknowledges that EU action will support national activities to make sports, leisure, cultural and recreational organizations and activities accessible, and use the possibilities for copyright exceptions in the Directive 2001/29/EC (Infosoc Directive). This article discusses to what extent the EU has realized the principle of accessibility and the right to access cultural goods and services envisaged in the UNCRPD. Previous research has yet to explore how web accessibility and digitization interact with the cultural dimension of disability policy in the European Union. This examination attempts to fill this gap by discussing to what extent the European Union has put this cultural dimension into effect and how web accessibility policies and the digitization of cultural materials influence these efforts.

Assumptions in the European Union biofuels policy: frictions with experiences in Germany, Brazil and Mozambique.

PubMed

Franco, Jennifer; Levidow, Les; Fig, David; Goldfarb, Lucia; Hönicke, Mireille; Mendonça, Maria Luisa

2010-01-01

The biofuel project is an agro-industrial development and politically contested policy process where governments increasingly become global actors. European Union (EU) biofuels policy rests upon arguments about societal benefits of three main kinds - namely, environmental protection (especially greenhouse gas savings), energy security and rural development, especially in the global South. Each argument involves optimistic assumptions about what the putative benefits mean and how they can be fulfilled. After examining those assumptions, we compare them with experiences in three countries - Germany, Brazil and Mozambique - which have various links to each other and to the EU through biofuels. In those case studies, there are fundamental contradictions between EU policy assumptions and practices in the real world, involving frictional encounters among biofuel promoters as well as with people adversely affected. Such contradictions may intensify with the future rise of biofuels and so warrant systematic attention.

European Union's public fishing access agreements in developing countries.

PubMed

Le Manach, Frédéric; Chaboud, Christian; Copeland, Duncan; Cury, Philippe; Gascuel, Didier; Kleisner, Kristin M; Standing, André; Sumaila, U Rashid; Zeller, Dirk; Pauly, Daniel

2013-01-01

The imperative to increase seafood supply while dealing with its overfished local stocks has pushed the European Union (EU) and its Member States to fish in the Exclusive Economic Zones of other countries through various types of fishing agreements for decades. Although European public fishing agreements are commented on regularly and considered to be transparent, this is the first global and historical study on the fee regime that governs them. We find that the EU has subsidized these agreements at an average of 75% of their cost (financial contribution agreed upon in the agreements), while private European business interests paid the equivalent of 1.5% of the value of the fish that was eventually landed. This raises questions of fisheries benefit-sharing and resource-use equity that the EU has the potential to address during the nearly completed reform of its Common Fisheries Policy.

The European Union's REACH regulation: a review of its history and requirements.

PubMed

Williams, E Spencer; Panko, Julie; Paustenbach, Dennis J

2009-01-01

In 2006, the European Union (EU) promulgated a monumental regulatory initiative for the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH). To date, several thousand pages of text have been needed to describe the expectations of this regulation. There were numerous reasons for the promulgation of REACH, but, by and large, it is an extension of the global desire to produce fewer industrial chemicals, to understand the possible human and ecological hazards of those that are produced, and to insure that any major threat is anticipated, as well as prevented. Most industry-related groups consider it the most wide-ranging and costly regulatory initiatives related to health risk assessment ever to be promulgated. This review presents a description of REACH that should inform scientists, managers, and others about its objectives and the means to satisfy them. Registration is required for all chemicals manufactured or imported into the EU, unless specifically exempted. Registration is expected to be a collaborative process among companies, which will generate a dossier containing data on physicochemical characteristics, as well as toxicological and ecotoxicological properties. Though the magnitude of the gaps in the data required for registration is uncertain at this point, it is clear that basic toxicology testing will have to be conducted for many chemical substances that have not undergone formal review up to this point. For many chemicals, an examination of hazards and risks arising from the use of these substances will also be required in the form of a chemical safety report (CSR). Beginning with the dual processes of dossier and substance evaluation, the European Chemicals Agency (ECHA), the Member States of the EU, and the European Commission will identify chemicals that may pose unacceptable hazards to human health and/or the environment, and will curtail or restrict their usage. The implementation of REACH will expand and deepen the fields of applied toxicology and exposure assessment by spurring activity and innovation in sampling and analysis, toxicology testing, exposure modeling, alternative toxicity testing, and risk assessment practices.

Population aging and migration - history and UN forecasts in the EU-28 and its east and south near neighborhood - one century perspective 1950-2050.

PubMed

Jakovljevic, Mihajlo Michael; Netz, Yael; Buttigieg, Sandra C; Adany, Roza; Laaser, Ulrich; Varjacic, Mirjana

2018-03-16

There is a gap in knowledge on long term pace of population aging acceleration and related net-migration rate changes in WHO European Region and its adjacent MENA countries. We decided to compare European Union (EU-28) region with the EU Near Neighborhood Policy Region East and EU Near Neighborhood Policy Region South in terms of these two essential features of third demographic transition. One century long perspective dating back to both historical data and towards reliable future forecasts was observed. United Nation's Department of Economic and Social Affairs estimates on indicators of population aging and migration were observed. Time horizon adopted was 1950-2050. Targeted 44 countries belong to either one of three regions named by EU diplomacy as: European Union or EU-28, EU Near Neighborhood Policy Region East (ENP East) and EU Near Neighborhood Policy Region South (ENP South). European Union region currently experiences most advanced stage of demographic aging. The latter one is the ENP East region dominated by Slavic nations whose fertility decline continues since the USSR Era back in late 1980s. ENP South region dominated by Arab League nations remains rather young compared to their northern counterparts. However, as the Third Demographic Transition is inevitably coming to these societies they remain the spring of youth and positive net emigration rate. Probably the most prominent change will be the extreme fall of total fertility rate (children per woman) in ENP South countries (dominantly Arab League) from 6.72 back in 1950 to medium-scenario forecasted 2.10 in 2050. In the same time net number of migrants in the EU28 (both sexes combined) will grow from - 91,000 in 1950 to + 394,000 in 2050. Long term migration from Eastern Europe westwards and from MENA region northwards is historically present for many decades dating back deep into the Cold War Era. Contemporary large-scale migrations outsourcing from Arab League nations towards rich European Protestant North is probably the peak of an iceberg in long migration routes history. However, in the decades to come acceleration of aging is likely to question sustainability of such movements of people.

Responding to "Crisis": Education Policy Research in Europe

ERIC Educational Resources Information Center

Alexiadou, Nafsika

2016-01-01

This paper discusses the significance of international and transnational developments for education policy research, with a focus on the European Union. The rise of policy projects at the EU level since 2000, has altered the relationships between the state, EU institutions and education policy, in terms of the definition of values, purposes, and…

Exploring the Social Benefits of Agri-Environment Schemes in England

ERIC Educational Resources Information Center

Mills, Jane

2012-01-01

Recent decades have seen sustainable development emerging as a core concern of European Union (EU) policy. In order to consider how policies can contribute more positively to the goals of sustainable development, major EU policies must undergo an assessment of their potential economic, environmental and social impacts. Within the agri-environment…

European Education, European Citizenship? On the Role of Education in Constructing Europeanness.

ERIC Educational Resources Information Center

Ollikainen, Aaro

2000-01-01

Focuses on the role of the European Union (EU) education programs in fostering a sense of European citizenship. Addresses the five meanings given to the concept of European citizenship: (1) recognition of European heritage; (2) EU loyalty; (3) right of free movement; (4) political participation; and (5) active citizenship. (CMK)

Operation EUFOR TCHAD/RCA and the European Union’s Common Security and Defense Policy

DTIC Science & Technology

2010-10-01

Lessons from EUFOR Tchad/RCA, March 2010. 152. For a more detailed description of the EU Battlegroups, see Gustav Lindstrom , “Enter the EU Battlegroups...Major General Gregg F. Martin Commandant ***** STRATEGIC STUDIES INSTITUTE Director Professor Douglas C. Lovelace, Jr. Director of Research Dr. Antulio J

An Ever Closer Union . . . of Linguistic Diversity

ERIC Educational Resources Information Center

Tomozeiu, Daniel

2017-01-01

The analysis carried out between October 2014 and February 2015 by a team of researchers from the University of Westminster with support from colleagues from across the EU identified the linguistic communities across the 28 EU member states as recognized (or not) by the country's legislation and the linguistic rights of these communities in…

Overview on Biofuels from a European Perspective

ERIC Educational Resources Information Center

Ponti, Luigi; Gutierrez, Andrew Paul

2009-01-01

In light of the recently developed European Union (EU) Biofuels Strategy, the literature is reviewed to examine (a) the coherency of biofuel production with the EU nonindustrial vision of agriculture, and (b) given its insufficient land base, the implications of a proposed bioenergy pact to grow biofuel crops in the developing world to meet EU…

Migrants and the Language of Instruction: Is the EU Policy Deficit Driving New Innovations in Social Inclusion?

ERIC Educational Resources Information Center

Cullen, Joe

2017-01-01

Language learning has long been seen as an important tool for achieving European Union (EU) targets for social inclusion. However, "mainstream" policy instruments like the "Action Plan on Promoting Language Learning and Linguistic Diversity" and the "European Charter for Minority Languages" have been undermined in…

Beyond Inclusion: Reconsidering Policies, Curriculum, and Pedagogy for Roma Students

ERIC Educational Resources Information Center

Miskovic, Maja; Curcic, Svjetlana

2016-01-01

This paper investigates the policies and politics of including European Roma students in mainstream educational systems within the context of two European Union (EU) policies: the Decade of Roma Inclusion (2005-2015) and EU National Roma Integration Strategies (2013-2020). Drawing on the scholarship about inclusion and its practical achievements,…

Making Learning Visible: Identification, Assessment and Recognition of Non-Formal Learning in Europe.

ERIC Educational Resources Information Center

Bjornavold, Jens

Policies and practices in the areas of identification, assessment, and recognition of nonformal learning in the European Union (EU) were reviewed. The review focused on national and EU-level experiences regarding the following areas and issues: recognition of the contextual nature of learning; identification of methodological requirements for…

An Application of the EPOSTL: Focus on Culture

ERIC Educational Resources Information Center

Arikan, Arda; Zorba, M. Galip

2016-01-01

Although Turkey is not a member state of the European Union (EU), educational and curricular documents produced by the EU such like the Common European Framework of Reference for Languages (CEFR), the European Language Portfolio (the ELP) and the European Portfolio for Student Teachers of Languages (EPOSTL) have been examined by Turkish…

Implementation of Inquiry-Based Science Education in Different Countries: Some Reflections

ERIC Educational Resources Information Center

Rundgren, Carl-Johan

2018-01-01

In this forum article, I reflect on issues related to the implementation of inquiry-based science education (IBSE) in different countries. Regarding education within the European Union (EU), the Bologna system has in later years provided extended coordination and comparability at an organizational level. However, the possibility of the EU to…

Challenges of Adolescent Psychology in the European Identity Context

ERIC Educational Resources Information Center

Lannegrand-Willems, Lyda; Barbot, Baptiste

2015-01-01

In Europe, the question of identity and youth civic engagement constitutes a challenge both for the European Union (EU) and for research on adolescent psychology. In this article, we discuss the European historical context and the current initiatives from the EU that aim to encourage civic engagement among young people. Then, we suggest some…

Multiculturalism Is D(r)ead in Europe

ERIC Educational Resources Information Center

Bajrektarevic, Anis

2014-01-01

There is a claim currently circulating the European Union (EU), both cynical and misleading: "multiculturalism is dead in Europe". No wonder, as the conglomerate of nation-states/EU has silently handed over one of its most important debates--that of European identity--to the left and right wing parties, recently followed by several…

Skill Mismatch: More than Meets the Eye. Briefing Note

ERIC Educational Resources Information Center

Cedefop - European Centre for the Development of Vocational Training, 2014

2014-01-01

The global financial and economic crisis has led to alarmingly high unemployment and underemployment in many European Union (EU) countries. Yet, surveys still find that more than one in three employers has problems filling vacancies. The latest European company survey, in spring 2013, found that about 40% of firms across the EU had difficulties…

Phytophthora ramorum and P. kernoviae: regulation in the European union

Treesearch

Stephen Hunter

2008-01-01

The history of the regulation of action against Phytophthora ramorum and P. kernoviae in the EU and U.K. is briefly summarised. For the former there are EU controls on the import of host plants, and the internal regime of plant passporting has been extended to cover Rhododendron, Viburnum and...

The European Union's Adequacy Approach to Privacy and International Data Sharing in Health Research.

PubMed

Stoddart, Jennifer; Chan, Benny; Joly, Yann

2016-03-01

The European Union (EU) approach to data protection consists of assessing the adequacy of the data protection offered by the laws of a particular jurisdiction against a set of principles that includes purpose limitation, transparency, quality, proportionality, security, access, and rectification. The EU's Data Protection Directive sets conditions on the transfer of data to third countries by prohibiting Member States from transferring to such countries as have been deemed inadequate in terms of the data protection regimes. In theory, each jurisdiction is evaluated similarly and must be found fully compliant with the EU's data protection principles to be considered adequate. In practice, the inconsistency with which these evaluations are made presents a hurdle to international data-sharing and makes difficult the integration of different data-sharing approaches; in the 20 years since the Directive was first adopted, the laws of only five countries from outside of the EU, Economic Area, or the European Free Trade Agreement have been deemed adequate to engage in data transfers without the need for further administrative safeguards. © 2016 American Society of Law, Medicine & Ethics.

[Trends concerning medical articles 1989-1998. A study of Danish articles compared to other members of the European Union].

PubMed

Jørgensen, H L; Praetorius, L; Ingwersen, P

1999-11-15

The paper analyses the development of the total number of journal articles indexed in the Medline database published by authors affiliated to Denmark 1989-1998 in medicine compared to the development in the European Union during the same period. The publication analysis is then compared to the citation impact of articles published in the central journals indexed in Science Citation Index (ISI) 1987-1996 through use of the National Science Indicators (NIS, ISI) database. The total number of Danish journal articles has remained relatively constant compared to a 50% increase in the EU as a whole. The number of Danish articles published in central journals, however, has increased by 20% (compared to 27% for the EU) and the number of citations obtained by these articles by 58% (compared to 66% for the EU) in the 1987-1996 period. By population, Denmark ranked third in total number of articles in 1998. In conclusion, Denmark is very active in medical research but neither the quantity nor the quality of Danish medical research has increased at the same rate as the EU average.

Prospects for public participation on nuclear risks and policy options: innovations in governance practices for sustainable development in the European Union.

PubMed

O'Connor, M; van den Hove, S

2001-09-14

We outline the potential participative governance and risk management in application to technological choices in the nuclear sector within the European Union (EU). Well-conducted public participation, stakeholder consultation and deliberation procedures can enhance the policy process and improve the robustness of strategies dealing with high-stakes investment and risk management challenges. Key nuclear issues now confronting EU member states are: public concern with large-scale environmental and health issues; the Chernobyl accident (and others less catastrophic) whose effect has been to erode public confidence and trust in the nuclear sector; the maturity of the nuclear plant, hence the emerging prominence of waste transportation, reprocessing and disposal issues as part of historical liability within the EU; the nuclear energy heritage of central and eastern European candidate countries to EU accession. The obligatory management of inherited technological risks and uncertainties on large temporal and geographical scales, is a novel feature of technology assessment and governance. Progress in the nuclear sector will aid the development of methodologies for technological foresight and risk governance in fields other than the nuclear alone.

Regulatory and associated political issues with respect to Bt transgenic maize in the European union.

PubMed

Saeglitz, Christiane; Bartsch, Detlef

2003-06-01

Legislation at the national level in Europe as well as that developed by the European Union (EU) generally permits release and commercialization of genetically modified organisms (GMOs). However, only 10 plant/event combinations were registered as of 2002: three maize events (Bt176, Mon810, and Bt11), with the other seven divided among carnation (3), oil-seed rape (2), tobacco (1), and raddiccio (1). Of these, only one maize event (Bt176) has been registered as a legal variety, and this was in Spain, where 22,000ha have been planted annually since 1998. In this paper, we first provide an overview on the complexity of EU GMO legislation. Then we discuss the minor role that results of EU-funded biosafety research have had on governmental policy. Finally, we provide information about initiatives for post-commercialization monitoring plans of Bt maize in Europe. As a result of the slow progress to date, we conclude that commercialization of GMOs will be seriously delayed in the EU for the next several years.

The proposed EU-regulation on clinical trials on medicinal products: an unethical proposal?

PubMed

Heringa, Jilles; Dute, Joseph

2013-09-01

The Commission has proposed a regulation 'on clinical trials on medicinal products for human use' to introduce one regulatory framework for clinical trials in the European Union. This regulation should replace the current clinical trials directive (2001/20/EC). In this article we describe and critically review the main provisions of the proposed regulation. We assess the consequences for a sound authorisation procedure of clinical trials and the level of protection for human subjects. We note that the proposed regulation is inconsistent with applicable international legal documents, such as the Biomedicine Convention and the Declaration of Helsinki. We conclude that the proposed regulation does not ensure a "high level of human health protection"--required by its legal basis in the TFEU--because it may force Member States concerned to accept a reporting Member States' approval of--in their estimation--an unethical clinical trial.

25 years of European Union (EU) quality schemes for agricultural products and foodstuffs across EU Member States.

PubMed

Albuquerque, Tânia G; Oliveira, M Beatriz Pp; Costa, Helena S

2018-05-01

Consumers are increasingly turning their attention to the quality and origin of products that they consume. European Union (EU) quality schemes are associated with a label, which was introduced to allow consumers to perform an informed choice and to protect producers from unfair practices. This present study provides an overview of the last 25 years of EU quality schemes [Protected Designations of Origin (PDO), Protected Geographical Indications (PGI) and Traditional Specialities Guaranteed (TSG)] on agricultural products and foodstuffs across the 28 EU Member States. According to the results, it was possible to conclude that Southern European countries have the highest number of registered products. The most used EU quality scheme is PGI, followed by PDO. Concerning the analysis of the evolution in the last 25 years, the number of registered products among EU Member States has increased significantly. The fruit, vegetables and cereals (fresh or processed) category is the one that accounts for the highest percentage (26.8%) of registered products, followed by cheeses and meat products (cooked, salted, smoked) categories, with 17.2% and 13.5%, respectively. Further investigations should address consumer preferences, knowledge and attitudes, especially Northern European countries with a lower number of registered products. Moreover, the investigation and registration of products should be encouraged among all EU Member States to allow the maintenance of important elements of the history, culture and heritage of the local areas, regions and countries. © 2017 Society of Chemical Industry. © 2017 Society of Chemical Industry.

Evolution of European Union legislation on emergency research.

PubMed

Mentzelopoulos, Spyros D; Mantzanas, Michail; van Belle, Gerald; Nichol, Graham

2015-06-01

Emergency research is necessary to prevent exposure of patients to unvalidated clinical practice (nonmaleficence), and to improve the dismal prognosis of disorders requiring emergent treatment such as cardiac arrest (beneficence). Regulations that govern clinical research should conform to bioethical principles of respect for nonmaleficence, beneficence, autonomy, and justice. Our objectives are to review the evolution of European Union (EU) legislation on emergency research, and to identify potentially remaining problems. EU legislative sources on clinical research and medical literature describing the impact of EU Regulations on emergency research. Article 5 of EU Directive 2001/20/EC required consent before enrolment in a research study to ensure the autonomy of potentially incapacitated research subjects. However, obtaining such consent is often impossible in emergency situations. Directive 2001/20/EC was criticized for potentially preventing emergency research. Several EU Member States addressed this problem by permitting deferred consent. International ethical guidelines supporting deferred consent were also cited by Good Clinical Practice Directive 2005/28/EC. However, Directive 2001/20/EC was not revised to achieve harmonization of EU emergency research, thus resulting in ongoing "ambiguity" as regards to emergency research legitimacy. This will be definitively addressed by applying EU Regulation No. 536/2014 and repealing Directive 2001/20/EC. The new EU Regulation permits using deferred consent under clearly specified conditions, and may foster emergency research that evaluates interventions posing minimal risk relative to standard practice. Legislation related to emergency research in Europe has evolved to increase concordance with bioethical principles so as to increase evidence-based improvements in emergency care. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Trends of mortality from Alzheimer's disease in the European Union, 1994-2013.

PubMed

Niu, H; Alvarez-Alvarez, I; Guillen-Grima, F; Al-Rahamneh, M J; Aguinaga-Ontoso, I

2017-06-01

In many countries, Alzheimer's disease (AD) has gradually become a common disease in elderly populations. The aim of this study was to analyse trends of mortality caused by AD in the 28 member countries in the European Union (EU) over the last two decades. We extracted data for AD deaths for the period 1994-2013 in the EU from the Eurostat and World Health Organization database. Age-standardized mortality rates per 100 000 were computed. Joinpoint regression was used to analyse the trends and compute the annual percent change in the EU as a whole and by country. Analyses by gender and by European regions were conducted. Mortality from AD has risen in the EU throughout the study period. Most of the countries showed upward trends, with the sharpest increases in Slovakia, Lithuania and Romania. We recorded statistically significant increases of 4.7% and 6.0% in mortality rates in men and women, respectively, in the whole EU. Several countries showed changing trends during the study period. According to the regional analysis, northern and eastern countries showed the steepest increases, whereas in the latter years mortality has declined in western countries. Our findings provide evidence that AD mortality has increased in the EU, especially in eastern and northern European countries and in the female population. Our results could be a reference for the development of primary prevention policies. © 2017 EAN.

Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation.

PubMed

Diel, Roland; Vandeputte, Joris; de Vries, Gerard; Stillo, Jonathan; Wanlin, Maryse; Nienhaus, Albert

2014-02-01

Without better vaccines it is unlikely that tuberculosis (TB) will ever be eliminated. An investment of ∼ €560 million is considered necessary to develop a new, effective vaccine in the European Union (EU). However, less is known about the costs of TB disease in the EU. We performed a systematic review of literature and institutional websites addressing the 27 EU members to summarise cost data. We searched MEDLINE, EMBASE and Cochrane bibliographies for relevant articles. Combining direct and indirect costs, we arrived at an average per-TB case costs in the original EU-15 states plus Cyprus, Malta and Slovenia of €10 282 for drug-susceptible TB, €57 213 for multidrug resistant (MDR)-TB and €170 744 for extensively drug resistant (XDR)-TB. In the remaining new EU states, costs amounted to €3427 for drug-susceptible TB and €24 166 for MDR-TB/XDR-TB. For the 70 340 susceptible TB cases, 1488 MDR-TB and 136 XDR-TB cases notified in 2011 costs of €536 890 315 accumulated in 2012. In the same year, the 103 104 disability-adjusted life years caused by these cases, when stated in monetary terms, amounted to a total of €5 361 408 000. Thus, the resulting economic burden of TB in the EU clearly outweighs the cost of investing in more efficient vaccines against TB.

EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 - 2005.

PubMed

Zerah, Simone; McMurray, Janet; Bousquet, Bernard; Baum, Hannsjorg; Beastall, Graham H; Blaton, Vic; Cals, Marie-Josèphe; Duchassaing, Danielle; Gaudeau-Toussaint, Marie-Françoise; Harmoinen, Aimo; Hoffmann, Hans; Jansen, Rob T; Kenny, Desmond; Kohse, Klaus P; Köller, Ursula; Gobert, Jean-Gérard; Linget, Christine; Lund, Erik; Nubile, Giuseppe; Opp, Matthias; Pazzagli, Mario; Pinon, Georges; Queralto, José M; Reguengo, Henrique; Rizos, Demetrios; Szekeres, Thomas; Vidaud, Michel; Wallinder, Hans

2006-01-01

The EC4 Syllabus for Postgraduate Training is the basis for the European Register of Specialists in Clinical Chemistry and Laboratory Medicine. The syllabus: Indicates the level of requirements in postgraduate training to harmonise the postgraduate education in the European Union (EU); Indicates the level of content of national training programmes to obtain adequate knowledge and experience; Is approved by all EU societies for clinical chemistry and laboratory medicine. The syllabus is not primarily meant to be a training guide, but on the basis of the overview given (common minimal programme), national societies should formulate programmes that indicate where knowledge and experience is needed. The main points of this programme are: Indicates the level of requirements in postgraduate training to harmonise the postgraduate education in the European Union (EU); Indicates the level of content of national training programmes to obtain adequate knowledge and experience; Is approved by all EU societies for clinical chemistry and laboratory medicine. Knowledge in biochemistry, haematology, immunology, etc.; Pre-analytical conditions; Evaluation of results; Interpretations (post-analytical phase); Laboratory management; and Quality insurance management. The aim of this version of the syllabus is to be in accordance with the Directive of Professional Qualifications published on 30 September 2005. To prepare the common platforms planned in this directive, the disciplines are divided into four categories: Indicates the level of requirements in postgraduate training to harmonise the postgraduate education in the European Union (EU); Indicates the level of content of national training programmes to obtain adequate knowledge and experience; Is approved by all EU societies for clinical chemistry and laboratory medicine. Knowledge in biochemistry, haematology, immunology, etc.; Pre-analytical conditions; Evaluation of results; Interpretations (post-analytical phase); Laboratory management; and Quality insurance management. General chemistry, encompassing biochemistry, endocrinology, chemical (humoral), immunology, toxicology, and therapeutic drug monitoring; Haematology, covering cells, transfusion serology, coagulation, and cellular immunology; Microbiology, involving bacteriology, virology, parasitology, and mycology; Genetics and IVF.

Languages and Institutions in the European Union. Mercator Working Papers.

ERIC Educational Resources Information Center

Alcaraz, Manuel

This paper situates languages in the framework of European construction, analyzing problems resulting from the definition of languages' official status in the European Union (EU) juridical system. It explains that the process of European construction is historically defined by means of two distinct features (it is an open process, and at the same…

Vocation or Vocational? Reviewing European Union Education and Mobility Structures

ERIC Educational Resources Information Center

Hadfield, Amelia; Summerby-Murray, Robert

2016-01-01

This article examines the role that education plays in European Union (EU) integration. We ask whether efforts which historically have been designed to endow European students with a "knowledge of Europe" in terms of an understanding of culture, politics and sensibility have been circumscribed by, or augmented, by the recently…

Europe in the Feminine: The Union of Contrasts.

ERIC Educational Resources Information Center

Bouder, Annie

1997-01-01

The relationship between training and the employment of women in the 12 countries of the European Union (EU) was examined. An analysis of the distribution of the female population by training levels revealed that women in the Netherlands, Germany, and Denmark generally had the highest overall levels of training, whereas women in Spain and Portugal…

"Youth" Making Us Fit: On Europe as Operator of Political Technologies

ERIC Educational Resources Information Center

Olsson, Ulf; Petersson, Kenneth; Krejsler, John B.

2011-01-01

This article problematizes the construction of youth as a "driving force" in the contemporary configuration of the European Union (EU) as an educational and political space. The study draws empirical nourishment out of documents that are central to the ongoing formation of the Union, be it White Papers, scripts or memos concerning…

Assessment of HIV molecular surveillance capacity in the European Union, 2016.

PubMed

Keating, Patrick; Pharris, Anastasia; Leitmeyer, Katrin; De Angelis, Stefania; Wensing, Annemarie; Amato-Gauci, Andrew J; Broberg, Eeva

2017-12-01

IntroductionExpanding access to HIV antiretroviral treatment is expected to decrease HIV incidence and acquired immunodeficiency syndrome (AIDS) mortality. However, this may also result in increased HIV drug resistance (DR). Better monitoring and surveillance of HIV DR is required to inform treatment regimens and maintain the long term effectiveness of antiretroviral drugs. As there is currently no formal European Union (EU)-wide collection of HIV DR data, this study aimed to assess the current HIV molecular surveillance capacity in EU/European Economic Area (EEA) countries in order to inform the planning of HIV DR monitoring at EU level. Methods: Thirty EU/EEA countries were invited to participate in a survey on HIV molecular surveillance capacity, which also included laboratory aspects. Results: Among 21 responding countries, 13 reported using HIV sequence data (subtype and/or DR) for surveillance purposes at national level. Of those, nine stated that clinical, epidemiological and sequence data were routinely linked for analysis. Discussion/conclusion : We identified similarities between existing HIV molecular surveillance systems, but also found important challenges including human resources, data ownership and legal issues that would need to be addressed.Information on capacities should allow better planning of the phased introduction of HIV DR surveillance at EU/EEA level.

The European Union Joint Procurement Agreement for cross-border health threats: what is the potential for this new mechanism of health system collaboration?

PubMed

Azzopardi-Muscat, Natasha; Schroder-Bäck, Peter; Brand, Helmut

2017-01-01

The Joint Procurement Agreement (JPA) is an innovative instrument for multi-country procurement of medical countermeasures against cross-border health threats. This paper aims to assess its potential performance. A literature review was conducted to identify key features of successful joint procurement programmes. Documentary analysis and a key informants' interview were carried out to analyse the European Union (EU) JPA. Ownership, equity, transparency, stable central financing, standardisation, flexibility and gradual development were identified as important prerequisites for successful establishment of multi-country joint procurement programmes in the literature while security of supply, favourable prices, reduction of operational costs and administrative burden and creation of professional expert networks were identified as desirable outcomes. The EU JPA appears to fulfil the criteria of ownership, transparency, equity, flexibility and gradual development. Standardisation is only partly fulfilled and central EU level financing is not provided. Security of supply is an important outcome for all EU Member States (MS). Price savings, reduction in administrative burden and creation of professional networks may be particularly attractive for the smaller MS. The JPA has the potential to increase health system collaboration and efficiency at EU level provided that the incentives for sustained commitment of larger MS are sufficiently attractive.

A VIEW OF TURKEY AND EUROPEAN RELATIONS FROM THE PERSPECTIVE OF MEDICAL LEGISLATION: AN ASSESMENT OF STATE OF PLAY

PubMed Central

Ekmekçi, Perihan Elif; Arda, Berna

2015-01-01

The aim of this paper is to reflect the situation of health legislation alignment in Turkey in its accession process to the European Union and Customs Union Agreement, and to discuss the the EU’s health priorities of in parallel with the Turkish ones. The health legislation alignment processes consist of three titles which are: European Union alignment process, the harmonization done in the framework of membership to Council of Europe, and the obligations under the Customs Union Agreement. Significant human resources are required for the adoption of the legislations which make ethically imperative the discussion of whether there is a harmony among the priorities of both parities. Unless this harmony and paralellisim is shown, the human resources appointed for the adoption of health legislation process would not prove their efficiency and effectiveness. In this article, the Customs Union and formal negotiations for full EU membership are included in the phrase “the alignment process to European Union”. Council Decisions 1/95 and 2/97 ground on the obligations provided by the Customs Union Agreement. The reference document used to discuss the formal negotiation process for full membership to European Union is the Turkish National Program for the Adoption of the EU Acquis 2008–2013. The legislative obligations of Turkey arising from its membership of the Council of Europe, which has significant contributions to the medical legislation especially in the field of medical ethics, are also included in this article. PMID:26269696

Age determination of unaccompanied asylum seeking minors in the European Union: a health law perspective.

PubMed

Abbing, Henriette D C Roscam

2011-01-01

In the European Union, unaccompanied asylum seekers below 18 years of age are entitled to specific treatment. Age assessment practices to verify the age-statement by the asylum seeker differ between EU Member States. Medical methods in use raise questions about accuracy, reliability and safety. The medical, legal and ethical acceptability of invasive methods (notably X-rays) in particular is controversial. Human rights are at stake. The lack of common practices results in different levels of protection (discrimination). The absence ofstandardisation is an obstacle for the functioning of the Common European Asylum System. EU Best Practice Guidelines should remedy the situation; such guidelines should reflect the best interest of the child.

Support Systems for Poor Readers: Empirical Data from Six EU Member States

ERIC Educational Resources Information Center

Ise, Elena; Blomert, Leo; Bertrand, Daisy; Faisca, Luis; Puolakanaho, Anne; Saine, Nina L.; Suranyi, Zsuzsanna; Vaessen, Anniek; Csepe, Valeria; Lyytinen, Heikki; Reis, Alexandra; Ziegler, Johannes C.; Schulte-Korne, Gerd

2011-01-01

This study surveyed and compared support systems for poor readers in six member states of the European Union (EU). The goal was to identify features of effective support systems. A large-scale questionnaire survey was conducted among mainstream teachers (n = 4,210) and remedial teachers (n = 2,395). Results indicate that the six support systems…

When Corruption Gets in the Way: Befriending Diaspora and EU-nionizing Bosnia's Higher Education

ERIC Educational Resources Information Center

Sabic-El-Rayess, Amra

2013-01-01

This article investigates the encounter of EU-unionization with a domesticated practice of corruption in Bosnian higher education. Relying on primary data collected in Bosnia's public higher education system, the study finds that the country's corrupt higher education is in conflict with the Bologna-themed reforms that would arguably help…

Government Expenditures on Education as the Percentage of GDP in the EU

ERIC Educational Resources Information Center

Galetic, Fran

2015-01-01

This paper analyzes the government expenditures as the percentage of gross domestic product across countries of the European Union. There is a statistical model based on Z-score, whose aim is to calculate how much each EU country deviates from the average value. The model shows that government expenditures on education vary significantly between…

Deconstructing European Poverty Measures: What Relative and Absolute Scales Measure

ERIC Educational Resources Information Center

Burkhauser, Richard V.

2009-01-01

Forster and d'Ercole (2009) outline the dominant method of conceptualization and operationalization of European poverty measures that informed the EU in its development of the questionnaire for the European Union--Survey of Income and Living Conditions (EU-SILC). They do so in the context of their explanation of how the Organization for Economic…

Changing Rules: A Review of Tempus Support to University Governance. A Tempus Study. Issue 01

ERIC Educational Resources Information Center

Reilly, John; Jongsma, Ard

2010-01-01

The Tempus Programme, which funds cooperation in higher education between universities in EU Member States and a defined set of partner countries outside the European Union, is excellently positioned to support explorations into higher education governance in countries that want to draw on the developing EU experience in this field. Governance is…

Facing the Changing Demands of Europe: Integrating Entrepreneurship Education in Finnish Teacher Training Curricula

ERIC Educational Resources Information Center

Seikkula-Leino, Jaana; Ruskovaara, Elena; Hannula, Heikki; Saarivirta, Tuija

2012-01-01

The European Union (EU) considers the learning of entrepreneurial skills to be an essential factor in creating welfare. Therefore, in the EU, one of the latest core aspects is to develop entrepreneurship education in teacher education. However, entrepreneurship education still seems to be, across the countries, a quite uncommon theme. This article…

EUROPE IN CRISIS

DTIC Science & Technology

2017-04-06

the only international organization that can manage the Syrian refugee security crisis causing problems for the EU from root to branch because NATO is...AIR WAR COLLEGE AIR UNIVERSITY EUROPE IN CRISIS By Peter Halseth, Civilian, Defense Logistics Agency A Research Report Submitted...Syrian refugee crisis and providing intelligence assistance to member countries in the European Union (EU) of foreign fighters returning from the

EU Funding and Issues of "Marketisation" of Higher Education in Greece

ERIC Educational Resources Information Center

Gouvias, Dionysios

2011-01-01

In the last 10 years, tens of millions of euros from European Union (EU) funding have started to flow into Greece's state schools and universities. New departments of higher education have been established all over the country, and a new institutional framework for lifelong learning has been recently set up. Considering the above context, certain…

Transgenic Crops and Sustainable Agriculture in the European Context

ERIC Educational Resources Information Center

Ponti, Luigi

2005-01-01

The rapid adoption of transgenic crops in the United States, Argentina, and Canada stands in strong contrast to the situation in the European Union (EU), where a de facto moratorium has been in place since 1998. This article reviews recent scientific literature relevant to the problematic introduction of transgenic crops in the EU to assess if…

Innovative Practice in Teacher and Trainer Training in Vocational Education and Training. Advisory Forum Subgroup D Report.

ERIC Educational Resources Information Center

Oldroyd, David

Members of a subgroup of the European Training Foundation's Advisory Forum were surveyed regarding their perceptions of problems and priorities relating to initial and inservice vocational teacher and trainer training and innovation in the European Union (EU). Advisory Forum members from 10 EU countries completed the questionnaire. Priorities…

Lifelong Learning in the EU: Changing Conceptualisations, Actors, and Policies

ERIC Educational Resources Information Center

Volles, Nina

2016-01-01

This paper explores the changing conceptualisations, actors, and policies of lifelong learning (LLL) in the European Union (EU) from the time the topic first emerged and was promoted by international organisations in the 1960s. The author uses Kingdon's Multiple Streams Framework to analyse how the LLL discourse became an important part of the EU…

Challenges in Evaluating the EU's Lifelong Learning Policies

ERIC Educational Resources Information Center

Clain, Alexandru

2016-01-01

Since the early 1990s, lifelong learning has become a major policy concern for the European Union, being seen as a means for enabling individuals to be more competitive in social and economic contexts that are continually changing. After a series of white papers and strategies in the field of lifelong learning, the EU launched the Lifelong…

Emergence and Outlook of Competence-Based Education in European Education Systems: An Overview

ERIC Educational Resources Information Center

Tchibozo, Guy

2011-01-01

This contribution takes stock on the emergence of competence-based education in European Union (EU) countries. The article explains how economic constraints but also educational motives led educational policies and systems in the EU to shift to competence-based education. The related instructional frame and concepts are presented, as are the major…

Intelligence Effectiveness in the European Union (E.U.) in the New Security Environment

DTIC Science & Technology

2012-12-01

works. When it comes to compliance with E.U. laws, Gerda Faulkner, an Austrian scholar identifies three worlds of compliance: “a world of law...www.europarl.europa.eu/RegData/etudes/note/libe/2011/462420/IPOL- LIBE_NT(2011)462420(PAR00)_EN.pdf. 79 Gerda Falkner, Oliver Treib, Miriam Hartlapp, and Simone...http://belfercenter.ksg.harvard.edu/files/Fagersten%20theoretical%20framework.p df. Falkner, Gerda . Treib, Oliver. Hartlapp, Miriam and Leiber

[Recent developments on the European ban on animal experiments for cosmetics].

PubMed

Ruhdel, I W

2001-01-01

For the second time the European Commission has postponed the sales ban on cosmetics products that have been developed and tested in animal experiments now until 2002. In the meantime the Commission wants to adopt the Seventh Amendment of the EU Cosmetics Directive. In its draft the Commission proposes to scrap the sales ban and replace it with an animal testing ban. This change would avoid possible conflicts with the WTO, however, from the animal welfare point of view would result in animal testing moving into third countries instead of avoiding them. This is because cosmetics products tested on animals outside the EU could be sold in the EU without any restrictions. As a consequence this measure would take the pressure from authorities and industry to further develop and adopt alternative methods. Other proposed measures are not acceptable from the animal welfare point of view, e.g. because they contradict Directive 86/609 and would result in a delay of the application of validated alternative methods. The Deutscher Tierschutzbund therefore still demands an immediate and complete sales ban in connection with an animal testing ban within the EU.

How Much Credence Does It Take? Evidence on the Trade-Off between Country-Of-Origin Information and Credence Attributes for Beef from a Choice Experiment in Sweden

PubMed Central

Hess, Sebastian; Johansson, Helena

2017-01-01

Based on a discrete choice experiment with 336 consumers, this study investigated whether the consumer propensity to choose a simplified European Union (EU) vs. non-EU denomination of origin for beef, instead of a specific country-of-origin (COO) denomination, depends upon the amount and type of credence information provided to the individual. The likelihood of choosing the EU/non-EU denomination of origin depended on the total number of other labelling credence attributes provided and also on the type of detailed credence attributes present in the choice. The presence of cues relating to animal welfare and far-reaching traceability had the highest likelihood of influencing the choice of the EU/non-EU denomination of origin. The compensatory qualities of each credence attribute in relation to the EU/non-EU origin denomination thus differed. PMID:28946674

Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.

PubMed

Kelly, Ruth; Zoubiane, Ghada; Walsh, Desmond; Ward, Rebecca; Goossens, Herman

2016-04-01

Antibacterial resistant infections are rising continuously, resulting in increased morbidity and mortality worldwide. With no new antibiotic classes entering the market and the possibility of returning to the pre-antibiotic era, the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) was established to address this problem. We aimed to quantify the scale and scope of publicly funded antibacterial resistance research across JPIAMR countries and at the European Union (EU) level to identify gaps and future opportunities. We did a systematic observational analysis examining antibacterial resistance research funding. Databases of funding organisations across 19 countries and at EU level were systematically searched for publicly funded antibacterial resistance research from Jan 1, 2007, to Dec 31, 2013. We categorised studies on the basis of the JPIAMR strategic research agenda's six priority topics (therapeutics, diagnostics, surveillance, transmission, environment, and interventions) and did an observational analysis. Only research funded by public funding bodies was collected and no private organisations were contacted for their investments. Projects in basic, applied, and clinical research, including epidemiological, public health, and veterinary research and trials were identified using keyword searches by organisations, and inclusion criteria were based on the JPIAMR strategic research agenda's six priority topics, using project titles and abstracts as filters. We identified 1243 antibacterial resistance research projects, with a total public investment of €1·3 billion across 19 countries and at EU level, including public investment in the Innovative Medicines Initiative. Of the total amount invested in antibacterial resistance research across the time period, €646·6 million (49·5%) was invested at the national level and €659·2 million (50·5%) at the EU level. When projects were classified under the six priority topics we found that 763 (63%) of 1208 projects funded at national level were within the area of therapeutics, versus 185 (15%) in transmission, 131 (11%) in diagnostics, 53 (4%) in interventions, and only 37 (3%) in environment and 39 (3%) in surveillance. This was the first systematic analysis of research funding of antibacterial resistance of this scale and scope, which relied on the availability and accuracy of data from organisations included. Large variation was seen between countries both in terms of number of projects and associated investment and across the six priority topics. To determine the future direction of JPIAMR countries a clear picture of the funding landscape across Europe and Canada is needed. Countries should work together to increase the effect of research funding by strengthening national and international coordination and collaborations, harmonising research activities, and collectively pooling resources to fund multidisciplinary projects. The JPIAMR have developed a publicly available database to document the antibacterial resistance research collected and can be used as a baseline to analyse funding from 2014 onwards. JPIAMR and the European Commission. Copyright © 2016 Kelly et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.. All rights reserved.

Regulations applicable to plant food supplements and related products in the European Union.

PubMed

Silano, Vittorio; Coppens, Patrick; Larrañaga-Guetaria, Ainhoa; Minghetti, Paola; Roth-Ehrang, René

2011-12-01

This paper deals with the current regulatory and legal settings of traditional plant food supplements and herbal medicinal products in the European Union (EU). Marketing of botanicals in foods and food supplements in the EU is subject to several provisions of food law, which cover aspects of safety, production, labelling and product composition, including the use of additives and maximum levels of contaminants and residues. However, due to limited harmonization at the EU level, specific national regulations adopted at a Member State level also apply and mutual recognition is the mechanism through which such products can be marketed in EU countries other than those of origin. Unlike food supplements, marketing of traditional herbal medicinal products is regulated by an ad hoc Directive (i.e. Directive 2004/24/EC) covering in detail all the relevant aspects of these products, including a facilitated registration procedure at national level. However, by distinguishing traditional herbal medicinal products from plant food supplements and establishing selective marketing modalities for these two product categories, the EU has been confronted with implementation difficulties for traditional herbal medicinal products and a lack of homogeneity in the regulatory approaches adopted in different EU Member States. In fact, currently the nature of the commercial botanical products made available to consumers as traditional medicinal products or food supplements, depends largely on the EU Member State under consideration as a consequence of how competent National Authorities and manufacturing companies interpret and apply current regulations rather than on the intrinsic properties of the botanical products and their constituents. When the EU approach is compared with approaches adopted in some non-European countries to regulate these product categories, major differences become evident.

Structure and Financing of Higher Education in Russia, Ukraine and the EU. Higher Education Policy Series 41.

ERIC Educational Resources Information Center

Hare, Paul G., Ed.

The papers in this book discuss the goals and constraints facing institutions of higher education in Russia, Ukraine, and the European Union countries. In the European Union countries budgetary pressures and the increasing number of students attending institutions of higher education have resulted in serious financial difficulties for many…

78 FR 68134 - Certificates of Public Convenience and Necessity and Foreign Air Carrier Permits

Federal Register 2010, 2011, 2012, 2013, 2014

2013-11-13

... behind any Member State of the European Union, via any point or points in any EU Member State and via... available to European Union carriers in the future. Barbara J. Hairston, Supervisory Dockets Officer, Docket... points in any member of the European Common Aviation Area; (iii) foreign charter air transportation of...

European Union Students Studying in English Higher Education Institutions. DIUS Research Report 08-09

ERIC Educational Resources Information Center

Morris, Marian; Rutt, Simon

2008-01-01

This study aimed to identify the pathways, intentions and relevant perceptions of (non-UK) European Union (EU) students entering English higher education. It sought to identify why students wished to obtain an English HE qualification, their attitudes towards the uptake and repayment of tuition fee loans and their future career plans. Drawing on…

[European Union Network for Patient Safety and Quality of Care (PASQ). Development and preliminary results in Europe and in the Spanish National Health System].

PubMed

Agra-Varela, Y; Fernández-Maíllo, M; Rivera-Ariza, S; Sáiz-Martínez-Acitorez, I; Casal-Gómez, J; Palanca-Sánchez, I; Bacou, J

2015-01-01

The joint action, European Union Network for Patient Safety and Quality of Care: PaSQ, aims to promote patient safety (PS) in the European Union (EU) and to facilitate the exchange of experiences among Member States (MS) and stakeholders on issues related to quality of care, PS, and patient involvement. The development and preliminary results are presented here, especially as regards the Spanish National Health System (SNHS). PaSQ is developed through 7 work packages, primarily aimed at sharing good practices (GP), which were identified using specific questionnaires and selected by means of explicit criteria, as well as to implement safe clinical practices (SCP) of proven effectiveness and agreed among MS. A total of 482 GP (39% provided by Spanish professionals) were identified. The 34 events organised in the EU, 11 including Spanish participation, facilitate sharing these practices. A total of 194 Health Care centres (49% in Spain) are implementing SCP (hand hygiene, safe surgery, medication reconciliation, and paediatric early warning scores) ACHIEVEMENTS AND FUTURE PERSPECTIVES: PaSQ is making it possible to strengthen collaboration between organizations and professionals at EU and SNHS level regarding PS and quality of care. Copyright © 2015 SECA. Published by Elsevier Espana. All rights reserved.

A clash of civilizations? Examining liberal-democratic values in Turkey and the European Union.

PubMed

Dixon, Jeffrey C

2008-12-01

Turkey's proposed entry into the European Union (EU) has been undermined by Europeans' perceptions of Turkish-European cultural differences, particularly regarding the liberal-democratic values that the EU promotes (democracy, rule of law, and respect for and appreciation of minority/human rights). Yet, cross-national research on values has not focused on Turkey, the EU, and these liberal-democratic values, leaving assumptions of cultural differences and their explanations untested. Through analyses of World and European Values Survey data (1999-2002), this article asks whether people in Turkey have the same values regarding democracy, rule of law (versus religious and authoritarian rule), and minority/human rights as people in EU member and candidate states (as of 2000)? What factors explain these values? I find that people in Turkey support democracy to the same extent as people in EU member and candidate states, but people in Turkey are more supportive of religious and authoritarian rule and are less tolerant of minorities. Although the 'clash of civilizations' thesis expects liberal values to be ordered according to countries' religious traditions, with western Christian the most supportive and Islamic the least, only for tolerance of minorities values is this pattern found. Instead, economic development most consistently explains differences between Turkey and EU member and candidate states in support for these values. I conclude with calls for theoretical refinement, particularly of the clash of civilizations thesis, along with suggestions for future research to examine more Muslim and Orthodox countries; I discuss the debate over Turkey's EU entry.

European Security in the Balkans: The Case of Macedonia

DTIC Science & Technology

2013-03-01

for the Republic of Macedonia; it is the problem of the European Union as well, due to the historical fact that the European Great Powers had...integration of Bulgaria and Romania in the European Union was based on the short term political interests of the EU - to create a safe ring toward... Union in the Security of Europe: From Cold War to Terror War, 117. 28 Nicola Guy, The Birth of Albania, “Ethnic Nationalism, the Great Powers of World

What the eye does not see: a critical interpretive synthesis of European Union policies addressing sexual violence in vulnerable migrants.

PubMed

Keygnaert, Ines; Guieu, Aurore

2015-11-01

In Europe, refugees, asylum seekers and undocumented migrants are more vulnerable to sexual victimisation than European citizens. They face more challenges when seeking care. This literature review examines how legal and policy frameworks at national, European and international levels condition the prevention of and response to sexual violence affecting these vulnerable migrant communities living in the European Union (EU). Applying the Critical Interpretive Synthesis method, we reviewed 187 legal and policy documents and 80 peer-reviewed articles on migrant sexual health for elements on sexual violence and further analysed the 37 legal and 12 peer-reviewed articles among them that specifically focused on sexual violence in vulnerable migrants in the EU-27 States. Legal and policy documents dealing with sexual violence, particularly but not exclusively in vulnerable migrants, apply 'tunnel vision'. They ignore: a) frequently occurring types of sexual violence, b) victimisation rates across genders and c) specific risk factors within the EU such as migrants' legal status, gender orientation and living conditions. The current EU policy-making paradigm relegates sexual violence in vulnerable migrants as an 'outsider' and 'female only' issue while EU migration and asylum policies reinforce its invisibility. Effective response must be guided by participatory rights- and evidence-based policies and a public health approach, acknowledging the occurrence and multiplicity of sexual victimisation of vulnerable migrants of all genders within EU borders. Copyright © 2015 Elsevier Inc. All rights reserved.

Cell-Based Veterinary Pharmaceuticals – Basic Legal Parameters Set by the Veterinary Pharmaceutical Law and the Genetic Engineering Law of the European Union

PubMed Central

Faltus, Timo; Brehm, Walter

2016-01-01

Cell-based therapies have been in use in veterinary medicine for years. However, the legal requirement of manufacturing, placing on the market and use of cell-based veterinary pharmaceuticals are not as well developed as the respective requirements of chemical pharmaceuticals. Cell-based veterinary pharmaceuticals are medicinal products in the sense of the pharmaceutical law of the European Union (EU). For that reason, such medicinal products principally require official approval for their manufacture and an official marketing authorization for their placement on the market before being used by the veterinarian. The manufacture, placing on the market, and use of cell-based veterinary pharmaceuticals without manufacturing approval and marketing authorization is permitted only in certain exceptional cases determined by EU and individual Member State law. Violations of this requirement may have consequences for the respective veterinarian under criminal law and under the code of professional conduct in the respective Member State. The regular use of cell-based veterinary pharmaceuticals within the scope of a therapeutic emergency as well as the import of such veterinary pharmaceuticals from non-European countries for use in the EU are currently out of the question in the EU because of a lack of legal bases. Here, we review the general legal requirement of manufacturing, placing on the market, and use of cell-based veterinary pharmaceuticals within the EU and point out different implementations of EU law within the different Member States. PMID:27965965

Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR®/ABASAGLAR®) approved in the European Union.

PubMed

Byrd, Richard A; Owens, Rebecca A; Blackbourne, Jamie L; Coutant, David E; Farmen, Mark W; Michael, M Dodson; Moyers, Julie S; Schultze, A Eric; Sievert, Michael K; Tripathi, Niraj K; Vahle, John L

2017-08-01

Basaglar ® /Abasaglar ® (Lilly insulin glargine [LY IGlar]) is a long-acting human insulin analogue drug product granted marketing authorisation as a biosimilar to Lantus ® (Sanofi insulin glargine [SA IGlar]) by the European Medicines Agency. We assessed the similarity of LY IGlar to the reference drug product, European Union-sourced SA IGlar (EU-SA IGlar), using nonclinical in vitro and in vivo studies. No biologically relevant differences were observed for receptor binding affinity at either the insulin or insulin-like growth factor-1 (IGF-1) receptors, or in assays of functional or de novo lipogenic activity. The mitogenic potential of LY IGlar and EU-SA IGlar was similar when tested in both insulin- and IGF-1 receptor dominant cell systems. Repeated subcutaneous daily dosing of rats for 4 weeks with 0, 0.3, 1.0, or 2.0 mg/kg LY IGlar and EU-SA IGlar produced mortalities and clinical signs consistent with severe hypoglycaemia. Glucodynamic profiles of LY IGlar and EU-SA IGlar in satellite animals showed comparable dose-related hypoglycaemia. Severe hypoglycaemia was associated with axonal degeneration of the sciatic nerve; the incidence and severity were low and did not differ between LY IGlar and EU-SA IGlar. These results demonstrated no biologically relevant differences in toxicity between LY IGlar and EU-SA IGlar. Copyright © 2017 Elsevier Inc. All rights reserved.

Cell-Based Veterinary Pharmaceuticals - Basic Legal Parameters Set by the Veterinary Pharmaceutical Law and the Genetic Engineering Law of the European Union.

PubMed

Faltus, Timo; Brehm, Walter

2016-01-01

Cell-based therapies have been in use in veterinary medicine for years. However, the legal requirement of manufacturing, placing on the market and use of cell-based veterinary pharmaceuticals are not as well developed as the respective requirements of chemical pharmaceuticals. Cell-based veterinary pharmaceuticals are medicinal products in the sense of the pharmaceutical law of the European Union (EU). For that reason, such medicinal products principally require official approval for their manufacture and an official marketing authorization for their placement on the market before being used by the veterinarian. The manufacture, placing on the market, and use of cell-based veterinary pharmaceuticals without manufacturing approval and marketing authorization is permitted only in certain exceptional cases determined by EU and individual Member State law. Violations of this requirement may have consequences for the respective veterinarian under criminal law and under the code of professional conduct in the respective Member State. The regular use of cell-based veterinary pharmaceuticals within the scope of a therapeutic emergency as well as the import of such veterinary pharmaceuticals from non-European countries for use in the EU are currently out of the question in the EU because of a lack of legal bases. Here, we review the general legal requirement of manufacturing, placing on the market, and use of cell-based veterinary pharmaceuticals within the EU and point out different implementations of EU law within the different Member States.

Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union.

PubMed

Unemo, Magnus; Ison, Catherine A; Cole, Michelle; Spiteri, Gianfranco; van de Laar, Marita; Khotenashvili, Lali

2013-12-01

Antimicrobial resistance (AMR) in Neisseria gonorrhoeae has emerged for essentially all antimicrobials following their introduction into clinical practice. During the latest decade, susceptibility to the last remaining options for antimicrobial monotherapy, the extended-spectrum cephalosporins (ESC), has markedly decreased internationally and treatment failures with these ESCs have been verified. In response to this developing situation, WHO and the European Centre for Disease Prevention and Control (ECDC) have published global and region-specific response plans, respectively. One main component of these action/response plans is to enhance the surveillance of AMR and treatment failures. This paper describes the perspectives from the diverse WHO European Region (53 countries), including the independent countries of the former Soviet Union, regarding gonococcal AMR surveillance networks. The WHO European Region has a high prevalence of resistance to all previously recommended antimicrobials, and most of the first strictly verified treatment failures with cefixime and ceftriaxone were also reported from Europe. In the European Union/European Economic Area (EU/EEA), the European gonococcal antimicrobial surveillance programme (Euro-GASP) funded by the ECDC is running. In 2011, the Euro-GASP included 21/31 (68%) EU/EEA countries, and the programme is further strengthened annually. However, in the non-EU/EEA countries, internationally reported and quality assured gonococcal AMR data are lacking in 87% of the countries and, worryingly, appropriate support for establishment of a GASP is still lacking. Accordingly, national and international support, including political and financial commitment, for gonococcal AMR surveillance in the non-EU/EEA countries of the WHO European Region is essential.

The Impact of Vocational Education on Poverty Reduction, Quality Assurance and Mobility on Regional Labour Markets--Selected EU-Funded Schemes

ERIC Educational Resources Information Center

Wallenborn, Manfred

2009-01-01

Vocational education can serve to promote social stability and sustainable economic and social development. The European Union (EU) strategically employs a range of vocational educational schemes to attain these overriding goals. Topical points of focus are selected in line with requirements in the individual partner countries or regions. However,…

The Rule of Mimetic Desire in Higher Education: Governing through Naming, Shaming and Faming

ERIC Educational Resources Information Center

Brøgger, Katja

2016-01-01

The initiation of the Bologna Process was accompanied by a radical transition of governance in higher education throughout Europe from government to governance. This article argues that this shift in the design of governing was connected to the need to subtly bypass the European Union (EU) subsidiarity principle that kept education out of the EU's…

Supranationalism Decision Making for Spanish Citizens and Its Relation to Personal Variables

ERIC Educational Resources Information Center

Coromina, Lluis

2013-01-01

A crucial issue in the European Union (EU) is which policies should be regulated by EU and which ones by national governments. Given this situation it is interesting to study the citizens' preference for the level of political decision making. The interest of the paper is mainly empirical, which consists in the creation of a measure for…

Detailed Work Programme on the Follow-Up of the Objectives of Education and Training Systems in Europe.

ERIC Educational Resources Information Center

Commission of the European Communities, Brussels (Belgium).

This report describes policy cooperation in the Education and Training Area in the European Union (EU) in response to the Lisbon strategy and provides a comprehensive plan to respond to the challenges of the knowledge society, globalization, and the enlargement of the EU. It focuses on these three objectives: (1) improving the quality and…

Towards a European Policy Discourse on Compulsory Education: The Case of Sweden

ERIC Educational Resources Information Center

Nordin, Andreas

2017-01-01

The aim of this article is to show how the European Union (EU) and the Swedish government have recently become co-producers of education policy that increasingly emphasises compulsory education. The paper draws on the following two kinds of empirical material: 1) an analysis of central official policy documents produced by the EU and the Swedish…

Language Management Theory as a Basis for the Dynamic Concept of EU Language Law

ERIC Educational Resources Information Center

Dovalil, Vít

2015-01-01

Language law is a tool used to manage problems of linguistic diversity in the EU. The paper analyzes the processes in which language law is found in the discursive practice of agents addressing the Court of Justice of the European Union with their language problems. The theoretical-methodological basis for the research is Language Management…

Lisbona's Goals and Bolonian Process-Issue of Education in EU Integration

ERIC Educational Resources Information Center

Cernetic, Metod

2011-01-01

Lisbona's (2000) goals and strategy gave us the answers to the question how EU (European Union) can be competitive in the long term and, at the same time, preserve European model of life, that means a balance between economical, social and environmental goals. Knowledge is the focal point of development. That is the reason why many European states…

Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area

PubMed Central

van den Wijngaard, Cees C; Hofhuis, Agnetha; Simões, Mariana; Rood, Ente; van Pelt, Wilfrid; Zeller, Herve; Van Bortel, Wim

2017-01-01

Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe. Erythema migrans (EM), an early, localised skin rash, is its most common presentation. Dissemination of the bacteria can lead to more severe manifestations including skin, neurological, cardiac, musculoskeletal and ocular manifestations. Comparison of LB incidence rates in the European Union (EU)/European Economic Area (EEA) and Balkan countries are difficult in the absence of standardised surveillance and reporting procedures. We explored six surveillance scenarios for LB surveillance in the EU/EEA, based on the following key indicators: (i) erythema migrans, (ii) neuroborreliosis, (iii) all human LB manifestations, (iv) seroprevalence, (v) tick bites, and (vi) infected ticks and reservoir hosts. In our opinion, neuroborreliosis seems most feasible and useful as the standard key indicator, being one of the most frequent severe LB manifestations, with the possibility of a specific case definition. Additional surveillance with erythema migrans as key indicator would add value to the surveillance of neuroborreliosis and lead to a more complete picture of LB epidemiology in the EU/EEA. The other scenarios have less value as a basis for EU-level surveillance, but can be considered periodically and locally, as they could supply complementary insights. PMID:28703098

Assessing the Risk of African Swine Fever Introduction into the European Union by Wild Boar.

PubMed

De la Torre, A; Bosch, J; Iglesias, I; Muñoz, M J; Mur, L; Martínez-López, B; Martínez, M; Sánchez-Vizcaíno, J M

2015-06-01

The presence of African swine fever (ASF) in the Caucasus region and Russian Federation has increased concerns that wild boars may introduce the ASF virus into the European Union (EU). This study describes a semi-quantitative approach for evaluating the risk of ASF introduction into the EU by wild boar movements based on the following risk estimators: the susceptible population of (1) wild boars and (2) domestic pigs in the country of origin; the outbreak density in (3) wild boars and (4) domestic pigs in the countries of origin, the (5) suitable habitat for wild boars along the EU border; and the distance between the EU border and the nearest ASF outbreak in (6) wild boars or (7) domestic pigs. Sensitivity analysis was performed to identify the most influential risk estimators. The highest risk was found to be concentrated in Finland, Romania, Latvia and Poland, and wild boar habitat and outbreak density were the two most important risk estimators. Animal health authorities in at-risk countries should be aware of these risk estimators and should communicate closely with wild boar hunters and pig farmers to rapidly detect and control ASF. © 2013 Blackwell Verlag GmbH.

Critical thinking: assessing the risks to the future security of supply of critical metals

NASA Astrophysics Data System (ADS)

Gunn, Gus

2015-04-01

Increasing world population, the spread of prosperity across the globe and the demands of new technologies have led to a revival of concerns about the availability of raw materials needed by society. Despite scare stories about resource depletion, physical exhaustion of minerals is considered to be unlikely. However, we do need to know which materials might be of concern so that we can develop strategies to secure adequate supplies and to mitigate the effects of supply disruption. This requirement has led to renewed interest in criticality, a term that is generally used to refer to metals and minerals of high economic importance that have a relatively high likelihood of supply disruption. The European Union (EU) developed a quantitative methodology for the assessment of criticality which led to the definition of 14 raw materials as critical to the EU economy (EC, 2010). This has succeeded in raising awareness of potential supply issues and in helping to prioritise requirements for new policies and supporting research. The EU has recently assessed a larger number of candidate materials of which 20 are now identified as critical to the EU (EC, 2014). These include metals such as indium, mostly used in flat-screen displays, antimony for flame retardants and cobalt for rechargeable batteries, alloys and a host of other products. Although there is no consensus on the methodology for criticality assessments and broad analyses at this scale are inevitably imperfect, they can, nevertheless, provide early warning of supply problems. However, in order to develop more rigorous and dynamic assessments of future availability detailed analysis of the whole life-cycle of individual metals to identify specific problems and develop appropriate solutions is required. New policies, such as the Raw Materials Initiative (2008) and the European Innovation Partnership on Raw Materials (2013), have been developed by the European Commission (EC) and are aimed at securing sustainable supplies of raw materials. These have led to major new programmes of research throughout the minerals value chain, in order to improve the raw materials knowledge base, to develop best practices and promote international collaboration. Although recycling will make an increasingly important contribution to supply, it can never meet the total requirement when demand is increasing. Therefore, new resources of primary materials, identified through geological research, will continue to be required. The availability of regional baseline datasets, comprising geological, geophysical and geochemical data, is fundamental to the identification of exploration targets. However, in order to focus exploration we also require robust mineral deposit models for the critical metals which hitherto these have been largely neglected because of their limited economic importance. For commodities such as the platinum-group metals (PGM), cobalt, niobium, indium, rare earth elements (REE) and cobalt we have some knowledge of the processes controlling their mobilisation and concentration under certain conditions although we have little understanding of the mechanisms of deposit formation elsewhere. We also need effective techniques to explore for these metals. This may involve the development of new geophysical techniques to explore on the sea-floor or beneath thick cover, or new analytical methods for the determination of these elements in exploration samples. Improved metallurgical techniques are also required for effective and energy-efficient recovery of critical metals from ores and concentrates. References European Commission (2010). Critical raw materials for the EU. Report of the Ad-hoc Working Group on Defining Critical Raw Materials. European Commission (2014). Report on Critical raw materials for the EU. Report of the Ad-hoc Working Group on Defining Critical Raw Materials.

[Health policy in the European Union: impact on the Spanish health system].

PubMed

Guimarães, Luisa; Freire, José-Manuel

2007-01-01

This text reviews the impact of European integration on the health sector (public health and health services) by studying European Union (EU) institutions, functioning, and responsibilities through the literature, documents, and authors' observations. The EU does not have direct health responsibilities, but Community legislation has important repercussions on all member states' health policies. This influence affects health protection issues, consumer safety, regulation of medicines and medical devices, mutual recognition of professional qualifications, freedom of movement for health professionals and patients, public contracts and bidding, research, etc. The evolution of EU health policy shows a progressive reinforcement of responsibilities consistent with the objective of reaching a high level of health protection, which in turn affects other European policies. The impact of European integration on the Spanish health system is analyzed as a case study, and key aspects and present and future challenges are highlighted. Lessons are also drawn for regional integration processes to foster equity and efficiency in health.

Emission of biocides from hospitals: comparing current survey results with European Union default values.

PubMed

Tluczkiewicz, Inga; Bitsch, Annette; Hahn, Stefan; Hahn, Torsten

2010-04-01

Under the European Union (EU) Biocidal Products Directive 98/8/EC, comprehensive evaluations on substances of the Third Priority List were conducted until 31 July 2007. This list includes, among other categories, disinfectants for human hygiene (e.g., skin and surface disinfection). For environmental exposure assessment of biocides, the EU emission scenarios apply. Currently available default values for disinfectants are based on consumption data from not more than 8 hospitals and were originally assembled for other purposes. To revalidate these default values, a survey on annual consumption data was performed in 27 German hospitals. These data were analyzed to provide consumption data per bed and day and per nurse and day for particular categories of active ingredients and were compared with default values from the EU emission scenario documents. Although several deviations were detected, an overall acceptable correspondence between Emission Scenario Documents default values and the current survey data was found. (c) 2009 SETAC

INTRAW, the EU Observatory for raw materials: fostering international cooperation and developing new opportunities

NASA Astrophysics Data System (ADS)

Correia, Victor; Allington, Ruth; Keane, Christopher

2016-04-01

A secure supply of raw materials is a European priority that extends beyond country borders and national policies. Recent European initiatives have pioneered the development of an EU strategy on raw materials emphasizing the concept of the "added value chain", which continues to pursue the three pillar strategy to: (1) ensure the fair and sustainable supply of raw materials from international markets, promoting international cooperation with developed and developing countries; (2) foster sustainable supply of raw materials from European sources, and (3) reduce consumption of primary raw materials by increasing resource efficiency and promoting recycling. This contribution presents the Horizon 2020 funded project INTRAW, the objective of which is to establish the European Union's International Observatory for Raw Materials. The creation and maintenance of the European Union's International Observatory for Raw Materials is designed to have a strong impact in two dimensions: 1. To narrow the existing gap in aspects of the raw materials knowledge infrastructure in the EU by providing a link with the same knowledge infrastructure in technologically advanced reference countries. This should contribute to the harmonization of mineral policies all over the EU, by providing data that enables evidence-based policies and appropriate, cost-effective management, planning and adaptation decisions by the public sector. This will benefit businesses, industry and society. The Observatory will also provide to policy makers in the EU and its Member States the data they need to facilitate discussion in multilateral forums. 2. To enable a better alignment of the R&I activities among the individual EU members and international cooperation countries AND between the European Union and international cooperation countries by boosting synergies with international research and innovation programmes. This way the EU's role and scientific capabilities in the raw materials area will be reinforced in the mid-term, and the conditions for sustainable access and supply of raw materials in the EU will benefit from the international cooperation. The authors will describe the key stages of the INTRAW project and explain how it aims to establish (and promote the continuation of) international cooperation at every stage of the raw materials value chain and to build a repository of information and analysis to support the development and strengthening of EU raw materials strategies. Key elements of the value chain upon which the project focuses are: industry and trade; education and outreach; and research and innovation. The roles of geoscientists in delivering the aims and objectives of INTRAW will be emphasised.

Strategies for public health research in European Union countries.

PubMed

Grimaud, Olivier; McCarthy, Mark; Conceição, Claudia

2013-11-01

'Health' is an identifiable theme within the European Union multi-annual research programmes. Public Health Innovation and Research in Europe (PHIRE), led by the European Public Health Association, sought to identify public health research strategies in EU member states. Within PHIRE, national public health associations reviewed structures for health research, held stakeholder workshops and produced reports. This information, supplemented by further web searches, including using assisted translation, was analysed for national research strategies and health research strategies. All countries described general research strategies, outlining organizational and capacity objectives. Thematic fields, including health, are mentioned in some strategies. A health research strategy was identified for 15 EU countries and not for 12. Ministries of health led research strategies for nine countries. Public health research was identified in only three strategies. National research strategies did not refer to the European Union's health research programme. Public health research strategies of European countries need to be developed by ministries of health, working with the research community to achieve the European Research Area.

Towards a better pesticide policy for the European Union.

PubMed

Storck, Veronika; Karpouzas, Dimitrios G; Martin-Laurent, Fabrice

2017-01-01

This opinion article aims to foster the debate about pesticide legislation in the European Union (EU). Numerous formerly authorized and widely used pesticides are now banned in the EU because unexpected and unacceptable risks emerged after their initial introduction to the market. Throughout this time lapse, environmental quality and human health have been threatened by the use of these compounds. These hazards could have been prevented by a more responsive pesticide regulatory framework. This article provides detailed insights into the pros and cons of pesticides, and points out weaknesses of the current pesticide environmental risk assessment procedures. Possibilities for improving the robustness and reliability of the pesticide regulatory framework are discussed. Copyright © 2016 Elsevier B.V. All rights reserved.

77 FR 59243 - Notice of Applications for Certificates of Public Convenience and Necessity and Foreign Air...

Federal Register 2010, 2011, 2012, 2013, 2014

2012-09-26

... transportation authorized by any additional route rights made available to European Union carriers in the future... transportation of persons, property, and mail from any point or points behind any Member State of the European Union, via any point or points in any EU Member State and via intermediate points, to any point or...

Erasmus+: Capacity Building in Higher Education. EU Support to Higher Education Institutions around the World

ERIC Educational Resources Information Center

Jongsma, Ard

2016-01-01

The aim of this brochure is to introduce those who are new to working with European Union funding, to the philosophy of Erasmus+ "capacity-building in higher education" projects. European Union experience of working on these types of projects will be shared. Examples of existing projects are scattered throughout the text to inspire you…

Educational Research Capacity Building in the European Union: A Critique of the Lived Experiences of Emerging Researchers

ERIC Educational Resources Information Center

Hallet, Fiona; Fidalgo, Patricia

2014-01-01

The purpose of this article is to explore the extent to which European Union (EU) policies impact upon the activities of associations such as the European Educational Research Association (EERA) and the experiences of emerging researchers aligned to such associations. In essence, the authors explore potential tensions between policy and the lived…

Towards the Learning Region: Education and Regional Innovation in the European Union and the United States. CEDEFOP Reference Document.

ERIC Educational Resources Information Center

Nyhan, Barry, Ed.; Attwell, Graham, Ed.; Deitmer, Ludger, Ed.

This book provides an overview of innovative education practices throughout regions in the United States (US) and Europe. It contains 16 papers written by experts from the educational, economic, and regional development fields in the US and the European Union (EU). Introductory materials are: a foreword (David O'Sullivan); preface (Stavros…

Lessons from Central and Southeast Europe for the Expanding Alliances

DTIC Science & Technology

2008-06-01

more than a token material and personnel contribution to alliances? Examining three geographically close but historically distinct cases, Austria...security regimes such as the United Nations, North Atlantic Treaty Organization and the European Union . Second, the three nations’ historical and...Collective Security, Collective Defense, Civil-Military Relations, North Atlantic Treaty Organization (NATO), European Union (EU) Common Foreign and

European Union's Moratorium Impact on Food Biotechnology: A Discussion-Based Scenario

ERIC Educational Resources Information Center

Snyder, Lori Unruh; Gallo, Maria; Fulford, Stephen G.; Irani, Tracy; Rudd, Rick; DiFino, Sharon M.; Durham, Timothy C.

2008-01-01

Genetically modified (GM) crops such as maize (Zea mays L.), cotton (Gossypium hirsutum L.), soybean [Glycine max (L.) Moench], and canola (Brassica rapa L.) have been widely adopted by American farmers. In spite of their use in the United States, the European Union (EU) imposed a 6-year de facto moratorium (1998-2004) on the cultivation/import of…

Voluntary health insurance in the European Union: a critical assessment.

PubMed

Mossialos, Elias; Thomson, Sarah M S

2002-01-01

The authors examine the role and nature of the market for voluntary health insurance in the European Union and review the impact of public policy, at both the national and E.U. levels, on the development of this market in recent years. The conceptual framework, based on a model of industrial analysis, allows a wide range of policy questions regarding market structure, conduct, and performance. By analyzing these three aspects of the market for voluntary health insurance, the authors are also able to raise questions about the equity and efficiency of voluntary health insurance as a means of funding health care in the European Union. The analysis suggests that the market for voluntary health insurance in the European Union suffers from significant information failures that seriously limit its potential for competition or efficiency and also reduce equity. Substantial deregulation of the E.U. market for voluntary health insurance has stripped regulatory bodies of their power to protect consumers and poses interesting challenges for national regulators, particularly if the market is to expand in the future. In a deregulated environment, it is questionable whether this method of funding health care will encourage a more efficient and equitable allocation of resources.

Will the European Union reach the United Nations Millennium declaration target of a 50% reduction of tuberculosis mortality between 1990 and 2015?

PubMed

van der Werf, Marieke J; Bonfigli, Sandro; Hruba, Frantiska

2017-07-06

The Millennium Development Goals (MDG) provide targets for 2015. MDG 6 includes a target to reduce the tuberculosis (TB) death rate by 50% compared with 1990. We aimed to assess whether this target was reached by the European Union (EU) and European Economic Area countries. We used Eurostat causes of death data to assess whether the target was reached in the EU. We calculated the reduction in reported and adjusted death rates and the annual average percentage decline based on the available data. Between 1999 and 2014, the TB death rate decreased by 50%, the adjusted death rate by 56% and the annual average percentage decline was 5.43% (95% confidence interval 4.94-6.74) for the EU. Twenty of 26 countries reporting >5 TB deaths in the first reporting year reached the target of 50% reduction in adjusted death rate. The EU reached the MDG target of a 50% reduction of the TB death rate and also the annual average percentage decline was larger than the 2.73% needed to reach the target. The World Health Organization 'End TB Strategy' requires a further reduction of the number of TB deaths of 35% by 2020 compared to 2015, which will challenge TB prevention and care services in the EU.

Diversity and dynamics of patient cost-sharing for physicians' and hospital services in the 27 European Union countries.

PubMed

Tambor, Marzena; Pavlova, Milena; Woch, Piotr; Groot, Wim

2011-10-01

During the past decades, many governments have introduced patient cost-sharing in their public health-care system. This trend in health-care reforms affected the European Union (EU) member states as well. This article presents a review of patient cost-sharing for health-care services in the 27 EU countries, and discusses directions for their improvement. Data are collected based on a review of international data bases, national laws and regulations, as well as scientific and policy reports. The analysis presents a combination of qualitative and quantitative research techniques. Patient cost-sharing arrangements in the EU have been changing considerably over the past two decades (mostly being extended) and are quite diverse at present. There is a relation between patient cost-sharing arrangements and some characteristics of the health-care system in a country. In a few EU countries, a mix of formal and informal charges exists, which creates a double financial burden for health-care consumers. The adequacy of patient cost-sharing arrangements in EU countries needs to be reconsidered. Most importantly, it is essential to deal with informal patient payments (where applicable) and to assure adequate exemption mechanisms to diminish the adverse equity effects of patient cost-sharing. A close communication with the public is needed to clarify the objectives and content of a patient payment policy in a country.

Public health implications of differences in U.S. and European Union regulatory policies for breast implants.

PubMed

Zuckerman, Diana; Booker, Nyedra; Nagda, Sonia

2012-12-01

The recall of tens of thousands of defective breast implants in Europe in 2011-12 as well as new data on risks have raised questions about regulatory standards for these and other medical implants in the United States (U.S.) and European Union (EU). In the U.S., breast implants are regulated as high-risk medical devices that must be proven reasonably safe and effective in clinical trials and subject to government inspection before they can be sold. In contrast, clinical trials and inspections have not been required for breast implants or other implanted devices in the EU; approval is based on other information. As a result of these differing standards, the PIP breast implants that were recalled across Europe had been removed from the market years earlier in the U.S. than in the EU, a decision U.S. government health agencies can point to with pride. Nevertheless, the FDA track record on post-marketing breast implant research indicates poorly implemented studies and little meaningful enforcement to ensure that studies have been conducted correctly or findings reported accurately or acted upon. In sum, neither the EU nor the US has used their regulatory authority to ensure the long-term safety of breast implants. However, in 2012 the EU announced regulatory changes that could improve that situation. Copyright © 2012 Reproductive Health Matters. Published by Elsevier Ltd. All rights reserved.

Authorisation within the European Union of vaccines against antigenically variable viruses responsible for major epizootic diseases.

PubMed

Mackay, D K J

2007-08-01

Antigenically variable viruses are responsible for some of the most contagious and economically important diseases that affect domestic livestock. The serious consequences of such diseases in terms of economic loss, and human and animal health, were clearly demonstrated by recent epizootics of foot and mouth disease, and outbreaks of avian influenza and bluetongue in the European Union (EU). For such diseases, government authorities need to be able to respond, if appropriate, by making use of vaccines that are suited to the epidemiological situation. The current EU regulatory framework is not well adapted for approval and maintenance of vaccines where the antigens included have to be chosen to reflect the epidemiological need. An extensive revision of the technical requirements for authorisation of veterinary medicinal products within the EU is currently underway. Additionally, a major revision of the regulations that control how such authorisations are kept up-to-date is about to start. This provides an ideal opportunity to introduce into EU legislation the concept of the 'multistrain dossier' whereby a potentially large number of approved strains may be included within a marketing authorisation and the final vaccines may be blended to include strains according to need. In addition, new strains may be added onto the marketing authorisation by means of a rapid regulatory procedure should new antigenic variants actually or potentially threaten the EU.

Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.

PubMed

Vlietinck, Arnold; Pieters, Luc; Apers, Sandra

2009-06-01

In the European Union (EU) herbal medicinal products have become increasingly important. This is, for instance, underlined by the recent introduction of a simplified procedure in the Member States of the EU allowing the registration of herbal medicinal products which fulfill the criteria of a traditional herbal medicinal product, i.e., sufficient evidence of its medicinal use throughout a period of at least 30 years for products in the EU and at least 15 years within the EU and 15 years elsewhere for products outside the EU. With regard to the manufacturing of these products and their quality, applications of traditional herbal medicinal products have to fulfil the same requirements as applications for a marketing authorization. The quality of herbal substances as well as herbal preparations will be determined by the availability of modern science-based public monographs in the European Pharmacopoeia and their equivalents developed by the pharmaceutical industry. The standards put forward in these monographs must allow us not only to define the quality of these products, but also to eliminate dangerous counterfeit, substandard, adulterated and contaminated (traditional) herbal medicinal products. The usefulness of these monographs to implement the criteria on quality and specifications put forward for these products in the different guidelines of the European Medicines Agency (EMEA) is discussed.

Effectiveness of text versus pictorial health warning labels and predictors of support for plain packaging of tobacco products within the European Union.

PubMed

Agaku, Israel T; Filippidis, Filippos T; Vardavas, Constantine I

2015-01-01

Tobacco product warning labels are a key health communication medium with plain packaging noted as the next step in the evolution of tobacco packaging. We assessed the self-reported impact of text versus pictorial health warnings and the determinants of support for plain packaging of tobacco products in the European Union (EU). The Special Eurobarometer 385 survey was analyzed for 26,566 adults from 27 EU countries in 2012. The self-reported impact of warning labels (text or pictorial) and determinants of EU-wide support for plain packaging were assessed using multivariate logistic regression. Current smokers in countries where cigarette pictorial warnings were implemented had higher odds of reporting that health warning labels had any effect on their smoking behavior (making a quit attempt or reducing number of cigarettes smoked per day) compared to respondents in countries with text-only warning labels (adjusted odds ratio, aOR = 1.31; 95% confidence interval, 95% CI: 1.10-1.56). Population support for plain packaging of tobacco packs was higher in countries where cigarette pictorial warnings already existed (aOR = 1.17; 95% CI: 1.07-1.28). These findings indicate that the implementation of pictorial warnings at an EU level may have a positive behavioral impact among smokers and pave the way for population support for plain packaging in the EU.

European Master's Program in Gerontology (EuMaG): Goals, Curriculum, and Students

ERIC Educational Resources Information Center

Aartsen, Marja

2011-01-01

The European Master's Program in Gerontology (EuMaG) started in September 2003 with support from the European Commission. The EuMaG is a modular, 2-year, part-time international training program about the aging process and its societal implications. The multidisciplinary curriculum comprises four domains of gerontology (i.e., social gerontology,…

EU-Level Competence Development Projects in Agri-Food-Environment: The Involvement of Sectoral Social Partners

ERIC Educational Resources Information Center

Mulder, Martin

2006-01-01

Purpose: The European Commission and social partner organisations at EU level encourage the lifelong development of qualifications and competence. This is reflected in many policy reports and reviews. This paper seeks to show the involvement of social partner organisations at the level of EU-funded competence development projects.…

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model.

PubMed

Tomaskova, Hana; Kuhnova, Jitka; Cimler, Richard; Dolezal, Ondrej; Kuca, Kamil

2016-01-01

Alzheimer's disease (AD) is a slowly progressing neurodegenerative brain disease with irreversible brain effects; it is the most common cause of dementia. With increasing age, the probability of suffering from AD increases. In this research, population growth of the European Union (EU) until the year 2080 and the number of patients with AD are modeled. The aim of this research is to predict the spread of AD in the EU population until year 2080 using a computer simulation. For the simulation of the EU population and the occurrence of AD in this population, a system dynamics modeling approach has been used. System dynamics is a useful and effective method for the investigation of complex social systems. Over the past decades, its applicability has been demonstrated in a wide variety of applications. In this research, this method has been used to investigate the growth of the EU population and predict the number of patients with AD. The model has been calibrated on the population prediction data created by Eurostat. Based on data from Eurostat, the EU population until year 2080 has been modeled. In 2013, the population of the EU was 508 million and the number of patients with AD was 7.5 million. Based on the prediction, in 2040, the population of the EU will be 524 million and the number of patients with AD will be 13.1 million. By the year 2080, the EU population will be 520 million and the number of patients with AD will be 13.7 million. System dynamics modeling approach has been used for the prediction of the number of patients with AD in the EU population till the year 2080. These results can be used to determine the economic burden of the treatment of these patients. With different input data, the simulation can be used also for the different regions as well as for different noncontagious disease predictions.

Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and Final Evaluation of the Action Plan on Drugs 2013-2016: Final report.

PubMed

Emilie, Balbirnie; Matthew, Davies; Emma, Disley; Cristina Gonzalez, Monsalve; Stephen, Hartka; Stijn, Hoorens; Kristy, Kruithof; Martin, Sacher; Jirka, Taylor

2018-01-01

The aim of the EU Drugs Strategy 2013-2020 is to contribute to a reduction in drug demand and drug supply within the EU. The Strategy has so far been implemented by an Action Plan covering the period 2013-2016. This article sets out the findings of an evaluation that assesses the degree of implementation of the Strategy and the Action Plan in terms of outputs and, where possible, impacts. It looks at the extent to which the objectives of the Strategy have been achieved. The evaluation aims to provide evidence to support the European Commission's decision about whether to propose a new Action Plan for the period 2017-2020 and, if so, what changes would be needed compared to the current plan. Through applying a mixed-methods approach, the evaluation examined the effectiveness, efficiency, relevance and coherence of the actions undertaken on the basis of the EU Drugs Strategy and the Action Plan, as well as their EU added value. The evaluation makes 20 recommendations, addressed to the European Commission, Member States, the European Council and other stakeholders. The key recommendation for the Commission is that a new Action Plan should be implemented for the period 2017-2020. This should be an updated version of the current Action Plan, rather than taking a new approach or introducing more new actions.

Analyzing Turkey's Data from TIMSS 2007 to Investigate Regional Disparities in Eighth Grade Science Achievement

ERIC Educational Resources Information Center

Erberber, Ebru

2009-01-01

Turkey is expected to be a full member of the European Union (EU) by 2013. In the course of its integration into the EU, Turkey has been simultaneously facing access, quality, and equity issues in education. Over the past decade, substantial progress has been made on increasing the access. However, improving the country's low level of education…

Matching Up to the Information Society: An Evaluation of the EU, the EU Accession Countries, Switzerland and the United States. Summary

ERIC Educational Resources Information Center

Graafland-Essers, Irma; Cremonini, Leon; Ettedgui, Emile; Botterman, Maarten

2003-01-01

This report presents the current understanding of the advancement of the Information Society within the European Union and countries that are up for accession in 2004, and is based on the SIBIS (Statistical Indicators Benchmarking the Information Society) surveys and analyses per SIBIS theme and country. The report is unique in its coherent and…

Matching Up to the Information Society: An Evaluation of the EU, the EU Accession Countries, Switzerland and the United States

ERIC Educational Resources Information Center

Graafland-Essers, Irma; Cremonini, Leon; Ettedgui, Emile; Botterman, Maarten

2003-01-01

This report presents the current understanding of the advancement of the Information Society within the European Union and countries that are up for accession in 2004, and is based on the SIBIS (Statistical Indicators Benchmarking the Information Society) surveys and analyses per SIBIS theme and country. The report is unique in its coherent and…

Funding Continuing Training in Small and Medium-Sized Enterprises: Discussion and Case Studies from across the EU. CEDEFOP Panorama Series.

ERIC Educational Resources Information Center

Pukkinen, Tommi; Romijn, Clemens; Elson-Rogers, Sarah

There are three main parts to this report of a study that used case studies to showcase the different approaches used to encourage more continuing training within small and medium-sized enterprises (SMEs) across the European Union (EU). Section 1 discusses the importance of funding training in SMEs and highlights the various types of funding…

European Higher Education, the Inclusion of Students from Under-Represented Groups and the Bologna Process

ERIC Educational Resources Information Center

Riddell, Sheila; Weedon, Elisabet

2014-01-01

The central questions addressed in this paper are the following: (1) In the context of the (European Union) EU's goal of severing the link between social class background and higher education participation, what progress has been made in widening access over the past two decades? (2) Has the Open Method of Coordination (OMC) helped EU countries to…

Modular framework to assess the risk of African swine fever virus entry into the European Union.

PubMed

Mur, Lina; Martínez-López, Beatriz; Costard, Solenne; de la Torre, Ana; Jones, Bryony A; Martínez, Marta; Sánchez-Vizcaíno, Fernando; Muñoz, María Jesús; Pfeiffer, Dirk U; Sánchez-Vizcaíno, José Manuel; Wieland, Barbara

2014-07-03

The recent occurrence and spread of African swine fever (ASF) in Eastern Europe is perceived as a serious risk for the pig industry in the European Union (EU). In order to estimate the potential risk of ASF virus (ASFV) entering the EU, several pathways of introduction were previously assessed separately. The present work aimed to integrate five of these assessments (legal imports of pigs, legal imports of products, illegal imports of products, fomites associated with transport and wild boar movements) into a modular tool that facilitates the visualization and comprehension of the relative risk of ASFV introduction into the EU by each analyzed pathway. The framework's results indicate that 48% of EU countries are at relatively high risk (risk score 4 or 5 out of 5) for ASFV entry for at least one analyzed pathway. Four of these countries obtained the maximum risk score for one pathway: Bulgaria for legally imported products during the high risk period (HRP); Finland for wild boar; Slovenia and Sweden for legally imported pigs during the HRP. Distribution of risk considerably differed from one pathway to another; for some pathways, the risk was concentrated in a few countries (e.g., transport fomites), whereas other pathways incurred a high risk for 4 or 5 countries (legal pigs, illegal imports and wild boar). The modular framework, developed to estimate the risk of ASFV entry into the EU, is available in a public domain, and is a transparent, easy-to-interpret tool that can be updated and adapted if required. The model's results determine the EU countries at higher risk for each ASFV introduction route, and provide a useful basis to develop a global coordinated program to improve ASFV prevention in the EU.

Modular framework to assess the risk of African swine fever virus entry into the European Union

PubMed Central

2014-01-01

Background The recent occurrence and spread of African swine fever (ASF) in Eastern Europe is perceived as a serious risk for the pig industry in the European Union (EU). In order to estimate the potential risk of ASF virus (ASFV) entering the EU, several pathways of introduction were previously assessed separately. The present work aimed to integrate five of these assessments (legal imports of pigs, legal imports of products, illegal imports of products, fomites associated with transport and wild boar movements) into a modular tool that facilitates the visualization and comprehension of the relative risk of ASFV introduction into the EU by each analyzed pathway. Results The framework’s results indicate that 48% of EU countries are at relatively high risk (risk score 4 or 5 out of 5) for ASFV entry for at least one analyzed pathway. Four of these countries obtained the maximum risk score for one pathway: Bulgaria for legally imported products during the high risk period (HRP); Finland for wild boar; Slovenia and Sweden for legally imported pigs during the HRP. Distribution of risk considerably differed from one pathway to another; for some pathways, the risk was concentrated in a few countries (e.g., transport fomites), whereas other pathways incurred a high risk for 4 or 5 countries (legal pigs, illegal imports and wild boar). Conclusions The modular framework, developed to estimate the risk of ASFV entry into the EU, is available in a public domain, and is a transparent, easy-to-interpret tool that can be updated and adapted if required. The model’s results determine the EU countries at higher risk for each ASFV introduction route, and provide a useful basis to develop a global coordinated program to improve ASFV prevention in the EU. PMID:24992824

Why study EU foreign policy at all? A response to Keuleers, Fonck and Keukeleire

PubMed Central

Dijkstra, Hylke; Vanhoonacker, Sophie

2016-01-01

In an important article on the state of European Union (EU) foreign policy research, Keuleers, Fonck and Keukeleire show that academics excessively focus on the study of the EU foreign policy system and EU implementation rather than the consequences of EU foreign policy for recipient countries. While the article is empirical, based on a dataset of 451 published articles on EU foreign policy, the normative message is that it is time to stop ‘navel-gazing’ and pay more attention to those on the receiving end of EU foreign policy. We welcome this contribution, but wonder why certain research questions have been privileged over others. We argue that this has primarily to do with the predominant puzzles of the time. We also invite Keuleers, Fonck and Keukeleire to make a theoretical case for a research agenda with more attention to outside-in approaches. We conclude by briefly reflecting on future research agendas in EU foreign policy. PMID:28546641

Prevalence of Salmonella spp. in Austrian broiler flocks in the context of the EU-wide baseline survey 2005-2006.

PubMed

Lassnig, Heimo; Much, Peter; Schliessnig, Harald; Osterreicher, Elfriede; Kostenzer, Klaus; Kornschober, Christian; Köfer, Josef

2012-01-01

In Austria an EU-wide baseline survey on the prevalence of Salmonella spp. in broilers organized by the EU commission was conducted from October 2005 to September 2006. The aim of this study was to produce comparable data on the prevalence of Salmonella in broiler flocks and holdings for all member states and for the EU-Commission to set EU-wide targets for the control of Salmonella in the broiler populations. A randomised sampling plan was designed according to EU-commission parameters (p = 50%; CI = 95%, a = 5%). Sampling was carried out regularly throughout the whole year. On every farm one flock was sampled with five pairs of boot swabs and analysed in the lab according to appendix D of ISO 6579 (2002). In Austria, 363 flocks on farms consisting of at least 5000 broilers each were tested. 28 flocks (7.7%) showed infections with Salmonella spp., eight flocks (2.2%) had either S. Enteritidis (six flocks) or S. Typhimurium (two flocks). In detail, S. Enteritidis (1.7%), S. Typhimurium (0.6%), S. Montevideo (4.1%), S. Infantis 0.6%, S. Senftenberg, S. Tennessee and S. Virchow (0.3% each) have been found. Data indicated that the risk of vertical transmission of Salmonella spp. to broiler flocks has almost been kept at bay; however, the risk of horizontal transmission still needs attention. Contamination of feeding stuff, possible persistence, spreading between barns of a farm as well as introduction of Salmonella spp. through individuals or materials are important factors for future control strategies.

An overview of Compassionate Use Programs in the European Union member states.

PubMed

Balasubramanian, Gayathri; Morampudi, Suman; Chhabra, Pankdeep; Gowda, Arun; Zomorodi, Behsad

2016-11-01

The past decade witnessed rapid development of novel drugs and therapeutic biological agents. The marketing authorization for novel therapies is often time consuming and distressing for patients. Earlier clinical trials were the only way to access new drugs under development. However, not every patient meets the enrolment criteria, and participation is difficult for patients with life-threatening, long-lasting or seriously debilitating diseases like rare diseases. Early access programs like "Compassionate Use Program (CUP)" have generated alternative channels for such patients. The European Medical Agency provides regulations and recommendations for compassionate use, upon which every European Union (EU) member state has developed its own rules and regulations. Despite previous reviews and studies, the available information is limited and gaps exist. This literature review explores CUP in 28 EU member states. Data was collected through literature review and use of country-specific search terms from the healthcare domain. Data sources were not limited to databases and articles published in journals, but also included grey literature. The results implied that CUP was present in 20 EU member states (71%). Of 28 EU states, 18 (∼64%) had nationalized regulations and processes were well-defined. Overall, this review identified CUP and its current status and legislation in 28 EU member states. The established legislation for CUP in the EU member states suggest their willingness to adopt processes that facilitate earlier and better access to new medicines. Further research and periodic reviews are warranted to understand the contemporary and future regulatory trends in early access programs.

The Potential of Transnational Language Policy to Promote Social Inclusion of Immigrants: An Analysis and Evaluation of the European Union's INCLUDE Project

ERIC Educational Resources Information Center

Bian, Cui

2017-01-01

Language issues and social inclusion consistently remain two major concerns for member countries of the European Union (EU). Despite an increasing awareness of the importance of language learning in migrants' social inclusion, and the promotion of language policies at European and national levels, there is still a lack of common actions at the…

International Crisis Information Network

DTIC Science & Technology

2006-12-01

AU African Union CA Civil Affairs (Specifically United States Army) CDHAM Center for Disaster and Humanitarian Assistance Medicine CEMAC Economic...Department of Defense DODD Department of Defense Directive ECOWAS Economic Community of West African States EU European Union FR First Responder HA...passion, such as rugby fans on Rugby365.com, or music lovers on MP3.com. These people exchange ideas and thoughts about the given passion.”83 The

The Future Development of the European Union Education, Training and Youth Programmes After 2006: A Public Consultation Document.

ERIC Educational Resources Information Center

Commission of the European Communities, Brussels (Belgium). Directorate-General for Education and Culture.

This document launches a wide public consultation with all those involved in and with an interest in the European Union's (EU's) education, training, and youth programs called Socrates, Tempus, Leonardo da Vinci, and Youth for Europe. It is the first step toward preparing the new generation of programs to start in 2007 and will inform the…

A quality assessment of the MARS crop yield forecasting system for the European Union

NASA Astrophysics Data System (ADS)

van der Velde, Marijn; Bareuth, Bettina

2015-04-01

Timely information on crop production forecasts can become of increasing importance as commodity markets are more and more interconnected. Impacts across large crop production areas due to (e.g.) extreme weather and pest outbreaks can create ripple effects that may affect food prices and availability elsewhere. The MARS Unit (Monitoring Agricultural ResourceS), DG Joint Research Centre, European Commission, has been providing forecasts of European crop production levels since 1993. The operational crop production forecasting is carried out with the MARS Crop Yield Forecasting System (M-CYFS). The M-CYFS is used to monitor crop growth development, evaluate short-term effects of anomalous meteorological events, and provide monthly forecasts of crop yield at national and European Union level. The crop production forecasts are published in the so-called MARS bulletins. Forecasting crop yield over large areas in the operational context requires quality benchmarks. Here we present an analysis of the accuracy and skill of past crop yield forecasts of the main crops (e.g. soft wheat, grain maize), throughout the growing season, and specifically for the final forecast before harvest. Two simple benchmarks to assess the skill of the forecasts were defined as comparing the forecasts to 1) a forecast equal to the average yield and 2) a forecast using a linear trend established through the crop yield time-series. These reveal a variability in performance as a function of crop and Member State. In terms of production, the yield forecasts of 67% of the EU-28 soft wheat production and 80% of the EU-28 maize production have been forecast superior to both benchmarks during the 1993-2013 period. In a changing and increasingly variable climate crop yield forecasts can become increasingly valuable - provided they are used wisely. We end our presentation by discussing research activities that could contribute to this goal.

The European initiative on low-dose risk research: from the HLEG to MELODI.

PubMed

Belli, Mauro; Tabocchini, Maria Antonella; Jourdain, Jean-René; Salomaa, Sisko; Repussard, Jacques

2015-09-01

The importance of low-dose risk research for radiation protection is now widely recognised. The European Commission (EC) and five European Union (EU) Member States involved in the Euratom Programme set up in 2008 a 'High Level and Expert Group on European Low Dose Risk Research' (HLEG) aimed at identifying research needs and proposing a better integration of European efforts in the field. The HLEG revised the research challenges and proposed a European research strategy based on a 'Multidisciplinary European LOw Dose Initiative' (MELODI). In April 2009, five national organisations, with the support of the EC, created the initial core of MELODI (http://www.melodi-online.eu) with a view to integrate the EU institutions with significant programmes in the field, while being open to other scientific organisations and stakeholders, and to develop an agreed strategic research agenda (SRA) and roadmap. Since then, open workshops have been organised yearly, exploring ideas for SRA implementation. As of October 2014, 31 institutions have been included as members of MELODI. HLEG recommendations and MELODI SRA have become important reference points in the radiation protection part of the Euratom Research Programme. MELODI has established close interactions through Memorandum of Understanding with other European platforms involved in radiation protection (Alliance, NERIS and EURADOS) and, together with EURADOS, with the relevant medical European Associations. The role of Joint Programming in priority setting, foreseen in the forthcoming EU Horizon 2020, calls for keeping MELODI an open, inclusive and transparent initiative, able to avoid redundancies and possible conflicts of interest, while promoting common initiatives in radiation protection research. An important issue is the establishment of a proper methodology for managing these initiatives, and this includes the set-up of an independent MELODI Scientific Committee recently extended to Alliance, NERIS and EURADOS, with the aim of identifying research priorities to suggest for the forthcoming Euratom research calls. © The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Analysis of Energy Intensive Enterprises under EU Emission Trading System in Latvia

NASA Astrophysics Data System (ADS)

Zahare, Dace; Rosa, Marika

2011-01-01

Climate change and global warming has become one of the main topics worldwide. The European Union Emission Trading System (EU ETS) was established to limit climate change, providing regulations which encourage companies to invest in cleaner production and more energy efficient production. Latvian energy intensive enterprises are operating under the EU ETS from the year 2005. The main goal of this paper is to provide an analysis of energy intensive installations in terms of their energy efficiency. Additionally, an analysis of EU ETS phase III which will start to operate in 2013 under new, more stringent rules has been conducted by modelling three Latvian energy intensive enterprise operations under this phase and estimating the barriers to meet the goal of the EU ETS phase III.

Exposure to major volatile organic compounds and carbonyls in European indoor environments and associated health risk.

PubMed

Sarigiannis, Dimosthenis A; Karakitsios, Spyros P; Gotti, Alberto; Liakos, Ioannis L; Katsoyiannis, Athanasios

2011-05-01

This paper summarizes recent data on the occurrence of major organic compounds (benzene, toluene, xylenes, styrene, acetaldehyde, formaldehyde, naphthalene, limonene, α-pinene and ammonia, classified by the European Commission's INDEX strategy report as the priority pollutants to be regulated) and evaluates accordingly cancer and non-cancer risks posed by indoor exposure in dwellings and public buildings in European Union (EU) countries. The review process indicated that significant differences in indoor air quality exist within and among the countries where data were available, indicating corresponding differences in sources and emission strength of airborne chemicals, identified or not. Conservative exposure limits were not exceeded for non-carcinogenic effects, except for formaldehyde; for carcinogenic agents the estimated risks were up to three orders of magnitude higher than the one (10(-6)) proposed as acceptable by risk management bodies. However, the risk assessment evaluation process faces crucial difficulties, either due to the relative paucity of indoor air quality measurements in many EU countries, or by the lack of sampling consistency in the already existing studies, indicating the need for additional measurements of indoor air quality following a harmonized sampling and analytical protocol. Additionally, uncertainties embodied in the cancer potency factors and exposure limit values impose further difficulties in substance prioritization and risk management. Copyright © 2011 Elsevier Ltd. All rights reserved.

Privacy and anonymity in the information society - challenges for the European Union.

PubMed

Tsoukalas, Ioannis A; Siozos, Panagiotis D

2011-03-01

Electronic information is challenging traditional views on property and privacy. The explosion of digital data, driven by novel web applications, social networking, and mobile devices makes data security and the protection of privacy increasingly difficult. Furthermore, biometric data and radiofrequency identification applications enable correlations that are able to trace our cultural, behavioral, and emotional states. The concept of privacy in the digital realm is transformed and emerges as one of the biggest risks facing today's Information Society. In this context, the European Union (EU) policy-making procedures strive to adapt to the pace of technological advancement. The EU needs to improve the existing legal frameworks for privacy and data protection. It needs to work towards a "privacy by education" approach for the empowerment of "privacy-literate" European digital citizens.

A Multi-Cultural Union

ERIC Educational Resources Information Center

Gotbaum, Victor

1975-01-01

This testimony, by the president of the Municipal Employees Union before a public hearing of the New York City Commission on Human Rights in May 1974, emphasizes that occupational categories segregate its membership and discusses the unions' efforts to relieve a segregation that imposes mainly upon black and Puerto Rican citizens the lowest…

75 FR 61747 - Union Leader Corporation; Supplemental Notice That Initial Market-Based Rate Filing Includes...

Federal Register 2010, 2011, 2012, 2013, 2014

2010-10-06

... of Union Leader Corporation's application for market-based rate authority, with an accompanying rate... DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Docket No. ER10-2780-000] Union Leader Corporation; Supplemental Notice That Initial Market-Based Rate Filing Includes Request for Blanket Section...

77 FR 11171 - License Renewal Application for Callaway Plant, Unit 1, Union Electric Company

Federal Register 2010, 2011, 2012, 2013, 2014

2012-02-24

... Callaway Plant, Unit 1, Union Electric Company AGENCY: Nuclear Regulatory Commission. ACTION: Intent to prepare environmental impact statement and conduct scoping process. SUMMARY: Union Electric Company, a..., MO. The current operating license for Callaway expires on October 18, 2024. DATES: The public scoping...

Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.

PubMed

Chin, William Wei Lim; Joos, Angelika

2016-12-01

Over the past two decades, there has been growing concern over the lack of proper medication for children. This review attempts to evaluate the current progress of EU Pediatric Regulation made since 2007. The lack of properly evaluated pediatric medication has for long been a source of concern in the European Union. The drugs that were used in the past were often not properly evaluated, and dosage was arbitrarily calculated. Therefore, it was necessary to establish the Pediatric Regulation (EC no. 1901/2006) in the EU which would mandate research for pediatric drugs. Current legislations in place not only require mandatory research by pharma industry but also have guidelines to direct the quality of pediatric research performed. The main aim of this regulation was to advance high-quality research and development of pediatric drugs, thereby increasing the availability of safe and effective drugs for children. It also aimed to improve the information available on existing pediatric drugs. It has been 9 years since the pediatric regulation was framed. The pharma industry now sees pediatric research as an integral process of development. Drug companies which develop plans for a new drug, new form of drug, new indication, or new route of administration for adults are obliged to integrate in their development plan similar research for pediatric populations as well. It is hoped that the implementation of the current legislation will be reflected better in the future by the marketing of better and safer drugs for the pediatric population. The upcoming assessment to the European Commission in 2017 will further inform us on the impact after 10 years implementation of the legislation. What is Known: • The lack of properly evaluated pediatric medication has for long been a source of concern in the European Union. • Therefore, it was necessary to establish the EU Pediatric Regulation which would mandate research for pediatric drugs. What is New: • It has been 9 years since the pediatric regulation was framed, and the teething problems are slowly being overcome and the regulation is being used with increasing confidence. • As the Regulation is due for revision in 2017, this paper gives a current perspective on the impact of the regulation on availability and access to medicine for children.

Providing healthcare assistants with better career opportunities.

PubMed

Filkins, Jacqueline

2014-10-30

NURSES' DEPENDENCE on the skills and experience of healthcare assistants (HCAs) is increasing, but the level of guidance and supervision offered to HCAs is variable. While there is noteworthy work that addresses training and development opportunities for HCAs across the UK, many people are unaware of this in the wider European Union (EU). Equally, there is limited awareness in other EU countries of the UK's HCA training and employment opportunities.

Participation in Non-Formal Learning in EU-15 and EU-8 Countries: Demand and Supply Side Factors

ERIC Educational Resources Information Center

Roosmaa, Eve-Liis; Saar, Ellu

2012-01-01

The main purpose of this paper is to provide an in-depth analysis of participation in non-formal learning in different European Union member states. The paper also seeks to extend analysis of the training gap by pursuing the distinction between the supply and the demand for skills. We use aggregate data from the Adult Education Survey (Eurostat)…

Come on RCN - What's your position on the EU referendum?

PubMed

Travis, Mike

2016-05-04

The Royal College of Midwives is ahead of other health unions on the great EU debate, issuing a clear statement of where they stand that will help members think about how they vote on June 23. The European question is complex and the media will not focus on economic and worker welfare. Where is the RCN in all this? It says it has a 'neutral' stance!

Questioning the Role of Internationalization in the Nationalization of Higher Education: The Impact of the EU TEMPUS Programme on Higher Education in Syria

ERIC Educational Resources Information Center

Ayoubi, Rami M.; Massoud, Hiba K.

2011-01-01

Given the need for major reform of the higher education programmes in Syria, and answering the voices that question the role of European Union (EU) in assisting the development of the higher education sector, this study presents an analysis of the contribution of (TEMPUS) Programme in modernising higher education in Syria. The study compares the…

A Welcome Proposal to Amend the GMO Legislation of the EU.

PubMed

Eriksson, Dennis; Harwood, Wendy; Hofvander, Per; Jones, Huw; Rogowsky, Peter; Stöger, Eva; Visser, Richard G F

2018-05-25

Is the European Union (EU) regulatory framework for genetically modified organisms (GMOs) adequate for emerging techniques, such as genome editing? This has been discussed extensively for more than 10 years. A recent proposal from The Netherlands offers a way to break the deadlock. Here, we discuss how the proposal would affect examples from public plant research. Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

English "in the Context of" European Integration: A Corpus-Driven Analysis of Lexical Bundles in English EU Documents

ERIC Educational Resources Information Center

Jablonkai, Reka

2010-01-01

This study extends research into the use of English as a lingua franca in the European context by investigating the most frequent word combinations in English documents issued by EU institutions. As there is little research on the use of the English language within the European Union for ESP pedagogic purposes, as part of a larger scale analysis,…

Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area.

PubMed

van den Wijngaard, Cees C; Hofhuis, Agnetha; Simões, Mariana; Rood, Ente; van Pelt, Wilfrid; Zeller, Herve; Van Bortel, Wim

2017-07-06

Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe. Erythema migrans (EM), an early, localised skin rash, is its most common presentation. Dissemination of the bacteria can lead to more severe manifestations including skin, neurological, cardiac, musculoskeletal and ocular manifestations. Comparison of LB incidence rates in the European Union (EU)/European Economic Area (EEA) and Balkan countries are difficult in the absence of standardised surveillance and reporting procedures. We explored six surveillance scenarios for LB surveillance in the EU/EEA, based on the following key indicators: (i) erythema migrans, (ii) neuroborreliosis, (iii) all human LB manifestations, (iv) seroprevalence, (v) tick bites, and (vi) infected ticks and reservoir hosts. In our opinion, neuroborreliosis seems most feasible and useful as the standard key indicator, being one of the most frequent severe LB manifestations, with the possibility of a specific case definition. Additional surveillance with erythema migrans as key indicator would add value to the surveillance of neuroborreliosis and lead to a more complete picture of LB epidemiology in the EU/EEA. The other scenarios have less value as a basis for EU-level surveillance, but can be considered periodically and locally, as they could supply complementary insights. This article is copyright of The Authors, 2017.

Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union.

PubMed

Inácio, P; Cavaco, A; Allan, E; Airaksinen, M

2018-02-01

In the European Union (EU), legislation allows patients to directly report adverse drug reactions (ADRs) to competent authorities. Five years after its implementation, patient reporting is not equal in all countries. This study aimed to explore key stakeholders' perceptions of patient reporting in four EU countries. Qualitative study design. Twelve representatives from national pharmacovigilance centres and/or authorities as well as national pharmaceutical industry bodies in four EU countries participated in the study. Supranational organizations were also included. Data collection was via face-semi-structured interviews. Inductive content analysis was performed thereafter, applying principles of risk management as a theoretical framework. Four themes (attitudes and beliefs, system maturation factors, regulatory improvements, and cultural shifts) emerged, conceptually interconnected. Participants from countries introducing patient reporting recently expressed a negative attitude. Participants highlighted the need for additional resources, both human and financial, to address patient reporting and associated advantages. The findings identified perceived barriers and facilitators of patient reporting. The involvement of patients, use of information, and dissemination of patient reporting are far from optimal. A better integration of the work by EU regulatory authorities is recommended. Copyright © 2017 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

The origins of the bioeconomy in the European Union.

PubMed

Patermann, Christian; Aguilar, Alfredo

2018-01-25

This article outlines the context and circumstances that favoured the development of a Bioeconomy Strategy in the European Union (EU) and the role played by the different Framework programmes for Research, Technological Development and Demonstration. Particular attention is given to the biotechnology related programmes and more specifically to the "Cell Factory" Key Action in the 5th Framework Programme (1998-2002). This, together with the parallel development of a Strategy on Biotechnology in 2002, served as a solid foundation for the creation of the, at the time, so-called Knowledge-Based Bio-Economy (KBBE). The KBBE concept emerged in 2005, a couple of years before the launch of the 7th Framework Programme (2007-2013). The experience accumulated over the years and the new societal expectations triggered the EU to launch a Strategy on Bioeconomy in 2012. This article concludes with a brief analysis of the two most important impacts of the EU Strategy on Bioeconomy. One is the Bioeconomy dedicated activity within the Programme Horizon 2020 (2014-2020), and the other the creation of a public-private partnership of bio-based industries. Both the impact of Horizon 2020 on the EU Bioeconomy Strategy and the bio-based industries public-private partnership are analysed in depth in two articles elsewhere in this volume. Copyright © 2017 Elsevier B.V. All rights reserved.

Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy.

PubMed

Aguilar, Alfredo; Magnien, Etienne; Thomas, Daniel

2013-06-25

This article traces back thirty years of biotechnology research sponsored by the European Union (EU). It outlines the crucial role played by De Nettancourt, Goffeau and Van Hoeck to promote and prepare the first European programme on biotechnology (1982-1986) run by the European Commission. Following this first biotechnology programme, others followed until the current one, part of the seventh Framework Programme for Research, Technological Development and Demonstration (2007-2013) (FP7). Particular attention is given to the statutory role of the European institutions in the design and orientation of the successive biotechnology programmes, compared to the more informal-yet visionary-role of key individuals upstream to any legislative decision. Examples of success stories and of the role of the biotechnology programmes in addressing societal issues and industrial competitiveness are also presented. Finally, an outline of Horizon 2020, the successor of FP7, is described, together with the role of biotechnology in building the bioeconomy. Copyright © 2012 Elsevier B.V. All rights reserved.

Safety Assessment of Food and Feed from GM Crops in Europe: Evaluating EFSA's Alternative Framework for the Rat 90-day Feeding Study.

PubMed

Hong, Bonnie; Du, Yingzhou; Mukerji, Pushkor; Roper, Jason M; Appenzeller, Laura M

2017-07-12

Regulatory-compliant rodent subchronic feeding studies are compulsory regardless of a hypothesis to test, according to recent EU legislation for the safety assessment of whole food/feed produced from genetically modified (GM) crops containing a single genetic transformation event (European Union Commission Implementing Regulation No. 503/2013). The Implementing Regulation refers to guidelines set forth by the European Food Safety Authority (EFSA) for the design, conduct, and analysis of rodent subchronic feeding studies. The set of EFSA recommendations was rigorously applied to a 90-day feeding study in Sprague-Dawley rats. After study completion, the appropriateness and applicability of these recommendations were assessed using a battery of statistical analysis approaches including both retrospective and prospective statistical power analyses as well as variance-covariance decomposition. In the interest of animal welfare considerations, alternative experimental designs were investigated and evaluated in the context of informing the health risk assessment of food/feed from GM crops.

Biological and Health Effects of Electromagnetic Fields Related to the Operation of MRI/TMS

NASA Astrophysics Data System (ADS)

Shigemitsu, Tsukasa; Ueno, Shoogo

This paper reviews issues of biological effects and safety aspects of the electromagnetic fields related to both Magnetic Resonance Imaging (MRI) and Transcranial Magnetic Stimulation (TMS) as a diagnostic technique. The noninvasive character of these diagnostic techniques is based on the utilization of the electromagnetic fields such as the static magnetic field, time-varying magnetic field, and radiofrequency electromagnetic field. Following the short view of the history and the principle of these noninvasive techniques, we review the biological effects of the electromagnetic fields, the health effects and safety issues related to MRI/TMS environments. Through a discussion of biological and health effects, it shows briefly guidelines which provide a consideration in human risk for both patients and medical staff. Finally, safety issues related to MRI/TMS are discussed with the highlighting of the guideline such as the International Commission on NonIonizing Radiation Protection (ICNIRP) and EMF Directive (Directve2013/35/EU) of European Union.

The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey.

PubMed

Lévy-Bruhl, D; Bousquet, V; King, L A; O'Flanagan, D; Bacci, S; Lopalco, P L; Salmaso, S

2009-10-01

Three surveys have been undertaken in European Union (EU) member states since January 2007, within the European Commission funded Vaccine European New Integrated Collaboration Effort (VENICE) project, to monitor the decision status regarding the introduction of human papillomavirus (HPV) vaccination into national immunisation schedules. A web-based questionnaire was developed and completed online by the 28 countries participating in VENICE. According to the last update (31st December 2008), 15 countries have decided to introduce HPV vaccination into their national immunisation schedule, while another six have started the decision-making process with a recommendation favouring introduction. Varying target populations have been selected by the countries which have introduced vaccination. The number of countries which have made a decision or recommendation has increased from 12 to 21 between October 2007 and December 2008. This survey demonstrates the rapidly evolving nature of HPV vaccine introduction in Europe. A further update should be available in the second half of 2009.

National action for European public health research.

PubMed

McCarthy, Mark; Zeegers Paget, Dineke; Barnhoorn, Floris

2013-11-01

Research and innovation are the basis for improving health and health services. The European Union (EU) supports research through multi-annual programmes. Public Health Innovation and Research in Europe (PHIRE) investigated how European countries cooperate for action in public health research. In PHIRE, following stakeholder workshops and consultations, a national report on public health research was created for 24 of 30 European countries. The report template asked five questions, on national links to European public health research and on national research through the Structural Funds and Ministry of Health. The national reports were assessed with framework analysis, and the country actions were classified strong/partial/weak or none. There were responses to the five questions sufficient for this analysis for between 14 and 20 countries Six countries had public health research aligned with the EU, while three (large) countries were reported not aligned. Only two countries expressed strong engagement in developing public health research within Horizon 2020: most Ministries of Health had no position and only had contact with EU health research through other ministries. Only two countries reported use of the 2007-13 Structural Funds for public health research. While seven Ministries of Health led research from their own funds, or linked with Ministries of Science in six, the Ministries of Health of seven countries were reported not to be involved in public health research. Ministries of Health and stakeholders are poorly engaged in developing public health research, with the Horizon 2020 research programme, or the Structural Funds. The European Commission should give more attention to coordination of public health research with member states if it is to give best value to European citizens.

Space and the complexity of European rules and policies: The common projects Galileo and GMES—precedence for a new European legal approach?

NASA Astrophysics Data System (ADS)

Froehlich, Annette

2010-04-01

The two European flagship space projects, Galileo and GMES, clearly show that the current existing legal rules of the two organisations involved (European Union and European Space Agency) are not compatible. Moreover, it is quite impossible to implement a common project if every single organisation insists on the application of its own rules strictu sensu. Nevertheless, due to the political desire to advance these projects rapidly and to make them a success, legal obstacles were to be overcome. Consequently, recently concluded agreements between ESA and the EU-Commission concerning the financial and governmental matters of the Galileo and GMES implementation feature a new approach to cooperation between these two organisations. However, the question remains if they can be taken as precedence for a future institutionalised cooperation? It follows that the agreements have to be analysed in order to understand how a mutually acceptable agreement was reached despite the disparity in the rules of both organisations. In this regard, especially the financial decision agreement concerning Galileo in December 2007 shows a very interesting and unique way in applying EU-competition law. In the same way, the GMES-Delegation Agreement of spring 2008 is a good example of how two different legal systems can be applied to make a project success. Additionally, the reasons and arguments of both organisations have to be considered, especially once the Treaty of Lisbon will be in force. As these two main projects of the European Space Policy are characterized by the desire for a successful European cooperation, they can be regarded as an important step forward for a new legal approach. A new system emerges which could be taken into consideration for further common projects undertaken by ESA and the EU.

The changes in hazard classification and product notification procedures of the new European CLP and Cosmetics Regulations.

PubMed

de Groot, Ronald; Brekelmans, Pieter; Herremans, Joke; Meulenbelt, Jan

2010-01-01

The United Nations Globally Harmonized System of Classification and Labelling of Chemicals (UN-GHS) is developed to harmonize the criteria for hazard communication worldwide. The European Regulation on classification, labeling, and packaging of substances and mixtures [CLP Regulation (European Commission, EC) No 1272/2008] will align the existing European Union (EU) legislation to the UN-GHS. This CLP Regulation entered into force on January 20, 2009, and will, after a transitional period, replace the current rules on classification, labeling, and packaging for supply and use in Europe. Both old and new classifications will exist simultaneously until 2010 for substances and until 2015 for mixtures. The new hazard classification will introduce new health hazard classes and categories, with associated new hazard pictograms, signal words, Hazard (H)-statements, and Precautionary (P)-statements as labeling elements. Furthermore, the CLP Regulation will affect the notification of product information on hazardous products to poisons information centers (PICs). At this moment product notification widely varies in procedures and requirements across EU Member States. Article 45 of the CLP Regulation contains a provision stating that the EC will (by January 20, 2012) review the possibility of harmonizing product notification. The European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) is recognized as an important stakeholder. For cosmetic products, the new Cosmetics Regulation will directly implement a new procedure for electronic cosmetic product notification in all EU Member States. Both the CLP Regulation and the Cosmetics Regulation will develop their own product notification procedure within different time frames. Harmonization of notification procedures for both product groups, especially a common electronic format, would be most effective from a cost-benefit viewpoint and would be welcomed by PICs.

Public health economic evaluation of different European Union-level policy options aimed at reducing population dietary trans fat intake.

PubMed

Martin-Saborido, Carlos; Mouratidou, Theodora; Livaniou, Anastasia; Caldeira, Sandra; Wollgast, Jan

2016-11-01

The adverse relation between dietary trans fatty acid (TFA) intake and coronary artery disease risk is well established. Many countries in the European Union (EU) and worldwide have implemented different policies to reduce the TFA intake of their populations. The aim of this study was to assess the added value of EU-level action by estimating the cost-effectiveness of 3 possible EU-level policy measures to reduce population dietary TFA intake. This was calculated against a reference situation of not implementing any EU-level policy (i.e., by assuming only national or self-regulatory measures). We developed a mathematical model to compare different policy options at the EU level: 1) to do nothing beyond the current state (reference situation), 2) to impose mandatory TFA labeling of prepackaged foods, 3) to seek voluntary agreements toward further reducing industrially produced TFA (iTFA) content in foods, and 4) to impose a legislative limit for iTFA content in foods. The model indicated that to impose an EU-level legal limit or to make voluntary agreements may, over the course of a lifetime (85 y), avoid the loss of 3.73 and 2.19 million disability-adjusted life-years (DALYs), respectively, and save >51 and 23 billion euros when compared with the reference situation. Implementing mandatory TFA labeling can also avoid the loss of 0.98 million DALYs, but this option incurs more costs than it saves compared with the reference option. The model indicates that there is added value of an EU-level action, either via a legal limit or through voluntary agreements, with the legal limit option producing the highest additional health benefits. Introducing mandatory TFA labeling for the EU common market may provide some additional health benefits; however, this would likely not be a cost-effective strategy.

Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review.

PubMed

Carrillo-Santisteve, Paloma; Tavoschi, Lara; Severi, Ettore; Bonfigli, Sandro; Edelstein, Michael; Byström, Emma; Lopalco, Pierluigi

2017-10-01

Most of the European Union (EU) and European Economic Area (EEA) is considered a region of very low hepatitis A virus (HAV) endemicity; however, geographical differences exist. We did a systematic review with the aim of describing seroprevalence and susceptibility in the general population or special groups in the EU and EEA. We searched databases and public health national institutes websites for HAV seroprevalence records published between Jan 1, 1975, and June 30, 2014, with no language restrictions. An updated search was done on Aug 10, 2016. We defined seroprevalence profiles (very low, low, and intermediate) as the proportion of the population with age-specific anti-HAV antibodies at age 15 and 30 years, and susceptibility profiles (low, moderate, high, and very high) as the proportion of susceptible individuals at age 30 and 50 years. We included 228 studies from 28 of 31 EU and EEA countries. For the period 2000-14, 24 countries had a very low seroprevalence profile, compared with five in 1975-89. The susceptibility among adults ranged between low and very high and had a geographical gradient, with three countries in the low susceptibility category. Since 1975, EU and EEA countries have shown decreasing seropositivity; however, considerable regional variability exists. The main limitations of this study are that the studies retrieved for analysis might not be representative of all EU and EEA publications about HAV and might have poor national representativeness. A large proportion of EU and EEA residents are now susceptible to HAV infection. Our Review supports the need to reconsider specific prevention and control measures, to further decrease HAV circulation while providing protection against the infection in the EU and EEA, and could be used to inform susceptible travellers visiting EU and EEA countries with different HAV endemicity levels. Copyright © 2017 Elsevier Ltd. All rights reserved.

Harmonization of European neurology education: the junior doctor's perspective.

PubMed

Macerollo, Antonella; Struhal, Walter; Sellner, Johann

2013-10-29

The objective of this article, written by executives of the European Association of Young Neurologists and Trainees (EAYNT), is to illustrate the status quo of neurology training in Europe and give an outlook on ongoing efforts and prospects for junior neurologists. The European Union is an economic and political union that currently encompasses 27 member states with more than 500 million inhabitants (or 7.3% of the world population) (interested readers are referred to http://en.wikipedia.org/wiki/European_Union). Countries of the European Union act as a single market with free movement of citizens, goods, services, and finances. As a consequence, a diploma and postgraduate training obtained in one EU country will be automatically recognized by all other EU member states. At the Lisbon European Council in March 2000, the Heads of State or Government signed a treaty that expresses their ambition of making Europe "the most competitive and dynamic knowledge-based economy in the world, capable of sustainable economic growth with more and better jobs and greater social cohesion" (www.en.wikipedia.org/wiki/Lisbon_Strategy). More than 1.6 million physicians in all the different medical specialties are represented by the European Union of Medical Specialists (UEMS). The UEMS was founded in 1958 and the objectives include the study, promotion, and harmonization of the highest level of training of medical specialists, medical practice, and health care within the European Union. The European Board of Neurology (UEMS-EBN; www.uems-neuroboard.org) is in charge of the implementation of the UEMS policy regarding neurology.

The EU environmental policy context for monitoring for and with raptors in Europe.

PubMed

Duke, Guy

2008-09-01

This paper outlines the importance of the policy context for monitoring with and for raptors, and, conversely, of the importance of such monitoring for policy. It then outlines two key areas of European Union (EU) environmental policy most relevant to monitoring for and with raptors, namely biodiversity policy and pollution policy. For each of the policy areas, the pertinent objectives and actions of the current EU policy are identified, and their relevance for raptor monitoring is discussed. The potential contribution of raptor monitoring to the further development of these policy areas is also addressed.

The Quantity and Quality of Illegally Imported Products of Animal Origin in Personal Consignments into the European Union Seized at Two German Airports between 2010 And 2014

PubMed Central

Jansen, Wiebke; Merkle, Majella; Daun, Anna; Flor, Matthias; Grabowski, Nils Th.; Klein, Günter

2016-01-01

The import of products of animal origin (POAO) in travellers’ personal consignments presents a considerable risk of introducing animal diseases and emerging zoonoses into the European Union. The current regulation (EU) 206/2009 implements strict measures for illegally imported POAO, whereupon non-complying products have to be seized and destroyed regardless. Especially airports serve as global bottlenecks for illegally imported POAO where passenger controls of non-European flights are performed by customs and veterinary services in collaboration. Results of these control measures have to be submitted in the form of annual reports to the European Commission. However, few data on qualities and quantities of seizures have been published so far. In this study, POAO seized at two German airports between 2010 and 2014 were analysed in terms of quantities, qualitative categories and region of origin. In most years considered, more than 20 tonnes POAO were seized at each airport. However, reported amounts of seizures seem to be only the tip of the iceberg as an all-passenger control is not feasible and therefore travellers are only spot-checked. The analysis suggests that the organisational structures of both customs and official veterinary services and their different risk perceptions interfere in completing an effective ban on the illegal import of POAO. PMID:26901158

The Quantity and Quality of Illegally Imported Products of Animal Origin in Personal Consignments into the European Union Seized at Two German Airports between 2010 And 2014.

PubMed

Jansen, Wiebke; Merkle, Majella; Daun, Anna; Flor, Matthias; Grabowski, Nils Th; Klein, Günter

2016-01-01

The import of products of animal origin (POAO) in travellers' personal consignments presents a considerable risk of introducing animal diseases and emerging zoonoses into the European Union. The current regulation (EU) 206/2009 implements strict measures for illegally imported POAO, whereupon non-complying products have to be seized and destroyed regardless. Especially airports serve as global bottlenecks for illegally imported POAO where passenger controls of non-European flights are performed by customs and veterinary services in collaboration. Results of these control measures have to be submitted in the form of annual reports to the European Commission. However, few data on qualities and quantities of seizures have been published so far. In this study, POAO seized at two German airports between 2010 and 2014 were analysed in terms of quantities, qualitative categories and region of origin. In most years considered, more than 20 tonnes POAO were seized at each airport. However, reported amounts of seizures seem to be only the tip of the iceberg as an all-passenger control is not feasible and therefore travellers are only spot-checked. The analysis suggests that the organisational structures of both customs and official veterinary services and their different risk perceptions interfere in completing an effective ban on the illegal import of POAO.

The bioeconomy in Poland within the context of the European Union.

PubMed

Woźniak, Ewa; Twardowski, Tomasz

2018-01-25

This article outlines the potential of the development of bioeconomy in Poland in the context of the European Union (EU). The analyses take into account the concept of bioeconomy, the overview of documents referring to the bioeconomy in the EU, including policy frameworks and agendas. Many countries including Poland emphasise the importance of bioeconomy, but have not yet developed a complex strategy. The state of bioeconomy in Poland is characterised by the sectors of agriculture, forestry and food production, as well as parts of the chemical, biotechnology and energy industries. In 2014 the global production volume in the Polish bioeconomy amounted to PLN 343 billion with the sector employing almost 3 million staff. However, the structure of the bioeconomy is dominated by traditional sectors, such as agriculture and agro-food industries. This article presents the analysis of research and development activity in Poland from 2009 to 2015. It reports the position of Poland on GMOs and their future development potential. It is worth mentioning that many EU states including Poland have declared themselves as being "GMO-free countries". Copyright © 2017 Elsevier B.V. All rights reserved.

The healthcare system and the provision of oral healthcare in European Union member states: Part 5: Romania.

PubMed

Oancea, R; Amariei, C; Eaton, K A; Widström, E

2016-04-01

Romania is one of the newest member states of the European Union (EU). It has 13 dental schools, 14,841 dentists and 2,935 dental technicians providing oral health care for a population, at 31 December 2014, of 21.3 million. The shift from a communist system to a democratic or capitalist society has contributed to an enormous change in the proportion of public and private sector oral health services. The lack of public funds during the post-communist years has contributed to a dependency on private oral healthcare rather than the government financed public provision. Affordability and social awareness have together established a mixed economy for oral health care costs and oral healthcare is growing slowly compared with other developed EU member states. At the same time, there has been overproduction of new dentists (currently 1500 graduate annually). This has led to un and under-employment and emigration of dentists to other EU member states. This paper explains the current oral healthcare system in Romania and changes in recent years.

Mobile surveillance units (MSU) for border protection of the enlarged economic union

NASA Astrophysics Data System (ADS)

Crandon, Christopher

2004-12-01

During the last 12 years the European Union (EU) has financed the new member applicant countries of Central and Eastern Europe in their preparation for joining the EU. Based on this enlargement of the EU, funding for Cross Border Protection has been made available from the overall infrastructure improvement budget. Border protection was required in areas where border conflicts had taken place and to limit Illegal Immigration (II) and smuggling. After 9/11/2001, defence against terrorist activities will no doubt be added to the requirement. This paper describes the approach taken in the design of the latest "containerised" police and para military Mobile Surveillance Units (MSUs). This approach may also be considered for Homeland Security initiatives. These MSU's utilise standard road vehicles, and off-road variants, converted to use high performance military thermal imagers, such as SiGMA. In future the current, in service, MSUs will require increased sensor integration and networking to cover land and coastal borders. The underlying key is affordability for the police and para-military markets whilst retaining the highest performance derived from the latest SFPA military standard thermal imagers.

9 CFR 92.3 - Movement restrictions.

Code of Federal Regulations, 2010 CFR

2010-01-01

... the European Commission (EC) establishes a quarantine for a disease in the European Union in a region... products from the quarantined area in the European Union, such animals and animal products are prohibited...

Innovation in Psychology Teaching in Europe: A Scoping Survey of European Union Universities Use of Technology, Aims and Status of Teaching, Drivers of Change, and a Thematic Review of Recent Publications

ERIC Educational Resources Information Center

Reddy, Peter; Hammond, Jennifer; Lewandowska, Anna; Trapp, Annie; Marques, J. Frederico

2014-01-01

To investigate innovation in psychology teaching in European Union (EU) higher education, Europlat partners were surveyed and 43 replies were received from 30 countries. Estimated use of e-learning and other technologies including e-books and journals, virtual learning environments, lecture recording, plagiarism detection, laboratory simulation…

Competence and Human Resource Development in Multinational Companies in Three European Union Member States: A Comparative Analysis between Austria, the Netherlands and the United Kingdom. CEDEFOP Panorama Series.

ERIC Educational Resources Information Center

Markowitsch, Jorg; Kollinger, Iris; Warmerdam, John; Moerel, Hans; Konrad, John; Burell, Catherine; Guile, David

A comparative analysis of human resources development and management in the subsidiaries of three multinational companies (Xerox, Glaxo Wellcome, and AXA Nordstern Colonia) was conducted in these three European Union (EU) member states: Austria, the United Kingdom, and the Netherlands. Case studies were used, focusing on competence needs and…

"Sport & Exercise Pedagogy". The Case for a New Integrative Sub-Discipline in the Field of Sport & Exercise Sciences/Kinesiology/Human Movement Sciences

ERIC Educational Resources Information Center

Armour, Kathleen M.; Chambers, Fiona C.

2014-01-01

The European Union Sport Unit has identified the societal and educational role of sport as a central topic in its new research agenda. It is argued that European Union (EU) citizens should be supported to learn continuously across the life course. In the sport/physical activity (PA) context, the role of teachers, coaches and exercise instructors…

Labour Market Outcomes of Vocational Education in Europe: Evidence from the European Union Labour Force Survey. Research Paper No 32

ERIC Educational Resources Information Center

Cedefop - European Centre for the Development of Vocational Training, 2013

2013-01-01

This report focuses on the outcomes of vocational education and, in particular, on the transition from education to work in the current employment situation for young adults in the European Union. Using anonymised microdata from the EU labour force survey 2009 ad hoc module, this is one of the first studies to undertake a large cross-country…

Use of Simulation in Nursing Education: Initial Experiences on a European Union Lifelong Learning Programme--Leonardo Da Vinci Project

ERIC Educational Resources Information Center

Terzioglu, Fusun; Tuna, Zahide; Duygulu, Sergul; Boztepe, Handan; Kapucu, Sevgisun; Ozdemir, Leyla; Akdemir, Nuran; Kocoglu, Deniz; Alinier, Guillaume; Festini, Filippo

2013-01-01

Aim: The aim of this paper is to share the initial experiences on a European Union (EU) Lifelong Learning Programme Leonardo Da Vinci Transfer of Innovation Project related to the use of simulation-based learning with nursing students from Turkey. The project started at the end of the 2010 involving 7 partners from 3 different countries including…

Gambling in Finland: problem gambling in the context of a national monopoly in the European Union.

PubMed

Tammi, Tuukka; Castrén, Sari; Lintonen, Tomi

2015-05-01

To describe and analyse the Finnish gambling market, regulatory system and the state of gambling research as well as the treatment system in operation for problem gamblers. A review of the literature and official documents relating to gambling in Finland, focusing primarily on the 1990s and 2000s. Only in recent years have gambling problems become a major issue for public debate in Finland. One reason for the increase in activity to address gambling problems is that, after Finland became a member of the European Union in 1995, the Finnish state gambling monopoly and its compatibility with European Union (EU) regulations have been questioned repeatedly. Since 2000, the Finnish government has put significant new resources into the research as well as the prevention and treatment of gambling problems. The resources grew from almost nothing to several million Euros in less than 10 years. This could be seen as an attempt to protect the national gambling monopoly system by showing that the Finnish monopoly system meets EU requirements. Since joining the European Union in 1995, the Finnish government has been able to maintain its gambling monopoly by providing substantial resources to signal a commitment to minimizing problem gambling. © 2015 Society for the Study of Addiction.

Economic Valuation for Improved Water Quality: Analyzing the Public's Preferences Using Geospatial Analysis

NASA Astrophysics Data System (ADS)

Tsagarakis, Konstantinos P.; Mavragani, Amaryllis; Gemitzi, Alexandra

2017-04-01

As the subject of water quality in the European Union is becoming all the more important, public awareness is of significant importance in exploring ways towards the implementation of better water quality. Over the last decade, significant steps towards this direction have been employed in EU, such as Directive 2008/105/EC and Directive 2013/39/EU and Groundwater Directive and Decision 2015/495. What has been suggested so far is that public participation and information levels are relatively low in some EU countries. This paper focuses on providing a review on economic valuation in EU and in regions with degradated waters by applying geospatial techniques. Overall, it is shown that public awareness and information levels are crucial in better assessing the issues that arise due to water quality, and help better implement EU legislation.

All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance.

PubMed

Gyssens, I C

2008-10-01

Despite many European Union (EU) conferences on fighting microbial resistance, rates of resistance in Europe continue to increase. Although research is catching up with discovery, the development of new antimicrobials is threatened by economic factors, in particular the need for a return of investment via high-volume sales. The EU should invest in independent research into the economic and business aspects of antibiotic development. Multidisciplinary input from the fields of finance, law, marketing, sociology and psychology will inform a broad agenda for change at the regulatory, academic and commercial levels and identify new options for novel anti-infective research and development, as recently recommended by the Science Academies of Europe (EASAC).

[Internship-test reveals increased knowledge gaps].

PubMed

Östgren, Carl-Johan; Krook-Brandt, Margareta; Carlborg, Andreas

2016-04-08

We present the results of the medical knowledge test after fulfilled internship for Swedish medical authorization during the years 2009 to the spring of 2015. A total of 7,613 tests were analyzed. Interns graduated from Swedish universities failed in 2.7% to 3.8% of the test moments. Interns who graduated from countries within the European Union (EU) failed in 21.2% and interns graduated from a non-EU country failed in 41.6%. The results from those who graduated from EU and non-EU countries have worsened compared to an earlier study in 2009. Proper measures have now to be implemented for doctors graduated from a non-Swedish university to improve the outcome and introduction to the Swedish health care system.

Rights of dental patients in the EU - a legal assessment.

PubMed

Van den Bossche, Anne-Marie; Ploscar, Paula

2012-11-30

This contribution presents the legal framework for intra-European mobility of dental patients. After presenting the EU competences in respect of healthcare and a brief look into the various routes of patient mobility, the article sets out the rules for access to dental care, treatment abroad and reimbursement through social security. In addition, we focus on the impact of European Union (EU) law upon national systems in respect of professional insurance, complaints procedures and information mechanisms. In conclusion, we reflect on the development in EU law of an independent set of rights to cross-border dental care and its consequences for financing and reimbursement of care, as well as for national practices in respect of professional liability and insurance.

EU ambition to build the world's leading bioeconomy-Uncertain times demand innovative and sustainable solutions.

PubMed

Bell, John; Paula, Lino; Dodd, Thomas; Németh, Szilvia; Nanou, Christina; Mega, Voula; Campos, Paula

2018-01-25

This article outlines the current context and the development of the European Bioeconomy Strategy. It analyses the current situation, challenges and needs for EU action and concludes with the next steps that the European Commission will undertake to review and update the Bioeconomy Strategy. Bioeconomy offers great opportunities to realising a competitive, circular and sustainable economy with a sound industrial base that is less dependent on fossil carbon. A sustainable bioeconomy also contributes to climate change mitigation, with oceans, forests and soils being major carbon sinks and fostering negative CO 2 emissions. The EU has invested significantly in research and innovation in this field and the European Commission is committed to lead on European bioeconomy strategy. Copyright © 2017 Elsevier B.V. All rights reserved.

Scientific critique of the paper “Climatic distribution of citrus black spot caused by Phyllosticta citricarpa. A historical analysis of disease spread in South Africa” by Martínez-Minaya et al. (2015)

USDA-ARS?s Scientific Manuscript database

The global potential distribution of Phyllosticta citricarpa, the causal organism of citrus black spot (CBS), is at the heart of an ongoing debate on the level of potential pest risk posed by P. citricarpa to citrus producing orchards within the European Union (EU). The EU currently regulates the i...

Comparison of neck skin excision and whole carcass rinse sampling methods for determining Salmonella prevalence and E. coli counts on broiler carcasses before and after immersion chilling

USDA-ARS?s Scientific Manuscript database

A regulatory agency (FSIS) in the U.S. rinses whole broiler carcasses with 400 ml of 1% buffered peptone water (BPW) for Salmonella detection, while the European Union (EU) samples a 25g composited neck skin from three carcasses. The purpose of the study was to evaluate the FSIS and EU procedures fo...

European Union centralised procedure for marketing authorisation of oncology drugs: an in-depth review of its efficiency.

PubMed

Netzer, Tilo

2006-03-01

In the European Union (EU) 20 anticancer agents have been successfully authorised via the Centralised Procedure since its implementation in 1995. Public information on these 20 agents has been reviewed in order to evaluate the effectiveness of the available regulatory mechanisms to facilitate the marketing authorisation of such drugs in the EU. These mechanisms include orphan drug legislation, exceptional circumstances provision and the accelerated evaluation procedure. Based on the fact that the EU orphan drug legislation was not implemented before the year 2000 no conclusions on its effectiveness to facilitate oncology drug development can be drawn today. Much more data are available on the effects of the exceptional circumstances provision, which was used in 6 out of 10 cases over the past four years. An analysis of the clinical data packages indicates that this provision allows authorisation of innovative oncology drugs based on smaller clinical data sets than required for full approval. The accelerated evaluation procedure was used in only one case and significantly reduced the scientific review time at the EU agencies. However, this mechanism does not influence the administrative time at the authorities, which accounted for almost one-third of the overall duration of the EU marketing authorisation procedures for oncology drugs. Revision of the EU drug legislation brings about some changes to the above-described provisions, with the potential for an improvement in the current situation. Thus, its implementation offers the chance to reduce the time that innovative oncology agents take to reach the market, although -- based on experience with the current procedures -- more effort is likely to be required to achieve this goal.

Researchers dodge UK migration cap

NASA Astrophysics Data System (ADS)

Dacey, James

2011-03-01

Research scientists are among those to be prioritized under the UK government's new immigration rules that will impose an annual cap on the number of work visas issued to those from outside the European Union (EU).

Acceptability of domestic violence against women in the European Union: a multilevel analysis.

PubMed

Gracia, Enrique; Herrero, Juan

2006-02-01

The acceptability of domestic violence against women (DVAW) plays an important part in shaping the social environment in which the victims are embedded, which in turn may contribute either to perpetuate or to reduce the levels of DVAW in our societies. This study analyses correlates of the acceptability of DVAW in the European Union (EU). Three level ordinal logistic regression of 13 457 people nested within 212 localities (cities), nested within 15 countries of the EU. Sampling is multistage with random probability. All interviews were face to face in people's homes. The outcome variable was acceptability of DVAW. Multiple correlates at the individual, locality, and country level were analysed. European Union, 1999. National data were used of residents 15 years old and above of all member states in 1999 (n = 13 457). Average response rate was 47%, although it varied across countries (23%-73%). Higher levels of acceptability were reported by those who perceived DVAW as less severe and less frequent. Acceptability is higher among men who know a perpetrator and lower among men who know a victim. Victim blaming attitude is associated with higher levels of acceptability. In countries with higher gender empowerment measure the difference in acceptability among those who blame and those who do not blame the victim is greater. There are still widespread attitudes in the EU such as victim blaming that condone DVAW, contributing to a climate of social acceptability of DVAW. Further efforts to reduce the acceptability of DVAW are still needed.

Defining a common set of indicators to monitor road accidents in the European Union.

PubMed

Farchi, Sara; Molino, Nunzio; Giorgi Rossi, Paolo; Borgia, Piero; Krzyzanowski, Michael; Dalbokova, Dafina; Kim, Rokho

2006-07-11

currently road accidents are mostly monitored through mortality and injury rates. This paper reports the methodology and the results of a project set forth by the European Union (EU) and coordinated by the WHO aimed at identifying and evaluating a core set of indicators to monitor the causal chain of road accident health effects. The project is part of the ECOEHIS (Development of Environment and Health Indicators for European Union Countries). a group of experts (WG), identified 14 indicators after a review of the information collected at the EU level, each of them representing a specific aspect of the DPSEEA (Driving, Pressure, State, Exposure, Effect, Action) model applied and adapted to the road accidents. Each indicator was scored according to a list of 16 criteria chosen by the WG. Those found to have a high score were analysed to determine if they were compatible with EU legislation and then tested in the feasibility study. 11 of the 14 indicators found to be relevant and compatible with the criteria of selection were proposed for the feasibility study. Mortality, injury, road accident rate, age of vehicle fleet, and distance travelled are the indicators recommended for immediate implementation. after overcoming the limitations that emerged (absence of a common definition of death by road accident and injury severity, underestimation of injuries, differences in information quality) this core set of indicators will allow Member States to carry out effective internal/external comparisons over time.

Defining a common set of indicators to monitor road accidents in the European Union

PubMed Central

Farchi, Sara; Molino, Nunzio; Giorgi Rossi, Paolo; Borgia, Piero; Krzyzanowski, Michael; Dalbokova, Dafina; Kim, Rokho

2006-01-01

Background currently road accidents are mostly monitored through mortality and injury rates. This paper reports the methodology and the results of a project set forth by the European Union (EU) and coordinated by the WHO aimed at identifying and evaluating a core set of indicators to monitor the causal chain of road accident health effects. The project is part of the ECOEHIS (Development of Environment and Health Indicators for European Union Countries). Methods a group of experts (WG), identified 14 indicators after a review of the information collected at the EU level, each of them representing a specific aspect of the DPSEEA (Driving, Pressure, State, Exposure, Effect, Action) model applied and adapted to the road accidents. Each indicator was scored according to a list of 16 criteria chosen by the WG. Those found to have a high score were analysed to determine if they were compatible with EU legislation and then tested in the feasibility study. Results 11 of the 14 indicators found to be relevant and compatible with the criteria of selection were proposed for the feasibility study. Mortality, injury, road accident rate, age of vehicle fleet, and distance travelled are the indicators recommended for immediate implementation. Conclusion after overcoming the limitations that emerged (absence of a common definition of death by road accident and injury severity, underestimation of injuries, differences in information quality) this core set of indicators will allow Member States to carry out effective internal/external comparisons over time. PMID:16834780

The Ideas of the Students of Education Faculty about the European Union Education and Youth Programs

ERIC Educational Resources Information Center

Ergün, Muammer; Kamer, S. Tunay

2009-01-01

The most important issue that Turkey has been dealing with since the beginning of 2000s is the entrance to the European Union and the preparatory activities for this period. No what how it is evaluated, as an opportunity or a threat to which will break us off our cultural values, EU is a reality that our country faces. The programs such as FORCE,…

78 FR 14840 - U.S.-EU High Level Regulatory Cooperation Forum-Stakeholder Session

Federal Register 2010, 2011, 2012, 2013, 2014

2013-03-07

... OFFICE OF MANAGEMENT AND BUDGET U.S.-EU High Level Regulatory Cooperation Forum--Stakeholder Session AGENCY: Office of Management and Budget. ACTION: Notice of Public Meeting. SUMMARY: On September... and Budget (OMB), together with the European Commission's Enterprise and Trade Directorates-General...

European perspectives of food safety.

PubMed

Bánáti, Diána

2014-08-01

Food safety has been a growing concern among European Union (EU) citizens over the last decades. Despite the fact that food has never been safer, consumers are considerably uncertain and increasingly critical about the safety of their food. The introduction of new principles, such as the primary responsibility of producers, traceability, risk analysis, the separation of risk assessment and risk management provided a more transparent, science-based system in Europe, which can help to restore consumers' lost confidence. The present EU integrated approach to food safety 'from farm to fork' aims to assure a high level of food safety within the EU. © 2014 Society of Chemical Industry.

The challenge of the standardization of nursing specializations in Europe.

PubMed

Ranchal, A; Jolley, M J; Keogh, J; Lepiesová, M; Rasku, T; Zeller, S

2015-12-01

The evolution of health care is driving the need for specialist nursing knowledge. Specialist nurses have undertaken a formal training that focuses on a specific clinical area or population and are legitimated by a professional award or legal status. Specialist nurses are better able to provide the most specific and most appropriate care for both people and populations. This paper considers nursing's loose understanding of 'specialization' and the impact this has on those who seek employment outside their own nation but within the family of nations known as the European Union (EU). There is a lack of standardization for nursing specializations across the European Union that leads to lack of mobility across countries. Reports were reviewed from within the European Union, including specialist nursing groups and regulatory nursing bodies. Nurse specialists can be regarded as operating at nursing's 'leading edge'; however, it is here that nursing lacks organization and common standards. This is readily apparent in a EU bound together by the principle of freedom of movement and common professional and academic standards. It is now time for European Union nurses to look beyond the common standards for pre-registration courses and to consider the development of common standards for specialist nursing. Historical attempts to achieve common standards for specialist nursing have largely been unsuccessful due to the diversity of approaches to nurse specialization. It is time now for this challenge to be re-addressed so that specialist nurses can more freely work throughout the European Union. There is a pressing need for policy makers to define specialist nursing and to enable European Union-wide standards. © 2015 International Council of Nurses.

75 FR 69080 - Federal Travel Regulation (FTR)

Federal Register 2010, 2011, 2012, 2013, 2014

2010-11-10

... GENERAL SERVICES ADMINISTRATION Federal Travel Regulation (FTR) Fly America Act; United States and European Union ``Open Skies'' Air Transport Agreement (US-EU Open Skies Agreement) AGENCY: Office of Governmentwide Policy, General Services Administration (GSA). [[Page 69081

Freight transportation : the European market

DOT National Transportation Integrated Search

2002-06-01

The purpose of the international scan was to investigate the issues, constraints, opportunities, and challenges : faced by the European Union (EU) in developing a policy of open boundaries and what strategies it uses to : implement the policy. : The ...

Members of the European Parliament (MEP) Heart Group.

PubMed

Tofield, Andros

2013-06-01

The MEP Heart Group is a discussion forum aimed at promoting measures to reduce the burden of cardiovascular disease in the European Union and raise cardiovascular disease as a priority on the EU political agenda.

Effect of policies on pellet production and forests in the U.S. South: a technical document supporting the Forest Service update of the 2010 RPA Assessment

Treesearch

Karen L. Abt; Robert C. Abt; Christopher S. Galik; Kenneth E. Skog

2014-01-01

Current policies in the European Union (EU) requiring renewable and low greenhouse gas-emitting energy are affecting wood products manufacturing and forests in the United States. These policies have led to increased U.S. pellet production and export to the EU, which has in turn affected U.S. forests and other wood products manufacturing. At this time, the primary...

Recent advances to address European Union Health Security from cross border chemical health threats.

PubMed

Duarte-Davidson, R; Orford, R; Wyke, S; Griffiths, M; Amlôt, R; Chilcott, R

2014-11-01

The European Union (EU) Decision (1082/2013/EU) on serious cross border threats to health was adopted by the European Parliament in November 2013, in recognition of the need to strengthen the capacity of Member States to coordinate the public health response to cross border threats, whether from biological, chemical, environmental events or events which have an unknown origin. Although mechanisms have been in place for years for reporting cross border health threats from communicable diseases, this has not been the case for incidents involving chemicals and/or environmental events. A variety of collaborative EU projects have been funded over the past 10 years through the Health Programme to address gaps in knowledge on health security and to improve resilience and response to major incidents involving chemicals. This paper looks at the EU Health Programme that underpins recent research activities to address gaps in resilience, planning, responding to and recovering from a cross border chemical incident. It also looks at how the outputs from the research programme will contribute to improving public health management of transnational incidents that have the potential to overwhelm national capabilities, putting this into context with the new requirements as the Decision on serious cross border threats to health as well as highlighting areas for future development. Crown Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Carbon, land, and water footprint accounts for the European Union: consumption, production, and displacements through international trade.

PubMed

Steen-Olsen, Kjartan; Weinzettel, Jan; Cranston, Gemma; Ercin, A Ertug; Hertwich, Edgar G

2012-10-16

A nation's consumption of goods and services causes various environmental pressures all over the world due to international trade. We use a multiregional input-output model to assess three kinds of environmental footprints for the member states of the European Union. Footprints are indicators that take the consumer responsibility approach to account for the total direct and indirect effects of a product or consumption activity. We quantify the total environmental pressures (greenhouse gas emissions: carbon footprint; appropriation of biologically productive land and water area: land footprint; and freshwater consumption: water footprint) caused by consumption in the EU. We find that the consumption activities by an average EU citizen in 2004 led to 13.3 tCO(2)e of induced greenhouse gas emissions, appropriation of 2.53 gha (hectares of land with global-average biological productivity), and consumption of 179 m(3) of blue water (ground and surface water). By comparison, the global averages were 5.7 tCO(2)e, 1.23 gha, and 163 m(3) blue water, respectively. Overall, the EU displaced all three types of environmental pressures to the rest of the world, through imports of products with embodied pressures. Looking at intra-EU displacements only, the UK was the most important displacer overall, while the largest net exporters of embodied environmental pressures were Poland (greenhouse gases), France (land), and Spain (freshwater).

Biodiversity funds and conservation needs in the EU under climate change.

PubMed

Lung, Tobias; Meller, Laura; van Teeffelen, Astrid J A; Thuiller, Wilfried; Cabeza, Mar

2014-07-01

Despite ambitious biodiversity policy goals, less than a fifth of the European Union's (EU) legally protected species and habitats show a favorable conservation status. The recent EU biodiversity strategy recognizes that climate change adds to the challenge of halting biodiversity loss, and that an optimal distribution of financial resources is needed. Here, we analyze recent EU biodiversity funding from a climate change perspective. We compare the allocation of funds to the distribution of both current conservation priorities (within and beyond Natura 2000) and future conservation needs at the level of NUTS-2 regions, using modelled bird distributions as indicators of conservation value. We find that funding is reasonably well aligned with current conservation efforts but poorly fit with future needs under climate change, indicating obstacles for implementing adaptation measures. We suggest revising EU biodiversity funding instruments for the 2014-2020 budget period to better account for potential climate change impacts on biodiversity.

Complementing, competing, or co-operating? Exploring newspapers' portrayals of the European Parliament and national parliaments in EU affairs.

PubMed

Eisele, Olga

2017-06-07

The paper explores newspapers' portrayals of the European Parliament and national parliaments (NPs) in European Union (EU) affairs. To understand underlying perceptions of journalists, it takes public parliamentary activities and looks at their influence on parliaments' news visibility in Finland, Germany and the UK in routine periods in 2011 and 2012. This is done against the background that parliaments, regarded as ultimate legitimisers of state power, depend on the mass media to reach their citizenry. However, journalists follow their own agenda in publishing parliamentary news. In this regard, they may highlight the complementarity, competition or cooperation of parliaments in the EU's unique multi-tier environment. Overall, our results suggest that NPs correspond stronger with newsmakers' anticipation of readership interest. In addition, findings seem to support the assumption that parliaments in the EU are mostly perceived as complementary, separate legislative branches in EU decision-making.

Car telephone use and road safety : an overview prepared for the European Commission

DOT National Transportation Integrated Search

2009-06-01

This is a fairly unbiased review of the issue of driver distraction framed for used in the EU. From the perspective of providing new data this paper is lacking, however this does framing for the EU and the more international perspective is interestin...

Potential for Introduction of Bat-Borne Zoonotic Viruses into the EU: A Review

PubMed Central

Simons, Robin R. L.; Gale, Paul; Horigan, Verity; Snary, Emma L.; Breed, Andrew C.

2014-01-01

Bat-borne viruses can pose a serious threat to human health, with examples including Nipah virus (NiV) in Bangladesh and Malaysia, and Marburg virus (MARV) in Africa. To date, significant human outbreaks of such viruses have not been reported in the European Union (EU). However, EU countries have strong historical links with many of the countries where NiV and MARV are present and a corresponding high volume of commercial trade and human travel, which poses a potential risk of introduction of these viruses into the EU. In assessing the risks of introduction of these bat-borne zoonotic viruses to the EU, it is important to consider the location and range of bat species known to be susceptible to infection, together with the virus prevalence, seasonality of viral pulses, duration of infection and titre of virus in different bat tissues. In this paper, we review the current scientific knowledge of all these factors, in relation to the introduction of NiV and MARV into the EU. PMID:24841385

A project to establish a skills competency matrix for EU nurses.

PubMed

Cowan, David T; Norman, Ian J; Coopamah, Vinoda P

Enhanced nurse workforce mobility in the European Union (EU) is seen as a remedy to shortages of nurses in some EU countries and a surplus in others. However, knowledge of differences in competence, culture, skill levels and working practices of nursing staff throughout EU countries is not fully documented because currently no tangible method exists to enable comparison. The European Healthcare Training and Accreditation Network (EHTAN) project intends to address this problem by establishing an assessment and evaluation methodology through the compilation of a skills competency matrix. To this end, subsequent to a review of documentation and literature on nursing competence definition and assessment, two versions of a nursing competence self-assessment questionnaire tool have been developed. The final competence matrix will be translated and disseminated for transnational use and it is hoped that this will inform EU and national policies on the training requirements of nurses and nursing mobility and facilitate the promotion of EU-wide recognition of nursing qualifications.

Migration from new-accession countries and duration expectancy in the EU-15: 2002–2008

PubMed Central

DeWaard, Jack; Ha, Jasmine Trang; Raymer, James; Wiśniowski, Arkadiusz

2016-01-01

European Union (EU) enlargements in 2004 and 2007 were accompanied by increased migration from new-accession to established-member (EU-15) countries. The impacts of these flows depend, in part, on the amount of time that persons from the former countries live in the latter over the life course. In this paper, we develop period estimates of duration expectancy in EU-15 countries among persons from new-accession countries. Using a newly developed set of harmonised Bayesian estimates of migration flows each year from 2002 to 2008 from the Integrated Modelling of European Migration (IMEM) Project, we exploit period age patterns of country-to-country migration and mortality to summarize the average number of years that persons from new-accession countries could be expected to live in EU-15 countries over the life course. In general, the results show that the amount of time that persons from new-accession countries could be expected to live in the EU-15 nearly doubled after 2004. PMID:28286353

Sustainable Water Management & Satellite Remote Sensing

EPA Science Inventory

Eutrophication assessment frameworks such as the Australian National Water Quality Management Strategy, Oslo Paris (OSPAR) Commission Common Procedure, Water Framework Directive (WFD) of the European Union, Marine Strategy Framework Directive (MSFD) from the European Commission, ...

A Report on IAU Commission 46: The Teaching of Astronomy

ERIC Educational Resources Information Center

Beetle, Dorothy E.

1974-01-01

Describes the purpose, inception, and services of the International Astronomical Union's Commission 46, which is composed of members from many nations who are interested in the teaching of astronomy. (MLH)

C46 `ASTRONOMY Education and Development': a Peculiar Commission

NASA Astrophysics Data System (ADS)

de Greve, Jean-Pierre; García, Beatriz; Gerbaldi, Michèle; Ferlet, Roger; Guinan, Edward; Hearnshaw, John; Jones, Barrie; Marschall, Laurence; Miley, George; Pasachoff, Jay; Ros, Rosa; Stavinschi, Magda; Torres-Peimbert, Silvia

2016-04-01

C46 was a Commission of the Executive Committee of the IAU under Division XII (Union-Wide Activities), then after 2012 under Division C (Education, Outreach, and Heritage). It was the only commission dealing exclusively with astronomy education; a previous Commission 38 (Exchange of Astronomers), which allocated travel grants to astronomers who needed them, and a Working Group on the Worldwide Development of Astronomy, have been absorbed by Commission 46.

Basic and clinical proteomics from the EU Health Research perspective.

PubMed

Dyląg, Tomasz; Jehenson, Philippe; van de Loo, Jan-Willem; Sanne, Jean-Luc

2010-12-01

The European Union (EU) is one of the main public funders of research in Europe and its major instrument for funding is the Seventh Framework Programme for research and technological development (FP7). The bulk of funding in FP7 goes to collaborative research, with the objective of establishing excellent research projects and networks. Understanding the functions of proteins is essential for the rational development of disease prevention, diagnosis and treatment, therefore the EU has largely invested in proteomics, in particular for technology development, data standardisation and sharing efforts, and the application of proteomics in the clinic. The scientific community, including both academia and industry, is encouraged to apply for FP7 funding so that the EU can even more efficiently support innovative health research and ultimately, bring better healthcare to patients.

Supporting health systems in Europe: added value of EU actions?

PubMed

Clemens, Timo; Michelsen, Kai; Brand, Helmut

2014-01-01

Since the start of the economic crisis, the European Union's (EU's) predominant discourse has been austerity and fiscal consolidation. The detrimental effects on Europe's health systems and the health status of its citizens are well described. However, little is known about the emerging EU-level initiatives to support national health systems handle the challenges of efficient care provision and system reorganisation aimed to meet their future needs. This review analyses the manner, conditions and prospects of such EU support. First, health system objectives are increasingly entering the EU health policy agenda. Second, professional and patient mobility provisions may support member states (MS) in copying with crisis related health challenges but can potentially acerbate them at the same time. Third, in recent initiatives health system goals are more closely tied to the EU's economic growth narrative. And fourth, health system issues are taken up in existing EU-level structures for debate and exchange between MS. In addition, the design of some policies may have the potential to intensify socioeconomic and health inequalities rather than ameliorate them.

[Drugs in the European Union: the health-market complex].

PubMed

Antoñanzas, Fernando; Rodríguez, Roberto; Sacristán, José Antonio; Illa, Rafael

2005-01-01

To characterize the peculiar economic nature of the pharmaceutical market in the EU, to study potential groupings of countries based on several pharmaceutical variables, to analyze some recent regulations designed to create the single market, and to present some thoughts on the decision making process in public health from the perspective of current public health budgets. We performed an economic analysis of health and pharmaceutical macrovariables, cluster analysis, review of EU pharmaceutical and industrial regulations and review of pharmaceutical budgeting legislation in the member states. The pharmaceutical market of the EU was characterized and EU countries were classified into two principal groups according to 5 selected variables. EU regulations tend to promote R + D and drug production and thus the EU industrial sector is backed up. National regulations differ in terms of pricing and drugs reimbursement. The creation of a single market for drugs in the EU should take this regulatory diversity into account and seek equilibrium between economic factors and public health. This single market may be a dangerous strategy if it becomes a general dogma and even more so if deadlines are fixed and short.

The crisis as catalyst for reframing health care policies in the European Union.

PubMed

Helderman, Jan-Kees

2015-01-01

Seen from the perspective of health, the global financial crisis (GFC) may be conceived of as an exogenous factor that has undermined the fiscal sustainability of European welfare states and consequently, their (expanding) health systems as well. Being one of the core programs of European welfare states, health care has always belonged to the sovereignty of European Member States. However, in past two decades, European welfare states have in fact become semi-sovereign states and the European Union (EU) no longer is an exogenous actor in European health policy making. Today, the EU not only puts limits to unsustainable growth levels in health care spending, it also acts as an health policy agenda setter. Since the outbreak of the GFC, it does so in an increasingly coercive and persuasive way, claiming authority over health system reforms alongside the responsibilities of its Member States.

From heterogeneity to harmonization? Recent trends in European health policy.

PubMed

Gerlinger, Thomas; Urban, Hans-Jürgen

2007-01-01

In the European Union (EU), health policy and the institutional reform of health systems have been treated primarily as national affairs, and health care systems within the EU thus differ considerably. However, the health policy field is undergoing a dynamic process of Europeanization. This process is stimulated by the orientation towards a more competitive economy, recently inaugurated and known as the Lisbon Strategy, while the regulatory requirements of the European Economic and Monetary Union are stimulating the Europeanization of health policy. In addition, the so-called open method of coordination, representing a new mode of regulation within the European multi-level system, is applied increasingly to the health policy area. Diverse trends are thus emerging. While the Lisbon Strategy goes along with a strategic upgrading of health policy more generally, health policy is increasingly used to strengthen economic competitiveness. Pressure on Member States is expected to increase to contain costs and promote market-based health care provision.

From the Digital Divide to Digital Inequality: A Secondary Research in the European Union

NASA Astrophysics Data System (ADS)

Stiakakis, Emmanouil; Kariotellis, Pavlos; Vlachopoulou, Maria

The digital divide is nowadays evolving to digital inequality, i.e., the socio-economic disparities inside the 'online population'. This paper examines two main dimensions of the digital inequality, namely 'skills' and 'autonomy' of Internet users. The level of formal education was selected as a representative variable of the skill dimension, as well as the density of population in different geographical areas as a representative variable of the autonomy dimension. The research was focused on the member states of the European Union (EU). The data, provided by Eurostat, included the daily use of computers for the last three months and the average use of the Internet at least once per week. The findings state that the EU already faces the problem of digital inequality to an extended rate, since there are significant disparities among the European countries with regard to the aforementioned variables.

An Evaluation of the Policy Context on Psychosocial Risks and Mental Health in the Workplace in the European Union: Achievements, Challenges, and the Future.

PubMed

Leka, Stavroula; Jain, Aditya; Iavicoli, Sergio; Di Tecco, Cristina

2015-01-01

Despite the developments both in hard and soft law policies in the European Union in relation to mental health and psychosocial risks in the workplace, a review of these policies at EU level has not been conducted to identify strengths, weaknesses, and gaps to be addressed in the future. Keeping in mind that the aim should be to engage employers in good practice, ideally such policies should include key definitions and elements of the psychosocial risk management process, covering risk factors, mental health outcomes, risk assessment and preventive actions, or interventions. The current paper aims to fill this gap by reviewing hard and soft law policies on mental health in the workplace and psychosocial risks applicable at EU level and conducting a gap analysis according to a set of dimensions identified in models of good practice in this area. Our review of ninety-four policies in total revealed several gaps, especially in relation to binding in comparison to nonbinding policies. These are discussed in light of the context of policy-making in the EU, and recommendations are offered for future actions in this area.

Food-borne zoonoses, the EU zoonosis legislation and the prospects for food safety and consumer protection during primary animal production.

PubMed

Smulders, Frans J M; Vågsholm, Ivar; Korkeala, Hannu

2008-01-01

Zoonoses are diseases that are transmitted naturally between animals and humans. The control of food-borne zoonoses within the European Union is a prerequisite for assuring a functional internal market and consequently represents an important item on the political agenda. Unfortunately, until recently, gaining a clear view of the current incidence of food-borne zoonoses and the prevalence of its causative agents has been frustrated by the absence of reliable monitoring and reporting systems. Similarly, it has become clear that, Europe wide, one has witnessed only limited success with regard to the control of important food-borne agents such as Salmonella spp. The European Union has adopted legislation to remedy this situation and to control food-borne zoonoses in primary production. This contribution discusses the incentives for introducing EU Directive 2003/99/EC and EU Regulation No. 2160/2003, summarises their essentials and discusses major ramifications of both pieces of legislation for the prevention of food-borne zoonoses. It is concluded that there is reason for cautious optimism concerning human salmonellosis, while for other food-borne zoonoses there should be a call for action.

An Evaluation of the Policy Context on Psychosocial Risks and Mental Health in the Workplace in the European Union: Achievements, Challenges, and the Future

PubMed Central

Leka, Stavroula; Jain, Aditya; Di Tecco, Cristina

2015-01-01

Despite the developments both in hard and soft law policies in the European Union in relation to mental health and psychosocial risks in the workplace, a review of these policies at EU level has not been conducted to identify strengths, weaknesses, and gaps to be addressed in the future. Keeping in mind that the aim should be to engage employers in good practice, ideally such policies should include key definitions and elements of the psychosocial risk management process, covering risk factors, mental health outcomes, risk assessment and preventive actions, or interventions. The current paper aims to fill this gap by reviewing hard and soft law policies on mental health in the workplace and psychosocial risks applicable at EU level and conducting a gap analysis according to a set of dimensions identified in models of good practice in this area. Our review of ninety-four policies in total revealed several gaps, especially in relation to binding in comparison to nonbinding policies. These are discussed in light of the context of policy-making in the EU, and recommendations are offered for future actions in this area. PMID:26557655

Publication ethics in biomedical journals from countries in Central and Eastern Europe.

PubMed

Broga, Mindaugas; Mijaljica, Goran; Waligora, Marcin; Keis, Aime; Marusic, Ana

2014-03-01

Publication ethics is an important aspect of both the research and publication enterprises. It is particularly important in the field of biomedical science because published data may directly affect human health. In this article, we examine publication ethics policies in biomedical journals published in Central and Eastern Europe. We were interested in possible differences between East European countries that are members of the European Union (Eastern EU) and South-East European countries (South-East Europe) that are not members of the European Union. The most common ethical issues addressed by all journals in the region were redundant publication, peer review process, and copyright or licensing details. Image manipulation, editors' conflicts of interest and registration of clinical trials were the least common ethical policies. Three aspects were significantly more common in journals published outside the EU: statements on the endorsement of international editorial standards, contributorship policy, and image manipulation. On the other hand, copyright or licensing information were more prevalent in journals published in the Eastern EU. The existence of significant differences among biomedical journals' ethical policies calls for further research and active measures to harmonize policies across journals.

The state of Health in All policies (HiAP) in the European Union: potential and pitfalls.

PubMed

Koivusalo, Meri

2010-06-01

Health in All Policies (HiAP) was formally legitimated as a European Union (EU) approach in 2006. It resulted from more long-term efforts to enhance action on considering health and health policy implications of other policies, as well as recognition that European-level policies affect health systems and scope for health-related regulation at national level. However, implementation of HiAP has remained a challenge. European-level efforts to use health impact assessment to benefit public health and health systems have not become strengthened by the new procedures. And, as a result of the Lisbon Treaty, European-level policy-making is expected to become more important in shaping national policies. HiAP has at European level remained mostly as rhetoric, but legitimate health arguments and provides policy space for health articulation within EU policy-making. HiAP is a broader approach than health impact assessment and at European level requires consideration of mechanisms that recognise the nature of European policy-making, as well as extending from administrative tools to increased transparency, accountability and scope for health and health policy-related arguments within political decision-making in the EU.

Salmonellosis associated with mass catering: a survey of European Union cases over a 15-year period.

PubMed

Osimani, A; Aquilanti, L; Clementi, F

2016-10-01

Salmonella spp. is the causative agent of a foodborne disease called salmonellosis, which is the second most commonly reported gastrointestinal infection in the European Union (EU). Although over the years the annual number of cases of foodborne salmonellosis within the EU has decreased markedly, in 2014, a total of 88 715 confirmed cases were still reported by 28 EU Member States. The European Food Safety Authority reported that, after the household environment, the most frequent settings for the transmission of infection were catering services. As evidenced by the reviewed literature, which was published over the last 15 years (2000-2014), the most frequently reported causative agents were Salmonella Enteritidis and Salmonella Typhimurium serovars. These studies on outbreaks indicated the involvement of various facilities, including hospital restaurants, takeaways, ethnic restaurants, hotels, in-flight catering, one fast-food outlet and the restaurant of an amusement park. The most commonly reported sources of infection were eggs and/or egg-containing foods, followed by meat- and vegetable-based preparations. Epidemiological and microbiological studies allowed common risk factors to be identified, including the occurrence of cross-contamination between heat-treated foods and raw materials or improperly cleaned food-contact surfaces.

Where are we coming from versus who we will become: the effect of priming different contents of European identity on cooperation.

PubMed

La Barbera, Francesco; Ferrara, Pia Cariota; Boza, Mihaela

2014-12-01

In two experiments, we investigated how priming European identity as common project versus common heritage affects participants' cooperation in a social dilemma; an additional aim was to explore the mediators involved in the process. In the first experiment, 82 students played a public good dilemma with a European bogus partner and then completed self-report measures of identification with the European Union (EU), group-based trust and collective interest. Results showed that priming a common project-based but not a common heritage-based European social identity fostered cooperative behaviour; this effect was mediated by two sequential mediators: the common project prime increased participants' strength of identification with EU (mediator 1) which, in turn, positively affected group-based trust (mediator 2), fostering greater cooperation. Experiment 2 was conducted with a similar procedure on a sample of 124 students, using a different measure of trust and changing the order of mediators. Results supported those of previous experiment: Priming a project-based EU identity content (compared to heritage-based one) had significant direct and indirect effects on cooperation. © 2014 International Union of Psychological Science.

Pesticide exposure assessment for surface waters in the EU. Part 1: Some comments on the current procedure.

PubMed

Bach, Martin; Diesner, Mirjam; Großmann, Dietlinde; Guerniche, Djamal; Hommen, Udo; Klein, Michael; Kubiak, Roland; Müller, Alexandra; Priegnitz, Jan; Reichenberger, Stefan; Thomas, Kai; Trapp, Matthias

2016-07-01

In 2001, the European Commission introduced a risk assessment project known as FOCUS (FOrum for the Coordination of pesticide fate models and their USe) for the surface water risk assessment of active substances in the European Union. Even for the national authorisation of plant protection products (PPPs), the vast majority of EU member states still refer to the four runoff and six drainage scenarios selected by the FOCUS Surface Water Workgroup. However, our study, as well as the European Food Safety Authority (EFSA), has stated the need for various improvements. Current developments in pesticide exposure assessment mainly relate to two processes. Firstly, predicted environmental concentrations (PECs) of pesticides are calculated by introducing model input variables such as weather conditions, soil properties and substance fate parameters that have a probabilistic nature. Secondly, spatially distributed PECs for soil-climate scenarios are derived on the basis of an analysis of geodata. Such approaches facilitate the calculation of a spatiotemporal cumulative distribution function (CDF) of PECs for a given area of interest and are subsequently used to determine an exposure concentration endpoint as a given percentile of the CDF. For national PPP authorisation, we propose that, in the future, exposure endpoints should be determined from the overall known statistical PEC population for an area of interest, and derived for soil and climate conditions specific to the particular member state. © 2016 Society of Chemical Industry. © 2016 Society of Chemical Industry.

A quantitative comparison of the safety margins in the european indicative occupational exposure limits and the derived no-effect levels for workers under REACH.

PubMed

Schenk, Linda; Johanson, Gunnar

2011-06-01

The new European Union (EU) REACH legislation requires derived no-effect levels (DNELs) to be calculated for substances produced in quantities above 10 tonnes/year. Meanwhile, the setting of occupational exposure limits (OELs) continues both at the member state and the EU levels. According to REACH, indicative OEL values (IOELVs) from the Commission may under some circumstances be used as worker-DNELs. On the other hand, worker-DNELs will be derived for several thousand substances, far more than the approximately 100 substances for which IOELVs have been established. Thus, the procedure to set health-based OELs may become influential on that of DNELs and vice versa. In this study, we compare the safety margins of 88 Scientific Committee on OELs (SCOEL) recommendations with those of the corresponding worker-DNELs, derived according to the default approach as described in the REACH guidance document. Overall, the REACH safety margins were approximately six times higher than those derived from the SCOEL documentation but varied widely with REACH/SCOEL safety margin ratios ranging by two orders of magnitude, from 0.3 to 58 (n = 88). The discrepancies may create confusion in terms of legal compliance, risk management, and risk communication. We also found that the REACH guidance document, although encompassing detailed advice on many issues, including default assessment factors for species and route extrapolation, gives little quantitative guidance on when and how to depart from defaults.

FennoFlakes: a project for identifying flake graphite ores in the Fennoscandian shield and utilizing graphite in different applications

NASA Astrophysics Data System (ADS)

Palosaari, Jenny; Eklund, O.; Raunio, S.; Lindfors, T.; Latonen, R.-M.; Peltonen, J.; Smått, J.-H.; Kauppila, J.; Lund, S.; Sjöberg-Eerola, P.; Blomqvist, R.; Marmo, J.

2016-04-01

Natural graphite is a strategic mineral, since the European Commission stated (Report on critical raw materials for the EU (2014)) that graphite is one of the 20 most critical materials for the European Union. The EU consumed 13% of all flake graphite in the world but produced only 3%, which stresses the demand of the material. Flake graphite, which is a flaky version of graphite, forms under high metamorphic conditions. Flake graphite is important in different applications like batteries, carbon brushes, heat sinks etc. Graphene (a single layer of graphite) can be produced from graphite and is commonly used in many nanotechnological applications, e.g. in electronics and sensors. The steps to obtain pure graphene from graphite ore include fragmentation, flotation and exfoliation, which can be cumbersome and resulting in damaging the graphene layers. We have started a project named FennoFlakes, which is a co-operation between geologists and chemists to fill the whole value chain from graphite to graphene: 1. Exploration of graphite ores (geological and geophysical methods). 2. Petrological and geochemical analyses on the ores. 3. Development of fragmentation methods for graphite ores. 4. Chemical exfoliation of the enriched flake graphite to separate flake graphite into single and multilayer graphene. 5. Test the quality of the produced material in several high-end applications with totally environmental friendly and disposable material combinations. Preliminary results show that flake graphite in high metamorphic areas has better qualities compared to synthetic graphite produced in laboratories.

A review of the UK methodology used for monitoring cigarette smoke yields, aspects of analytical data variability and their impact on current and future regulatory compliance.

PubMed

Purkis, Stephen W; Drake, Linda; Meger, Michael; Mariner, Derek C

2010-04-01

The European Union (EU) requires that tobacco products are regulated by Directive 2001/37/EC through testing and verification of results on the basis of standards developed by the International Organization for Standardization (ISO). In 2007, the European Commission provided guidance to EU Member States by issuing criteria for competent laboratories which includes accreditation to ISO 17025:2005. Another criterion requires regular laboratory participation in collaborative studies that predict the measurement tolerance that must be observed to conclude that test results on any particular product are different. However, differences will always occur when comparing overall data across products between different laboratories. A forum for technical discussion between laboratories testing products as they are manufactured and a Government appointed verification laboratory gives transparency, ensures consistency and reduces apparent compliance issues to the benefit of all parties. More than 30years ago, such a forum was set up in the UK that continued until 2007 and will be described in this document. Anticipating further testing requirements in future product regulation as proposed by the Framework Convention on Tobacco Control, cooperation between accredited laboratories, whether for testing or verification, should be established to share know-how, to ensure a standardised level of quality and to offer competent technical dialogue in the best interest of regulators and manufacturers alike. Copyright 2009 Elsevier Inc. All rights reserved.

The European Union’s Policy Regarding Peace and Security in Sub-Saharan Africa Since the End of the Cold War: Concepts and Implementation

DTIC Science & Technology

2007-06-01

Alexandra Krause , analyzing the EU’s role as an international actor in Africa, argues that the “policy of the EU towards sub-Saharan Africa – seen from a...Mwesiga Baregu and Christopher Landsberg (London, Boulder: Lynne Rienner Publishers, 2003), 301-316. 3 Alexandra Krause , “The European Union’s Africa...Intervening Variables,” in Krasner, ed. International Regimes, Ithaca: Cornell University Press, 1983. Krause , Alexandra. “Die EU als

The Post-9/11 European Union Counterterrorism Response: Legal-Institutional Framework

DTIC Science & Technology

2012-12-01

www.diw.de/documents/publikationen/73/diw_01.c.386651. de /diw_econsec0055.pdf. 23 EUROPOL, TE-SAT 2012 EU Terrorism Situation and Trend Report (The...europoltsat.pdf. 11 should be taken with a certain caution because some of positive outcomes are not known in public. De Goede concludes “due...www.diw.de/documents/publikationen/73/diw_01.c.94888. de /diw_econsec0002.pdf; Bures, EU Counterterrorism Policy, 31-58. 12 Eurobarometer28 as the

Synthetic biology and its regulation in the European Union.

PubMed

Buhk, Hans-Jörg

2014-12-25

The term synthetic biology is used increasingly, but without a clear definition. Most of the recent research carried out in this field is genetic engineering, as defined by current GMO-legislation in the EU. Synthetic biology has developed its own language. In vitro synthesis of DNA also carries the label synthetic biology. It is important to analyze whether present and future activities of synthetic biology are within the scope of existing EU-legislation. Copyright © 2014 Elsevier B.V. All rights reserved.

An Analysis of Ict Development Strategy Framework in Chinese Rural Areas

NASA Astrophysics Data System (ADS)

Duan, Meiying; Warren, Martyn; Lang, Yunwen; Lu, Shaokun; Yang, Linnan

Information and Communication Technology (ICT) development strategy in Chinese rural areas is an indispensable part of national development strategies. This paper reviews the ICT framework in agriculture and rural areas launched by the Department of Agriculture in China. It compares the rural ICT policies and strategies between China and the European Union (EU). The ICT development strategy framework is analyzed based on the situation in Chinese rural area and the experiences of the EU. Some lessons and suggestions are provided.

Changes in dentist and dental hygienist numbers in the European Union and economic area.

PubMed

Widström, E; Eaton, K A; Luciak-Donsberger, C

2010-08-01

To investigate the extent to which changes in the numbers of dental hygienists and dentists have occurred in the Member States of the European Union and Economic Area (EU/EEA) during the last ten years and discuss the changes in relation to the possibilities of sharing tasks between the two groups. Numbers for active dentists, registered hygienists and EU/EEA member state populations in 2007 were taken from the website of the Council of European Chief Dental Officers (CECDO) (www.cecdo.org) and from CECDO records for the EU/EEA member states in 1998 and for the new EU member states (who joined in 2004 and 2007) in 2000. From these data, population: active dentists, population: registered dental hygienist and active dentists: registered dental hygienist ratios were calculated together with percentage changes in the number of dentists and dental hygienists by member state, between 1998 and 2007 for the old and between 2000 and 2007 for the new EU member states. In 2007, there were a total of 343,922 active dentists and 30,963 registered dental hygienists in the 30 EU/EEA member states plus Switzerland. The mean population to dentist ratio was about 1500:1 and the mean population to dental hygienist ratio (in the 25 states where dental hygienists were registered) was 13,454:1. During the study period, the population of the EU/EEA plus Switzerland increased by less that 3%, the number of dentists increased by 13% and the number dental hygienists by 42%. The overall ratio of active dentists: dental hygienists changed from 18:1 to 11:1. In six of the 30 member states plus Switzerland the population to dental hygienist ratio was between 2000:1 and 6000:1 and the dentist: dental hygienist ratio less than 1:3. Although, most member states educate dental hygienists and their numbers in the EU/EEA during the last 10 years have risen more than the dentist numbers, there are still only a handful countries where the hygienist numbers are great enough to make a significant difference to the delivery of oral health care.

Energy from waste in Europe: an analysis and comparison of the EU 27.

PubMed

Sommer, Manuel; Ragossnig, Arne

2011-10-01

This article focuses on analysing the development of waste-generated energy in the countries of the European Union (EU 27). Besides elaborating the relevant legal and political framework in the waste and energy sector as well as climate protection, the results from correlation analyses based on the databases of the energy statistics from Eurostat are discussed. The share of energy from waste is correlated with macro-economic, waste- and energy-sector-related data, which have been defined as potentially relevant for energy recovery from waste in the countries of the European Union. The results show that a single factor influencing the extent of waste-generated energy could not be isolated as it is being influenced not only by the state of economic development and the state of development of waste management systems in the respective countries but also by energy-sector-related factors and the individual priority settings in those countries. Nevertheless the main driving force for an increase in the utilization of waste for energy generation can be seen in the legal and political framework of the European Union leading to the consequence that market conditions influence the realization of waste management infrastructure for waste-generated energy.

The epidemiological transition in Eastern and Western Europe: a historic natural experiment.

PubMed

Karanikolos, Marina; Adany, Roza; McKee, Martin

2017-10-01

The continent of Europe has experienced remarkable changes in the past 25 years, providing scope for natural experiments that offer insight into the complex determinants of health. We analysed trends in life expectancy at birth in three parts of Europe, those countries that were members of the European Union (EU) prior to 2004, countries that joined the European Union since then, and the twelve countries that emerged from the Soviet Union to form the Commonwealth of Independent States (CIS). The contribution of deaths at different ages to these changes was assessed using Arriaga's method of decomposing changes in life expectancy. Europe remains divided geographically, with an East-West gradient. The former Soviet countries experienced a marked initial decline in life expectancy and have only recovered after 2005. However, the situation for those of working ages is little better than in 1990. The pre-2004 EU has seen substantial gains throughout the past 25 years, although there is some evidence that this may be slowing, or even reversing, at older ages. The countries joining the EU in 2004 subsequently began to see some improvements in the early 1990s, but have experienced larger gains since 2000. Europe offers a valuable natural laboratory for understanding the impact of political, economic, and social changes on health. While the historic divisions of Europe are still visible, there is also evidence that individual countries are doing better or worse than their neighbours, providing many lessons that can be learned from. © The Author 2017. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

77 FR 1778 - U.S.-EU High Level Working Group on Jobs and Growth

Federal Register 2010, 2011, 2012, 2013, 2014

2012-01-11

... Commission President Barroso, and European Council President Von Rompuy directed the Transatlantic Economic... measures to increase U.S.-EU trade and investment to support mutually beneficial job creation, economic... development of rules and principles on global issues of common concern and also for the achievement of shared...

Review and Analysis of the EU Teacher-Related Policies and Activities

ERIC Educational Resources Information Center

Stéger, Csilla

2014-01-01

This article aims at raising awareness of the key role the EU already plays in matters of teacher policy. It takes stock of European teacher policy related documents and activities, such as relevant strategies, presidency priorities, Council Conclusions, Commission working documents, the activities of thematic working groups, of networks, of data…

The impact of restrictions on neonicotinoid and fipronil insecticides on pest management in maize, oilseed rape and sunflower in eight European Union regions†

PubMed Central

Castañera, Pedro; Alonso‐Prados, José Luis; Gómez‐Barbero, Manuel; Rodríguez‐Cerezo, Emilio

2017-01-01

Abstract BACKGROUND In 2013, the European Commission restricted the use of three neonicotinoids (clothianidin, imidacloprid and thiamethoxam) and the pyrazole fipronil, which are widely used to control early‐season pests. Here, we used original farm survey data to examine the impact of the restrictions on pest management practices in eight regional case studies including maize, oilseed rape and sunflower in seven European Union (EU) countries. RESULTS In four case studies, farmers switched to using untreated seeds as no alternative seed treatments were available. In three case studies, farmers switched to using unrestricted neonicotinoid‐ or pyrethroid‐treated seeds. In five case studies, farmers increased the use of soil or foliar treatments, with pyrethroids as the principal insecticide class. Other changes in pest management practices ranged from increased sowing density to more frequent scouting for pests. Many farmers perceived that the time, cost and amount of insecticides required to protect crops increased, along with pest pressure. Alternative seed treatments were mostly perceived as being less effective than the restricted seed treatments. CONCLUSION Farmers generally relied on alternative seed treatments or more soil/foliar treatments in the first growing season after the restrictions took effect. Further study is required to assess the effectiveness and sustainability of these alternatives compared with the restricted insecticides. © 2017 The Authors. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry. PMID:28842940

The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non-Hodgkin's B-Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

PubMed Central

Flores, Beatriz; Hudson, Ian; Sjöberg, Jan; Dunder, Kristina; Salmonson, Tomas; Gisselbrecht, Christian; Laane, Edward; Pignatti, Francesco

2013-01-01

On May 10, 2012, the European Commission issued a conditional marketing authorization valid throughout the European Union for pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma (NHL). Pixantrone is a cytotoxic aza-anthracenedione that directly alkylates DNA-forming stable DNA adducts and cross-strand breaks. The recommended dose of pixantrone is 50 mg/m2 administered on days 1, 8, and 15 of each 28-day cycle for up to 6 cycles. In the main study submitted for this application, a significant difference in response rate (proportion of complete responses and unconfirmed complete responses) was observed in favor of pixantrone (20.0% vs. 5.7% for pixantrone and physician's best choice, respectively), supported by the results of secondary endpoints of median progression-free and overall survival times (increase of 2.7 and 2.6 months, respectively). The most common side effects with pixantrone were bone marrow suppression (particularly of the neutrophil lineage) nausea, vomiting, and asthenia. This article summarizes the scientific review of the application leading to approval in the European Union. The detailed scientific assessment report and product information, including the summary of product characteristics, are available on the European Medicines Agency website (http://www.ema.europa.eu). PMID:23615696

Fragrance exposure in the UK: has there been a change in the last decade?

PubMed

Webber, L; Keith, D; Walker-Smith, P; Buckley, D A

2018-06-26

Fragrance allergy constitutes a significant public health problem that affects 1-2% of the general population and 6-13% of consecutively patch tested patients 1 . The European Union (EU) Scientific Committee on Consumer Safety (SCCS) independently advises the EU on its regulation of allergens such as fragrance. At present, a total of 26 fragrance allergens are subject to mandatory individual labelling on product packaging in the EU, including all 14 that form Fragrance Mixes 1 and 2 in the European and British Baseline patch test series. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

The Revenge of Europe: NATO and the Transatlantic Relationship in the Era of the European Union

DTIC Science & Technology

2004-04-01

AU/AF FELLOWS/NNN/2004-04 AIR FORCE FELLOWS (SDE) AIR UNIVERSITY THE REVENGE OF EUROPE NATO AND THE TRANSATLANTIC RELATIONSHIP IN THE ERA OF THE...REPORT TYPE N/A 3. DATES COVERED - 4. TITLE AND SUBTITLE The Revenge of Europe Nato and the Transatlantic Relationship in the Era of the European...examines the transatlantic relationship and the North Atlantic Treaty Organization (NATO) in light of the rise of the European Union (EU). Recent

Strategic Planning for Comprehensive Security in the European Union’s Military Operations: EUFOR RD Congo, EUFOR Tchad/RCA, and EUNAVFOR Somalia

DTIC Science & Technology

2010-06-01

Globalization and Environmental Challenges: Reconceptualizing Security in the 21st Century, 947. 11 Marco A. Ferroni and Ashoka Mody, International Public...Security and Defence Policy, 67–70; Howorth, Security and Defence Policy in the European Union, 152–154. 47 Hubert Zimmermann, “Security Exporters...consilium.europa.eu/showPage.aspx?id=1519&lang=en (accessed 12 March 2010). Ferroni, Marco A. and Ashoka Mody. International Public Goods: Incentives

European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.

PubMed

Coppens, Patrick; da Silva, Miguel Fernandes; Pettman, Simon

2006-04-03

This article describes the legislation that is relevant in the marketing of functional foods in the European Union (EU), how this legislation was developed as well as some practical consequences for manufacturers, marketers and consumers. It also addresses some concrete examples of how the EU's safety requirements for food products have impacted a range of product categories. In the late nineties, research into functional ingredients was showing promising prospects for the use of such ingredients in foodstuffs. Due mainly to safety concerns, these new scientific developments were accompanied by an urgent call for legislation. The European Commission 2000 White Paper on Food Safety announced some 80 proposals for new and improved legislation in this field. Among others, it foresaw the establishment of a General Food Law Regulation, laying down the principles of food law and the creation of an independent Food Authority endowed with the task of giving scientific advice on issues based upon scientific risk assessment with clearly separated responsibilities for risk assessment, risk management and risk communication. Since then, more than 90% of the White Paper proposals have been implemented. However, there is not, as such, a regulatory framework for 'functional foods' or 'nutraceuticals' in EU Food Law. The rules to be applied are numerous and depend on the nature of the foodstuff. The rules of the general food law Regulation are applicable to all foods. In addition, legislation on dietetic foods, on food supplements or on novel foods may also be applicable to functional foods depending on the nature of the product and on their use. Finally, the two proposals on nutrition and health claims and on the addition of vitamins and minerals and other substances to foods, which are currently in the legislative process, will also be an important factor in the future marketing of 'nutraceuticals' in Europe. The cornerstone of EU legislation on food products, including functional foods and nutraceuticals is 'safety'. Decisions on the safety-basis of legislation are based on risk analysis, in which scientific risk assessment is performed by the European Food Safety Authority and risk management is performed by the European Commission, the Member States, and in case of legislation, together with the European Parliament. In the risk management phase, both the precautionary principle and other legitimate factors may be considered in choosing the best way of dealing with an issue. Due to the numerous pieces of legislation applying and to the different procedures to be followed, the process of having 'functional foods' ready for the market is certainly a costly and time-consuming task. However, it may also be clearly worth it in terms of market success and improved consumer health.

Pharmaceutical expenditure forecast model to support health policy decision making.

PubMed

Rémuzat, Cécile; Urbinati, Duccio; Kornfeld, Åsa; Vataire, Anne-Lise; Cetinsoy, Laurent; Aballéa, Samuel; Mzoughi, Olfa; Toumi, Mondher

2014-01-01

With constant incentives for healthcare payers to contain their pharmaceutical budgets, modelling policy decision impact became critical. The objective of this project was to test the impact of various policy decisions on pharmaceutical budget (developed for the European Commission for the project 'European Union (EU) Pharmaceutical expenditure forecast' - http://ec.europa.eu/health/healthcare/key_documents/index_en.htm). A model was built to assess policy scenarios' impact on the pharmaceutical budgets of seven member states of the EU, namely France, Germany, Greece, Hungary, Poland, Portugal, and the United Kingdom. The following scenarios were tested: expanding the UK policies to EU, changing time to market access, modifying generic price and penetration, shifting the distribution chain of biosimilars (retail/hospital). Applying the UK policy resulted in dramatic savings for Germany (10 times the base case forecast) and substantial additional savings for France and Portugal (2 and 4 times the base case forecast, respectively). Delaying time to market was found be to a very powerful tool to reduce pharmaceutical expenditure. Applying the EU transparency directive (6-month process for pricing and reimbursement) increased pharmaceutical expenditure for all countries (from 1.1 to 4 times the base case forecast), except in Germany (additional savings). Decreasing the price of generics and boosting the penetration rate, as well as shifting distribution of biosimilars through hospital chain were also key methods to reduce pharmaceutical expenditure. Change in the level of reimbursement rate to 100% in all countries led to an important increase in the pharmaceutical budget. Forecasting pharmaceutical expenditure is a critical exercise to inform policy decision makers. The most important leverages identified by the model on pharmaceutical budget were driven by generic and biosimilar prices, penetration rate, and distribution. Reducing, even slightly, the prices of generics had a major impact on savings. However, very aggressive pricing of generic and biosimilar products might make this market unattractive and can be counterproductive. Worth noting, delaying time to access innovative products was also identified as an effective leverage to increase savings but might not be a desirable policy for breakthrough products. Increasing patient financial contributions, either directly or indirectly via their private insurances, is a more likely scenario rather than expanding the national pharmaceutical expenditure coverage.

Pharmaceutical expenditure forecast model to support health policy decision making

PubMed Central

Rémuzat, Cécile; Urbinati, Duccio; Kornfeld, Åsa; Vataire, Anne-Lise; Cetinsoy, Laurent; Aballéa, Samuel; Mzoughi, Olfa; Toumi, Mondher

2014-01-01

Background and objective With constant incentives for healthcare payers to contain their pharmaceutical budgets, modelling policy decision impact became critical. The objective of this project was to test the impact of various policy decisions on pharmaceutical budget (developed for the European Commission for the project ‘European Union (EU) Pharmaceutical expenditure forecast’ – http://ec.europa.eu/health/healthcare/key_documents/index_en.htm). Methods A model was built to assess policy scenarios’ impact on the pharmaceutical budgets of seven member states of the EU, namely France, Germany, Greece, Hungary, Poland, Portugal, and the United Kingdom. The following scenarios were tested: expanding the UK policies to EU, changing time to market access, modifying generic price and penetration, shifting the distribution chain of biosimilars (retail/hospital). Results Applying the UK policy resulted in dramatic savings for Germany (10 times the base case forecast) and substantial additional savings for France and Portugal (2 and 4 times the base case forecast, respectively). Delaying time to market was found be to a very powerful tool to reduce pharmaceutical expenditure. Applying the EU transparency directive (6-month process for pricing and reimbursement) increased pharmaceutical expenditure for all countries (from 1.1 to 4 times the base case forecast), except in Germany (additional savings). Decreasing the price of generics and boosting the penetration rate, as well as shifting distribution of biosimilars through hospital chain were also key methods to reduce pharmaceutical expenditure. Change in the level of reimbursement rate to 100% in all countries led to an important increase in the pharmaceutical budget. Conclusions Forecasting pharmaceutical expenditure is a critical exercise to inform policy decision makers. The most important leverages identified by the model on pharmaceutical budget were driven by generic and biosimilar prices, penetration rate, and distribution. Reducing, even slightly, the prices of generics had a major impact on savings. However, very aggressive pricing of generic and biosimilar products might make this market unattractive and can be counterproductive. Worth noting, delaying time to access innovative products was also identified as an effective leverage to increase savings but might not be a desirable policy for breakthrough products. Increasing patient financial contributions, either directly or indirectly via their private insurances, is a more likely scenario rather than expanding the national pharmaceutical expenditure coverage. PMID:27226830

Input analysis for two public consultations on the EU Clinical Trials Regulation.

PubMed

Langhof, Holger; Lander, Jonas; Strech, Daniel

2016-09-17

The European Union's (EU) Clinical Trials Directive was replaced by an EU-Regulation as of 2016. The policy revision process was subject to a formal impact assessment exercised by the European Commission (EC) from 2008 to 2014. Following the EU principles of Good Governance, deliberation with stakeholders was an integral part of this impact assessment and the policy formulation process. Hence, two public consultations (PCs) were held by the EC in 2009 and 2011, respectively. Various stakeholders contributed and submitted their written input to the EC. Though often cited in the further revision process, the input gathered in the PC was not communicated with full transparency and it is unclear how and to what extent the input has been processed and used in the policy formulation. The objective of this study was an analysis of submissions to both PCs in order to systematically present what topics have been discussed and which possible policy options have been raised by the stakeholders. All written submissions publicly available were downloaded from the EC's homepage and assessed for stakeholder characteristics. Thematic text analysis was applied to assess the full text of a random sample of 33% of these submissions. A total of 198 different stakeholders from the EU and the United States of America contributed to one or both of the two PCs. In total, 44 various themes have been addressed that could be clustered under 24 main themes, including the articulation of problems as well as possible policy solutions to face these problems. The two PCs on the Clinical Trials Directive were highly appreciated by the various stakeholders and their input allowed an in-depth view on their particular interests. This input provided a rich source of information for all stakeholders in the field of clinical trials as well as to the EC's impact assessment. Although the EC obviously gathered a large quantity of expert knowledge on practical implications of trials legislation by consulting stakeholders, it remained unclear how this input was used in the development of the new regulation. For the sake of transparency, it is recommended that in future PCs the EC uses better standardized methods for a more transparent analysis and presentation of results.

Trends in cancer mortality in the European Union and accession countries, 1980-2000.

PubMed

Levi, F; Lucchini, F; Negri, E; Zatonski, W; Boyle, P; La Vecchia, C

2004-09-01

Cancer mortality rates and trends over the period 1980-2000 for accession countries to the European Union (EU) in May 2004, which include a total of 75 million inhabitants, were abstracted from the World Health Organization (WHO) database, together with, for comparative purposes, those of the current EU. Total cancer mortality for men was 166/100,000 in the EU, but ranged between 195 (Lithuania) and 269/100,000 (Hungary) in central and eastern European accession countries. This excess related to most cancer sites, including lung and other tobacco-related neoplasms, but also stomach, intestines and liver, and a few neoplasms amenable to treatment, such as testis, Hodgkin's disease and leukaemias. Overall cancer mortality for women was 95/100,000 in the EU, and ranged between 100 and 110/100,000 in several central and eastern European countries, and up to 120/100,000 in the Czech Republic and 138/100,000 in Hungary. The latter two countries had a substantial excess in female mortality for lung cancer, but also for several other sites. Furthermore, for stomach and especially (cervix) uteri, female rates were substantially higher in central and eastern European accession countries. Over the last two decades, trends in mortality were systematically less favourable in accession countries than in the EU. Most of the unfavourable patterns and trends in cancer mortality in accession countries are due to recognised, and hence potentially avoidable, causes of cancer, including tobacco, alcohol, dietary habits, pollution and hepatitis B, plus inadequate screening, diagnosis and treatment. Consequently, the application of available knowledge on cancer prevention, diagnosis and treatment may substantially reduce the disadvantage now registered in the cancer mortality of central and eastern European accession countries.

Occurrence and removal of organic micropollutants: An overview of the watch list of EU Decision 2015/495.

PubMed

Barbosa, Marta O; Moreira, Nuno F F; Ribeiro, Ana R; Pereira, Manuel F R; Silva, Adrián M T

2016-05-01

Although there are no legal discharge limits for micropollutants into the environment, some regulations have been published in the last few years. Recently, a watch list of substances for European Union-wide monitoring was reported in the Decision 2015/495/EU of 20 March 2015. Besides the substances previously recommended to be included by the Directive 39/2013/EU, namely two pharmaceuticals (diclofenac and the synthetic hormone 17-alpha-ethinylestradiol (EE2)) and a natural hormone (17-beta-estradiol (E2)), the first watch list of 10 substances/groups of substances also refers three macrolide antibiotics (azithromycin, clarithromycin and erythromycin), other natural hormone (estrone (E1)), some pesticides (methiocarb, oxadiazon, imidacloprid, thiacloprid, thiamethoxam, clothianidin, acetamiprid and triallate), a UV filter (2-ethylhexyl-4-methoxycinnamate) and an antioxidant (2,6-di-tert-butyl-4-methylphenol) commonly used as food additive. Since little is known about the removal of most of the substances included in the Decision 2015/495/EU, particularly regarding realistic concentrations in aqueous environmental samples, this review aims to: (i) overview the European policy in the water field; (ii) briefly describe the most commonly used conventional and advanced treatment processes to remove micropollutants; (iii) summarize the relevant data published in the last decade, regarding occurrence and removal in aqueous matrices of the 10 substances/groups of substances that were recently included in the first watch list for European Union monitoring (Decision 2015/495/EU); and (iv) highlight the lack of reports concerning some substances of the watch list, the study of un-spiked aquatic matrices and the assessment of transformation by-products. Copyright © 2016 Elsevier Ltd. All rights reserved.

47 CFR 87.1 - Basis and purpose.

Code of Federal Regulations, 2013 CFR

2013-10-01

... Federal Communications Commission (Commission) to regulate radio transmission and to issue licenses for radio stations. These rules conform with applicable statutes and international treaties, agreements and...). (2) International Telecommunication Union Radio Regulations, in force for the United States—(Radio...

47 CFR 87.1 - Basis and purpose.

Code of Federal Regulations, 2012 CFR

2012-10-01

... Federal Communications Commission (Commission) to regulate radio transmission and to issue licenses for radio stations. These rules conform with applicable statutes and international treaties, agreements and...). (2) International Telecommunication Union Radio Regulations, in force for the United States—(Radio...

47 CFR 87.1 - Basis and purpose.

Code of Federal Regulations, 2011 CFR

2011-10-01

... Federal Communications Commission (Commission) to regulate radio transmission and to issue licenses for radio stations. These rules conform with applicable statutes and international treaties, agreements and...). (2) International Telecommunication Union Radio Regulations, in force for the United States—(Radio...

47 CFR 87.1 - Basis and purpose.

Code of Federal Regulations, 2014 CFR

2014-10-01

... Federal Communications Commission (Commission) to regulate radio transmission and to issue licenses for radio stations. These rules conform with applicable statutes and international treaties, agreements and...). (2) International Telecommunication Union Radio Regulations, in force for the United States—(Radio...

Training infection control and hospital hygiene professionals in Europe, 2010: agreed core competencies among 33 European countries.

PubMed

Brusaferro, S; Cookson, B; Kalenic, S; Cooper, T; Fabry, J; Gallagher, R; Hartemann, P; Mannerquist, K; Popp, W; Privitera, G; Ruef, C; Viale, P; Coiz, F; Fabbro, E; Suetens, C; Varela Santos, C

2014-12-11

The harmonisation of training programmes for infection control and hospital hygiene (IC/HH) professionals in Europe is a requirement of the Council recommendation on patient safety. The European Centre for Disease Prevention and Control commissioned the 'Training Infection Control in Europe' project to develop a consensus on core competencies for IC/HH professionals in the European Union (EU). Core competencies were drafted on the basis of the Improving Patient Safety in Europe (IPSE) project's core curriculum (CC), evaluated by questionnaire and approved by National Representatives (NRs) for IC/HH training. NRs also re-assessed the status of IC/HH training in European countries in 2010 in comparison with the situation before the IPSE CC in 2006. The IPSE CC had been used to develop or update 28 of 51 IC/HH courses. Only 10 of 33 countries offered training and qualification for IC/HH doctors and nurses. The proposed core competencies are structured in four areas and 16 professional tasks at junior and senior level. They form a reference for standardisation of IC/HH professional competencies and support recognition of training initiatives.

How Does Medical Device Regulation Perform in the United States and the European Union? A Systematic Review

PubMed Central

Kramer, Daniel B.; Xu, Shuai; Kesselheim, Aaron S.

2012-01-01

Background Policymakers and regulators in the United States (US) and the European Union (EU) are weighing reforms to their medical device approval and post-market surveillance systems. Data may be available that identify strengths and weakness of the approaches to medical device regulation in these settings. Methods and Findings We performed a systematic review to find empirical studies evaluating medical device regulation in the US or EU. We searched Medline using two nested categories that included medical devices and glossary terms attributable to the US Food and Drug Administration and the EU, following PRISMA guidelines for systematic reviews. We supplemented this search with a review of the US Government Accountability Office online database for reports on US Food and Drug Administration device regulation, consultations with local experts in the field, manual reference mining of selected articles, and Google searches using the same key terms used in the Medline search. We found studies of premarket evaluation and timing (n = 9), studies of device recalls (n = 8), and surveys of device manufacturers (n = 3). These studies provide evidence of quality problems in pre-market submissions in the US, provide conflicting views of device safety based largely on recall data, and relay perceptions of some industry leaders from self-surveys. Conclusions Few studies have quantitatively assessed medical device regulation in either the US or EU. Existing studies of US and EU device approval and post-market evaluation performance suggest that policy reforms are necessary for both systems, including improving classification of devices in the US and promoting transparency and post-market oversight in the EU. Assessment of regulatory performance in both settings is limited by lack of data on post-approval safety outcomes. Changes to these device approval and post-marketing systems must be accompanied by ongoing research to ensure that there is better assessment of what works in either setting. Please see later in the article for the Editors' Summary. PMID:22912563

Two Decades of E-Learning Policy Evolution at EU Level: Motivations, Institutions and Instruments

ERIC Educational Resources Information Center

Salajan, Florin D.; Roumell, Elizabeth A.

2016-01-01

This article records and documents the historical development of e-learning policies at EU level by conducting a discourse and content analysis of four key e-learning policy documents drafted and implemented by the European Commission over the past 20 years: "Learning in the Information Society: Action Plan for a European Education…

Inclusive Education in Progress: Policy Evolution in Four European Countries

ERIC Educational Resources Information Center

Smyth, Fiona; Shevlin, Michael; Buchner, Tobias; Biewer, Gottfried; Flynn, Paula; Latimier, Camille; Šiška, Jan; Toboso-Martín, Mario; Rodríguez Díaz, Susana; Ferreira, Miguel A. V.

2014-01-01

This paper seeks to compare the evolution of inclusive education policy in the four countries of an EU-funded research project (QualiTYDES) operating under the shared policy environment of the UN, EU and European Commission. A shared policy cannot of course be assumed to result in common legislative or provisional outcomes at national level. The…

Observations related to the Salmonella EU layer baseline survey in the United Kingdom: follow-up of positive flocks and sensitivity issues.

PubMed

Carrique-Mas, J J; Breslin, M; Snow, L; Arnold, M E; Wales, A; McLaren, I; Davies, R H

2008-11-01

A follow-on study was carried out on 23 holdings identified as Salmonella positive in the 2004/2005 European Union (EU) baseline survey of Salmonella in laying hens. Eleven of 13 cage and 4/7 floor houses remained positive for Salmonella when the new flock was tested, and from 10/13 cage and 3/7 floor houses a Salmonella of the same serovar/phage type as found in the EU survey was isolated. There was a high correlation between the level of contamination in the houses at the time of the EU survey and in the follow-on flock. On seven occasions the house identified as positive in the EU survey was sampled after cleaning and disinfection but before a new flock was placed, and in all of them Salmonella could be isolated from the houses. The observed number of infected houses in infected holdings suggests that the holding-level prevalence in the United Kingdom would be about 21% higher than the results obtained in the EU survey.

Observations related to the Salmonella EU layer baseline survey in the United Kingdom: follow-up of positive flocks and sensitivity issues

PubMed Central

CARRIQUE-MAS, J. J.; BRESLIN, M.; SNOW, L.; ARNOLD, M. E.; WALES, A.; McLAREN, I.; DAVIES, R. H.

2008-01-01

SUMMARY A follow-on study was carried out on 23 holdings identified as Salmonella positive in the 2004/2005 European Union (EU) baseline survey of Salmonella in laying hens. Eleven of 13 cage and 4/7 floor houses remained positive for Salmonella when the new flock was tested, and from 10/13 cage and 3/7 floor houses a Salmonella of the same serovar/phage type as found in the EU survey was isolated. There was a high correlation between the level of contamination in the houses at the time of the EU survey and in the follow-on flock. On seven occasions the house identified as positive in the EU survey was sampled after cleaning and disinfection but before a new flock was placed, and in all of them Salmonella could be isolated from the houses. The observed number of infected houses in infected holdings suggests that the holding-level prevalence in the United Kingdom would be about 21% higher than the results obtained in the EU survey. PMID:18177519

Status, quality and specific needs of Zika virus (ZIKV) diagnostic capacity and capability in National Reference Laboratories for arboviruses in 30 EU/EEA countries, May 2016

PubMed Central

Mögling, Ramona; Zeller, Hervé; Revez, Joana; Koopmans, Marion; Reusken, Chantal

2017-01-01

With international travel, Zika virus (ZIKV) is introduced to Europe regularly. A country's ability to robustly detect ZIKV introduction and local transmission is important to minimise the risk for a ZIKV outbreak. Therefore, sufficient expertise and diagnostic capacity and capability are required in European laboratories. To assess the capacity, quality, operational specifics (guidelines and algorithms), technical and interpretation issues and other possible difficulties that were related to ZIKV diagnostics in European countries, a questionnaire was conducted among national reference laboratories in 30 countries in the European Union/European Economic Area (EU/EEA) in May 2016. While the coverage and capacity of ZIKV diagnostics in the EU/EEA national reference laboratories were found to be adequate, the assessment of the quality and needs indicated several crucial points of improvement that will need support at national and EU/EEA level to improve ZIKV preparedness, response and EU/EEA ZIKV surveillance activities. PMID:28920574

Lifelong Learning Key Competence Levels of Graduate Students

ERIC Educational Resources Information Center

Adabas, Abdurrahman; Kaygin, Hüseyin

2016-01-01

The European Union defines lifelong learning as all activities aimed at improving an individual's knowledge, skills and competences individually, socially or vocationally throughout his/her life. In 2007, eight key competences necessary for lifelong learning were identified by the European Union Education and Culture Commission. These competences…

Composition, labelling, and safety of food supplements based on bee products in the legislative framework of the European Union - Croatian experiences.

PubMed

Vujić, Mario; Pollak, Lea

2015-12-01

The European Union market is overflown by food supplements and an increasing number of consumers prefer those where bee products play an important part in their composition. This paper deals with complex European Union legislation concerning food supplements based on bee products, placing a special emphasis on their composition, labelling, and safety. Correct labelling of food supplements also represents a great challenge since, in spite of legal regulations in force, there are still open issues regarding the statements on the amount of propolis, which is not clearly defined by the legal framework. One of the key issues are the labels containing health claims from the EU positive list approved by the European Food Safety Authority. Emphasis will also be placed on informing consumers about food, as statements which imply the healing properties of food supplements and their capacity to cure diseases are forbidden. One of the key elements of product safety is HACCP based on the EU Regulations EC 178/02 and 852/2004. Health safety analyses of food supplements with bee products used as raw materials, which are standardised by legal regulations will also be discussed. In the future, attention should also be paid to establishing the European Union "nutrivigilance" system. Croatian experiences in addressing challenges faced by producers, supervisory entities, and regulatory and inspection bodies may serve as an example to countries aspiring to become part of the large European family.

New European commission regulation on variations to the terms of marketing authorization for medicinal products and its impact on Croatian legislation.

PubMed

Martinac, Adrijana Ilić; Tomić, Sinisa; Simicić, Mirna

2010-09-01

Variations introduced to medicinal product documentation must not affect the quality, efficacy, and safety of the product. Croatian Medicinal Products Act and accompanying ordinances are largely aligned with the EU regulations. The EU has now tried to simplify the issue of variations with a new Regulation, creating differences in the definition of and approach to resolving certain types of variations between Croatia and the EU. These differences could hinder the approval procedure for variations in Croatia, particularly for medicines already approved in the EU. Amending the Croatian Ordinance on medicines already authorised in the EU would be one way of maintaining the efficiency of the Croatian regulatory system.

Transposition and implementation of EU rare disease policy in Eastern Europe.

PubMed

Pejcic, Ana V; Iskrov, Georgi; Raycheva, Ralitsa; Stefanov, Rumen; Jakovljevic, Mihajlo Michael

2017-12-01

А series of European Union (EU) political decisions have made rare diseases one of the cornerstones of the common European health policy. Adopted in 2009, Council Recommendation on an action in the field of rare diseases aimed to serve as a policy-making guideline. However, the implementation report, which followed it, neither performed detailed cross-country comparison, nor assessed the impact of the policies. Areas covered: A 10-indicator set was elaborated to structure the review and to describe rare disease activities in 14 Eastern European countries. Expert commentary: Taking into account all indicators, EU member states outperform candidate and potential candidate countries in terms of rare disease policy planning and implementation. Hungary is the top performer, followed by Bulgaria and Czech Republic. Non-EU countries form the bottom tier, with Serbia being the best ranked among them. While EU adhesion is a major facilitator for planning and adopting rare disease policies, local stakeholders are the triggering factor for their successful implementation. European reference networks are likely to be the future of rare disease activities in the EU. They need to synchronize and closely collaborate with all important EU projects in the field of rare diseases if they are to achieve their objectives.

Food and feed chemical contaminants in the European Union: Regulatory, scientific, and technical issues concerning chemical contaminants occurrence, risk assessment, and risk management in the European Union.

PubMed

Silano, Marco; Silano, Vittorio

2017-07-03

A priority of the European Union is the control of risks possibly associated with chemical contaminants in food and undesirable substances in feed. Following an initial chapter describing the main contaminants detected in food and undesirable substances in feed in the EU, their main sources and the factors which affect their occurrence, the present review focuses on the "continous call for data" procedure that is a very effective system in place at EFSA to make possible the exposure assessment of specific contaminants and undesirable substances. Risk assessment of contaminants in food atances in feed is carried currently in the European Union by the CONTAM Panel of EFSA according to well defined methodologies and in collaboration with competent international organizations and with Member States.

Risk of African swine fever introduction into the European Union through transport-associated routes: returning trucks and waste from international ships and planes.

PubMed

Mur, Lina; Martínez-López, Beatriz; Sánchez-Vizcaíno, José Manuel

2012-08-30

The uncontrolled presence of African swine fever (ASF) in Russian Federation (RF) poses a serious risk to the whole European Union (EU) pig industry. Although trade of pigs and their products is banned since the official notification in June 2007, the potential introduction of ASF virus (ASFV) may occur by other routes, which are very frequent in ASF, and more difficult to control, such as contaminated waste or infected vehicles. This study was intended to estimate the risk of ASFV introduction into the EU through three types of transport routes: returning trucks, waste from international ships and waste from international planes, which will be referred here as transport-associated routes (TAR). Since no detailed and official information was available for these routes, a semi-quantitative model based on the weighted combination of risk factors was developed to estimate the risk of ASFV introduction by TAR. Relative weights for combination of different risk factors as well as validation of the model results were obtained by an expert opinion elicitation. Model results indicate that the relative risk for ASFV introduction through TAR in most of the EU countries (16) is low, although some countries, specifically Poland and Lithuania, concentrate high levels of risk, the returning trucks route being the analyzed TAR that currently poses the highest risk for ASFV introduction into the EU. The spatial distribution of the risk of ASFV introduction varies importantly between the analyzed introduction routes. Results also highlight the need to increase the awareness and precautions for ASF prevention, particularly ensuring truck disinfection, to minimize the potential risk of entrance into the EU. This study presents the first assessment of ASF introduction into the EU through TAR. The innovative model developed here could be used in data scarce situations for estimating the relative risk associated to each EU country. This simple methodology provides a rapid and easy to interpret results on risk that may be used for a target and cost-effective allocation of resources to prevent disease introduction.

Risk of African swine fever introduction into the European Union through transport-associated routes: returning trucks and waste from international ships and planes

PubMed Central

2012-01-01

Background The uncontrolled presence of African swine fever (ASF) in Russian Federation (RF) poses a serious risk to the whole European Union (EU) pig industry. Although trade of pigs and their products is banned since the official notification in June 2007, the potential introduction of ASF virus (ASFV) may occur by other routes, which are very frequent in ASF, and more difficult to control, such as contaminated waste or infected vehicles. This study was intended to estimate the risk of ASFV introduction into the EU through three types of transport routes: returning trucks, waste from international ships and waste from international planes, which will be referred here as transport-associated routes (TAR). Since no detailed and official information was available for these routes, a semi-quantitative model based on the weighted combination of risk factors was developed to estimate the risk of ASFV introduction by TAR. Relative weights for combination of different risk factors as well as validation of the model results were obtained by an expert opinion elicitation. Results Model results indicate that the relative risk for ASFV introduction through TAR in most of the EU countries (16) is low, although some countries, specifically Poland and Lithuania, concentrate high levels of risk, the returning trucks route being the analyzed TAR that currently poses the highest risk for ASFV introduction into the EU. The spatial distribution of the risk of ASFV introduction varies importantly between the analyzed introduction routes. Results also highlight the need to increase the awareness and precautions for ASF prevention, particularly ensuring truck disinfection, to minimize the potential risk of entrance into the EU. Conclusions This study presents the first assessment of ASF introduction into the EU through TAR. The innovative model developed here could be used in data scarce situations for estimating the relative risk associated to each EU country. This simple methodology provides a rapid and easy to interpret results on risk that may be used for a target and cost-effective allocation of resources to prevent disease introduction. PMID:22935221

[A procedure for estimating the rate of occupational accidents in non-European-Union workers with irregular immigrant status].

PubMed

Marchiori, L; Marangi, G; Mazzoccoli, P; Scoizzato, L; Buja, Alessandra; Mastrangelo, G

2008-01-01

Statistics on occupational accidents provided by the Italian Institute for Occupational Diseases and Accidents (INAIL, Italian acronym) include only events that occurred in workers with regular employment status. The aim of the study was to establish a procedure in order to estimate the rate of occupational accidents in non-European-Union (non-EU) workers with irregular employment status and/or irregular immigrant status. The sources of data were the clinical records of the Emergency Department of San Bonifacio Hospital, and the population data of District 4 of Local Health Authority 20 of Verona, which was considered the catchment area of this hospital. Among 419 cases of accidents occurred in the numerator of the rate. The denominator of the rate was estimated by calculating: (1) the subjects of working age resident in District 4 (= 83714); (2) the total number of non-EU workers, assuming that the percentage was similar to that in San Bonifacio Municipality (= 0.115); the number of irregular non-EU workers, assuming that the percentage was similar to that in north-eastern Italy (= 0.103). Non-EU workers with irregular employment status and/or irregular immigrant status should, according to these calculations, be 992 (= 83714 x 0.115 x 0.103). The rate--147.2 (= 146/992) occupational accidents per 1000 irregular non-EU workers--is more than twice as high as that calculated in 2004 in Italy in regular non-EU workers (approximately 65 accidents per 1000). The difference can be explained by the fact that irregular workers find employment mainly in agriculture, building and the metallurgic industry, which have a high frequency of accidents, and are more willing to accept risky work and longer work shifts. On the assumption that the rate of occupational accidents in the 500,000 irregular workers living in Italy in 2004 was 147.2 per 1000 (as in the catchment area of the San Bonifacio Hospital), the number of accidents would be 73,600, against the 116,000 that occurred among regular non-EU workers in 2004 according to INAIL. Official INAIL statistics on occupational accidents therefore show a considerable underestimation.

Distribution of glyphosate and aminomethylphosphonic acid (AMPA) in agricultural topsoils of the European Union.

PubMed

Silva, Vera; Montanarella, Luca; Jones, Arwyn; Fernández-Ugalde, Oihane; Mol, Hans G J; Ritsema, Coen J; Geissen, Violette

2018-04-15

Approval for glyphosate-based herbicides in the European Union (EU) is under intense debate due to concern about their effects on the environment and human health. The occurrence of glyphosate residues in European water bodies is rather well documented whereas only few, fragmented and outdated information is available for European soils. We provide the first large-scale assessment of distribution (occurrence and concentrations) of glyphosate and its main metabolite aminomethylphosphonic acid (AMPA) in EU agricultural topsoils, and estimate their potential spreading by wind and water erosion. Glyphosate and/or AMPA were present in 45% of the topsoils collected, originating from eleven countries and six crop systems, with a maximum concentration of 2mgkg -1 . Several glyphosate and AMPA hotspots were identified across the EU. Soil loss rates (obtained from recently derived European maps) were used to estimate the potential export of glyphosate and AMPA by wind and water erosion. The estimated exports, result of a conceptually simple model, clearly indicate that particulate transport can contribute to human and environmental exposure to herbicide residues. Residue threshold values in soils are urgently needed to define potential risks for soil health and off site effects related to export by wind and water erosion. Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Which lessons can we learn from the European Union legal framework of medicines for the regulation of direct-to-consumer genetic tests?

PubMed

van Hellemondt, Rachèl; Hendriks, Aart; Breuning, Martijn

2012-01-01

The legal framework of the European Union (EU) for regulating access to and supply of direct-to-consumer (DTC) genetic tests is very liberal compared to the legal and regulatory framework for (internet) medicines. Nevertheless, both health related products can cause equally serious damage to the well being of individuals. In this contribution we examine whether the legal framework of the EU for the safety and responsible use of (internet) medicines could be an example for regulating access to and supply of DTC genetic tests. The EU laws governing medicines can, notwithstanding their shortcomings, serve as an example for (central) authorising the marketing of DTC genetic tests on the internal market in accordance with strict criteria regarding predictive value and clinical usefulness. Furthermore, a legal framework controlling DTC genetic tests also should introduce system supervision as well as quality criteria with respect to the information to be provided to consumers in order to enhance health protection. However, DTC genetic tests purchased through online ordering are difficult to supervise by any agency. Adequately protecting individuals against questionable testing kits calls for international vigilance and comprehensive measures by the international community. For Europe, it is important to rank the regulation of DTC genetic tests on the European regulatory agenda.

Licensing procedures and registration of medical doctors in the European Union.

PubMed

Kovacs, Eszter; Schmidt, Andrea E; Szocska, Gabor; Busse, Reinhard; McKee, Martin; Legido-Quigley, Helena

2014-06-01

The current proposals to update the European Union (EU) directive on professional qualifications will have potentially important implications for health professions. Yet those discussing it will struggle to find basic information on key issues such as licensing and registration of physicians in different countries. A survey was conducted among national experts in 14 EU member states, supplemented by literature and independent expert review. The questionnaire covered five components of licensing and registration: (1) definitions, (2) regulatory basis, (3) governance, (4) the process of registration and (5) flow and quantity of applications. We identify seven areas of concern: (1) the meaning of terminology, which is inconsistent; (2) the role of language assessments and the responsibility for them; (3) whether approval to practise should be lifelong or time limited, subject to periodic assessment; (4) the need for improved systems to identify those deemed no longer fit to practise in one member state; (5) the complexity of processes for graduates from non-EU/European Economic Area (EAA) countries; (6) public access to registers; and (7) transparency of systems of governance. The systems of licensing and registration of doctors in Europe have developed within specific national contexts and vary widely. This creates inevitable problems in the context of free movement of professionals and increasing mobility. © 2014 Royal College of Physicians.

Compensation of research-related injuries in the European Union.

PubMed

Avilds, Miguelangel Ramiro

2014-12-01

The planned reform of the Clinical Trials Directive has re-opened the debate over how to implement and interpret research-related injuries regulation. In the European Union (EU), clinical trials are currently regulated by Directive 2001/20/EC, which establishes the provision of mandatory insurance before clinical trials commence but is silent on the system of liability. The proposed new Regulation will impact biomedical research assurance in all EU Member States because it points to insurance costs as being one of the causes of the fall in the number of clinical trials carried out in the EU. Despite the adoption of a risk-balance approach, the proposed new Regulation does not include a no-fault compensation system to protect subjects participating in clinical trials. An adequate protection of the rights and wellbeing of trial subjects would require not only mandatory insurance for clinical trials but also a no-fault compensation system. The new regulation should include a general clause requiring mandatory insurance and establishing liability insurance based on no-fault compensation; an exception clause, enabling the performance of clinical trials without insurance in the case of low-risk interventions or non-commercial clinical trials; and an exclusion clause, excluding compensation when there is no causal connection between injuries and clinical trial.

Continent of pessimism or continent of realism? A multilevel study into the impact of macro-economic outcomes and political institutions on societal pessimism, European Union 2006-2012.

PubMed

Steenvoorden, Eefje H; van der Meer, Tom Wg

2017-06-01

The often-posed claim that Europe is a pessimistic continent is not unjustified. In 2012, 53 percent of European Union (EU) citizens were pessimistic about their country. Surprisingly, however, societal pessimism has received very little scientific attention. In this article, we examine to what extent political and economic factors drive societal pessimism. In terms of political factors, we expect that supranationalization, political instability, and corruption increase societal pessimism, as they diminish national political power and can inspire collective powerlessness. Economically, we expect that the retrenchment of welfare state provisions and economic decline drive societal pessimism, as these developments contribute to socioeconomic vulnerability. We assess the impact of these political and economic factors on the level of societal pessimism in the EU, both cross-nationally and over time, through multilevel analyses of Eurobarometer data (13 waves between 2006 and 2012 in 23 EU countries). Our findings show that the political factors (changes in government, corruption) primarily explain cross-national differences in societal pessimism, while the macro-economic context (economic growth, unemployment) primarily explains longitudinal trends within countries. These findings demonstrate that, to a large extent, societal pessimism cannot be viewed separately from its political and economic context.

Tendency for age-specific mortality with hypertension in the European Union from 1980 to 2011.

PubMed

Tao, Lichan; Pu, Cunying; Shen, Shutong; Fang, Hongyi; Wang, Xiuzhi; Xuan, Qinkao; Xiao, Junjie; Li, Xinli

2015-01-01

Tendency for mortality in hypertension has not been well-characterized in European Union (EU). Mortality data from 1980 to 2011 in EU were used to calculate age-standardized mortality rate (ASMR, per 100,000), annual percentage change (APC) and average annual percentage change (AAPC). The Joinpoint Regression Program was used to compare the changes in tendency. Mortality rates in the most recent year studied vary between different countries, with the highest rates observed in Slovakia men and Estonia women. A downward trend in ASMR was demonstrated over all age groups. Robust decreases in ASMR were observed for both men (1991-1994, APC = -13.54) and women (1996-1999, APC = -14.80) aged 55-65 years. The tendency of systolic blood pressure (SBP) from 1980 to 2009 was consistent with ASMR, and the largest decrease was observed among Belgium men and France women. In conclusion, SBP associated ASMR decreased significantly on an annual basis from 1980 to 2009 while a slight increase was observed after 2009. Discrepancies in ASMR from one country to another in EU are significant during last three decades. With a better understanding of the tendency of the prevalence of hypertension and its mortality, efforts will be made to improve awareness and help strict control of hypertension.

Tendency for age-specific mortality with hypertension in the European Union from 1980 to 2011

PubMed Central

Tao, Lichan; Pu, Cunying; Shen, Shutong; Fang, Hongyi; Wang, Xiuzhi; Xuan, Qinkao; Xiao, Junjie; Li, Xinli

2015-01-01

Tendency for mortality in hypertension has not been well-characterized in European Union (EU). Mortality data from 1980 to 2011 in EU were used to calculate age-standardized mortality rate (ASMR, per 100,000), annual percentage change (APC) and average annual percentage change (AAPC). The Joinpoint Regression Program was used to compare the changes in tendency. Mortality rates in the most recent year studied vary between different countries, with the highest rates observed in Slovakia men and Estonia women. A downward trend in ASMR was demonstrated over all age groups. Robust decreases in ASMR were observed for both men (1991-1994, APC = -13.54) and women (1996-1999, APC = -14.80) aged 55-65 years. The tendency of systolic blood pressure (SBP) from 1980 to 2009 was consistent with ASMR, and the largest decrease was observed among Belgium men and France women. In conclusion, SBP associated ASMR decreased significantly on an annual basis from 1980 to 2009 while a slight increase was observed after 2009. Discrepancies in ASMR from one country to another in EU are significant during last three decades. With a better understanding of the tendency of the prevalence of hypertension and its mortality, efforts will be made to improve awareness and help strict control of hypertension. PMID:25932090

Continent of pessimism or continent of realism? A multilevel study into the impact of macro-economic outcomes and political institutions on societal pessimism, European Union 2006–2012

PubMed Central

Steenvoorden, Eefje H; van der Meer, Tom WG

2017-01-01

The often-posed claim that Europe is a pessimistic continent is not unjustified. In 2012, 53 percent of European Union (EU) citizens were pessimistic about their country. Surprisingly, however, societal pessimism has received very little scientific attention. In this article, we examine to what extent political and economic factors drive societal pessimism. In terms of political factors, we expect that supranationalization, political instability, and corruption increase societal pessimism, as they diminish national political power and can inspire collective powerlessness. Economically, we expect that the retrenchment of welfare state provisions and economic decline drive societal pessimism, as these developments contribute to socioeconomic vulnerability. We assess the impact of these political and economic factors on the level of societal pessimism in the EU, both cross-nationally and over time, through multilevel analyses of Eurobarometer data (13 waves between 2006 and 2012 in 23 EU countries). Our findings show that the political factors (changes in government, corruption) primarily explain cross-national differences in societal pessimism, while the macro-economic context (economic growth, unemployment) primarily explains longitudinal trends within countries. These findings demonstrate that, to a large extent, societal pessimism cannot be viewed separately from its political and economic context. PMID:28690338

The implementation of traceability systems.

PubMed

Ammendrup, S; Barcos, L O

2006-08-01

Traceability is a tool to help countries meet their objectives of controlling, preventing and eradicating animal diseases. This article sets out the required steps in a traceability system. Before designing a system of traceability, one must identify the different characteristics that need to be traced throughout the various steps in the food production chain. The interaction between different sectors in defining the objectives and the resulting needs of a traceability system is fundamental. A clear legal framework is also indispensable. European Union (EU) legislation requires identification and registration for cattle, pigs, sheep and goats. For intra-EU trade these animals must be accompanied by a health certificate providing information on their identity and health status. The required identification is harmonised on an EU-wide basis with the aim of ensuring traceability for veterinary purposes. Furthermore EU legislation requires that the traceability of food, feed and food-producing animals be established at all stages of production.

CONGRESS ON SCIENCE TEACHING AND ECONOMIC GROWTH.

ERIC Educational Resources Information Center

Inter-Union Commission on the Teaching of Science, Paris (France).

REPORTED ARE THE ACTIVITIES OF THE CONGRESS ORGANIZED BY THE INTER-UNION COMMISSION ON SCIENCE TEACHING (CEIS) OF THE INTERNATIONAL COUNCIL OF SCIENTIFIC UNIONS (ICSU). STUDIED WERE PROBLEMS ARISING IN SEVERAL BRANCHES OF KNOWLEDGE DUE TO BOTH INCREASED NUMBERS OF STUDENTS AND SHORTAGE OF TEACHERS. OF PARTICULAR INTEREST WERE THE PROBLEMS OF…

The Development of the Market of the Production of Solar Energy in Poland and Selected EU Countries in the Years 2009-2014 - Comparative Analysis

NASA Astrophysics Data System (ADS)

Dorozińska, Weronika; Gawron, Maciej; Stańko, Paulina; Stępień, Natalia; Świstak, Patrycja; Ji, Han Yeon

2016-03-01

The paper discusses issues related to the development of solar energy production in Poland and selected EU countries in the years 2009-2014. The analysis of data concerning the production of solar energy in Poland and selected EU countries is presented as well as the strategic goals of the Union in respect the development of the `solar energy industry'. The article discusses the benefits and costs of the transformation of energy engineering and development of the production of solar energy, which is one of the most widespread and popular technologies of the production of energy from renewable resources in view of environment protection or reduction of the costs of energy consumption.

Towards a greater understanding of the illicit tobacco trade in Europe: a review of the PMI funded ‘Project Star’ report

PubMed Central

Gilmore, Anna B; Rowell, Andy; Gallus, Silvano; Lugo, Alessandra; Joossens, Luk; Sims, Michelle

2014-01-01

Background Following a legal agreement with the European Union (EU), Philip Morris International (PMI) commissions a yearly report (‘Project Star’, PS) on the European illicit cigarette trade from KPMG, the global accountancy firm. Methods Review of PS 2010 report. Comparison with data from independent sources including a 2010 pan-European survey (N=18 056). Findings Within PS, data covering all 27 EU countries are entered into a model. While the model itself seems appropriate, concerns are identified with the methodologies underlying the data inputs and thus their quality: there is little transparency over methodologies; interview data underestimate legal non-domestic product partly by failing to account for legal cross-border sales; illicit cigarette estimates rely on tobacco industry empty pack surveys which may overestimate illicit; and there is an over-reliance on data supplied by PMI with inadequate external validation. Thus, PMI sales data are validated using PMI smoking prevalence estimates, yet PMI is unable to provide sales (shipment) data for the Greek islands and its prevalence estimates differ grossly from independent data. Consequently, comparisons with independent data suggest PS will tend to overestimate illicit cigarette levels particularly where cross-border shopping is frequent (Austria, Finland, France) and in Western compared with Eastern European countries. The model also provides data on the nature of the illicit cigarette market independent of seizure data suggesting that almost a quarter of the illicit cigarette market in 2010 comprised PMI's own brands compared with just 5% counterfeited PMI brands; a finding hidden in PMI's public representation of the data. Conclusions PS overestimates illicit cigarette levels in some European countries and suggests PMI's supply chain control is inadequate. Its publication serves the interests of PMI over those of the EU and its member states. PS requires greater transparency, external scrutiny and use of independent data. PMID:24335339

Novel methodology for pharmaceutical expenditure forecast.

PubMed

Vataire, Anne-Lise; Cetinsoy, Laurent; Aballéa, Samuel; Rémuzat, Cécile; Urbinati, Duccio; Kornfeld, Åsa; Mzoughi, Olfa; Toumi, Mondher

2014-01-01

The value appreciation of new drugs across countries today features a disruption that is making the historical data that are used for forecasting pharmaceutical expenditure poorly reliable. Forecasting methods rarely addressed uncertainty. The objective of this project was to propose a methodology to perform pharmaceutical expenditure forecasting that integrates expected policy changes and uncertainty (developed for the European Commission as the 'EU Pharmaceutical expenditure forecast'; see http://ec.europa.eu/health/healthcare/key_documents/index_en.htm). 1) Identification of all pharmaceuticals going off-patent and new branded medicinal products over a 5-year forecasting period in seven European Union (EU) Member States. 2) Development of a model to estimate direct and indirect impacts (based on health policies and clinical experts) on savings of generics and biosimilars. Inputs were originator sales value, patent expiry date, time to launch after marketing authorization, price discount, penetration rate, time to peak sales, and impact on brand price. 3) Development of a model for new drugs, which estimated sales progression in a competitive environment. Clinical expected benefits as well as commercial potential were assessed for each product by clinical experts. Inputs were development phase, marketing authorization dates, orphan condition, market size, and competitors. 4) Separate analysis of the budget impact of products going off-patent and new drugs according to several perspectives, distribution chains, and outcomes. 5) Addressing uncertainty surrounding estimations via deterministic and probabilistic sensitivity analysis. This methodology has proven to be effective by 1) identifying the main parameters impacting the variations in pharmaceutical expenditure forecasting across countries: generics discounts and penetration, brand price after patent loss, reimbursement rate, the penetration of biosimilars and discount price, distribution chains, and the time to reach peak sales for new drugs; 2) estimating the statistical distribution of the budget impact; and 3) testing different pricing and reimbursement policy decisions on health expenditures. This methodology was independent of historical data and appeared to be highly flexible and adapted to test robustness and provide probabilistic analysis to support policy decision making.

Joint action on monitoring injuries in Europe (JAMIE).

PubMed

Rogmans, W H J

2012-08-28

The hospital sector provides the best setting for collecting information as this information relates to the most severe cases (while less severe cases are treated by family doctors of school nurses for instance) and information can be obtained easily on a large number of cases at low cost (while surveys are expensive and suffering serious deficiencies as regards the specificity of data obtained). The WHO-International Classification of Diseases and its derivative classification on external causes of injuries provide the proper tools for standardised data collection on injuries treated within the health sector.In order to make injury data collection affordable for countries to collect and to have a greater number of countries joining the data exchange efforts, JAMIE envisages to have a relatively limited set data elements being collected in a representative sample of emergency departments in countries, while collecting in a few departments deeper information on the circumstances of the injury event. Injuries due to accidents or violence constitute a major public health problem globally and also within the 27 member states of the European Union (EU-MSs). In spite of the magnitude and the severity of the problem, injury surveillance systems are not yet sufficiently well developed to accurately quantify the burden of injuries on individuals, health services and society in the EU-region. Much of the injury information generated up until now is not comparable between countries, and not between registers, due to the lack of harmonised methodology and classification. JAMIE project aims at having by 2015 a common emergency departmental-based surveillance system for injury prevention in operation in all MS. Such a system should report on external causes of injuries due to accidents and violence as part of the Community Statistics on Public Health. The project will build on previous work on injury data exchange initiated by the European Commission (EC) and a number of EU-member states, which resulted to the so called Injury Data Base hosted by the EC.

Federal Election Commission.

ERIC Educational Resources Information Center

Elliot, Lee Ann

1996-01-01

Presents a concise overview of the responsibilities, membership, structure, and requirements of the Federal Election Commission (FEC). Created in 1974, the FEC oversees the financial activities of candidates and political parties. Discusses corporate and union political action committees (PACs) as well as contribution limits and prohibitions. (MJP)

Losses of Ammonia and Nitrate from Agriculture and Their Effect on Nitrogen Recovery in the European Union and the United States between 1900 and 2050.

PubMed

van Grinsven, Hans J M; Bouwman, Lex; Cassman, Kenneth G; van Es, Harold M; McCrackin, Michelle L; Beusen, Arthur H W

2015-03-01

Historical trends and levels of nitrogen (N) budgets and emissions to air and water in the European Union and the United States are markedly different. Agro-environmental policy approaches also differ, with emphasis on voluntary or incentive-based schemes in the United States versus a more regulatory approach in the European Union. This paper explores the implications of these differences for attaining long-term policy targets for air and water quality. Nutrient surplus problems were more severe in the European Union than in the United States during the 1970s and 1980s. The EU Nitrates and National Emission Ceilings directives contributed to decreases in fertilizer use, N surplus, and ammonia (NH) emissions, whereas in the United States they stabilized, although NH emissions are still increasing. These differences were analyzed using statistical data for 1900-2005 and the global IMAGE model. IMAGE could reproduce NH emissions and soil N surpluses at different scales (European Union and United States, country and state) and N loads in the Rhine and Mississippi. The regulation-driven changes during the past 25 yr in the European Union have reduced public concerns and have brought agricultural N loads to the aquatic environment closer to US levels. Despite differences in agro-environmental policies and agricultural structure (more N-fixing soybean and more spatially separated feed and livestock production in the United States than in the European Union), current N use efficiency in US and EU crop production is similar. IMAGE projections for the IAASTD-baseline scenario indicate that N loading to the environment in 2050 will be similar to current levels. In the United States, environmental N loads will remain substantially smaller than in the European Union, whereas agricultural production in 2050 in the United States will increase by 30% relative to 2005, as compared with an increase of 8% in the European Union. However, in the United States, even rigorous mitigation with maximum recycling of manure N and a 25% reduction in fertilizer use will not achieve the policy target to halve the N export to the Gulf of Mexico. Copyright © by the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America, Inc.

Collaborative study for the establishment of the Ph. Eur. Hepatitis E virus RNA for NAT testing biological reference preparation batch 1.

PubMed

Baylis, S A; Terao, E; Blümel, J; Hanschmann, K-M O

2017-01-01

A new European Pharmacopoeia (Ph. Eur.) biological reference preparation (BRP) had to be established further to the decision to include nucleic acid testing (NAT) for the detection of hepatitis E virus (HEV) RNA in the monograph Human plasma (pooled and treated for virus inactivation) (1646). To this purpose, an international collaborative study was launched in the framework of the Biological Standardisation Programme (BSP) of the European Directorate for the Quality of Medicines & HealthCare (EDQM) and the Commission of the European Union (EU). The study was run in conjunction with the establishment of the 1 st World Health Organization (WHO) international reference panel (IRP) for hepatitis E virus RNA genotypes (8578/13). Twenty-three laboratories used in-house developed and commercially available assays to calibrate a lyophilised candidate BRP prepared from a HEV 3f strain positive human plasma against the 1 st WHO International Standard (IS) for HEV RNA (6329/10). Results from quantitative and qualitative assays were in good agreement and were combined to calculate an assigned potency. Real-time stability studies indicated that the candidate BRP is very stable at lower temperatures and is thus suitable for long-term use. Based on these results, in February 2016, the Ph. Eur. Commission adopted the candidate material as the hepatitis E virus RNA for NAT testing BRP batch 1, with an assigned unitage of 2.1 × 10 4 IU/vial (4.32 log 10 IU/vial).

EU Water Governance: Striking the Right Balance between Regulatory Flexibility and Enforcement?

EPA Science Inventory

Considering the challenges and threats currently facing water management and the exacerbation of uncertainty by climate change, the need for flexible yet robust and legitimate environmental regulation is evident. The European Union took a novel approach toward sustainable water r...

[Employment status and perceived health in Italy: data from the European Union Statistics on Income and Living Conditions (EU-SILC) longitudinal study].

PubMed

Bacci, Silvia; Seracini, Marco; Chiavarini, Manuela; Bartolucci, Francesco; Minelli, Liliana

2017-01-01

The aim of this study was to investigate the relationship between employment status (permanent employment, fixed-term employment, unemployment, other) and perceived health status in a sample of the Italian population. Data was obtained from the European Union Statistics on Income and Living Condition (EU-SILC) study during the period 2009 - 2012. The sample consists of 4,848 individuals, each with a complete record of observations during four years for a total of 19,392 observations. The causal relationship between perceived/self-reported health status and employment status was tested using a global logit model (STATA). Our results confirm a significant association between employment status and perceived health, as well as between perceived health status and economic status. Unemployment that was dependent on an actual lack of work opportunities and not from individual disability was found to be the most significant determinant of perceived health status; a higher educational level produces a better perceived health status.

HBV and HCV infection among non-European Union immigrants in North-East Italy.

PubMed Central

Chiaramonte, M.; Pupo, A.; Menegon, T.; Baldo, V.; Malatesta, R.; Trivello, R.

1998-01-01

The status of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection among non-European Union (non-EU) immigrants in North-East Italy was evaluated. Among the 1683 individuals tested the prevalence of HBsAg was 8.9% (150 subjects) and of HBV antibodies (anti-HBc with/without anti-HBs) was 38.9% (654 subjects). The distribution of HBV serological markers showed significant differences according to region of origin; the highest prevalence of infection (76.9%) and carriage (16.1%) was found in immigrants from sub-Saharan Africa. Among the 933 individuals screened for HCV infection, prevalence of antibody was much lower (0.9%) than that observed in the Italian general population (3.2-12.6%). The large number of HBV carriers among immigrants could increase the number of new adult infections due to life-style habits or professional risks in the host population. In contrast, the risk of HCV spread from non-EU immigrants is very low. PMID:9747770

Mapping communicable disease control in the European union.

PubMed

Elliott, Heather A; Jones, David K; Greer, Scott L

2012-12-01

Understanding both the current performance of communicable disease control in Europe and the scale of the differences among systems is crucial to understanding its present performance and possible Europeanization. We attempt to identify the structure of authority in communicable disease control in each European Union (EU) member state. The primary sources of information were the competent bodies list posted on the European Centre for Disease Prevention and Control website and the Health in Transition reports produced by the European Observatory on Health Systems and Policies. Three key patterns emerge to answer the question of who does what. First, the landscape is full and crowded, with many actors involved. Second, the landscape is highly fragmented, with many organizations performing overlapping functions in each country. Third, regional patterns describe which types of organizations are assigned which functions. These full, fragmented, and regionally disparate systems show no signs of constituting a shared model. As a result, if there is an EU model of communicable disease control today, it is at most an aspiration.

Sport Sponsorship and Tobacco: Implications and Impact of Federal Trade Commission v. Pinkerton Tobacco Company.

ERIC Educational Resources Information Center

Stotlar, David

1992-01-01

The union of sports and tobacco represents a multimillion dollar enterprise. Recent litigation, the Federal Trade Commission v. Pinkerton Tobacco Company, jeopardizes sport sponsorship agreements. Tobacco advertising may no longer be displayed anywhere during televised sporting events. (SM)

Inequality, poverty, and material deprivation in new and old members of the European Union.

PubMed

Matković, Teo; Sucur, Zoran; Zrinscak, Sinsa

2007-10-01

To analyze the main indicators of income inequality, objective and subjective poverty, material deprivation, and the role of public social transfers in the reduction of poverty in 15 old and 10 new member states of the European Union (EU), undergoing post-communist socio-economic transition, as well as in Croatia, a candidate EU country. Objective poverty rates, poverty reduction rates, poverty thresholds in purchasing power standards (PPS), total social expenditure, inequality indicators, and risks of poverty according to demographics were calculated using the data from the Eurostat databases, in particular, Household Budget Survey. For Croatia, Central Bureau of Statistics first releases on poverty indicators were used, as well as database of the Ministry of Finance (social expenditure). Subjective poverty rates and non-monetary deprivation index were calculated using the European Quality of Life Survey, which was carried out in 2003 in EU countries and in 2006 in Croatia. According to the indicators of income inequality and objective poverty, there was a divide among old EU member states (EU15), with UK, Ireland and South European countries having higher and Continental and Nordic countries lower indicators of inequality and poverty. Among new member states (NMS10), Baltic countries and Poland had the highest and Slovenia and the Czech Republic the lowest indicators of inequality and poverty. In all EU15 countries, except Greece, subjective poverty rates were lower than objective ones, whereas in all NMS10 countries the levels of subjective poverty were much higher than those of objective poverty. With some exceptions, NMS10 countries had low or even decreasing social expenditures. The share of respondents who were deprived of more than 50% of items was 6 times higher in the NMS10 than in the EU15 countries. When standard of living was measured by income inequality, relative poverty rates, poverty reduction rates, total social protection expenditures, and non-monetary deprivation, only Slovenia, the Czech Republic, and Hungary, out of the NMS10, were in the upper half of the distribution, while Croatia had a medium position among NMS10 states. Our analysis demonstrated that poverty in countries undergoing post-socialist socioeconomic transition is widespread and could seriously limit human development. Continual research and monitoring of different aspects of poverty is needed for setting appropriate policies across the EU to effectively combat poverty and social exclusion and to promote convergence process.

Division C Commission 55: Communicating Astronomy with the Public

NASA Astrophysics Data System (ADS)

Christensen, Lars Lindberg; Russo, Pedro; Fienberg, Richard Tresch; Cheung, Sze-Leung; Robson, Ian; Ödman-Govender, Carolina; Arcand, Kimberly Kowal; Sekiguchi, Kazuhiro; Zhu, Jin; Wheeler, Pete

2016-04-01

The IAU Division C Commission 55, Communicating Astronomy with the Public, played an active role in Union affairs within Division C, Education, Outreach and Heritage. The International Astronomical Union (IAU) vested considerable responsibility for its public outreach efforts in Commission 55 (C55), Communicating Astronomy with the Public. This article briefly recounts the origin and history of C55 over the past decade, and describes the work of C55 until it became Division C Commission C.C2 in 2015. As stated on our website, http://www.communicatingastronomy.org, C55 was founded on the principle that ``it is the responsibility of every practising astronomer to play some role in explaining the interest and value of science to our real employers, the taxpayers of the world.'' While this was true a decade ago, when the Working Group that eventually became C55 first took shape, it is even more true today, when funding for the astronomical sciences (and science more generally) is under threat on nearly every continent.

Health research and systems' governance are at risk: should the right to data protection override health?

PubMed

Di Iorio, C T; Carinci, F; Oderkirk, J

2014-07-01

The European Union (EU) Data Protection Regulation will have profound implications for public health, health services research and statistics in Europe. The EU Commission's Proposal was a breakthrough in balancing privacy rights and rights to health and healthcare. The European Parliament, however, has proposed extensive amendments. This paper reviews the amendments proposed by the European Parliament Committee on Civil Liberties, Justice and Home Affairs and their implications for health research and statistics. The amendments eliminate most innovations brought by the Proposal. Notably, derogation to the general prohibition of processing sensitive data shall be allowed for public interests such as the management of healthcare services,but not health research, monitoring, surveillance and governance. The processing of personal health data for historical, statistical or scientific purposes shall be allowed only with the consent of the data subject or if the processing serves an exceptionally high public interest, cannot be performed otherwise and is legally authorised. Research, be it academic, government,corporate or market research, falls under the same rule.The proposed amendments will make difficult or render impossible research and statistics involving the linkage and analysis of the wealth of data from clinical,administrative, insurance and survey sources, which have contributed to improving health outcomes and health systems performance and governance; and may illegitimise efforts that have been made in some European countries to enable privacy-respectful data use for research and statistical purposes. If the amendments stand as written, the right to privacy is likely to override the right to health and healthcare in Europe.

Advances in the development of common noise assessment methods in Europe: The CNOSSOS-EU framework for strategic environmental noise mapping.

PubMed

Kephalopoulos, Stylianos; Paviotti, Marco; Anfosso-Lédée, Fabienne; Van Maercke, Dirk; Shilton, Simon; Jones, Nigel

2014-06-01

The Environmental Noise Directive (2002/49/EC) requires EU Member States to determine the exposure to environmental noise through strategic noise mapping and to elaborate action plans in order to reduce noise pollution, where necessary. A common framework for noise assessment methods (CNOSSOS-EU) has been developed by the European Commission in co-operation with the EU Member States to be applied for strategic noise mapping as required by the Environment Noise Directive (2002/49/EC). CNOSSOS-EU represents a harmonised and coherent approach to assess noise levels from the main sources of noise (road traffic, railway traffic, aircraft and industrial) across Europe. This paper outlines the process behind the development of CNOSSOS-EU and the parts of the CNOSSOS-EU core methodological framework which were developed during phase A of the CNOSSOS-EU process (2010-2012), whilst focusing on the main scientific and technical issues that were addressed, and the implementation challenges that are being faced before it can become fully operational in the EU MS. Copyright © 2014. Published by Elsevier B.V.

Development and testing of a European Union-wide farm-level carbon calculator.

PubMed

Tuomisto, Hanna L; De Camillis, Camillo; Leip, Adrian; Nisini, Luigi; Pelletier, Nathan; Haastrup, Palle

2015-07-01

Direct greenhouse gas (GHG) emissions from agriculture accounted for approximately 10% of total European Union (EU) emissions in 2010. To reduce farming-related GHG emissions, appropriate policy measures and supporting tools for promoting low-C farming practices may be efficacious. This article presents the methodology and testing results of a new EU-wide, farm-level C footprint calculator. The Carbon Calculator quantifies GHG emissions based on international standards and technical specifications on Life Cycle Assessment (LCA) and C footprinting. The tool delivers its results both at the farm level and as allocated to up to 5 main products of the farm. In addition to the quantification of GHG emissions, the calculator proposes mitigation options and sequestration actions that may be suitable for individual farms. The results obtained during a survey made on 54 farms from 8 EU Member States are presented. These farms were selected in view of representing the diversity of farm types across different environmental zones in the EU. The results of the C footprint of products in the data set show wide range of variation between minimum and maximum values. The results of the mitigation actions showed that the tool can help identify practices that can lead to substantial emission reductions. To avoid burden-shifting from climate change to other environmental issues, the future improvements of the tool should include incorporation of other environmental impact categories in place of solely focusing on GHG emissions. © 2015 The Authors. Integrated Environmental Assessment and Management Published by Wiley Periodicals, Inc. on behalf of SETAC.

Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014

PubMed Central

Miglietta, Alessandro; Quinten, Chantal; Lopalco, Pier Luigi; Duffell, Erika

2018-01-01

Hepatitis B prevention in European Union/European Economic Area (EU/EEA) countries relies on vaccination programmes. We describe the epidemiology of acute hepatitis B virus (HBV) at country and EU/EEA level during 2006–2014. Using a multi-level mixed-effects Poisson regression model we assessed differences in the acute HBV infection notification rates between groups of countries that started universal HBV vaccination before/in vs after 1995; implemented or not a catch-up strategy; reached a vaccine coverage ≥ 95% vs < 95% and had a hepatitis B surface antigen prevalence ≥ 1% vs < 1%. Joinpoint regression analysis was used to assess trends by groups of countries, and additional Poisson regression models to evaluate the association between three-dose HBV vaccine coverage and acute HBV infection notification rates at country and EU/EEA level. The EU/EEA acute HBV infection notification rate decreased from 1.6 per 100,000 population in 2006 to 0.7 in 2014. No differences (p > 0.05) were found in the acute HBV infection notification rates between groups of countries, while as vaccine coverage increased, such rates decreased (p < 0.01). Countries with universal HBV vaccination before 1995, a catch-up strategy, and a vaccine coverage ≥ 95% had significant decreasing trends (p < 0.01). Ending HBV transmission in Europe by 2030 will require high vaccine coverage delivered through universal programmes, supported, where appropriate, by catch-up vaccination campaigns. PMID:29439751

Temporal bone bank: complying with European Union directives on human tissue and cells.

PubMed

Van Rompaey, Vincent; Vandamme, Wouter; Muylle, Ludo; Van de Heyning, Paul H

2012-06-01

Availability of allograft tympano-ossicular systems (ATOS) provides unique reconstructive capabilities, allowing more radical removal of middle ear pathology. To provide ATOS, the University of Antwerp Temporal Bone Bank (UATB) was established in 1988. ATOS use was stopped in many countries because of safety issues concerning human tissue transplantation. Our objective was to maintain an ATOS tissue bank complying with European Union (EU) directives on human tissues and cells. The guidelines of the Belgian Superior Health Council, including EU directive requirements, were rigorously applied to UATB infrastructure, workflow protocols and activity. Workflow protocols were updated and an internal audit was performed to check and improve consistency with established quality systems and changing legislations. The Belgian Federal Agency of Medicines and Health Products performed an inspection to examine compliance with national legislatives and EU directives on human tissues and cells. A sample of important procedures was meticulously examined in its workflow setting next to assessment of the infrastructure and personnel. Results are reported on infrastructure, personnel, administrative workflow, procurement, preparation, processing, distribution, internal audit and inspection by the competent authority. Donors procured: 2006, 93 (45.1%); 2007, 64 (20.6%); 2008, 56 (13.1%); 2009, 79 (6.9%). The UATB was approved by the Minister of Health without critical or important shortcomings. The Ministry accords registration each time for 2 years. An ATOS tissue bank complying with EU regulations on human allografts is feasible and critical to assure that the patient receives tissue, which is safe, individually checked and prepared in a suitable environment.

Legislative regulation and ethical governance of medical research in different European Union countries.

PubMed

Veerus, Piret; Lexchin, Joel; Hemminki, Elina

2014-06-01

To obtain information about the similarities and differences in regulating different types of medical research in the European Union (EU). Web searches were performed from September 2009 to January 2011. Notes on pre-determined topics were systematically taken down from the web pages. The analysis relied only on documents and reports available on the web, reflecting the situation at the end of 2010. In several countries, regulatory legislation applied only to clinical trials on drugs and medical devices, in other states various types of research were also regulated but by laws different from those concerning trials, and in many countries, some research areas were not controlled by legislation at all. In very few countries was all medical research handled similarly from a legal point of view. The number of research ethics committees (RECs) in a single country varied from one to 264. Their areas of responsibility, working principles and length of time to grant research permission varied as well as the rules for obtaining informed consent from vulnerable groups. In 10 EU countries, there was no appeal mechanism after a negative decision by an REC. The RECs were not accountable to any organisation in five EU countries. There is a need for a fundamental debate regarding whether and which kinds of changes are needed for the further harmonisation of medical research governance in the EU and how cross-country medical research could be facilitated in the future. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Teenage pregnancies in the European Union in the context of legislation and youth sexual and reproductive health services.

PubMed

Part, Kai; Moreau, Caroline; Donati, Serena; Gissler, Mika; Fronteira, Inês; Karro, Helle

2013-12-01

To study cross-country and regional variations and trends in reported teenage pregnancies in the context of legislation and youth sexual and reproductive health (SRH) services in Europe. Data were collected on teenage live births and induced abortions, abortion legislation and youth SRH services. Population-based statistics from the European Union (EU) member states. Fifteen- to nineteen-year-old female teenagers. Detailed statistical information for each member state about teenage live births, induced abortions, abortion legislation and youth SRH services were compiled relying on national and international data sources. The annual reported pregnancies per 1000 women aged 15-19 years. Teenage pregnancy rates have declined since 2001, although progress has been uneven across regions and countries. Eastern Europe has a higher average teenage pregnancy rate (41.7/1000) than Northern (30.7/1000), Western (18.2/1000) and Southern Europe (17.6/1000). While data on teenage live births are available across Europe, data on teenage abortions are unavailable or incomplete in more than one-third of EU countries. Reported teenage pregnancy rates are generally lower for countries where parental consent for abortion is not required, youth SRH services are available in all areas and contraceptives are subsidized for all minors, compared with countries where these conditions are not met. The collection of standardized teenage pregnancy statistics is critically needed in the EU. The remarkable variability in teenage pregnancy rates across the EU is likely to be explained, among other factors, by varying access to abortion and youth SRH services. © 2013 Nordic Federation of Societies of Obstetrics and Gynecology.

Classification of the European Union member states according to the relative level of sustainable development.

PubMed

Anna, Bluszcz

Nowadays methods of measurement and assessment of the level of sustained development at the international, national and regional level are a current research problem, which requires multi-dimensional analysis. The relative assessment of the sustainability level of the European Union member states and the comparative analysis of the position of Poland relative to other countries was the aim of the conducted studies in the article. EU member states were treated as objects in the multi-dimensional space. Dimensions of space were specified by ten diagnostic variables describing the sustainability level of UE countries in three dimensions, i.e., social, economic and environmental. Because the compiled statistical data were expressed in different units of measure, taxonomic methods were used for building an aggregated measure to assess the level of sustainable development of EU member states, which through normalisation of variables enabled the comparative analysis between countries. Methodology of studies consisted of eight stages, which included, among others: defining data matrices, calculating the variability coefficient for all variables, which variability coefficient was under 10 %, division of variables into stimulants and destimulants, selection of the method of variable normalisation, developing matrices of normalised data, selection of the formula and calculating the aggregated indicator of the relative level of sustainable development of the EU countries, calculating partial development indicators for three studies dimensions: social, economic and environmental and the classification of the EU countries according to the relative level of sustainable development. Statistical date were collected based on the Polish Central Statistical Office publication.

Comparative development of knowledge-based bioeconomy in the European Union and Turkey.

PubMed

Celikkanat Ozan, Didem; Baran, Yusuf

2014-09-01

Biotechnology, defined as the technological application that uses biological systems and living organisms, or their derivatives, to create or modify diverse products or processes, is widely used for healthcare, agricultural and environmental applications. The continuity in industrial applications of biotechnology enables the rise and development of the bioeconomy concept. Bioeconomy, including all applications of biotechnology, is defined as translation of knowledge received from life sciences into new, sustainable, environment friendly and competitive products. With the advanced research and eco-efficient processes in the scope of bioeconomy, more healthy and sustainable life is promised. Knowledge-based bioeconomy with its economic, social and environmental potential has already been brought to the research agendas of European Union (EU) countries. The aim of this study is to summarize the development of knowledge-based bioeconomy in EU countries and to evaluate Turkey's current situation compared to them. EU-funded biotechnology research projects under FP6 and FP7 and nationally-funded biotechnology projects under The Scientific and Technological Research Council of Turkey (TUBITAK) Academic Research Funding Program Directorate (ARDEB) and Technology and Innovation Funding Programs Directorate (TEYDEB) were examined. In the context of this study, the main research areas and subfields which have been funded, the budget spent and the number of projects funded since 2003 both nationally and EU-wide and the gaps and overlapping topics were analyzed. In consideration of the results, detailed suggestions for Turkey have been proposed. The research results are expected to be used as a roadmap for coordinating the stakeholders of bioeconomy and integrating Turkish Research Areas into European Research Areas.

The Politics of the Economics of Education in the European Union

ERIC Educational Resources Information Center

Jones, Peter

2010-01-01

This article critically examines the work of the European Commission-sponsored network, the European Expert Network on Economics of Education (EENEE). The aim is to develop understanding of the context and significance of the mobilization of the economics of education research and policy paradigm within the European Union's Education and Training…

Report

NASA Astrophysics Data System (ADS)

Ehrenfreund, Pascale Foing; Kwok, Sun; Irvine, William; Galante, Douglas; Gargaud, Muriel; Levasseur-Regourd, Anne-Chantal; Haghighipour, Nader; Holm, Nils; Lineweaver, Charley; Jayawardhana, Ray; Ohishi, Masatoshi

2016-04-01

The International Astronomical Union's Commission 51 was established in 1982 as ``Bioastronomy: Search for Extraterrestrial Life''. As the interests of Commission members expanded to include all aspects of the study of the origin, evolution, and distribution of life in the universe, C51 was renamed simply ``Bioastronomy'' in 2006. Thus, the term ``bioastronomy'' became for the Commission essentially synonymous with the NASA-coined term ``astrobiology``. Since the latter term has been adopted by many scientific societies around the world with similar interests, under the new Division and Commission structure of the IAU the Commission has been again renamed and is now Commission F-3 ``Astrobiology''.

Development and testing of a European Union-wide farm-level carbon calculator

PubMed Central

Tuomisto, Hanna L; De Camillis, Camillo; Leip, Adrian; Nisini, Luigi; Pelletier, Nathan; Haastrup, Palle

2015-01-01

Direct greenhouse gas (GHG) emissions from agriculture accounted for approximately 10% of total European Union (EU) emissions in 2010. To reduce farming-related GHG emissions, appropriate policy measures and supporting tools for promoting low-C farming practices may be efficacious. This article presents the methodology and testing results of a new EU-wide, farm-level C footprint calculator. The Carbon Calculator quantifies GHG emissions based on international standards and technical specifications on Life Cycle Assessment (LCA) and C footprinting. The tool delivers its results both at the farm level and as allocated to up to 5 main products of the farm. In addition to the quantification of GHG emissions, the calculator proposes mitigation options and sequestration actions that may be suitable for individual farms. The results obtained during a survey made on 54 farms from 8 EU Member States are presented. These farms were selected in view of representing the diversity of farm types across different environmental zones in the EU. The results of the C footprint of products in the data set show wide range of variation between minimum and maximum values. The results of the mitigation actions showed that the tool can help identify practices that can lead to substantial emission reductions. To avoid burden-shifting from climate change to other environmental issues, the future improvements of the tool should include incorporation of other environmental impact categories in place of solely focusing on GHG emissions. Integr Environ Assess Manag 2015;11:404–416. © 2015 The Authors. Published by Wiley Periodicals, Inc. on behalf of SETAC. Key Points The methodology and testing results of a new European Union-wide, farm-level carbon calculator are presented. The Carbon Calculator reports life cycle assessment-based greenhouse gas emissions at farm and product levels and recommends farm- specific mitigation actions. Based on the results obtained from testing the tool in 54 farms in 8 European countries, it was found that the product-level carbon footprint results are comparable with those of other studies focusing on similar products. The results of the mitigation actions showed that the tool can help identify practices that can lead to substantial emission reductions. PMID:25655187

Globalisation, Transnational Policies and Adult Education

ERIC Educational Resources Information Center

Milana, Marcella

2012-01-01

Globalisation, transnational policies and adult education--This paper examines policy documents produced by the United Nations Educational, Scientific and Cultural Organization (UNESCO) and the European Union (EU) in the field of adult education and learning. Both these entities address adult education as an explicit object of policy. This paper…

Highway Safety Information System guidebook for the Maine state data files. Volume 2 : single variable tabulations

DOT National Transportation Integrated Search

2012-10-01

The United States and European Union (EU) share many of the same transportation research issues, challenges, and goals. They also share a belief that cooperative vehicle (also termed connected vehicle) systems, based on vehicle-to-vehicle and vehicle...

Sentinel-2a: multi-spectral instrument first in-orbit performance

NASA Astrophysics Data System (ADS)

Fernandez, Valerie; Isola, Claudia; Hoersch, Bianca; Gascon, Ferran; Tréma, Thierry

2017-09-01

Copernicus is a European Union (EU) led initiative designed to establish a European capacity for the provision and use of operational monitoring information for environment and security applications. Within the Copernicus program, ESA is responsible for the development of the Space Component and Ground Segment..

The European Dimension in Education.

ERIC Educational Resources Information Center

Council of Europe, Strasbourg (France). Directorate of Education, Culture and Sport, Documentation Section.

This paper addresses concerns about a European dimension in education that has been created by the enlargement of the European Union (EU) (the inclusion of Austria, Finland, and Sweden) and the gradual transformations of institutions into a future federal state. Sections of the paper include: (1) "Introduction"; (2) "Defining the…

Making Higher Education More European through Student Mobility? Revisiting EU Initiatives in the Context of the Bologna Process

ERIC Educational Resources Information Center

Papatsiba, Vassiliki

2006-01-01

This paper focuses on the analysis of student mobility in the EU as a means to stimulate convergence of diverse higher education systems. The argument is based on official texts and other texts of political communication of the European Commission. The following discussion is placed within the current context of the Bologna process and its aim to…

The impact of restrictions on neonicotinoid and fipronil insecticides on pest management in maize, oilseed rape and sunflower in eight European Union regions.

PubMed

Kathage, Jonas; Castañera, Pedro; Alonso-Prados, José Luis; Gómez-Barbero, Manuel; Rodríguez-Cerezo, Emilio

2018-01-01

In 2013, the European Commission restricted the use of three neonicotinoids (clothianidin, imidacloprid and thiamethoxam) and the pyrazole fipronil, which are widely used to control early-season pests. Here, we used original farm survey data to examine the impact of the restrictions on pest management practices in eight regional case studies including maize, oilseed rape and sunflower in seven European Union (EU) countries. In four case studies, farmers switched to using untreated seeds as no alternative seed treatments were available. In three case studies, farmers switched to using unrestricted neonicotinoid- or pyrethroid-treated seeds. In five case studies, farmers increased the use of soil or foliar treatments, with pyrethroids as the principal insecticide class. Other changes in pest management practices ranged from increased sowing density to more frequent scouting for pests. Many farmers perceived that the time, cost and amount of insecticides required to protect crops increased, along with pest pressure. Alternative seed treatments were mostly perceived as being less effective than the restricted seed treatments. Farmers generally relied on alternative seed treatments or more soil/foliar treatments in the first growing season after the restrictions took effect. Further study is required to assess the effectiveness and sustainability of these alternatives compared with the restricted insecticides. © 2017 The Authors. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry. © 2017 The Authors. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.

PubMed

Papatheodoridis, G V; Hatzakis, A; Cholongitas, E; Baptista-Leite, R; Baskozos, I; Chhatwal, J; Colombo, M; Cortez-Pinto, H; Craxi, A; Goldberg, D; Gore, C; Kautz, A; Lazarus, J V; Mendão, L; Peck-Radosavljevic, M; Razavi, H; Schatz, E; Tözün, N; van Damme, P; Wedemeyer, H; Yazdanpanah, Y; Zuure, F; Manns, M P

2018-03-01

Hepatitis C virus (HCV) infection is a major public health problem in the European Union (EU). An estimated 5.6 million Europeans are chronically infected with a wide range of variation in prevalence across European Union countries. Although HCV continues to spread as a largely "silent pandemic," its elimination is made possible through the availability of the new antiviral drugs and the implementation of prevention practices. On 17 February 2016, the Hepatitis B & C Public Policy Association held the first EU HCV Policy Summit in Brussels. This summit was an historic event as it was the first high-level conference focusing on the elimination of HCV at the European Union level. The meeting brought together the main stakeholders in the field of HCV: clinicians, patient advocacy groups, representatives of key institutions and regional bodies from across European Union; it served as a platform for one of the most significant disease elimination campaigns in Europe and culminated in the presentation of the HCV Elimination Manifesto, calling for the elimination of HCV in Europe by 2030. The launch of the Elimination Manifesto provides a starting point for action in order to make HCV and its elimination in Europe an explicit public health priority, to ensure that patients, civil society groups and other relevant stakeholders will be directly involved in developing and implementing HCV elimination strategies, to pay particular attention to the links between hepatitis C and social marginalization and to introduce a European Hepatitis Awareness Week. © 2018 John Wiley & Sons Ltd.

The EU sustainable energy policy indicators framework.

PubMed

Streimikiene, Dalia; Sivickas, Gintautas

2008-11-01

The article deals with indicators framework to monitor implementation of the main EU (European Union) directives and other policy documents targeting sustainable energy development. The main EU directives which have impact on sustainable energy development are directives promoting energy efficiency and use of renewable energy sources, directives implementing greenhouse gas mitigation and atmospheric pollution reduction policies and other policy documents and strategies targeting energy sector. Promotion of use of renewable energy sources and energy efficiency improvements are among priorities of EU energy policy because the use of renewable energy sources and energy efficiency improvements has positive impact on energy security and climate change mitigation. The framework of indicators can be developed to establish the main targets set by EU energy and environmental policies allowing to connect indicators via chain of mutual impacts and to define policies and measures necessary to achieve established targets based on assessment of their impact on the targeted indicators representing sustainable energy development aims. The article discusses the application of indicators framework for EU sustainable energy policy analysis and presents the case study of this policy tool application for Baltic States. The article also discusses the use of biomass in Baltic States and future considerations in this field.

[Accidents and injuries in the EU. Results of the EuroSafe Reports].

PubMed

Bauer, R; Steiner, M; Kisser, R; Macey, S M; Thayer, D

2014-06-01

Accidents and injuries are a relevant although largely preventable public health problem. Information on the causes of accidents is the basis for accident prevention and product safety. The current report "Injuries in the European Union", edited by EuroSafe, the European Association for Injury Prevention and Safety Promotion, is a summary of key statistics on accidents and injuries at the EU level. In addition to international data on cause of death, the data of the European Injury Data Base (IDB) in particular are presented. The IDB is a unique data source for the EU based on an internationally standardized dataset of external causes and circumstances of injuries, which is collected in the emergency department of hospitals. Thus, the IDB covers the entire spectrum of accidents and injuries in sufficient detail as is necessary for the derivation of preventive measures and the knowledge of involved products. The currently available IDB data are collected by the participating Member States (2012: Austria, Cyprus, Denmark, Germany, Italy, Latvia, Malta, The Netherlands, Norway, Portugal, Slovenia, and Sweden) in self-interest (i.e., without legal obligation) with the support of the EU health programs. The central database for the IDB is run by the European Commission and provides public access to the aggregated data of the participating countries. Currently, over 100 IDB hospitals in the EU upload around 300,000 cases per year into the EU database. The IDB contains information on all accident sectors (transport, workplace, school etc.) with a focus on leisure and sports accidents. Depending on the accident sector, up to 25 variables (activities, products involved, means of transport etc.) and often also short narratives are recorded for each case. The report shows that 40 million people are treated in a hospital annually in the EU after accidents and violence, and that about 233,000 people die as a consequence of injury. There are large differences between countries in the rates of fatal and nonfatal injuries; these differences can be interpreted as a measure of the potential for prevention and as an indication of targeted measures in the countries with higher accident rates. The report also includes snapshots of the eight priority themes for injury prevention, as defined in the Recommendation of the European Council on Injury Prevention and Safety Promotion in 2007: children, adolescents and older people, vulnerable road users, sports, the use of products and services, violence, and self-injury. The implementation of the IDB has proven to be feasible and useful for the participating countries, especially for data-based accident prevention in the important areas of home, leisure, and sports accidents. In the framework of the EU project JAMIE (2011-2014, Joint Action for Injury Monitoring in Europe), the IDB partners are currently working on further improving the IDB standards and quality criteria as well as the recruitment of further IDB countries. The medium-term goal is to integrate the EU IDB in the Eurostat Statistical System and to put the collection of IDB data on a statutory footing.

Enhancing the role of science in the decision-making of the European Union.

PubMed

Allio, Lorenzo; Ballantine, Bruce; Meads, Richard

2006-02-01

Used well, science provides effective ways of identifying potential risks, protecting citizens, and using resources wisely. It enables government decisions to be based on evidence and provides a foundation for a rule-based framework that supports global trade. To ensure that the best available science becomes a key input in the decisions made by EU institutions, this abridged version of a working paper produced for the European Policy Centre, a leading, independent think tank, considers how science is currently used in the policy and decision-making processes of the EU, what the limitations of scientific evidence are, and how a risk assessment process based on scientific 'good practices' can be advantageous. Finally, the paper makes recommendations on how to improve the use of science by EU institutions.

European Universe Awareness

NASA Astrophysics Data System (ADS)

Russo, P.; Miley, G.; Westra van Holthe, F.; Schrier, W.; Reed, S.

2011-10-01

The European Universe Awareness (EU-UNAWE) programme uses the beauty and grandeur of the cosmos to encourage young children, particularly those from underprivileged backgrounds, to develop an interest in science and technology and to foster a sense of global citizenship. EU-UNAWE is already active in 40 countries and comprises a global network of almost 500 astronomers, teachers and other educators. The programme was recently awarded a grant of 1.9 million euros by the European Union so that it can be further developed in five European countries and South Africa. The grant will be used to organise teacher training workshops and to develop educational materials, such as an astronomy news service for children and games. During this presentation we will outline some of the biggest achievements of EU-UNAWE to date and discuss future plans for the programme.

Stakeholder integration and public engagement of EU and national research projects in Germany

NASA Astrophysics Data System (ADS)

Ruhnau, Meike; Guo, Chenbo; Walter, Anastasia; Schneider, Nadine

2017-04-01

The talk addresses the feasibility and difficulties of research projects to reach out and to integrate a sufficient number of stakeholders (vgl. Carrada, 2006; Poulsen, 2007; Zikos et al. 2012; Lee & Belohlav, 2014). With "stakeholders" we understand end-users, policy makers, students for capacity building, administrators and interested general public. The design and later the implementation of stakeholder integration and public engagement strongly depend on the priority-setting and requirements of funding agencies (EU [1], DFG, BMBF and the regional ministries in Germany). They affect the size and constellation of consortia as well as the longevity and continuity of research community; on the other hand they also determine the weighting of communication, dissemination, outreach (and networking) activities within the project. For instance by public engagement of EU funded projects a share of 10% for communication and outreach activities was rated as best practices in 2014 [2]. On the national level there is no such appointment so far. In our talk we will quantify and compare activities among selected EU and nationally funded collaborative projects in Germany, address the hurdles, investigate the communication tools, examine the outreach channels and dissemination tactics, reflect the performances and the results achieved so far, with the objective to answer the following questions: - What tools/channels have been applied so far? Were they efficient and expedient? - What can be count as best practices? - Are such activities sustainable at all? The goal of this talk is to show the complexity of the stakeholder integration and public engagement in research projects, to critically assess our experiences gained in past and running projects, and to subsequently have an interactive exchange with other project professionals at EGU. [1] European Commission (2004, 2008, 2010, 2014). Communicating EU research and innovation guidance for project participants; [2] European Commission (2014) - Project COMET (best practice); European Commission (2016) - Project EUPORIAS (success story)

Lindsay and the German Universities: An Oxford Contribution to the Post-War Reform Debate.

ERIC Educational Resources Information Center

Phillips, David

1980-01-01

Discusses British involvement in educational reconstruction in Germany after World War II and the influence of Lord Lindsay of Birker in setting up the Royal Commission. The Commission consisted of German representatives from institutions of higher education, trade unions, churches, and the land authorities. (KC)

Effect of tasting and information on consumer opinion about pig castration.

PubMed

Kallas, Zein; Gil, José Maria; Panella-Riera, Nuria; Blanch, Marta; Font-i-Furnols, Maria; Chevillon, Patrick; De Roest, Kees; Tacken, Gemma; Oliver, Maria Angels

2013-10-01

Our research explored the relative importance of pig castration amongst other aspects of animal welfare, and the potential impact of information and sensory experiences on European Union (EU) consumers' preferences. The EU is considering a future ban on surgical pig castration by 2018 which may affect markets and consumers' preferences. We carried out an empirical study using consumer-level data obtained from questionnaires completed in a controlled environment by a total of 825 consumers. The experiment was carried out in six EU countries (Spain, United Kingdom, The Netherlands, France, Italy and Germany) which account for 66.0% of the EU-27's and 76.3% of the EU-15's meat production. Results show that consumers do not perceive pig castration to be a relevant aspect of animal welfare nor its relationship with meat quality. Consumers with healthy life styles, concerned about animal welfare and who have had a negative sensory experience with boar meat are willing to accept paying more to avoid boar taint. Copyright © 2013 Elsevier Ltd. All rights reserved.

Estimating the Public Health Impact of Setting Targets at the European Level for the Reduction of Zoonotic Salmonella in Certain Poultry Populations

PubMed Central

Messens, Winy; Vivas-Alegre, Luis; Bashir, Saghir; Amore, Giusi; Romero-Barrios, Pablo; Hugas, Marta

2013-01-01

In the European Union (EU), targets are being set for the reduction of certain zoonotic Salmonella serovars in different animal populations, including poultry populations, within the framework of Regulation (EC) No. 2160/2003 on the control of zoonoses. For a three-year transitional period, the EU targets were to cover only Salmonella Enteritidis and S. Typhimurium (and in addition S. Hadar, S. Infantis and S. Virchow for breeding flocks of Gallus gallus). Before the end of that transitional period, the revision of the EU targets was to be considered, including the potentially addition of other serovars with public health significance to the permanent EU targets. This review article aims at providing an overview of the assessments carried out by the Scientific Panel on Biological Hazards of the European Food Safety Authority in the field of setting targets for Salmonella in poultry populations (breeding flocks of Gallus gallus, laying flocks of Gallus gallus, broiler flocks of Gallus gallus and flocks of breeding and fattening turkeys) and their impact in subsequent changes in EU legislation. PMID:24157508

Previous Open Rotor Research in the US

NASA Technical Reports Server (NTRS)

VanZante, Dale

2011-01-01

Previous Open Rotor noise experience in the United States, current Open Rotor noise research in the United States and current NASA prediction methods activities were presented at a European Union (EU) X-Noise seminar. The invited attendees from EU industries, research establishments and universities discussed prospects for reducing Open Rotor noise and reviewed all technology programs, past and present, dedicated to Open Rotor engine concepts. This workshop was particularly timely because the Committee on Aviation Environmental Protection (CAEP) plans to involve Independent Experts in late 2011 in assessing the noise of future low-carbon technologies including the open rotor.

Time-varying long term memory in the European Union stock markets

NASA Astrophysics Data System (ADS)

Sensoy, Ahmet; Tabak, Benjamin M.

2015-10-01

This paper proposes a new efficiency index to model time-varying inefficiency in stock markets. We focus on European stock markets and show that they have different degrees of time-varying efficiency. We observe that the 2008 global financial crisis has an adverse effect on almost all EU stock markets. However, the Eurozone sovereign debt crisis has a significant adverse effect only on the markets in France, Spain and Greece. For the late members, joining EU does not have a uniform effect on stock market efficiency. Our results have important implications for policy makers, investors, risk managers and academics.

Bureaucracy blights funding in Europe

NASA Astrophysics Data System (ADS)

Banks, Michael

2009-04-01

The process of applying for money from the Framework programme of the European Union (EU) is a "stain" on the EU's reputation and a "radical overhaul" of the administration is needed. That is the view of an independent panel of scientists charged with evaluating the €18bn Sixth Framework programme, which lasted from 2002 to 2006 and funded collaborative research performed within more than one country. The panel says that grants handed out by the programme take, on average, over a year to get approved, with a quarter of proposals taking more than 450 days before being signed.

Future Education: Learning the Future. Scenarios and Strategies in Europe. CEDEFOP Reference Series.

ERIC Educational Resources Information Center

van Wieringen, Fons; Sellin, Burkart; Schmidt, Ghislaine

Five research institutes covering five European Union (EU) member states and five Central and Eastern European countries participated in a scenario project designed to improve understanding of vocational education and training (VET) systems in their economic-technological, employment-labor, and training-knowledge environments. The participating…

Evaluation of Bacteroides fragilis GB-124 bacteriophages as novel human-associated faecal indicators in the United States

EPA Science Inventory

Phages infecting human-associated Bacteroides fragilis (GB-124 phages) have been employed in the European Union (EU) to identify human fecal pollution, but their utility for U.S. was unclear. Primary sewage effluent samples were collected seasonally from seven wastewater treatme...

75 FR 76253 - Dairy Import Licensing Program

Federal Register 2010, 2011, 2012, 2013, 2014

2010-12-08

... associations, a counsel to the Cheese Importers Association of America and several of its member companies, a... suspension included the declining availability of cheese from the European Union (EU), a weaker U.S. dollar.... market. Conclusion: The quota-fill rates for Swiss, Gruyere, and low-fat type cheeses have continued to...